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Abstract 
Cystic kidney diseases are a fascinating cluster of discrete conditions and an important, 
common cause of established renal failure.  Both isolated and syndromic inherited 
cystic kidney diseases are known to be linked by their pathogenesis involving ciliary 
dysfunction.  Interestingly to date, all mutated genes which have been related to cystic 
kidney disease, encode proteins which are located on cilia, the basal body or 
centrosomes and are required for ciliary function.  To date, over 50 causal genes have 
been identified and are capable of causing additional disease phenotypes, such as 
neurological disorders and blindness, often of variable severity.  Understanding this 
clinical heterogeneity may considerably guide appropriate genetic counselling and 
screening of patients for relevant complications. 
Zebrafish are a well-recognised animal model, their advantages of: transparency; 
conserved genome; representative kidney and rapid external development; make them 
useful for studying organogenesis in the context of disease.  Furthermore the ability to 
perform combined gene knockdown in zebrafish, to study the effect of oliogenicity, 
which was proposed to influence clinical phenotypes in cystic kidney disease related 
ciliopathies, was of interest. 
Using zebrafish models, this work studied the impact of four key genes, independently 
and in combination: ahi1, cc2d2a, nphp6 and mks3 on the development of cystic kidney 
disease and ciliopathy phenotypes, to resemble the human diseases nephronophthisis 
(NPHP), Joubert syndrome (JBTS) and Meckel Gruber syndrome, (MKS).  A frequent 
finding in zebrafish morphants was a reduction in the number of cilia, which was 
usually associated with abnormal development of left-right body patterning and cystic 
kidney disease.  Additionally, combined gene knockdown of: nphp6 and cc2d2a; ahi1 
and cc2d2a; ahi1 and nphp6 was associated with a synergistic increase in disease 
phenotypes, suggesting an interaction between these genes.  
In conclusion, zebrafish are a powerful developmental model to study and ideally 
improve understanding of cystic kidney disease related ciliopathies. 
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Chapter 1 Introduction 
1.1 Cystic kidney disease – an important area to research 
Cystic kidney diseases are an interesting group of distinct conditions characterised by 
multiple kidney cysts and a varied spectrum in terms of: aetiology; incidence; mode of 
presentation; association with other organ disease and comorbidities; impact on kidney 
function and overall prognosis.  This variety is what makes cystic kidney disease such 
an interesting area to research, to try to unveil some of the many areas of uncertainty.  
Furthermore, cystic kidney disease is an important clinical challenge, in part because it 
has implications for a significant number of people within the UK, but also because 
under its umbrella are some ’rare diseases’, which the UK government acknowledged a 
commitment to improving services and developing a strategy for managing patients 
with ‘rare diseases’ (Limb, 2011; Mollet et al., 2002).  This drive for change followed a 
report in December 2010 which identified that the needs of patients with ‘rare diseases' 
and their families were not able to be met by the national health service (NHS) (Limb, 
2010).     
The definition of a ‘rare disease’ was made by the European Union as one in which the 
prevalence is less than 1 in 2000 of the general population (Montserrat, 2009, June).  
Unfortunately, currently in the UK we do not know the exact number of people who are 
affected by various conditions, however within the field of kidney disease considerable 
efforts are being made to address this short fall.  Collaborative efforts from the Renal 
Association and the British Association of Paediatric Nephrology have generated 
informative rare disease websites, www.rarerenal.org, which lists various ‘rare 
diseases’.  Some of these conditions already have working groups currently striving to 
develop web based rare disease registries (RADAR, www.renalradar.org), to enable 
collection of patient data which is hoped to lead to improved understanding, facilitate 
research and the delivery of better patient care.   
The term ‘rare disease’ is slightly controversial and on the rare renal disease website, 
several cystic kidney diseases are listed (incidence/prevalence quoted where known), 
not all of which would classically be considered as ‘rare diseases’: autosomal recessive 
polycystic kidney disease (ARPKD, estimated worldwide prevalence of 1 in 20,000 
(Zerres et al., 1998)); renal cysts and diabetes (RCAD, HNF1β mutations); medullary 
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cystic kidney disease (MCKD); nephronophthisis (NPHP, incidence 1 in 50-900,000 
(Hildebrandt and Zhou, 2007)); autosomal dominant polycystic kidney disease 
(ADPKD, estimated worldwide prevalence 1 in 400-1000 (Torres and Harris, 2009)); 
tuberous sclerosis (incidence of 1 in 6000 (Curatolo et al., 2008)) and von Hippel-
Lindau syndrome (incidence of 1 in 36,000 (Joerger et al., 2005)).  This classification of 
a ‘rare disease’ does not detract from the significance of these disorders.  The European 
Council has suggested that approximately 1 in 17 people will be affected by a ‘rare 
disease’ during their life, which equates to 3.5 million people within the UK (Limb, 
2011) and acknowledgement by the former chief medical officer for England, Sir Liam 
Donaldson in 2009, that ‘Rare is Common’ (Limb, 2011). 
Indeed, whether defined as a ‘rare disease’ or not, the relevance of researching these 
disorders which often manifest a significant demand on health and social economics, in 
part because of ineffective collaboration between various specialty services, must 
continue to be recognised.  Within the cystic kidney diseases, certain aspects of the 
pathogenesis may be shared and collaboration within the research field should continue 
to be encouraged with the ultimate aim of improving services for patients in the UK.   
1.2 Normal renal development 
In order to begin to understand the abnormalities which may occur in cystic kidney 
disease, one must first comprehend normal kidney development.  In humans (all 
vertebrates), kidney development is derived from the intermediate mesoderm with 
successive differentiation of the initial two pairs of transient kidneys, the pronephros 
and mesonephros into the final functioning and permanent kidney, the metanephros 
(Figure 1.1) (Gilbert, 2000; Jennette, 2007).  This pattern of development is 
evolutionarily conserved, with humans, mammals and reptiles developing a metanephric 
kidney as the final functional kidney (Sukhatme, 2003).  This is different in fish as even 
the initial kidney, the pronephros, is functional and is described in detail below. 
In humans, on day 22 of embryological development, the pronephric duct begins to 
develop from the intermediate mesoderm in front of the somites (Gilbert, 2000).  Cells 
of the pronephric duct move caudally and signal to adjacent nephrogenic mesenchyme 
to form tubules.  Although most of the pronephros regresses, the distal pronephric duct 
becomes the Wolffian duct, which forms part of the excretory system (Gilbert, 2000).  
At the end of the fourth week, the non-functional pronephros regresses and 
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simultaneously, from adjacent mesenchyme, the mesonephric tubules begin to develop 
(Gilbert, 2000).  During mesonephric kidney development, nephrons develop with 
glomeruli forming from capillaries in each mesonephric segment, which are connected 
to branches of the aorta (Jennette, 2007).  Additionally, the mesonephros is important 
for development of the male genital tract (Gilbert, 2000).  The transient mesonephros 
begins  to degenerate during the sixth week of gestation (Jennette, 2007).  
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Figure 1.1 Development of the human kidney   
The overlapping stages of kidney development begin on day 22 with (A) nephrogenic 
mesenchyme forming the pronephric duct which migrates caudally developing tubules, 
constituting the pronephros.  (B) As the pronephros degenerates (dashed lines), the 
mesonephric tubules develop in a caudal direction.  The mesonephros eventually 
regresses as (C) the metanephros, final mammalian kidney, develops from mesenchyme 
interacting with the ureteric bud, which branches from the nephric duct.  Modified from 
(Gilbert, 2000).  
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Development of the final kidney, the metanephros, begins in the fifth week and involves 
interactions between epithelial cells in the ureteric bud (a derivative of the mesonephric 
duct) and metanephrogenic mesenchyme from the intermediate mesoderm (Gilbert, 
2000; Winyard and Chitty, 2008).  Coordinated signals between the ureteric bud and 
metanephrogenic mesenchyme mediates cell proliferation, apoptosis and differentiation 
leading to serial branching of the ureteric bud which ultimately becomes the collecting 
ducts and ureter (Winyard and Chitty, 2008).  The metanephrogenic mesenchyme, 
surrounding the tips of the branching ureteric bud, converts to epithelium and forms an 
epithelial cluster which then differentiates into a nephron (Figure 1.2) (Gilbert, 2000). 
Glomeruli begin to form at 8-9 weeks and new nephrons continue to develop until 32-
36 weeks (Winyard and Chitty, 2008).  The final number of nephrons, the functional 
units in each human kidney is thought to range between 0.6-1.3 million (Winyard and 
Chitty, 2008).  
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Figure 1.2 Reciprocal interaction between tissues during human kidney 
development   
(A) The ureteric bud enters the metanephrogenic mesenchyme and reciprocal signals 
induce the ureteric bud to branch with aggregates of mesenchymal cells at the tips of the 
branches (B).  (C) These clusters of mesenchymal cells convert into epithelium and 
digest the basement membrane of the ureteric bud to connect to the ureteric bud 
epithelium (D).  The epithelialised mesenchyme becomes the nephron (renal tubules and 
Bowman's capsule, where blood is filtered), the ureteric bud becomes the urine 
collecting duct (E, F).  Modified from (Gilbert, 2000). 
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1.3 Cystic kidney disease – a heterogeneous group of disorders    
The aetiology of cystic kidney diseases includes: hereditary, novel mutations or 
inherited mutations leading to isolated polycystic kidney disease (PKD) or cystic kidney 
disease associated with other disorders; developmental aberrations; acquired cysts 
(Katabathina et al., 2010).  Inherited cystic kidney disease is further discussed below 
(see section 1.4).  Developmental abnormalities of the kidneys, ‘dysplastic kidneys’, 
may be detected in utero following antenatal ultrasound or at birth, tend to be grouped 
with other Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) and are 
defined as any abnormal development including renal agenesis to cystic kidneys 
(Winyard and Chitty, 2008).  The incidence of a unilateral dysplastic kidney is 1 in 
1000 (Winyard and Chitty, 2008) and of a unilateral multicystic dysplastic kidney is 1 
in 4300 (Truong et al., 2003).  Multicystic dysplastic kidneys are thought to develop 
because of obstruction of the urinary tract and failure of the ureteric bud to branch 
(Katabathina et al., 2010; Winyard and Chitty, 2008).  If unilateral, a multicystic 
dysplastic kidney may be associated with vesicoureteral reflux in the contralateral 
kidney (Katabathina et al., 2010), typically they regress with time and are not functional 
(Katabathina et al., 2010).  Acquired cystic kidney disease is defined as three or more 
simple cysts which develop in patients with established renal failure not caused by 
inherited cystic kidney disease (Katabathina et al., 2010).  Kidney cysts are observed in 
8-13% of people with chronic kidney disease (Katabathina et al., 2010) and this 
frequency increases in people with established renal failure with longevity of dialysis 
therapy to 50% following 6 years of dialysis and 100% following 10 years of dialysis 
(Truong et al., 2003).  In this context, cysts are postulated to develop because of 
destruction of normal kidney parenchyma and compensatory hypertrophy of remaining 
tubular epithelial tissue (Grantham, 1991).  Additionally, simple cysts can develop in 
the general population, are more common in men and the frequency increases with age, 
occurring in 11-30% of people over 50 years of age (Ravine et al., 1993).  The 
complications associated with acquired kidney cysts are the same as other cystic kidney 
diseases and include: bleeding, infection and malignant transformation.  In patients with 
established renal failure, renal tumours occur in 3-7% (Tickoo et al., 2006).  Following 
acceptance of the Bosniak classification system (Israel and Bosniak, 2005) for renal 
cysts which can be applied to renal ultrasound, computed tomography (CT) or magnetic 
resonance imaging (MRI), screening criteria have been proposed for selected patient 
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groups (Floege et al., 2010), to facilitate differentiation between simple cysts and more 
complex, potentially malignant cysts.          
This heterogeneity continues within the group of inherited cystic kidney diseases and   
is what makes researching cystic kidney disease such an interesting area.    
1.4 Inherited cystic kidney disease 
Inherited cystic kidney disease is the commonest genetic kidney disease worldwide.  
This statement is not meant to confuse and should be understood in the context that 
many of these inherited cystic kidney disease are acknowledged as ‘rare diseases’ 
(www.rarerenal.org).  The pattern of inheritance can be utilised to categorise cystic 
kidney disease into autosomal dominant (AD) and autosomal recessive (AR), polycystic 
kidney disease (PKD).   
1.4.1 Autosomal Dominant Polycystic Kidney Disease 
Perhaps the most recognised condition, is autosomal dominant polycystic kidney 
disease (ADPKD), which as noted above has a worldwide prevalence of between 1:400 
and 1:1000 (Torres and Harris, 2009).  In the UK, ADPKD accounts for 9.6% of all 
adults requiring renal replacement therapy (dialysis or transplantation) (Byrne et al., 
2010).  Mutations in two causal genes, PKD1 (Consort, 1994) on chromosome 16p13.3 
and PKD2 (Hayashi et al., 1997) on chromosome 4q22.1, account for all patients (85% 
and 15% respectively) with ADPKD.  PKD1 mutations are generally associated with a 
more severe form of cystic kidney disease and patients may present 20 years earlier than 
patients with PKD2 mutations, because of more numerous cysts in the former (Torres, 
2009).  However in patients with PKD1 mutations the extent of disease can be highly 
variable, even within families and does not appear to be associated with the type of 
mutation.  The location of the mutation in the PKD1 gene has occasionally been linked 
to the severity of kidney disease and the potential risk for developing cerebral 
aneurysms (Torres, 2009).  In addition to intracranial aneurysms, other extra-renal 
manifestations of ADPKD are: polycystic liver disease, mitral valve disease (Pirson, 
2010), pancreatic cysts, colonic diverticulae (Kumar et al., 2006).  The successful 
identification of the causal genes in ADPKD has enabled researchers to target their 
studies on understanding mechanisms of the disease and focus on testing novel drug 
therapies aiming to reduce cell proliferation and fluid secretion (Chang and Ong, 2012).  
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1.4.2 Autosomal Recessive Polycystic Kidney Disease  
ARPKD has an incidence of approximately 1 in 20,000 and is usually identified 
antenatally or during the neonatal period by enlarged echogenic kidneys (Harris and 
Torres, 2009).  Perinatal mortality rates may be as high as 30%, associated with 
respiratory insufficiency (Harris and Torres, 2009).  Approximately 30% of surviving 
children with ARPKD will develop kidney failure and require dialysis (Harris and 
Torres, 2009) or combined liver-kidney transplantation.  The pathognomonic features of 
ARPKD related hepatobiliary disease include: biliary dysgenesis; congenital hepatic 
fibrosis and intrahepatic bile duct dilatation; cholangitis; portal hypertension and varices 
(Harris and Torres, 2009).  Sometimes the diagnosis of ARPKD may be delayed until 
adolescence or even adulthood in individuals with hypertension and less severe kidney 
disease (Harris and Torres, 2009).  ARPKD is caused by mutations in PKHD1 on 
chromosome 6q21 (Zerres et al., 1994), which encodes the protein fibrocystin.  As with 
other cystic kidney diseases, the presentation and extent of clinical phenotypes of 
ARPKD are highly variable.  It is a rare disease and has been recognised by the 
RADAR project in the UK.  Currently the ARPKD working group are developing a 
database to record UK patient data and holding family information days, guided and 
supported by international collaborators.  
1.4.3 Other inherited cystic kidney diseases 
NPHP (see section 1.5), Joubert Syndrome (JBTS, see section 1.6) and Meckel Gruber 
Syndrome (MKS, see section 1.7) are syndromic PKD and will be described in detail 
below.  Renal cysts and diabetes (RCAD) although first described in 2001 (Kolatsi-
Joannou et al., 2001), is probably an under diagnosed syndrome and requires clinical 
suspicion.  The incidence of RCAD is currently uncertain and is caused by mutations in 
HNF1β on chromosome 17q21 (Kolatsi-Joannou et al., 2001), which encodes a widely 
distributed transcription factor, vital for normal development of the kidney, pancreas, 
liver and genital tract (Edghill et al., 2006).  It is inherited in an autosomal dominant 
pattern, with new mutations occurring in up to 40% of cases (Heidet et al., 2010).  
Interestingly, patients with mutations in HNF1β do not necessarily have either renal 
cysts or diabetes, however they have a 50% lifetime risk of developing diabetes (Edghill 
et al., 2006) and renal disease is the most common phenotype.  The renal phenotype is 
very heterogeneous and includes: glomerulocystic kidneys; multiple renal cysts; 
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horseshoe kidney and single kidney.  Gout and hypomagnesaemia are also recognised 
features, the latter because HNF1β regulates FXYD2 which is involved in renal tubular 
handling of magnesium (Adalat et al., 2009).   
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome caused by 
mutations in tumour suppressor genes which leads to the development of benign 
hamartomas in various organs including the kidneys, skin, brain, heart, lungs and eyes 
(Curatolo et al., 2008).  Mutations in TSC1 on chromosome 9q32 (van Slegtenhorst et 
al., 1997) and TSC2 on chromosome 16p13 (European Chromosome 16 Tuberous 
Sclerosis, 1993) encode the proteins hamartin and tuberin respectively, which inhibit the 
mammalian target of rapamycin pathway to control cell proliferation (Curatolo et al., 
2008).  The incidence is 1 in 6000 and most patients are diagnosed in infancy (Curatolo 
et al., 2008).  Although seizures, developmental delay and skin lesions are more 
frequent clinical features, renal involvement has been identified in 70-90% (Lagos and 
Gomez, 1967) of patients.  The pathognomonic renal lesions are multiple 
angiomyolipomas (abnormal thick walled blood vessels with smooth muscle and 
adipose tissue), however diffuse cystic kidney disease is well recognised in up to 50% 
of patients and only rarely, in 2-3% of cases, do malignant renal tumours develop 
(Curatolo et al., 2008).  The cystic kidney disease associated with TSC is usually 
asymptomatic unless there is an associated contiguous gene deletion of TSC2 and PKD1 
(both adjacent on chromosome 16) which can lead to severe hypertension, massive 
cystic kidneys and early onset established renal failure (Curatolo et al., 2008).   
Von Hippel-Lindau (VHL) is amongst the differential diagnoses for ADPKD.  VHL is a 
rare, incidence of 1 in 36,000 (Joerger et al., 2005), autosomal dominant, multisystem 
malignant tumour predisposition syndrome caused by mutations in the tumour 
suppressor gene VHL on chromosome 3p25 (Latif et al., 1993).  VHL is associated with 
haemangioblastomas (retinal, central neural system), renal cell carcinomas, 
phaeochromocytomas, pancreatic endocrine tumours and renal/pancreatic cysts (Kaelin, 
2007).  Renal cysts occur in up 60% of patients with VHL, tend to be a few, bilateral, 
are rarely associated with deteriorating renal function (Kaelin, 2007), however may be 
pre-malignant (Siroky et al., 2009).   
Medullary cystic kidney disease (MCKD) is inherited in an autosomal dominant pattern 
and is histopathologically identical to NPHP, with normal sized or small kidneys with 
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corticomedullary cysts, tubular atrophy and interstitial fibrosis.  It is caused by 
mutations in: MCKD1 on chromosome 1q21 (Christodoulou et al., 1998; Stavrou et al., 
2002) with slowly progressive kidney disease leading to established renal failure by 60 
years; or MCKD2 (UMOD) on chromosome 16p11.2 (Scolari et al., 1999) which is also 
associated with gout, hence the alternative name of familial juvenile hyperuricaemic 
nephropathy (Hart et al., 2002).  MCKD2 is associated with an earlier age of onset with 
renal impairment beginning from 15 years of age and the development of established 
renal failure within 10-20 years (Dahan et al., 2001). 
Bardet-Biedl Syndrome (BBS) is an autosomal recessive multisystem disorder caused 
by mutations in up to seventeen genes (BBS1-12, MKS1, NPHP6, FRITZ/C2ORF86, 
SDCCAG8, LZTFL1) (Cardenas-Rodriguez et al., 2012) which account for 
approximately 80% of patients (Forsythe and Beales, 2012), thus it is likely that further 
genes may be discovered.  The incidence of BBS is between 1:100-160,000 (Beales et 
al., 1999) and characteristic features include retinal dystrophy, learning difficulties, 
obesity, polydactyly, hypogonadism and renal anomalies which occur in up to 40% of 
patients (O'Dea et al., 1996).  The renal manifestations include: the cystic kidney 
disease NPHP; dysplasia and focal segmental glomerulosclerosis.  Similar to some of 
the above described cystic kidney related disorders, there is intrafamilial variability in 
the nature and severity of clinical phenotypes in BBS and this is considered to be related 
to additional genetic mutations (epistasis) which modify the subsequent phenotype 
(Cardenas-Rodriguez et al., 2012).     
From the above descriptions of the inherited cystic kidney diseases (summarised in 
Table 1.1), a recurring theme within this group appears to be their clinical and genetic 
heterogeneity.  To date, mutations in over 50 different genes (Table 1.2), some of which 
are allelic, have been identified in patients with cystic kidney disease.  These cystic 
kidney disease related conditions are now referred to as ciliopathies (further discussed 
see section 1.14) (Hildebrandt et al., 2011), because the protein products encoded by the 
genes with identified mutations are located in the primary cilium/basal body complex.  
Although cystic kidney disease can occur in isolation, where the kidney phenotype 
dominates, often, as suggested above, the cystic kidney disease is part of a multisystem 
disorder.  JBTS (see section 1.6) and MKS (see section 1.7) are cystic kidney disease 
related multisystem disorders which will be further described below.  NPHP is a classic 
example of both an isolated and an overlapping syndromic cystic kidney disease. 
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Condition Inheritance Clinical features References 
Autosomal dominant polycystic 
kidney disease 
Autosomal 
Dominant 
Enlarged polycystic kidneys, liver cysts, pancreatic 
cysts, cerebral aneurysms, hypertension, hernias, 
mitral valve prolapse 
(Torres and Harris, 2009) 
Autosomal recessive polycystic 
kidney disease 
Autosomal 
Recessive 
Enlarged polycystic kidneys, biliary duct anomalies, 
hepatic fibrosis, cholangitis, pulmonary hypoplasia 
(Sweeney and Avner, 2011) 
Nephronophthisis Autosomal 
Recessive 
Normal sized kidneys with corticomedullary cysts ± 
retinitis pigmentosa, developmental delay, 
bronchiectasis, situs inversus 
(Hildebrandt and Zhou, 2007) 
Renal cysts and diabetes Autosomal 
Dominant 
Renal dysplasia: glomerulocystic kidneys, multiple 
renal cysts, horseshoe/single kidney, diabetes 
mellitus, gout, uterine anomalies 
(Edghill et al., 2008) 
Tuberous sclerosis Autosomal 
Dominant 
Seizures, developmental delay, autism, hamartomas, 
skin lesions, interstitial lung disease, renal 
angiomyolipomas/cysts 
(Roach et al., 1998) 
Von Hippel-Lindau Autosomal 
Dominant 
Haemangioblastomas (retina, cerebellum), 
phaeochromocytoma, renal cysts/carcinomas 
(Kaelin, 2008) 
Medullary cystic kidney disease Autosomal 
Dominant 
Normal sized kidneys with corticomedullary cysts, 
gout 
(Hildebrandt and Otto, 2000) 
Meckel Gruber Syndrome Autosomal 
Recessive 
Enlarged kidneys with renal cystic dysplasia, hepatic 
developmental anomalies/fibrosis, 
neurodevelopmental anomalies/occipital 
encephalocele 
(Dawe et al., 2007) 
Bardet-Biedl Syndrome Autosomal 
Recessive 
Retinal dystrophy, obesity, polydactyly, 
developmental delay, hypogonadism, renal cystic 
dysplasia 
(Forsythe and Beales, 2012) 
Table 1.1 Inheritance pattern and clinical features of genetic cystic kidney diseases 
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 Gene Locus Gene Symbol Chromosome Other Gene locus References 
Autosomal Dominant Polycystic Kidney Disease 
PKD1 PKD1 16p13.3 - (Consort, 1994) 
PKD2 PKD2 4q22.1 - (Hayashi et al., 1997) 
Autosomal Recessive Polycystic Kidney Disease 
FCYT PKHD1 6p21.1-p12.2 - (Zerres et al., 1994) 
Medullary Cystic Kidney Disease 
MCKD1 MCKD1 1q21 - (Christodoulou et al., 1998) 
UMOD MCKD2 16p12.3 - (Scolari et al., 1999) 
Nephronophthisis 
NPHP1 NPHP1 2q13 JBTS4 (Hildebrandt et al., 1997; Saunier et al., 1997) 
NPHP2 INVS 9q31 - (Otto et al., 2003) 
NPHP3 NPHP3 3q22.1 MKS7 (Olbrich et al., 2003) 
NPHP4 NPHP4 1p36.22 - (Mollet et al., 2002) 
NPHP5 IQCB1 3q21.1 - (Otto et al., 2005) 
NPHP6 CEP290 12q21.32 JBTS5, MKS4, BBS14 (Sayer et al., 2006) 
NPHP7 GLIS2 16p13.3 - (Attanasio et al., 2007) 
NPHP8 RPGRIP1L 16q12.2 JBTS7, MKS5 (Wolf et al., 2007) 
NPHP9 NEK8 17q11.1 
 
(Otto et al., 2008) 
NPHP10 SDCCAG8 1q44 BBS16 (Otto et al., 2010) 
NPHP11 TMEM67 8q22.1 JBTS6, MKS3 (Otto et al., 2009) 
NPHP12 TTC21B 2q24.3 JBTS11 (Davis et al., 2011) 
NPHP13 WDR19 4p14 
 
(Bredrup et al., 2011) 
 ____________________________________________________________________________________________________________________________ Chapter 1:  Introduction 
 
 
3
6
 
 Gene Locus Gene Symbol Chromosome Other Gene locus References 
 
AHI1 6q23.3 JBTS3 (Utsch et al., 2006) 
 
ATXN10 22q13.31 
 
(Sang et al., 2011) 
NPHP14 ZNF423 16q12 JBTS? (Chaki et al., 2012) 
 
CEP164 11q23.3 JBTS? (Chaki et al., 2012) 
Joubert Syndrome 
JBTS1 INPP5E 9q34.3 - (Bielas et al., 2009) 
JBTS2 TMEM216 11q13.1 MKS2 (Edvardson et al., 2010; Valente et al., 2010) 
JBTS8 ARL13B 3q11.2 - (Cantagrel et al., 2008) 
JBTS9 CC2D2A 4p15.33 MKS6 (Gorden et al., 2008; Tallila et al., 2008) 
JBTS10 OFD1 Xp22.2 - (Coene et al., 2009) 
JBTS12 KIF7 15q26.1 - (Dafinger et al., 2011) 
JBTS13 TCTN1 12q24.11 - (Garcia-Gonzalo et al., 2011) 
JBTS14 TMEM237 2q33.2 - (Huang et al., 2011) 
JBTS15 CEP41 7q32 - (Lee et al., 2012a) 
JBTS16 TMEM138 11q12.2 - (Lee et al., 2012b) 
JBTS17 C5ORF42 5p13.2 - (Srour et al., 2012b) 
 TCTN2 12q24.31 MKS8 (Sang et al., 2011) 
 
TMEM231 16q23.1 - (Srour et al., 2012a) 
Meckel Gruber Syndrome 
MKS1 MKS1 17q22 BBS13 (Kyttala et al., 2006) 
MKS9 B9D1 17p11.2 - (Hopp et al., 2011) 
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 Gene Locus Gene Symbol Chromosome Other Gene locus References 
Bardet-Biedl Syndrome 
BBS1 BBS1 11q13.2 - (Mykytyn et al., 2002) 
BBS2 BBS2 16q12.2 - (Nishimura et al., 2001) 
BBS3 ARL6 3q11.2 - (Sheffield et al., 1994) 
BBS4 BBS4 15q24.1 - (Mykytyn et al., 2001) 
BBS5 BBS5 2q31.1 - (Li et al., 2004) 
BBS6 MKKS 20p12.2 - (Katsanis et al., 2000; Slavotinek et al., 2000) 
BBS7 BBS7 4q27 - (Badano et al., 2003) 
BBS8 TTC8 14q31.3 - (Ansley et al., 2003) 
BBS9 PTHB1 7p14.3 - (Nishimura et al., 2005) 
BBS10 BBS10 12q21.2 - (Stoetzel et al., 2006) 
BBS11 TRIM32 9q33.1 - (Chiang et al., 2006) 
BBS12 BBS12 4q27 - (Stoetzel et al., 2007) 
BBS15 C2ORF86 2p15 - (Kim et al., 2010) 
BBS17 LZTFL1 3p21.3 - (Marion et al., 2012) 
 
 
 
 
Table 1.2 Genes mutated in Cystic Kidney Disease and related syndromes   
ADPKD, autosomal dominant polycystic kidney disease; ARPKD autosomal recessive polycystic kidney; BBS, Bardet-Biedl syndrome; JBTS, Joubert 
syndrome; MCKD, medullary cystic kidney disease; MKKS, McKusick-Kaufman syndrome; MKS, Meckel-Gruber syndrome; NPHP, 
nephronophthisis; OFD1 alias CXORF5. 
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1.5 Nephronophthisis  
NPHP is an autosomal recessive cystic kidney disease and a leading genetic cause of 
established renal failure in children and young adults (Hildebrandt et al., 2009a).  The 
incidence varies worldwide from 1 in 50,000 in Canada, to 1 in 61,000 in Finland to 1 
in 900,000 in the USA (Hildebrandt and Zhou, 2007).  Data from the UK paediatric 
Renal Registry reports that NPHP accounts for 6.5% of children with established renal 
failure (Lewis et al., 2007; Lewis et al., 2009), who require renal replacement therapy 
with transplantation or dialysis in order to sustain life. 
NPHP was originally described in an individual patient in 1945 (Smith, 1945) as a 
medullary cystic kidney disease.  In 1951, its description was further defined as a 
familial NPHP (Fanconi et al., 1951), with progressive chronic tubulointerstitial 
nephritis leading to established renal failure (Salomon et al., 2009).  The term NPHP, 
describes part of its histology and literally means ‘disappearance or disintregration of 
nephrons’ (Wolf and Hildebrandt, 2011), this is because cysts develop by replacing 
normal tissue, suggesting that apoptosis is a more prominent feature than proliferation 
(Hildebrandt and Otto, 2005).  The other key characteristic histological features of 
NPHP are: tubular atrophy with tubular basement membrane disruption; interstitial cell 
infiltrate and fibrosis (Waldherr et al., 1982; Zollinger et al., 1980).  
Clinically, children with NPHP typically present with polyuria, nocturia or secondary 
enuresis (Ala-Mello et al., 1998), caused by an inability to concentrate urine (Krishnan 
et al., 2008).  Children with NPHP may additionally have polydipsia and generalised 
lethargy, secondary to anaemia (Ala-Mello et al., 1996).  NPHP is however clinically 
heterogeneous and extra-renal manifestations occur in 10-15% of patients (Hildebrandt 
and Zhou, 2007).  The most typical NPHP associated feature is retinal degeneration, 
however other recognised conditions include: cerebellar vermis hypoplasia (JBTS); 
occipital encephalocele and hepatic fibrosis (MKS); situs inversus; bronchiectasis; 
skeletal defects; BBS (Hildebrandt et al., 2009a).  When considering the array of 
possible presentations of a child with NPHP, one must be aware of the genetic 
heterogeneity; and both the inter and intrafamilial variability.  Furthermore many of 
these causal genes of NPHP are pleiotropic, such as NPHP6, which could therefore lead 
to a presentation with a JBTS, MKS or even a BBS phenotype (Table 1.1, Table 1.2) 
(Coppieters et al., 2010).   
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Since NPHP is a monogenic, recessive condition (Hildebrandt, 2010), by definition 
affected individuals will have two homozygous or compound heterozygous mutations in 
a single gene (Wolf and Hildebrandt, 2011).  However oligogenicity (see 1.15) has been 
reported for a number of genes in patients with NPHP (Hoefele et al., 2007).  The effect 
of potential modifier genes are considered to be a factor influencing intrafamilial 
variation and the severity of disease phenotype (Benzing and Schermer, 2012; Davis et 
al., 2011; Hoefele et al., 2007).  
The list of genes which can cause NPHP continues to grow all the time.  Since 
identification of the first NPHP gene by positional cloning in 1997 (Hildebrandt et al., 
1997; Saunier et al., 1997), new genes are regularly being discovered utilising 
specialised gene hunting techniques combining homozygosity mapping and whole-
exome resequencing (Chaki et al., 2012; Otto et al., 2010).  The advantages of these 
techniques are they overcome the difficulty when a small number of affected individuals 
cluster in a single family and enable detection of candidate genes (Hildebrandt et al., 
2009b).  Inspite of these considerable achievements, the genetic cause remains 
undetermined in many patients, as acknowledged following a recent mutation analysis 
of known NPHP related genes, using DNA pooling and next generation sequencing, 
failed to identify a mutation in 90 patients, 75% of a cohort with a NPHP related 
condition (Otto et al., 2011). 
Currently, mutations in 17 different genes (Table 1.2) have been identified and together 
explain the diagnosis in up to 50% of patients with NPHP (Chaki et al., 2012).  NPHP1 
was the first gene to be discovered (Hildebrandt et al., 1997; Saunier et al., 1997) and 
remains the most frequently identified cause of NPHP, accounting for 20-25% of 
patients (Hildebrandt et al., 2009a).  Although the other causal genes have only been 
identified in small numbers of patients with NPHP, a few key discoveries unveiled a 
link between these genes, which has facilitated the identification of further candidate 
NPHP genes.  In 2003, mutations in NPHP2 (Inversin) were identified in patients with a 
younger age of onset, an ‘infantile’ variant of NPHP, with enlarged cystic kidneys (Otto 
et al., 2003).  The protein products of NPHP1 and NPHP2 were found to interact and 
form a complex with β-tubulin, a key scaffolding protein of primary cilia (Otto et al., 
2003).  Furthermore at this time, mutations in NPHP3 (Olbrich et al., 2003) and NPHP4 
(Mollet et al., 2002; Otto et al., 2002), the latter associated with a retinal phenotype, 
were identified in patients.  NPHP1-4 were all found to interact and colocalise on 
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primary cilia (Mollet et al., 2002; Mollet et al., 2005; Olbrich et al., 2003; Otto et al., 
2003).  A correlation between the pathogenesis of NPHP and the function of primary 
cilia was considered (Hildebrandt and Otto, 2005).   
Evaluation of the literature of the related cystic kidney disease, PKD, identified that in 
the orpk mouse model of ARPKD, mutations in Tg737 (encodes the protein polaris, 
required for intraflagellar transport, cilia assembly and maintenance), resulted in 
shortened primary cilia in renal epithelial cells (Moyer et al., 1994).  This result linking 
primary cilia to the pathogenesis of ARPKD was confirmed using IFT-88, the 
Chlamydomonas orthologue of Tg737 (Pazour et al., 2000).  The association between 
cilia and ADPKD was identified following work in Caenorhabditis elegans showed that 
PKD1 and PKD2 homologs, lov-1 and pkd2, are expressed in cilia and work together in 
the same pathway (Barr et al., 2001).  Theories regarding the role of primary cilia in the 
pathophysiology of ADPKD and consequences of aberrations in their structure or 
function, were suggested following localisation of the polycystins, the protein products 
of PKD1 and PKD2 to primary cilia of renal epithelial cells (Yoder et al., 2002).  The 
polycystin complex (polycystin 1 is a G protein-coupled receptor whilst polycystin 2 is 
a cation channel) interact on cilia in kidney tubules to behave as a urinary flow sensor, 
to mediate calcium influx via the polycystin 2 channel (Gunay-Aygun, 2009; Harris, 
2009; Nauli et al., 2003; Zhou, 2009).  This localisation of the polycystins on cilia 
appears to be fundamental for their ability to regulate calcium signalling in response to 
urinary flow (Gascue et al., 2011).   
Furthermore, in 2003, the possibility that abnormalities of primary cilia could lead to 
protein dysfunction and subsequent disease, even multisystem disease with a significant 
cystic kidney disease phenotype, was postulated for BBS (Ansley et al., 2003).  In 2005, 
recognition of this data, the fact that the protein products of the genes identified to be 
mutated in ADPKD and NPHP: PKD1, PKD2, NPHP1-5 were all located in the primary 
cilium/basal body, led to a new hypothesis in humans and animal models (mice, 
zebrafish): that cystic kidney diseases are ciliopathies (see sections 1.14, 1.16) 
(Hildebrandt and Otto, 2005).  This proposal has helped to guide the direction of 
subsequent research in the field of NPHP and related conditions, facilitating the 
identification of cilia related candidate genes and study of primary cilia structure and 
function. 
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1.6 Joubert Syndrome 
JBTS related disorders are congenital ataxias which were first described in 1968 in 4 
siblings in a consanguineous family with hypotonia/ataxia, developmental delay, 
oculomotor apraxia and an abnormal respiratory pattern (Joubert et al., 1968).  The 
worldwide incidence of JBTS is uncertain, however it is estimated to be between 
1:80,000-1:100,000 live births across Europe and America (Kroes et al., 2008; Parisi et 
al., 2007).  Whilst the mode of inheritance in the majority of patients with JBTS is 
autosomal recessive (Parisi et al., 2007), mutations in OFD1 have been identified in a 
few patients, providing an alternative X-linked recessive pattern of inheritance (Coene 
et al., 2009). 
To date, mutations in 19 different genes have been reported in patients with JBTS 
(Table 1.2).  Several of these genes are pleiotropic and can therefore cause isolated 
NPHP, JBTS and MKS.  Mutations in AHI1 are the leading cause of JBTS and have 
been identified in 7-11% of patients (Parisi et al., 2006; Valente et al., 2006a), 80% of 
which have an associated retinal phenotype (Valente et al., 2008).  The other frequently 
reported genetic causes of JBTS are: CC2D2A in up to 9% of patients who may develop 
associated retinal or renal phenotypes (Gorden et al., 2008); NPHP6 mutations in 7-
10% of patients who tend to develop additional oculo-renal features (Sayer et al., 2006; 
Valente et al., 2008) and MKS3 in 8% of patients who may develop ocular colobomas 
(Baala et al., 2007b; Doherty et al., 2010).  These four genes are being concentrated on 
in the work presented herein. 
Although genetic heterogeneity is well recognised in JBTS and related disorders, the 
tendency to develop certain phenotypes or at least clearly associate the predictive nature 
of mutations in certain genes with development of particular phenotypes has been 
proposed (Figure 1.3).  The purpose of these acknowledgements back in 2008, were to 
develop a recommended algorithim for the order of genetic testing patients for 
mutations.  This concept is important when performing genetic counselling, particularly 
in families with known mutations, to help provide prognostic information and direct 
appropriate screening and ongoing medical management.  
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Figure 1.3 Genotype-Phenotype correlations in Joubert Syndrome   
This Venn diagram demonstrates both individual and overlapping genotype-phenotype 
associations identified in mutation screens.  Individual phenotypes are represented as: 
pure JBTS (JS in this figure) (yellow), isolated NPHP (blue) and isolated LCA (red) 
colours.  The overlapping circles represent the syndromic/multiorgan phenotypes 
associated with certain genes, emphasising their pleiotropy.  The relevant genes are 
listed in each segment, underlined is the main causal gene and bracketed, are rarer 
causes.  CORS, cerebello-oculo-renal syndrome; JBTS, Joubert syndrome; LCA, 
Leber’s congenital amaurosis, retinal dystrophy; NPHP, nephronophthisis; SLS, Senior 
Loken syndrome, oculo-renal disease.  From (Valente et al., 2008).  
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The pathognomonic radiological feature of JBTS (Parisi et al., 2007; Valente et al., 
2008) is a midbrain-hindbrain malformation, which because of its appearance on 
cerebral MRI, is called ‘molar tooth sign’ (MTS, Figure 1.4) and was described in 1997 
(Maria et al., 1997).  MTS is characterised by cerebellar vermis hypoplasia, a deep 
interpeduncular fossa and elongated, thin superior cerebellar peduncles (Parisi, 2009).  
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Figure 1.4 Cerebral MRI of a normal cerebellar vermis and Molar Tooth Sign  
Magnetic resonance imaging (MRI) of the human brain showing axial (1) and mid-
sagittal (2) sections.  The molar tooth sign (MTS) is identified in a patient with Joubert 
Syndrome (MTS1, a deep interpeduncular fossa between white arrows) with an 
abnormally raised fourth ventricle (white arrowhead, MTS2) and cerebellar vermis 
hypoplasia (white arrows surround, MTS2).  Normal (N1, N2) cerebral images are 
shown for comparison.  Adapted from (Parisi, 2009). 
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The cardinal clinical features of JBTS are neurological as described above, however 
multiorgan involvement is recognised, with conditions including: retinal dystrophy, 
NPHP, hepatic fibrosis and skeletal anomalies (Valente et al., 2008).  The variable 
clinical spectrum of JBTS is still being classified and in part is thought to relate to the 
heterogeneity of the identified mutated genes.  The most recent attempt to create a 
system to classify JBTS has generated six subgroups based on the principle organ 
affected and correlating the genotype with phenotype (Table 1.3) (Brancati et al., 2010).  
The predominant renal condition associated with JBTS is NPHP and occurs in up to 
25% of patients (Brancati et al., 2010).   
  
 ________________________________________________________________ Chapter 1:  Introduction 
46 
 
Subgroup Clinical features Unaffected organs Associated genes 
Pure 
JBTS 
MTS, cardinal neuro. 
(hypotonia/ataxia, dev. delay), ± 
irregular respiration, abnormal eye 
movements, impaired intellect 
kidneys, liver CC2D2A, 
TMEM216, 
INPP5E, ARL13B, 
OFD1, AHI1, 
MKS3 
JBTS-O Neuro., retinal dystrophy - AHI1 
JBTS-R Neuro., NPHP eyes NPHP1, 
RPGRIP1L 
JBTS-OR Neuro., retinal dystrophy, NPHP - NPHP6 
JBTS-H Neuro., CHF ± colobomas, NPHP - TMEM67 
JBTS-
OFD 
Neuro., bifid tongue, oral frenulae, 
polydactyly ± pituitary aplasia 
- TMEM216 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.3 Classification of Joubert Syndrome related disorders   
CHF, congenital hepatic fibrosis; dev., developmental; JBTS, Joubert syndrome; JBTS-
H, JBTS with hepatic defect; JBTS-O, JBTS with ocular defect; JBTS-OFD, JBTS with 
oro-facio-digital defects; JBTS-OR, JBTS with oculorenal defects; JBTS-R, JBTS with 
renal defect; MTS, molar tooth sign; neuro., neurological; NPHP, nephronophthisis.  
From (Brancati et al., 2010). 
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1.7 Meckel Gruber Syndrome  
MKS is an autosomal recessive, embryonically lethal developmental disorder which is 
considered to be at the severe end of a spectrum of related conditions progressing from 
isolated retinal dystrophy, to NPHP, to JBTS to MKS (Brancati et al., 2010).  The 
clinical features which define MKS are a triad of large multicystic kidneys, biliary 
dysgenesis/hepatic fibrosis and neurodevelopmental anomalies, with occipital 
encephalocele being the most frequent (Logan et al., 2011).  Additional clinical features 
are now recognised, explained by genetic pleiotropy and may include: polydactyly, 
skeletal dysplasia, cardiac laterality defects and microphthalmia (Salonen and Norio, 
1984).  MKS is described as a rare condition with previously estimated incidences 
ranging from 1:9000 in Finland (Salonen and Norio, 1984), 1:13,250 in the USA 
(Holmes et al., 1976) to 1:140,000 in the UK (Seller, 1978), however more recent 
(1996-2005) estimates of the incidence in the UK city of Bradford were significantly 
more at 1:3000 (Logan et al., 2011).   
Currently, mutations in nine genes have been identified (Table 1.2) in patients with 
MKS.  These genes account for approximately 75-80% of patients with MKS (Logan et 
al., 2011).  NPHP6 and CC2D2A both account for 20% of patients with MKS, whilst 
MKS3 is the third most frequent genetic cause of MKS (Logan et al., 2011).  Several of 
these genes are pleiotropic as can be seen from Table 1.2, however a genotype-
phenotype correlation has only been identified for MKS3 (Otto et al., 2009) and 
CC2D2A (Mougou-Zerelli et al., 2009): missense mutations tend to cause NPHP or 
JBTS, whilst truncating mutations lead to MKS (Mougou-Zerelli et al., 2009; Otto et 
al., 2009).  Understanding the clinical heterogeneity associated with other genetic 
causes of MKS remains to be resolved.  As identified for JBTS above, the association 
between certain primary causal genes and modifying genes for NPHP, JBTS, MKS and 
BBS are shown in Table 1.4. 
  
 ________________________________________________________________ Chapter 1:  Introduction 
48 
 
 
Phenotypes 
Gene NPHP JBTS BBS MKS 
AHI1 M Y - - 
NPHP6 Y, M Y Y Y 
CC2D2A - Y - Y 
MKS3 Y Y M Y 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.4 Association between genes and phenotypic spectrum   
Gene mutation can either be primary cause of phenotype (Y, yes) or modify (M) leading 
to the disease phenotype.  Phenotypes are listed in increasing order of severity 
including: NPHP, nephronophthisis; JBTS, Joubert syndrome; BBS, Bardet-Biedl 
syndrome; MKS, Meckel-Gruber syndrome.  Modified from (Davis and Katsanis, 
2012).   
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1.8 Cilia 
Cilia were first observed as ‘little legs’ on protozoa in 1675 (Dobell, 1932), however the 
term ‘cilia’, which translates from Latin as ‘eyelashes’ (Beales, 2012; Müller and 
Fabricius, 1786), was not thought to be used until 1786.  In 1898, realisation that in 
addition to the previously identified ‘motile’ cilia, there were another type of cilia was 
acknowledged, when the latter were reported as a single ‘antennae like’, sensing 
structure projecting from the surface of kidney cells (Zimmerman, 1898).  The term 
‘primary cilium’ was used to describe these sensory cellular appendages in 1968, 
because they were noted to develop prior to multiciliated cilia (Sorokin, 1968).  Primary 
cilia are ancient, highly conserved hair-like organelles, with a diameter of 
approximately 0.25µm (Rodat-Despoix and Delmas, 2009), which extend from the 
apical surface of most polarised, non-proliferating cells (Satir et al., 2010), the 
exceptions being myeloid cells, lymphoid cells and intercalated cells of the collecting 
duct (Latta et al., 1961; Wheatley, 1995).  The length of primary cilia varies according 
to the phenotype and function of the cell it populates, in vivo in mammals, it has been 
reported to extend between 2-5µm long (Pazour and Witman, 2003; Rodat-Despoix and 
Delmas, 2009).    
1.9 Structure of cilia 
Cilia develop when the cell cycle becomes arrested and the basal body (BB)/centrosome 
moves to the apical cell membrane (Pedersen and Rosenbaum, 2008).  Here the BB 
functions as a microtubule organising centre (MTOC) to coordinate access to the cilium 
and enable the development of the microtubule based ‘axoneme’ core (Berbari et al., 
2009; Davenport and Yoder, 2005; Marshall, 2008) by a process of intraflagellar 
transport (Pedersen and Rosenbaum, 2008).  In all cilia, the central axoneme is 
composed of nine microtubule doublets, however the presence or absence of an 
additional central pair of microtubule singlets has been the basis of a classification 
system for cilia (Berbari et al., 2009; Davenport and Yoder, 2005).  Typically, ‘motile’ 
‘9+2’ cilia have an extra central pair of microtubule singlets, which use dynein arms to 
generate force (Davenport and Yoder, 2005), whereas ‘primary’ usually ‘immotile’ 
‘9+0’ cilia lack the central pair (Figure 1.5) (Berbari et al., 2009).   
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Figure 1.5 Structure of cilia  
(A) Primary cilia contain nine peripheral microtubule doublets which form the axoneme 
extending from the basal body, which anchors the cilium and lies perpendicular to the 
cell membrane.  Motile cilia additionally contain a central pair of singlet microtubules.  
(B) Cross section through axoneme of primary ‘9+0’ and motile ‘9+2’ cilia, 
demonstrating dynein arms and radial spokes in the motile cilia.  Adapted from 
(Davenport and Yoder, 2005). 
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Although the ultrastructure of cilia as determined by electron microscopy (Figure 1.6) 
has historically been used to differentiate function, these distinctions are considered 
inaccurate and too simplistic (Badano et al., 2006b), as there are exceptions, notably at 
the embryonic node (Berbari et al., 2009): motile primary ‘9+0’ cilia (McGrath et al., 
2003); both motile and immotile primary cilia (McGrath et al., 2003); motile ‘9+2’ cilia 
(Kramer-Zucker et al., 2005; Sarmah et al., 2007) have been identified.  Indeed, motile 
cilia are considered to additionally have a sensory capacity (Bloodgood, 2010).  
Additionally, uncharacteristically, motile cilia have been detected in renal tubular cells 
in patients with kidney disease (Ong and Wagner, 2005), although only ‘9+0’ cilia are 
described (Webber and Lee, 1975).  As shown in Figure 1.6A, dynein arms are present 
in some primary ‘9+0’ cilia and were confirmed to be capable of movement (Kramer-
Zucker et al., 2005). 
Motility in cilia is mediated by the additional structural components present in ‘9+2’ 
cilia (see Figure 1.5B): the central microtubules are connected by radial spokes to the 
outer microtubule doublets which have dynein arms attached and are able to generate 
movement by ATP dependent reactions (Ibanez-Tallon et al., 2003).  The dynein arms 
are described as the molecular motors of motile cilia (Ibanez-Tallon et al., 2003). 
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Figure 1.6 Ultrastructure of ‘primary’ and ‘motile’ cilia 
Transmission electron microscopy showing (A, C) the ‘9+0’ microtubule structure of a 
primary cilium and (B) the ‘9+2’ microtubule structure of a typical ‘motile’ cilium.  In 
both A and B outer dynein arms are arrowed, this supports the fact that primary cilia can 
be motile (A) or immotile (C).  These images have been optimised as far as possible, it 
is appreciated that the clarity is not ideal.  A (ependymal cilia) and B (pronephric cilia) 
adapted from (Kramer-Zucker et al., 2005) and C (nodal cilia) adapted from (Bellomo et 
al., 1996).  
 
C 
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1.10 Cilia in development  
In developing mammals and zebrafish embryos (discussed in section 1.18), the 
embryonic node or Kupffer’s vesicle (KV) respectively, are conserved transient, ciliated 
structures required for the establishment of normal left-right body patterning (Essner et 
al., 2005; Essner et al., 2002; Nonaka et al., 1998).  In mouse models, although the 
nodal cilia have a ‘9+0’ structure, two distinct cilia groups have been described, 
functioning to generate or sense movement (McGrath et al., 2003).  In zebrafish, cilia in 
KV have all been described as motile and only a ‘9+2’ structure has been reported 
(Kramer-Zucker et al., 2005; Sarmah et al., 2007).  There are several studies 
demonstrating that knockdown of genes whose protein products function in primary 
cilia or intraflagellar transport leads to aberrant body asymmetry such as: situs inversus 
(Marszalek et al., 1999; Murcia et al., 2000); altered expression of left-right genes 
(Kramer-Zucker et al., 2005); reversed cardiac looping (Essner et al., 2005; Schilling et 
al., 1999; Simms et al., 2012) and is associated with changes in the structure or function 
of cilia at the node/KV.  Although the distinct mechanisms for why cardiac looping is 
reversed rather than randomised in several zebrafish morphants and mutants remains 
unclear, hypotheses based on results herein will be discussed in section 3.3.3.     
1.11 Function of Primary Cilia 
Previously primary cilia were considered innocent bystanders and their role, if any, was 
certainly, unclear.  Even in 1975, following the detection of primary cilia throughout the 
renal tubules on transmission electron microscopy studies, they were hypothesised to 
most likely represent vestigial organelles, although the possibility that they may have a 
sensory role was acknowledged (Webber and Lee, 1975).  Revelations in the last 15 
years have highlighted the prime importance of cilia in maintaining cellular wellbeing 
and function, possibly explaining their essential and ubiquitous expression on most cells 
(Goetz and Anderson, 2010).  
The design, location and versatile functional capabilities of primary cilia make them a 
quintessential organelle for normal development and sustained health.  Primary cilia 
located at the apex of a cell, project directly into the extracellular space and use their 
extensive surface area to detect environmental cues (Bergmann, 2012).  Depending on 
their location and the activity of the associated tissue, primary cilia can behave as 
mechanosensors, osmosensors, photosensors or chemosensors, to detect a range of 
 ________________________________________________________________ Chapter 1:  Introduction 
54 
 
extracellular stimuli including fluid flow, extracellular fluid composition, shear stress, 
light, hormones and chemokines (Bergmann, 2012).  In response to the detected 
information, primary cilia mediate activity in appropriate cellular signalling pathways 
including Wnt non-canonical (planar cell polarity (PCP)), Sonic hedgehog (Shh) and 
JAK-STAT (Bergmann, 2012) to regulate proliferation, apoptosis, orientated cell 
development, tissue maintenance and repair (Germino, 2005). 
1.12 Cilia in the kidney 
In humans and higher vertebrates, the structure of cilia in the kidney is ‘9+0’ (Webber 
and Lee, 1975).  In the pronephros of zebrafish only ‘9+2’ cilia have been identified and 
are motile (Kramer-Zucker et al., 2005).  In the kidney, primary cilia are considered to 
be behave as mechanosensors and chemosensors, to bend in response to fluid flow 
(Figure 1.7) (Berbari et al., 2009; Rodat-Despoix and Delmas, 2009).  The lateral force 
generated by fluid flow, mediates an influx of calcium via a polycystin-1/2 complex on 
the cilia membrane (Nauli et al., 2003), this intracellular calcium is further augmented 
by calcium release from intracellular stores (Rodat-Despoix and Delmas, 2009; Torres, 
2008).  The increased calcium inhibits accumulation of cyclic adenosine 
monophosphate (cAMP), which influences the length of cilia and mediates other 
downstream pathways (Hoey et al., 2012).   
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Figure 1.7 Primary cilia function as mechanosensors in the kidney   
Urine flowing through a kidney tubule is shown in the top left corner and amplified for 
the main image to show two kidney cells with primary cilia projecting into the urinary 
space.  In response to urinary flow, primary cilia bend and calcium influx occurs via 
polycystin receptors localised on the cilium.  This initiates intracellular signalling 
cascades.  The presence of the nephrocystins and other cystic kidney disease related 
proteins are shown to localise on the primary cilia.  Adapted from (Siroky and Guay-
Woodford, 2006). 
Urine 
flow 
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1.13 Cilia in Cystic kidney disease 
A body of evidence associates primary cilia with cystic kidney disease (Mollet et al., 
2002; Olbrich et al., 2003; Otto et al., 2003; Pazour et al., 2000; Yoder et al., 2002) and 
was discussed in section 1.4.  It is recognised that changes in the structure or function of 
cilia adversely modifies subsequent cellular signalling pathways and leads to aberrant 
protein interactions, culminating in cystic kidney disease (Berbari et al., 2009; Sang et 
al., 2011).  Although the exact nature of how changes in the ciliary signalling pathways 
lead to cystic kidney disease remains uncertain, an overview of the current hypotheses 
follows. 
Normal renal tubule morphogenesis requires coordinated cell proliferation, 
differentiation and spatial orientation of cells along the tubule axis.  In order to maintain 
a constant tubular diameter during lengthening (and prevent circumferential expansion 
and cyst formation), renal tubules require intrinsic polarisation of mitotic spindles and 
the ciliary basal body of cells within a tissue plane, known as PCP (Fischer et al., 2006; 
Hildebrandt et al., 2011).  PCP is regulated by the non-canonical Wnt signalling 
pathway (Berbari et al., 2009).  Defective PCP leads to cystic kidney disease (Figure 
1.8) and has been shown to precede tubular dilation and cyst formation in the pck rat 
model of ADPKD (Fischer et al., 2006).  Further evidence from mouse and zebrafish 
studies support the link between ciliary defects, kidney cysts, PCP defects and the non-
canonical Wnt signalling pathway (Jones et al., 2008; Oishi et al., 2006; Saburi et al., 
2008).   
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Figure 1.8 Aberrant Planar cell polarity causes cystic kidney disease 
During normal renal tubule development (top image), correct mitotic spindle location 
relative to the renal tubule axis enables orientated cell division to generate a normal 
longitudinal tubule.  If the mitotic spindle becomes disorientated, renal tubular 
development is disorganised and along a different trajectory and may result in cystic 
tubular expansion.  Taken from (Hildebrandt et al., 2011).  
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Primary cilia are essential for the normal function of the Shh signalling pathway 
(Huangfu et al., 2003).  The Shh signalling pathway is evolutionarily conserved and 
plays an essential role in regulating organ development (Figure 1.9) (Goetz and 
Anderson, 2010; Wilson and Stainier, 2010).  Hedgehog (Hh) is a protein which binds 
to its receptor patched (Ptch) located on the cilia membrane (Rohatgi et al., 2007).  
Several other effectors of the Hh pathway, the Gli transcription factors, are localised 
within cilia and upon activation, exit the cilium and travel to the cell nucleus to 
transcribe Hh target genes (Goetz and Anderson, 2010; Oh and Katsanis, 2012).  
Impaired Hh signalling is associated with congenital defects, particularly of the nervous 
system and cancers (Mullor et al., 2002).  The Hh pathway has been linked to cystic 
kidney disease and in particular NPHP, following identification of a cree indian family 
with mutations in GLIS2/NPHP7 (Attanasio et al., 2007).  GLIS2 encodes the GLIS2 
transcription factor which is an effector in the Hh pathway. 
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Figure 1.9 Hedgehog signalling and the primary cilium    
When Hedgehog (Hh) binds to Patched (Ptc) in the ciliary membrane, the Hh/Ptc 
complex exits the cilium and Smoothened (Smo) is activated and enters the cilium.  
Smo utilises the scaffolding protein Kinesin-7(Kif-7) and suppressor of Fused (Sufu) to 
signal to the Gli proteins, which exit the cilium and travel to nucleus to transcribe Hh 
target genes.  Taken from (Wilson and Stainier, 2010). 
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Primary cilia also play a key role in regulating cell cycle control and cell division.  
Disassembly and resorption of the primary cilium are required to enable cell division to 
occur (Hildebrandt et al., 2011).  Specific links between cell cycle control and NPHP 
were made following the identification of patients with mutations in NPHP9/NEK8 
(never in mitosis kinase 8) (Otto et al., 2008).  NEK8, the protein product of NEK8 
localises to cilia and centrosomes (Otto et al., 2008) and is a significant player in control 
of the cell cycle (Hildebrandt et al., 2011).  NEK8 also regulates the expression and 
localisation of polycystin-1 and 2 (Sohara et al., 2008), the ADPKD proteins, which 
have been independently associated with regulating cell growth (Hildebrandt et al., 
2011).  The association between cystic kidney disease and cell cycle regulation was 
further evident following the successful use of roscovitine, a cyclin-dependent kinase 
inhibitor, to effectively treat mouse models of ARPKD and NPHP (Bukanov et al., 
2006).  
1.14 Ciliopathies:  Cystic kidney disease and beyond  
As detailed above, primary cilia play a vital role in controlled cell division, establishing 
left-right body asymmetry, organogenesis, tissue maintenance and ciliary signalling 
pathways.  Understandably, damage to this fundamental and diverse organelle will lead 
to a range of adverse ‘ciliary’ phenotypes (Baker and Beales, 2009).  The association 
between ciliary dysfunction or structural change and cystic kidney disease has been 
detailed above, with recognition of cystic kidney diseases as ciliopathies (Hildebrandt 
and Otto, 2005).  The ciliopathies are a recently defined heterogeneous group of genetic 
diseases caused by mutations in a gene, whose defective protein product leads to 
dysfunctional cellular physiology and a broad range of phenotypes (Baker and Beales, 
2009; Hildebrandt et al., 2011; Waters and Beales, 2011).  The common phenotypes 
typically associated with ciliopathies include: cystic kidney disease, retinal 
degeneration, liver disease, cerebellar hypoplasia/encephalocele, developmental delay, 
polydactyly, obesity, situs inversus, skeletal dysplasia (Badano et al., 2006b; Waters 
and Beales, 2011).  The presence of several of these ciliary phenotypes overlaps in 
many clinical syndromes, which have been classified as ciliopathies (Table 1.5) 
(Badano et al., 2006b).  Senior-Loken syndrome is a rare genetic cause of blindness and 
is characterised by retinal degeneration and cystic renal disease (Adams et al., 2007).   
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Whilst cystic kidney disease and liver disease are frequently identified in ciliopathies, 
retinal and neurological disease also recurrently manifest (Waters and Beales, 2011).  
The group of conditions defined as ciliopathies are predicted to grow, both the London 
Dysmorphology Database and Online Mendelian Inheritance in Man (OMIM, 
www.ncbi.nlm.nih.gov/omim) sources have been utilised to review ‘ciliopathy’ 
phenotypes and explore combinations of phentoypes (Badano et al., 2006b; Baker and 
Beales, 2009).  Understanding the associated pathophysiology of ciliopathies with their 
variable and extensive clinical phenotypes, would clearly have a considerable impact on 
the health and wellbeing of much of society. 
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Phenotype SLS NPHP JBTS BBS MKS 
Renal cysts X X X X X 
Liver disease X X X X X 
Retinopathy X X X X  
Cerebellar hypoplasia  X X X  
Posterior encephalocele     X 
Developmental delay  X X X  
Polydactyly   X X X 
Situs inversus X X X X X 
Skeletal dysplasia     X 
Obesity   X X  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.5 Clinical phenotypes associated with several ciliopathies   
Clinical features present (X) in conditions which are now defined as ciliopathies.  
Cystic kidneys (highlighted in blue), liver disease and situs inversus are the most 
frequent clinical sequelae.  BBS, Bardet-Biedl syndrome; JBTS, Joubert syndrome; 
MKS, Meckel-Gruber syndrome; NPHP, nephronophthisis; SLS, Senior-Loken 
syndrome.  Modified from (Gerdes et al., 2009). 
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1.15 Ciliopathies:  Variable severity and phenotype 
The ciliopathy disorders are clearly a heterogeneous group both in terms of clinical 
presentation and genetic cause (Hildebrandt et al., 2011).  Four mechanisms are 
postulated to contribute to the variability in extent and severity of organ involvement: 
genetic locus; nature of mutation; presence of triallelism, or additional modifier genes; 
oligogenicity (Hildebrandt et al., 2011).  The term triallelism specifically describes the 
inheritance pattern when three mutant alleles at two different loci have been identified 
in an individual with a disease phenotype (Katsanis et al., 2001) and has classically 
been associated with BBS (Katsanis, 2004).  Triallelism is a form of oligogenicity, 
which is a more general concept and has been defined as heterozygous mutations in at 
least two different recessive genes which independently do not cause disease, however 
in combination can (Hildebrandt et al., 2011; Leitch et al., 2008).  In some studies the 
terms, triallelism and oligogenicity have overlapped and been utilised to describe the 
same phenomenon (Hoefele et al., 2007).   
Whilst the nature of the gene locus can influence the occurrence of some ciliopathy 
phenotypes, such as homozygous NPHP5 mutations induce retinal degeneration (Otto et 
al., 2005), generally there is no consistent correlation between genotype and phenotype 
(Coppieters et al., 2010; Hurd and Hildebrandt, 2011).  The nature of the mutation 
influencing the severity of phenotype, this has been well characterised for the lethal 
disorder MKS, caused by two truncating mutations (in MKS1, MKS3, NPHP3, NPHP6, 
NPHP8), whereas the phenotype is rescued to a milder ciliopathy such a SLS or JBTS, 
if the mutations are a combination of missense and truncating (Bergmann et al., 2008; 
Delous et al., 2007; Wolf and Hildebrandt, 2011). 
Triallelism and the impact of a modifier gene has been identified in patients with NPHP 
(Hoefele et al., 2007), JBTS (Tory et al., 2007), BBS (Leitch et al., 2008) and MKS 
(Hopp et al., 2011).  Mutations in TTC21B have been identified as an independent cause 
for NPHP and JBTS, additionally, TTC21B has been considered as a modifier gene in 
ciliopathies, as mutations were detected in up to 5% of a cohort of patients with 
ciliopathies (Davis et al., 2011).  Table 1.6 details the genetic mutations and associated 
ciliopathies in which triallelism and oligogenicity have been reported.  It is expected 
that this list will continue to grow, as presently only a single heterozygous mutation has 
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been identified in some patients with NPHP (Chaki et al., 2011), JBTS and MKS 
(Gorden et al., 2008; Mougou-Zerelli et al., 2009). 
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Gene 2
nd
 Gene Ciliopathy References 
NPHP1 (hom) NPHP3 (het) NPHP (Hoefele et al., 2007) 
NPHP4 (het) NPHP (Hoefele et al., 2007) 
NPHP6 (het) NPHP, SLS (Tory et al., 2007) 
RPGRIP1L (het) NPHP, SLS, JBTS (Hildebrandt et al., 2011) 
AHI1 (het) NPHP, JBTS (Tory et al., 2007) 
INVS (het) NPHP3 (het) NPHP (Hoefele et al., 2007) 
IQCB1 (hom) NEK8 (het) NPHP (Otto et al., 2008) 
IQCB1 (het) RPGRIP1L (het) SLS (Khanna et al., 2009) 
NPHP6 (hom) NPHP4 (het) MKS (Coppieters et al., 2010; Hoefele et al., 2005) 
TMEM67/MKS3 (het) BBS (Leitch et al., 2008) 
AHI1 (het) NPHP, SLS (Tory et al., 2007) 
PKHD1 (hom) MKS (Baala et al., 2007a) 
NPHP6 (het) NPHP4 (het) SLS (Coppieters et al., 2010) 
RPGRIP1L (het) JBTS (Khanna et al., 2009) 
CC2D2A (het) MKS (Hopp et al., 2011) 
B9D1 (het) MKS (Hopp et al., 2011) 
RPGRIP1L (het) 
 
NPHP6 (het)/IQCB1 (het) SLS (Khanna et al., 2009) 
NPHP3 (comp. het) SLS (Khanna et al., 2009) 
MKS1 (het) BBS (Khanna et al., 2009) 
CC2D2A (hom) PKDH1 (het) MKS (Hopp et al., 2011) 
CC2D2A (het) NPHP3 (het) MKS (Hopp et al., 2011) 
TTC21B (het) NPHP4 (het) NPHP (Davis et al., 2011) 
C2ORF86 (het) MKS (Davis et al., 2011) 
 
 
 
Table 1.6 Mutational load reported in patients with ciliopathies   
Mutations identified in patients were homozygous (hom) or heterozygous (het).  BBS, Bardet-Biedl syndrome; JBTS, Joubert syndrome; MKS, 
Meckel-Gruber syndrome; NPHP, nephronophthisis; SLS, Senior-Loken syndrome.     
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1.16 Animal models of cystic kidney disease related ciliopathies 
Animal models have been utilised for years to improve understanding of human genetic 
conditions in terms of identifying causal genes and defining their function.  Although 
genome wide association studies (GWAS) and advanced sequencing technologies in 
humans have improved the identification of causal genes in human diseases, these 
techniques do not explain the pathophysiology of the associated disease.  Further 
limitations of simply studying humans to further understand disease pathogenesis, 
includes ethical barriers and the appropriateness of certain experiments.  Whilst human 
cell lines are available to study biological pathways and improve understanding, cell 
lines are limited by their locus within the hierarchy of systems and inability to reflect 
processes at the organ and whole body level.  Thus animal models continue to provide 
an essential tool for understanding the pathogenesis of human diseases.  By creating 
animal models representative of human diseases, the basic biological processes involved 
in the pathogenesis can be closely studied and manipulated to address specific 
hypotheses (Aitman et al., 2011).    
1.17 Mouse models of cystic kidney disease related ciliopathies 
The use of mice and rats, has contributed a wealth of knowledge to the study of human 
disease, particularly genetic disease (Norris and Grimes, 2012).  Accepting the 
limitations of studying humans, research in mice has generated valuable knowledge 
regarding the role of cilia in health and disease.  Mice are considered an appropriate 
model because of their genetic, anatomical and physiological similarity to humans 
(Norris and Grimes, 2012).  Both mutant mouse models and embryonic stem cell lines 
exist for several of the identified ciliopathy genes.  Table 1.7 lists the currently 
characterised mouse models of NPHP, JBTS, MKS and BBS.   
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Gene locus Other Gene locus Mutants Type Survival References 
Nphp1 Jbts4 Nphp1
tm1.1Hung
 Targeted-null AV (Jiang et al., 2008) 
  
Nphp1
tm1Jgg
 Targeted-null AV (Louie et al., 2010) 
Nphp2 
 
Invs
Inv
 Random insertion AV (Yokoyama et al., 1993) 
Nphp3 Mks7 Nphp3
pcy
 Hypomorphic AV (Olbrich et al., 2003) 
  
Nphp3
tm1Cbe
 Targeted-null EL (Bergmann et al., 2008) 
Nphp4 
 
Nphp4
nmf192
 ENU AV (Won et al., 2011) 
Nphp6 Jbts6, Mks4, Bbs14 Cep290
rd16
 Spontaneous AV (Chang et al., 2006) 
  
Cep290
tm1jgg
 Targeted-null AV (Lancaster et al., 2011) 
Nphp7 
 
Glis2
tm1Amj
 Targeted-null AV (Kim et al., 2008) 
  
Glis2
tm1Tre
 Targeted reporter AV (Attanasio et al., 2007) 
Nphp8 Jbts7, Mks5 Rpgrip1l
tmUrt
 Targeted-null Birth (Vierkotten et al., 2007) 
Nphp9 Jbts6 Nek
jck
 Possible hypomorph AV (Liu et al., 2002) 
Nphp11 
 
Tmem67
tm1Dgen
 Targeted reporter PNL (Garcia-Gonzalo et al., 2011) 
Nphp12 Jbts11 Ttc21b
aln
 ENU - probably null EL (Tran et al., 2008) 
Jbts1 
 
Inpp5e
tm1.15sch
 Targeted conditional null EL (global KO) (Jacoby et al., 2009) 
Jbts3 
 
Ahi1
tm1Jgg
 Targeted null PNL (80%) 
(Lancaster et al., 2011; Lancaster et 
al., 2009) 
  
Ahi1
tm1Rujf
 Targeted reporter - null ND 
(Hsiao et al., 2009; Westfall et al., 
2010) 
Jbts8 
 
Arl13b
hnn
 ENU - null EL (Caspary et al., 2007) 
Jbts9 Mks6 Cc2d2a
Gt(AA0274)Wtsi
 Gene trap - null EL (Garcia-Gonzalo et al., 2011) 
Jbts10 
 
Ofd1
tm2.1Bfra
 Targeted conditional null Male:EL; female: birth (Ferrante et al., 2006) 
Jbts12 
 
Kif7
1.2Hui
 Targeted null Birth (Cheung et al., 2009) 
  
Kif7
maki
 ENU El (late) (Liem et al., 2009) 
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Gene locus Other Gene locus Mutants Type Survival References 
Jbts13 
 
Tctn1
Gt(KST296)8yg
 Gene trap - null EL (Reiter and Skarnes, 2006) 
Jbts15 
 
Tsga14
Gt(AWO157)Wtsi
 Gene trap - null EL (Lee et al., 2012a) 
Mks1 Bbs13 Mks1
del64-323
 ENU - dominant negative EL (Cui et al., 2011) 
  
Mks1
1krc
 ENU - probably null EL (Weatherbee et al., 2009) 
Mks8 
 
Tctn2
tm1.1Reit
 Targeted - null EL 
(Garcia-Gonzalo et al., 2011; Sang 
et al., 2011) 
Mks9 
 
B9d1
tm1a(EUCOMM)Wtsi
 Gene trap - null EL (Dowdle et al., 2011) 
Mks10 
 
B9d2/Tgfb1
tm1flv 
(Stumpy) Targeted deletion ND (Town et al., 2008) 
Bbs1 
 
Bbs1
GT1NK
 Gene trap - probably null EL, AV (Kulaga et al., 2004) 
  
Bbs1 
tm1Vcs(M390R)
 Targeted knock-in AV (Davis et al., 2007) 
Bbs2 
 
Bbs2
tm1Vcs
 Targeted null AV (Nishimura et al., 2004) 
Bbs3 
 
Arl6
tm1Vcs
 
Targeted deletion - 
transcript specific AV (Pretorius et al., 2010) 
Bbs4 
 
Bbs4
Gt1Nk
 Gene trap EL, birth, AV (Kulaga et al., 2004) 
  
Bbs4
tm1Vsc
 Targeted null EL, birth, AV (Mykytyn et al., 2004) 
Bbs6 
 
Mkks
Gt(0ST367255)Lex
 Gene trap EL, AV (Ross et al., 2005) 
  
Mkks
tm1Vcs
 Targeted null EL, AV (Fath et al., 2005) 
Bbs7 
 
Bbs7
nulla
 Targeted ND (Zhang et al., 2012) 
Bbs8 
 
Tct8
tm1Reed
 Targeted reporter - null AV (Tadenev et al., 2011) 
Bbs11 
 
Trim32
Gt(BGA355)Byg
 Gene trap - probably null AV (Kudryashova et al., 2009) 
  
Trim32
tm1Spc
 
Targeted knock-in - 
hypomorphic AV (Kudryashova et al., 2011) 
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Table 1.7 Mouse mutants of NPHP, JBTS, MKS and BBS ciliopathies 
BBS, Bardet-Biedl syndrome; JBTS, Joubert syndrome; MKS, Meckel Gruber syndrome; NPHP, Nephronophthisis.  Mutants in: blue boxes are gene 
traps, targeted alleles; green boxes are spontaneous; orange boxes are chemical mutants.  Survival is described as: AV, adult viable; EL, embryonic 
lethality; ND, not determined; PNL, postnatal lethal.  Modified from (Norris and Grimes, 2012).    
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A few limitations associated with utilising mice to study the more severe ciliopathies 
including JBTS and MKS is that survival is poor.  Often homozygous null mice are 
embryonically lethal or only a minority survive to adulthood, restricting the ability to 
study them (Norris and Grimes, 2012).  Perhaps reflecting the genetic pleiotropy of 
NPHP related ciliopathies, not all mouse models display the full array of expected 
phenotypes, for example, Nphp1
tm1.1Hung 
and Nphph1
tm1Jgg 
develop retinopathy however 
do not develop cystic kidneys (Jiang et al., 2008; Louie et al., 2010).  Furthermore, the 
diagnostic molar tooth sign, pathognomonic of JBTS, may be specific to humans and 
does not appear to be modelled in mice (Norris and Grimes, 2012).  Finally, the genetic 
background of a mouse appears to influence both the survival and expression of certain 
ciliopathy phenotypes and requires careful control (Norris and Grimes, 2012).  These 
are amongst some of the reasons why additional animal models, such as zebrafish, are 
required to facilitate further understanding the pathogenesis of the cystic kidney disease 
related ciliopathies and enable high-throughput drug screening (Norris and Grimes, 
2012).   
1.18 Zebrafish:  a model organism 
Zebrafish are recognised as an excellent animal model in which to study development 
and disease.  They were first used by developmental biologists in the 1970s (Hsu et al., 
2007) and in 1981, genetic manipulation of zebrafish was first reported, enabling the 
generation of homozygous lines to study development in a vertebrate model organism 
(Streisinger et al., 1981).  In order to recognise aberrations in development as a 
consequence of mutations or pathological processes, normal development must first be 
understood.  In 1995, a description of the normal stages of embryonic development in 
zebrafish was published (Kimmel et al., 1995).  From 1996, zebrafish have been utilised 
to perform large scale mutagenesis screens to identify new genes associated with 
organogenesis and disease (Driever et al., 1996; Haffter et al., 1996) including kidney 
development (Drummond et al., 1998).  Over the years, the focus of zebrafish in 
research has expanded from understanding basic science to involve more translational 
studies modelling several human diseases including: congenital disorders (Fraser 
syndrome (Carney et al., 2010), Waardenburg syndrome (Dutton et al., 2009)); cancers 
(melanoma (Patton and Zon, 2005), neuroendocrine carcinoma (Yang et al., 2004), 
leukaemia (Langenau et al., 2003)); neurodegenerative disorders (Parkinson’s disease 
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(Flinn et al., 2009) and cystic kidney diseases (ADPKD (Mangos et al., 2010), NPHP 
(Sayer et al., 2006; Schafer et al., 2008; Zhou et al., 2010b)).   
In addition to studying development and the pathogenesis of diseases, zebrafish are 
recognised as a valuable pre-clinical tool for drug screening and therapeutic 
development (Parng et al., 2002).  With the recent development of automated, high-
throughput in vivo chemical screening, it is feasible that zebrafish may improve the 
efficacy and cost effectiveness of drug discovery (Letamendia et al., 2012). 
In terms of therapeutics, it is exciting to learn that zebrafish are being utilised to 
understand mechanisms of tissue repair and regeneration of vital organs including the 
heart (Jopling et al., 2010; Poss et al., 2002), retina (Vihtelic and Hyde, 2000) and 
kidney (Zhou et al., 2010a).  Interestingly, even in adulthood, zebrafish retain the ability 
to develop new nephrons (Zhou et al., 2010a), suggesting a supply of renal stem cells 
which would be capable of regenerating kidney function after injury (Reimschuessel, 
2001).  Transplantation of nephron progenitor cells has been performed and led to 
successful development of numerous nephrons (Diep and Davidson, 2011). These 
exciting developments give hope that further research may enable the identification or 
generation of equivalent human renal progenitor cells (Diep and Davidson, 2011).  
Zebrafish are small freshwater tropical fish which measure approximately 3-4cm in 
length as adults.  The qualities of zebrafish which make them attractive models to utilise 
include their: fecundity (females lay several hundred embryos per spawning), rapid ex-
vivo development (major organogenesis is complete by 48hpf), transparency (enabling 
direct visualisation of organogenesis under light microscopy), conserved genome (75% 
similar to human) and tractability to study genetics (Hsu et al., 2007).  
There are several options for studying genes related to development and disease in 
zebrafish including: targeted gene ‘knockdown’ using antisense morpholino 
oligonucleotides (MO) to assess the effect of temporary loss of gene (Eisen and Smith, 
2008); transgenic reporter lines which express a fluorescent signal in a targeted tissue; 
expression of genes using in situ hybridisation and immunohistochemistry (Swanhart et 
al., 2011).  Forward genetic techniques using a chemical mutagenesis screen can be 
used to identify new causal genes which may lead to certain phenotypes or diseases 
(Amsterdam and Hopkins, 2006). 
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Antisense MOs are an accepted, informative, tractable and efficacious technique 
enabling in vivo assessment of gene function in zebrafish.  MOs are synthetic DNA 
analogues composed of: a 6 member ‘morpholine’ ring; more stable, uncharged 
phosphorodiamidate backbone of approximately 25 units (Figure 1.10) (Summerton and 
Weller, 1997).  A gene specific MO is designed to bind to mRNA and prevent protein 
synthesis (Bedell et al., 2011).   
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Figure 1.10 Comparative structure of DNA and Morpholino oligonucleotides 
Conventional DNA has a 5 member deoxyribose ring and anionic phosphodiester 
backbone.  A morpholino oligonucleotide (MO) has a 6 member morpholine ring and 
non-ionic phosphorodiamidate backbone.  R and R’ represent progression of the 
oligomer chain in the 5’ or 3’ prime direction respectively.  Modified from (Corey and 
Abrams, 2001). 
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Since MOs were first shown to effectively knockdown specific gene expression in 
zebrafish in 2000 (Nasevicius and Ekker, 2000), their widespread use within the 
research community has resulted in lessons regarding some of their limitations and 
acknowledgment of the need for essential controls (Bedell et al., 2011).  Following 
microinjection into embryos, MOs are usually very effective for at least 50 hours, 
although they can lose efficacy as time progresses, they have successfully been used to 
study later aspects of development (Bedell et al., 2011; Smart et al., 2004).  However, a 
major concern with regards to MOs was that some of the observed ‘phenotypes’ 
following MO injection were not related to the targeted sequence, but rather were non-
specific, confounding, ‘off-target’ effects (Eisen and Smith, 2008).  Recognised off-
target phenotypes include: neural death, with black areas in the usually transparent 
brain; shortened, bent and ‘gnarled’ tails, which have an unusual, easily identifiable 
abnormal appearance (Robu et al., 2007).  Although the exact mechanism of ‘off-target’ 
effects is not completely understood, they are proposed to be mediated in part by p53 
activation (Robu et al., 2007).  It is therefore recommended that co-injection of a p53 
MO should be performed at least during initial characterisation of a new MO (Bedell et 
al., 2011; Eisen and Smith, 2008).  Further recommendations for controls in MO 
experiments are directed at confirming specificity of gene knockdown and validating a 
phenotype.  Suggested methods include: injection of a second, independent MO, such as 
a splice-site targeting and translation blocking MO; performing RNA rescue by co-
injecting the MO sequence with sequence specific mRNA (Bedell et al., 2011).   
Although zebrafish have some inherent differences from humans which may be difficult 
to explain physiologically, they are an outstanding model organism for studying 
developmental disease (Bedell et al., 2011).  In particular, the zebrafish rudimentary 
kidney has representative features of the human kidney (see section 1.19) and original 
observations in several species of fish in the 1950s has generated seminal understanding 
of renal physiology (Smith, 1953).    
1.19 Normal development of zebrafish kidney 
During embryogenesis in zebrafish, the pronephros is the first kidney to develop and 
principally functions similarly to the human kidney, to remove waste and balance 
electrolytes in the blood, to regulate the body composition (Drummond and Davidson, 
2010).  In comparison, in humans and all mammals, although the pronephros is an 
important initial stage of kidney development, it does not function (Vize et al., 2003).  
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In zebrafish, the pronephros is the functional kidney from 2-12dpf (Zhou et al., 2010a), 
when the mesonephros begins to form around the pronephros and is the final stage of 
kidney development.  The mesonephros functions as the adult zebrafish kidney 
(Drummond and Davidson, 2010).  Contrary to humans, zebrafish kidneys do not have a 
third stage of development and do not form a metanephros.  Since the function of the 
metanephros involves concentrating urine in mammals (Drummond and Davidson, 
2010), this may explain why zebrafish do not develop a metanephric kidney, since they 
are obligatory water losers, generating large volumes of dilute urine (Westerfield, 
1995).  Although simple in form, the considerable advantages of the zebrafish 
pronephros have led to its frequent use in kidney disease research (Drummond, 2000; 
Drummond, 2005).  For these reasons, the zebrafish pronephros was an attractive model 
to use in this work. 
Structurally, the zebrafish pronephros consists of two nephrons (functional units of the 
kidney) which unite in the midline at a single glomerulus (filtering unit of the kidney) 
(Drummond, 2000).  In comparison, the number of glomeruli per kidney in humans is 
thought to range between 330,000 to 1,400,000 (Nyengaard and Bendtsen, 1992).  From 
the glomerulus, the pronephric tubules, which are segmentally discrete and 
representative of the human kidney, extend caudally towards the pronephric ducts, 
which fuse at the cloaca, the communal exit for urine/faeces in zebrafish (Drummond, 
2003; Wingert and Davidson, 2008).  The segments of the pronephric tubules in 
zebrafish are divided into functional segments (similar to humans): proximal convoluted 
tubule, proximal straight tubule, distal early tubule, corpuscle of stannius (equivalent of 
human parathyroid gland (Greenwood et al., 2009)), distal late tubule, pronephric ducts, 
cloaca (Figure 1.11) (Wingert and Davidson, 2008).  The suggested function of each 
tubular segment was identified using in situ hybridisation to determine the expression of 
ion transporters (Drummond and Davidson, 2010) and is detailed in Table 1.8.   
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Figure 1.11 Discrete segmentation of zebrafish pronephric tubule  
Lateral view of the location of the pronephros (blue) on zebrafish embryo.  Dorsal view 
shows enlargement of the pronephric tubules and pattern of each segment extending 
from the single glomerulus (P), neck (N), proximal convoluted tubule (PCT), proximal 
straight tubule (PST), distal early (DE) tubule, corpuscle of stannius (CS, equivalent of 
human parathyroid gland (Greenwood et al., 2009)), distal late (DL) tubule, pronephric 
ducts (PD) to the cloaca (C, urethral exit).  Modified from (Wingert and Davidson, 
2008).    
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Tubular segment Constituents/channel Function References 
PCT Developed brush border, high columnar epithelial cells Reabsorption (Drummond and Davidson, 2010) 
Endocytic receptors: megalin, cubalin Absorption (Anzenberger et al., 2006) 
AE2, NBCl, NHE acid-base homeostasis (Nichane et al., 2006; Shmukler et 
al., 2005; Wingert et al., 2007) 
PST slc13a1, trpm7 Less certain; sulphate and calcium 
transporters, if mutated result in kidney 
stones 
(Drummond and Davidson, 2010; 
Elizondo et al., 2005) 
DE slc12a1, Romk2, Clck Reabsorbs sodium, potassium, chloride, 
creates dilute urine 
(Drummond and Davidson, 2010; 
Wingert et al., 2007) 
DL slc12a3, Not certain; sodium, chloride absorption, 
modify dilute urine 
(Drummond and Davidson, 2010) 
 
 
 
 
Table 1.8 Structural features and function of pronephric tubule segments  
AE2, chloride/bicarbonate anion exchanger; Clck, chloride channel; DE, distal early tubule; DL, distal late tubule; NBCl, sodium/bicarbonate 
cotransporter; NHE, sodium/hydrogen exchanger; PCT, proximal convoluted tubule; PST, proximal straight tubule; Ref., reference; Romk2, apical 
potassium channel; seg., segment; slc12a1, sodium-potassium-chloride symporter; slc12a3, sodium/chloride cotransporter; slc13a1, sodium/sulphate 
symporter; trpm7, calcium cation channel. 
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The pattern of pronephric development in zebrafish occurs in reverse order, beginning 
caudally.  In terms of time scale, the pronephric ducts are the first to form and this is 
complete by 24hpf, subsequently between 30-40hpf the pronephric tubules form and 
finally, following vascularisation, the glomerulus becomes a functional filter by 48hpf 
(Drummond et al., 1998).  Generally, nephrogenesis is divided into four stages (Figure 
1.12) which will be detailed below: 1) specification of mesoderm to a nephrogenic 
determination, 2) epithelialisation and growth of pronephric duct in proximal pattern, 3) 
differentiation of glomerular and tubular cell types, 4) endothelial cells from the dorsal 
aorta invade the glomerulus and develop a functional capillary tuft (Drummond, 2003; 
Drummond, 2000). 
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Figure 1.12 Stages of development of the zebrafish pronephros   
I In early somitogenesis, the nephrogenic fate of the intermediate mesoderm (im) is 
visualised using renal transcription factors such as pax2.1.  II Growth and 
epithelialisation of the pronephric duct (pnd) begins anterior to somite 3 (~11 hpf) and 
extends caudally, it is defined by expression of transcription factors.  III Between 24-
48hpf differentiation of cells destined to develop into podocytes or tubular cell types 
occurs, beginning at the pronephric duct (np).  IV Endothelial cells from the dorsal 
aorta (da) migrate into the glomerulus (gl) to develop a functional capillary tuft.  
Modified from (Drummond, 2000). 
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Early studies of nephrogenesis in zebrafish identified an overlap in the type of cells 
which were destined to become kidney and blood cells (Kimmel et al., 1990).  Both of 
these cell types are derived from the intermediate mesoderm (IM) and tissue patterning 
is determined by expression of kidney specific tissue markers (Drummond and 
Davidson, 2010).  From the 3 somite stage (approximately 11hpf (Kimmel et al., 
1995)), podocytes, the neck and PCT develop progressively from the IM, anterior to and 
at pace in concert with sequential somite development (Drummond and Davidson, 
2010).  Appropriate segmentation of the pronephric tubule requires retinoic acid, which 
facilitates organisation of the pronephros (Wingert and Davidson, 2008). Organisation 
of the pronephric tubular epithelium involves mesenchyme to epithelial transition, akin 
to humans, with establishment of polarised epithelial cells containing ion transporters, 
enabling osmoregulation (Drummond et al., 1998).   
Similar to humans, the zebrafish glomerulus consists of podocytes, which express 
homologs of nephrin and podocin from 24hpf, which enables development of 
specialised filters, slit-diaphragms, between podocyte foot processes (Drummond and 
Davidson, 2010).  Between 36-40hpf, podocytes extend foot processes which wrap 
around the adjacent endothelial cells of the dorsal aorta.  Vascularisation is facilitated 
by podocytes expressing proteins which enable angiogenesis: vascular endothelial 
growth factor (VEGF) and angiopoietin2.  Similarly, nearby endothelial cells destined 
to be capillary forming, express a VEGF receptor and between 40-48hpf invade the 
glomerular epithelium, becoming surrounded by podocytes.  Although glomerular 
filtration occurs from 48hpf, the glomerular barrier is not mature in terms of 
appropriately restricting passage of large molecular weight proteins until approximately 
4dpf (Drummond and Davidson, 2010).   
The pronephric ducts meet at the cloaca and regulated by bone morphogenetic protein 
(BMP) signalling forms an opening by 24hpf (Pyati et al., 2006).  Since the cloaca is a 
communal exit for urine and faeces, the proctodeum contributes to its development and 
surrounds the cloaca during development (Parkin et al., 2009).   
1.20 Zebrafish models of cystic kidney disease    
Several zebrafish mutants and morphants have been identified with abnormal kidney 
development and pronephric cysts.  An N-ethyl N-nitrosourea (ENU) mutagenesis 
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screen led to the identification of fifteen different mutants with pronephric cysts, 
suggesting that at least fifteen genes are required for normal development and function 
of the pronephros (Drummond et al., 1998).  Pronephric cysts were evident by 48hpf 
and frequently associated with additional phenotypes including: generalised oedema, 
considered due to loss of osmoregulation; and a ventral body axis curvature 
(Drummond et al., 1998).  Furthermore, the link between cilia and cystic kidney disease 
was confirmed following an insertional mutagenesis screen identified mutations in ten 
genes caused pronephric cysts and three of these genes were homologs of intraflagellar 
transport genes (Sun et al., 2004).  The existing zebrafish models of cystic kidney 
disease and related ciliopathies are listed in Table 1.9. 
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Human Gene Zebrafish phenotype References 
PKD1 Pronephic cysts, dorsal axis curvature, hydrocephalus, jaw defects (Mangos et al., 2010) 
PKD2 Pronephric cysts, dorsal axis curvature, pericardial oedema, hydrocephalus, laterality defects (Obara et al., 2006) 
TCF2 Pronephric cysts, underdevelopment of pancreas and liver, small otic vesicles (Sun and Hopkins, 2001) 
INVS Pronephric cysts, ventral axis curvature, pericardial oedema, laterality defects (Otto et al., 2003) 
NPHP3 Pronephric cysts, ventral axis curvature, pericardial oedema, hydrocephalus, laterality defects, 
fewer and shorter cilia in KV 
(Zhou et al., 2010b) 
NPHP4 Pronephric cysts, ventral axis curvature, pericardial oedema, vesicle laterality defects, shorter cilia 
in KV and PND, vesicle obstructs cloaca formation  
(Slanchev et al., 2011) 
IQCB1 Pronephric cysts, axis curvature, hydrocephalus (Schafer et al., 2008) 
CEP290 Pronephric cysts, ventral axis curvature, hydrocephalus, loss of retinal tissue (Sayer et al., 2006) 
RPGRIP1L shortened dorsal axis curvature, thin somites, kinking of the notochord  (Khanna et al., 2009) 
NEK8 Pronephric cysts  (Liu et al., 2002) 
TMEM67 
(MKS3) 
Pronephric cysts, axis curvature, pericardial oedema, hydrocephalus, kinking of the notochord, 
unilateral microphthalmia, altered number of otoliths 
(Adams et al., 2012) 
TMEM216 Ventral axis curvature, pericardial oedema, hydrocephalus  (Valente et al., 2010) 
AHI1 Pronephric cysts, ventral axis curvature, pericardial oedema, hydrocephalus, laterality defects, 
fewer/loss of cilia in KV, abnormal eye development, altered number of otoliths 
(Simms et al., 2012) 
ARL13B Pronephric cysts, ventral axis curvature, laterality defects, fewer cilia in KV and the pronephros (Duldulao et al., 2009) 
CC2D2A Pronephric cysts, dorsal axis curvature (Gorden et al., 2008) 
OFD1 Axis curvature, pericardial oedema, hydrocephalus, laterality defects, shorter cilia in KV (Ferrante et al., 2009) 
 
 
 
 
 
Table 1.9 Zebrafish models of human cystic kidney disease and related ciliopathies 
Zebrafish models for: autosomal dominant polycystic kidney disease (ADPKD, blue shading); renal cysts and diabetes (RCAD, orange shading); 
nephronophthisis (NPHP, green shading); Joubert syndrome (JBTS, pink shading); KV, Kupffer’s vesicle.  Modified from (Swanhart et al., 2011). 
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Frequently, cystic kidney disease and aberrant left-right body patterning are co-features, 
leading to interest in evaluating the ciliated zebrafish organ of laterality, KV.  KV arises 
from dorsal forerunner cells in the tailbud (Essner et al., 2002) and is transiently present 
between 12-16hpf (8-14 somites), however it regresses with time (Kimmel et al., 1995).  
Cilia located within KV beat in a counterclockwise pattern to generate leftward fluid 
and control the left-right development of the brain, heart and gut (as discussed in section 
1.10) (Essner et al., 2005).  
Understanding the potential mechanisms of cystogenesis can be studied in zebrafish and 
many cystic mutants have been found to have impaired cell polarity with 
mislocalisation of Na
+
K
+
 ATPase channels leading to defective osmoregulation 
(Drummond et al., 1998). 
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1.21 Aims of this research 
Inherited cystic kidney disease and related ciliopathies encompass a heterogeneous 
group of monogenic disorders with a curious spectrum of severity.  Causal genes 
continue to be identified and are associated with abnormal structure or signalling 
mediated by primary cilia.  It is evident that many of the ciliopathy proteins interact and 
even function as protein networks (Sang et al., 2011).  However studying the effects of 
mutations in genes, particularly more than one gene, in vivo can be limited by 
embryonic lethality, the latter can be a problem with mouse models.  An advantage of 
zebrafish as a model organism is the ability to study genetic interactions to evaluate 
complex disease phenotypes.  
We hypothesise that the clinical heterogeneity of cystic kidney disease related 
ciliopathies is not simply influenced by the gene locus or nature of mutation.  
Triallelism or oligogenic inheritance will modify the development of particular 
phenotypes, which will alter prognosis.  Since the encoded proteins of the cystic kidney 
disease related causal genes are located on the primary cilium and basal body complex, 
changes in primary cilia will be evident.  
The frequently associated phenotype of cystic kidney disease links the increasingly 
severe ciliopathies of NPHP, JBTS and MKS.  The aim of this work was to evaluate the 
influence on phenotype following targeted single and combined knockdown of selected 
genes.  Where possible, this included identifying any association between the 
development of a phenotype and changes in cilia.  Four key causal genes have been 
chosen to study because of their recognised role in inducing all or two of the ciliopathy 
spectrum NPHP-JBTS-MKS.   
AHI1 was the initial focus of study, Chapter 3, because: it is the leading cause of JBTS, 
in the middle of the range of severity of ciliopathy conditions; its role has not previously 
been reported in zebrafish; oligogenicity has been reported in patients with mutations in 
AHI1 and NPHP6.   
In Chapter 4, the aim was to create zebrafish models of three other cystic kidney disease 
related ciliopathy genes, CC2D2A, NPHP6 and MKS3, to individually evaluate the 
associated phenotypes.  To study CC2D2A, both a spontaneous zebrafish mutant and 
morphant were created.  Generation of the NPHP6 zebrafish model was principally to 
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enable later combined genetic studies with AHI1 and CC2D2A, however an additional 
aim was to characterise cilia in developing morphants.  MKS3 morphants were created 
to assess development of the severe end of the ciliopathy spectrum. 
Finally, in Chapter 5, the aim was to evaluate oligogenicity in cystic kidney disease 
related ciliopathies by studying the phenotypes of zebrafish embryos after combined 
interference with: nphp6 and cc2d2a; ahi1 and cc2d2a; ahi1 and nphp6.  When 
assessing the effect of oligogenicity with cc2d2a, both MO knockdown and a cc2d2a 
spontaneous mutant zebrafish model were used. 
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Chapter 2 Materials and Methods 
2.1 Bioinformatics  
Various online bioinformatic databases were utilised to identify and compare the human 
and zebrafish genomes.  The Vertebrate Online Annotation database 
(http://vega.sanger.ac.uk) enabled identification and review of the evidence for 
nucleotide and amino acid transcipts.  The SMART (Simple Modular Architecture 
Research Tool, http://smart.embl-heidelberg.de) domain was used to provide 
information regarding the identity and function of components of the proteins.  
Alignment software was used to evaluate the degree of evolutionary conservation of 
genes of interest. 
2.2 Zebrafish lines and husbandry 
Wild type AB
1
 or golden (homozygous pigmentation mutant useful for developmental 
studies and in situ hybridisation) (C Nusslein-Volhard, 2002) zebrafish were utilised in 
most experiments.  Additional strains used were: 
claudin-b:Lyn-GFP: this transgenic line express GFP at epithelial tight junctions (Haas 
and Gilmour, 2006; Lopez-Schier et al., 2004), with strong expression in the posterior 
lateral line, telencephalon, otic placode and pronephros.  The aim was to facilitate study 
of the pronephros.  This line were a kind gift from Dr S. Burtey. 
sentinel: this line have a spontaneous nonsense mutation in cc2d2a, the only zebrafish 
ortholog of CC2D2A, a ciliopathy gene known to cause JBTS and related ciliopathies 
(Gorden et al., 2008).  This line were a kind gift from Dan Doherty’s laboratory, 
Washington.  
sentinel:claudin-b:Lyn-GFP: this transgenic line were created in our laboratory by 
crossing sentinel and claudin-b:Lyn-GFP heterozygotes and screening the embryos for 
GFP expression and sentinel phenotype.  The purpose of this line was to facilitate study 
of the pronephros when evaluating combined gene interference to study oligogenicity.  
cmcl2:GFP: this transgenic line express GFP specifically and intensely in cardiac cells 
(Huang et al., 2003), highlighting the heart which was useful for assessing left-right 
                                                 
1
 An established wild type line of zebrafish. 
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patterning and asymmetry during development.  This line was kindly loaned by Dr Bill 
Chaudhry. 
2.2.1 Zebrafish maintenance 
All zebrafish lines were maintained in our laboratory in standards according to the UK 
Home Office license regulations.  The zebrafish laboratory technician follows 
guidelines with regards to appropriate breeding to enable maintenace of wild type and 
mutant stocks which are genotyped for confirmation (C Nusslein-Volhard, 2002).  
Although as in other vertebrate models such as mice, the genetic background can 
influence the development of a phenotype, reports of this occurring in zebrafish are rare 
(Sanders and Whitlock, 2003).  This is possibly because of the emphasis on maintaining 
‘closed, inbred’ zebrafish lines and monitoring for the development of lethal mutations 
which would interfere with analysis of offspring embryos (C Nusslein-Volhard, 2002). 
The zebrafish laboratory facilities must be carefully regulated including: water supply, 
temperature, illumination, cleaning and feeding to maintain the wellbeing and fecundity 
of the zebrafish (C Nusslein-Volhard, 2002).  In our laboratory, the water quality was 
checked daily in terms of temperature, pH (<6 and >8 is associated with toxicity (C 
Nusslein-Volhard, 2002)) and conductivity.  On a weekly basis, the water was tested for 
nitrate, nitrites, chlorine and general hardness using Tetra Aquarium 6 in 1 test strips (D 
Burns, former Zebrafish Technician, personal communication). 
2.3 Zebrafish Morpholino Experiments 
2.3.1 Overview 
All zebrafish MO experiments were performed with the aim of characterising the effect 
of knockdown of a gene on the subsequent development, focusing on structural and 
functional changes.  Whilst pronephric development was the key focus, extra-renal 
organs, particularly the brain and eye were evaluated in the context of cystic kidney 
disease related ciliopathies.   
2.3.2 MO Design and preparation 
MO were designed with guidance from Gene Tools, www.gene-tools.com, to interfere 
with mRNA translation or splicing, leading to knockdown of the expression of a 
specific gene.  Usually both splice and translation blocking antisense MOs were 
 ________________________________________________________ Chapter 2:  Materials and Methods 
88 
 
designed to facilitate determining specificity of gene knockdown (discussed in section 
1.18).  Control MOs were also utilised as recommended (Eisen and Smith, 2008) 
including a standard control MO (designed by Gene Tools as a negative control, it 
targets a human beta-globin intron mutation that causes beta-thalessemia and is not 
known to create any other phenotypes) and a p53 MO to exclude off-target effects 
(described in section 1.18).  Table 2.1 lists the genes targeted and MO sequences.   
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Gene Antisense MO Name Antisense sequence (5’-…-3’) 
ahi1 ahi1_ie_exon 8 (splice) CCACACTCTGAAAGGGAAAAACATT 
ahi1 ahi1_5UTR (translation) GAGTCATTAGCAGCTTTGTTTTTCC 
cc2d2a cc2d2a_ie_exon 14 (splice) CTTCGTCTGCATAGCCGTACCTGTT 
nphp6 nphp6_ATG (translation) AGGCATTCTTCAGGTCAGCTGCAAA 
nphp6 nphp6_ei_exon 42 (splice) TGAAAAGTTGCACCTACAGAGGGTC 
mks3 mks3_ei_exon 4 (splice) GTAAAAATGACAAGCGCCTACCCAG 
 Standard Control CCTCTTACCTCAGTTACAATTTATA 
p53 p53 GCGCCATTGCTTTGCAAGAATTG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1 Gene targeted and antisense morpholino oligonucleotide sequence   
 ________________________________________________________ Chapter 2:  Materials and Methods 
90 
 
For each MO, in order to determine the optimal MO concentration to create a phenotype 
without inducing off-target effects or excess mortality, a volume of each stock MO was 
diluted in varying concentrations of a buffer (danieau solution (58mM NaCl, 0.7mM 
KCl, 0.4mM MgSO4, 0.6mM Ca(NO3)2, 5mM HEPES, pH 7.1-7.3) (C Nusslein-
Volhard, 2002) and 0.1% phenol red, the latter enables clear visualisation of the 
solution during injection).  This enabled a range of doses of each individual MO to be 
injected into embryos, to generate a dose concentration curve.  These imperative initial 
experiments were performed at least in triplicate and carefully analysed for phenotypes 
to enable determination of the optimal MO concentration to utilise in subsequent 
experiments. 
2.3.3 MO injections of zebrafish embryos 
Male and female zebrafish adults were placed in breeding tanks separated by a divider, 
to acclimatise, the evening prior to a planned experiment.  The following morning the 
divider was removed and mating commenced.  MO injections were performed in freshly 
delivered embryos, which were aligned against a microscope slide and injected at the 1-
4 cell stage (Figure 2.1).   
In advance, needles were pulled from glass capillary tubes using a Micropipette Puller 
(P-97, Sutter Instruments).  Needles were loaded with approximately 4µl of MO 
containing solution (as described above), to enable numerous injections and direct 
visualisation of injection delivery.  The needle tips were manipulated using precision 
watchmaker’s forceps, to enable injection of a recommended volume of approximately 
500-750pL (Rosen, 2009).  The approximate volume of injection was assessed by 
injecting a drop onto a droplet of oil positioned on a micrometer glass slide to confirm 
the diameter measured 0.1-0.15mm.  The volume of injection was determined using the 
formula: 4/3πr3, where r is the radius, equivalent to half the diameter.  
Following MO injection using an Eppendorf Femtojet microinjector (Eppendorf), 
embryos were maintained in E2 media (Appendix A) (C Nusslein-Volhard, 2002), with 
or without 0.003% 1-phenyl-2-thiourea (PTU, Sigma) to suppress pigmentation, this 
prolongs the transparency of embryos (Westerfield, 1995).  The time of delivery of each 
clutch of embryos was recorded and petri dishes of time-matched uninjected embryos 
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were also maintained in E2 media, as controls.  Thereafter embryos were incubated at 
28.5C and staged by counting somites and hours post fertilisation. 
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Figure 2.1 Alignment of zebrafish embryos for microinjection  
Using a microscope slide, 1-2 cell stage zebrafish embryos were aligned and 
microinjected.  The injected solution contains 0.1% phenol red dye to enable direct 
visualisation of delivery of morpholino oligonucleotide. 
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2.3.4 mRNA Rescue   
Rescue experiments were performed to further confirm specificity of a MO knockdown 
by co-injecting ‘gene relevant’ RNA from a different species (Eisen and Smith, 2008).  
For example, for ahi1 morphants, rescue experiments involved co-injecting ahi1 MO 
with in vitro transcribed mouse Ahi1 mRNA (mMessage Machine, Ambion).  For mks3 
morphants, phenotypic rescue was performed by co-injecting mks3 MO with capped 
human MKS3 mRNA (a kind gift from Dr John Sayer).     
For all rescue experiments, to ascertain an appropriate dose and to ensure there were no 
overexpression phenotypes a range of doses (50-200pg) of the mouse Ahi1 or human 
MKS3 mRNA were injected into zebrafish embryos.    
2.3.5 Mortality assessments  
Approximately 4-6 hours post MO injection, all petri dishes of uninjected control and 
MO injected embryos were reviewed under light microscopy using a stereomicroscope 
(Leica MZ16 F).  All dying or deceased embryos were removed and petri dishes 
replaced in incubators at 28.5ºC.  Petri dishes of embryos were again reviewed at 24, 48 
and 72hpf to record mortality and remove any deceased embryos.  All mortality data 
were recorded on data sheets (Appendix B).  Where necessary, embryos were 
transferred to fresh petri dishes or E2 media was replaced.   
The maximal duration of any experiment was 5 days, when embryos were euthanised by 
immersing in a 4mg/ml solution of Tricaine (ethyl-m-aminobenzoate 
methanesulphonate).  The Tricaine solution was prepared by technicians from the 
zebrafish laboratory, who dissolved 4g of ethyl-m-aminobenzoate methanesulphonate 
powder in 1L of ddH2O (double distilled water) and added sodium hydroxide (as 
required) to achieve a pH of 7.0.  The Tricaine solution was stored at 4ºC.      
2.3.6 Phenotyping by light microscopy 
In order to phenotype zebrafish embryos, they were transferred into a fresh petri dish 
containing a few drops of 4mg/ml Tricaine, to anaesthetise.  To characterise the 
development of embryos and potential interference by a gene of interest (using MO 
knockdown), embryos were studied at various time points using a stereomicroscope 
with a camera (Leica, MZ16F) attached, enabling images to be recorded.  Both the 
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normal developmental phenotype of time matched, uninjected, wild type (WT) control 
embryos were reviewed in real time and sketches of the normal stages of zebrafish 
embryonic development were referenced (Kimmel et al., 1995).     
Kupffer’s vesicle (KV) was reviewed, or fixed for later experiments, at 13-14hpf (8-10 
somites, Figure 2.2) because of the optimal size and for consistency of reporting. 
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Figure 2.2 Localisation of KV in developing zebrafish embryos   
Light microscopy views (a, c, e, arrows) and sketches (b, d, f, lateral view, red arrows) 
of zebrafish embryos highlighting the localisation of KV in paired dorsal/lateral views 
(where feasible) significantly facilitated identification of KV in experiments.  Modified 
from Figures 1 and 15 from (Kimmel et al., 1995). 
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Embryos of or older than 24hpf were dechorionated (using precision foreceps) in order 
to clearly visualise their features.  The other major time points evaluated were: 48 and 
72hpf.  Often, to carefully follow the development of particular embryos over several 
days, they were placed in individual wells of 24 multiwell culture plates (Sigma-
Aldrich).  All observations regarding the appearance of embryos were recorded on a 
phenotype scoring sheet (Appendix C).  Initially, in addition to identifying individual 
dysmorphic features, embryos were classified as normal, mild, moderate or severe.  This 
grading system was determined by subjectively assessing each dysmorphic feature, with 
the most marked/severe individual anomaly determining the overall classification, rather 
than utilising a summative score.  The intention was to obtain information regarding the 
extent of dysmorphology, to identify if this was similar to the variable spectrum of 
disease seen in patients with NPHP, JBTS and related disorders.  However on assessing 
the reproducibility of this severity classification, by reviewing images of zebrafish, 
rescoring them and comparing the results to those originally recorded on spreadsheets at 
the time of the experiment and capture of the image, showed that there was more than 
acceptable variability in severity scores.  This led to the severity score being abandoned 
in further experiments and not being analysed.   
To assess cardiac looping (Appendix D), embryos were reviewed between 48-56hpf 
(Ahmad et al., 2004) and when cmcl2:GFP transgenic embryos were being studied, the 
fluorescent camera (Leica, MZ16F) was utilised to record images. 
The brain phenotype of hydrocephalus was assessed by light microscopy and resin 
embedding with sectioning as described in section 2.8.  Although magnetic resonance 
histology has been utilised in zebrafish (Ullmann et al., 2010) to create a three 
dimensional atlas of the zebrafish brain and may have enabled evaluation of an 
equivalent Molar Tooth Sign, diagnostic of Joubert Syndrome, this was not performed 
herein.  Initially videos were taken to evaluate whether morphant zebrafish embryos 
could be having seizures, these observations were not particularly frequent and were 
therefore not further evaluated by performing an electroencephalogram (Pineda et al., 
2011). 
An assessment of kidney function was attempted to determine whether this may be 
abnormal and provide an alternative or additional read out from pronephric cysts, incase 
identification of the latter were being missed.  Embryos were anaesthetised in 4mg/ml 
 ________________________________________________________ Chapter 2:  Materials and Methods 
97 
 
Tricaine and aligned, ventral side up, against a microscope slide and perpendicular 
cover slip in minimal Tricaine/E2 water.  Microinjection of a small volume of 10kDa 
rhodamine labelled dextran (Invitrogen) was performed into the pericardium of wild 
type embryos at 48 and 72hpf with the intent of optimising a protocol.  Embryos were 
then maintained in E2 water at 28.5C to be reviewed at 24 and 48 hours post injection 
and photographed using a fluorescent microscope (Leica, MZ16F).  Although mortality 
rates as a consequence of the pericardial injection were acceptable, no reliable 
fluorescent signal was detected in the embryos.  These preliminary experiments were 
performed at an early stage of working with zebrafish and fluorescent microscopy skills 
were likely inadequate, in particular the ability to attempt to quantify the intensity of 
detected fluorescence.  Clearly following publication of methods by others who had 
successfully performed this assay of kidney function (Tobin and Beales, 2008), it would 
have been important to review embryos a few hours following injection.  This 
interesting area was not further pursued because of the generation of more fruitful 
results in various other experimental pathways at that time. 
2.3.7 Mounting and imaging zebrafish embryos 
For imaging KV following immunofluorescence, embryos were placed on either: a 
single well concavity slide (VWR) which was subsequently inverted and imaged 
through the coverslip (VWR); or placed in a glass based six well tissue culture plates 
(Iwaki, www.well.ox.ac.uk/cytogenetics/downloads/Iwaki.pdfref) which could be 
imaged through directly.  Embryos were placed in Vectashield hardset mounting 
medium with DAPI (4',6-diamidino-2-phenylindole, which stains nuclei, Vector Labs) 
and positioned to enable imaging through the dorsal side.  If the concavity slides were 
used, a coverslip was applied and nail varnish utilised to maintain adherence.  The 
ability to image KV herein was similar regardless of whether imaging whole mount 
embryos or following dissection and removal of the yolk sac.  All embryos were stored 
in the dark at 4ºC until imaged.  Whole mount imaging of 48-72hpf embryos following 
immunofluorescence was performed as above.   
For light microscopy imaging of live or fixed embryos of 24-72hpf, embryos were 
placed in a petri dish in a small volume of E2 water (± Tricaine for anaesthetic effect) or 
3% methylcellulose, the latter particularly if they had a curly tail or imaging of cardiac 
looping was being performed.  3% methylcellulose was made by dissolving 3g 
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methylcellulose (M0387, Sigma) in 100ml ddH2O, dispensed into eppendorfs and stored 
at -20ºC until used.  When mounting embryos, the 3% methylcellulose was defrosted 
and maintained on ice on the bench or at 4ºC.  After considerable trial and error of 
various different methods of imaging and mounting embryos during this research, a 
methodology paper was subsequently published which proved insightful (Jaffe et al., 
2010).     
2.4 Zebrafish RNA isolation and RT-PCR 
2.4.1 Overview 
Uninjected WT ‘control’ embryos or embryos following MO injection were reviewed 
using light microscopy, dechorionated using precision watchmaker’s forceps and fixed 
prior to RNA isolation.  This procedure was performed for embryos individually and in 
groups of 20-30.  RNA isolation using a standard Trizol protocol was repeated at 
various time points including 12, 24 and 72 hpf.  RNA concentrations were determined 
using a Nanodrop Spectrophotometer (ND-800, Labtech) and equal concentrations of 
RNA were incorporated into RT-PCR reactions.  Agarose gel electrophoresis (see 
section 2.4.7) was performed and gels visualised under ultraviolet (UV) light using a 
Geldoc camera to determine the size of bands.   
2.4.2 Fixation for RNA isolation from zebrafish embryos 
Selected individual embryos were placed in a petri dish containing phosphate-buffered 
saline (PBS) and a few drops of 4mg/ml Tricaine for 1min to euthanise.  Embryos were 
then washed in PBS, transferred to individual universal containers in minimal PBS and 
transported to the main laboratory on ice.  Embryos were either stored at -20ºC or RNA 
was isolated from them (see sections 2.4.3, 2.4.4).  It is important to avoid 4% 
paraformaldehyde (PFA) when fixing zebrafish specimens for RNA isolation as this 
prevents Trizol from being able to penetrate and separate samples.    
2.4.3 Tissue homogenisation 
In a fumehood, 1ml of Trizol (Invitrogen) was added to a universal container containing 
a single, fixed zebrafish embryo.  A TissueRuptor (Qiagen) was then used to 
homogenise tissue.  The 1ml sample was transferred into a screw top eppendorf to 
proceed with RNA isolation. 
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2.4.4 RNA Isolation 
The 1ml Trizol/homogenised zebrafish solution was centrifuged at 12,000G for 10mins 
at 2-8ºC in a microcentrifuge (Eppendorf 5415D).  This separates the insoluble material 
from the supernatant, which contains RNA and can be aspirated into a fresh screw top 
eppendorf, to incubate for 5mins at room temperature.  0.2ml of chloroform was then 
added to the supernatant, the screw tap tightly applied and the eppendorf shaken 
manually for 15s then incubated at room temperature for 2.5mins.  The chloroform-
supernatant solution was further centrifuged at 12,000G for 15mins at 2-8ºC, this 
resulted in separation of the mixture into three phases.  Theoretically, RNA is present in 
the colourless upper aqueous phase and should have a volume of two thirds of the 
chloroform-supernatant solution.  Therefore approximately 600µl of supernatant (which 
should contain RNA) was carefully aspirated into a fresh eppendorf.  The RNA was 
precipitated by adding 0.5ml isopropyl alcohol and incubated at room temperature for 
10mins, then centrifuged at 12,000G for 10mins at 2-8ºC.  This resulted in a pellet of 
RNA forming at the bottom edge of the eppendorf, bathed in supernatant, which was 
aspirated and discarded.  The RNA pellet was washed and vortexed in 1ml of 75% 
ethanol, then centrifuged at 7,500G for 5mins at 2-8ºC.  The remaining ethanol was 
removed and the RNA pellet air dried at room temperature for 5-10mins.  The RNA 
pellet was resuspended in 10µl of RNAse free water and incubated at 57.5ºC for 10mins 
to dissolve. 
2.4.5 Determining RNA concentration 
After appropriately calibrating the Nanodrop Spectrophotometer (ND-800, Labtech), the 
concentration (ng/µl) of RNA isolated was quantified using 1µl of RNA.  RNA stocks 
were then stored in individual eppendorfs at -20ºC. 
2.4.6 RT-PCR protocol 
All reactions were performed in PCR multiwell plates (Sigma) and prepared on ice.  
Equal concentrations of RNA were used in each experimental group for RT-PCR 
reactions by diluting with RNAse free water where necessary.  For the reverse 
transcription reaction, a Superscript VILO cDNA synthesis kit (Invitrogen) was used, 
with a 10µl reaction volume: 2µl chosen RNA, 2µl VILOx5 mix (random primers, 
magnesium chloride (MgCl2), and deoxyribonucleotide triphosphates (dNTPs, which 
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are essential for building cDNA)), 1µl 10xSuperScript (reverse transcriptase) enzyme 
mix and 5µl RNAse free H2O.  A ddH2O sample was also run as a control and in 
parallel, a further control reaction was run in which no 10xSuperScript (reverse 
transcriptase) enzyme mix was included.  The following conditions were set: 25C for 
10mins, 42C for 60mins, 85C for 5mins.  Samples were then stored at 4C or on ice 
whilst the PCR reaction was being prepared, or alternatively at -20C if PCR was 
deferred to the following day.   
For PCR reactions, a Taq PCR Master Mix kit (Qiagen) and Peltier Thermal Cycler 
were used.  A 20 µl reaction volume included: 2µl cDNA (from reverse transcription 
reaction above), 1µl 10µM forward primer, 1µl 10µM reverse primer, 10µl Taq PCR 
Master Mix (DNA Polymerase enzyme, MgCl2, PCR Buffer and dNTPs), 6µl RNAse 
free H2O.  An online program, Primer3 (www.ncbi.nlm.nih.gov/tools/primer-blast/) was 
used to facilitate design of specific primers and provided relevant primer melting 
temperatures and the predicted PCR product size.  For each gene, specific primer pairs, 
annealing temperatures and PCR cycles were used as shown in Table 2.2.  Samples 
were then stored at 4C, on ice, or alternatively at -20C until an agarose gel 
electrophoresis was performed (see section 2.4.7). 
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Table 2.2 Zebrafish gene specific primer pairs and PCR information 
Forward and reverse primer pair sequences for the zebrafish genes.  Oligonucleotide 
primers were ordered from Integrated DNA Technologies (http://eu.idtdna.com/site).  
The annealing temperature and number of PCR cycles used are shown for each primer 
pair. 
  
Gene Primer sequence (5’-…-3’) Annealing Temp. PCR cycles 
ahi1 F: GAGGTCAGATGGGCTGTTTT 55C 35 
ahi1 R: AGACCCAGGCATAACTTCG 
cc2d2a F: CCCGTCTCGCTCAACTGTAT 56C 35 
cc2d2a R: GTTGGGCTTCTCTGGTTCCT 
nphp6 F: TGGAGCAGGAGAAGGTGAGT 55C 30 
nphp6 R: GGGATGGGGTATCAGAACCT 
mks3 F: GAGCCTGTCTTGCGTGAAAT 54C 30 
mks3 R: CCGCAAACACAAGACTGAGA 
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2.4.7 Agarose gel electrophoresis 
RT-PCR products were run on 1 to 2% agarose gels (depending on the predicted size of 
products), prepared by dissolving 1-2g of agarose (Sigma) in approximately 100ml of 1 
x TAE buffer (Appendix E) in a conical flask, heated in a microwave on full power for 
2-3mins.  Meanwhile, an appropriately sized gel tray and comb were prepared.  The 
conical flask containing hot agarose solution was placed in cool water for approximately 
10s prior to adding 100µl GelRed (Biotium) and mixing, this enables PCR samples to 
fluoresce.  The agarose gel was then poured into a gel tray with a comb in situ and 
allowed to set at room temperature for 15-30mins. 
When solid, the comb was removed and agarose gel immersed in a tank of 1xTAE 
buffer.  Samples to be run on the gel were prepared in a multiwell plate and consisted of 
3µl of 6 x loading dye added to 5µl of each RT-PCR product.  A standard 100bp DNA 
ladder (Biolabs) was used to size products and gels run at 100-120 volts.  Images of gels 
were captured using a Geldoc Camera (http://uvp.com/geldocit.html).   
2.4.8 Excision of RT-PCR bands and PCR clean-up 
To extract a band of interest from an agarose gel, the gel was positioned on top of a UV 
transilluminator.  A scalpel was used to cut around the edges of the band, with as 
minimal excess gel as possible.  Safety eye wear and a face shield must be worn when 
using the UV transilluminator.  The band was placed in an eppendorf of known weight 
and subsequently weighed, to enable calculation of the weight of the gel containing the 
band.  A gel volume of 100mg is equivalent to 100µl, this theory is important and 
enables determination of the appropriate volumes of solutions to be used during 
subsequent gel extraction and purification.  A Gel extraction and purification kit 
(Qiagen) and protocol were used (page 25 (Qiagen, 2008)) to extract cDNA from the 
gel band.  Three volumes of QG buffer (which contains a pH indicator, if yellow 
indicates the pH < 7.5) were added to the gel volume and incubated at 50C for up to 
10mins, until the gel had dissolved.  The dissolved gel mixture should be a yellow 
colour, which suggests the pH is appropriately <7.5, otherwise it must be acidified by 
adding 3M sodium acetate (included in Qiagen kit).  To increase the DNA yield of 
smaller DNA fragments (<500bp), the Qiagen protocol recommended adding 1 gel 
volume of isopropanol to the gel mixture (Qiagen, 2008).  A QIAquick spin column was 
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placed in a collection tube and then filled with the gel mixture, prior to being 
centrifuged at room temperature for 1min using a microcentrofuge (Eppendorf 5415D).  
The liquid which filtered through and gathered in the collection tube was disposed of 
then another 0.5ml buffer QG was added to the spin column and centrifuged for a 
further 1min.  To wash the sample, 0.75ml buffer PE was added to the spin column and 
incubated at room temperature for 2-5mins, prior to a 1min centrifuge.  The fluid which 
filtered through was again discarded and a further 1min centrifuge performed.  The 
QIAquick spin column was transferred into a fresh microcentrifuge tube, 30µl RNAse 
free water was added and the sample incubated for 2mins before a final 1 min 
centrifuge.  The cDNA sample should be stored at -20C.   
For direct sequencing (MWG Eurofins), in separate microcentrifuge tubes: 10µl of 
cDNA sample was premixed with 1µl of 10pmol/ml of relevant forward oligonucleotide 
primer; a further 10µl of cDNA sample was premixed with 1µl of 10pmol/ml of 
relevant reverse oligonucleotide primer.  The quality of the sequenced data was 
reviewed by assessing the relevant chromatogram.  Subsequently, the sequenced data 
was identified by pasting it into a programme called BLAT (http://genome.ucsc.edu/cgi-
bin/hgBlat?command=start), which mapped the sequence within the genome.    
2.5 Sentinel Genotyping, Sequencing and Rapamycin therapy 
2.5.1 Overview 
Sequencing of the sentinel mutant zebrafish genomic DNA identified a spontaneous 
nonsense mutation (G>A) in exon 14 of cc2d2a, resulting in a premature stop codon 
rather than a tryptophan at amino acid position 491 (Owens et al., 2008).  In order to 
confirm the genotype of sentinel embryos, PCR using specific dCAP (derived Cleaved 
Amplified Polymorphic Sequence) primers was required.  This technique introduces a 
restriction enzyme site into WT embryos and following a restriction enzyme digest it 
was evident that WT embryos have a smaller product (128bp), compared with sentinel 
embryos (156bp), in which the DNA was not cut (Gorden et al., 2008).  Appropriate 
controls must be used with each experiment including WT embryos with and without 
the addition of the restriction enzyme.  Since the sentinel mutant zebrafish were 
predicted to develop pronephric cysts in up to 33% (Gorden et al., 2008), treatment of 
embryos with Rapamycin (Sigma) was attempted.    
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2.5.2 Sentinel Genotyping 
At 72hpf, suspected sentinel morphants (10-20 embryos) identified by their 
characteristic sine wave shaped tail were euthanised in 4mg/ml Tricaine for a few 
minutes.  The Tricaine was removed and they were bathed in PBS and transported to the 
main laboratory on ice.  Embryos were transferred into a cone shaped eppendorf and 
60µl of sodium hydroxide (25mM )/ethylenediaminetetraacetic acid (EDTA, 0.2mM) 
was added.  Embryos were placed in a thermomixer at 95C for 45mins.  Subsequently 
60µl of 40mM Tris/HCl was added to the embryo mixture and vortexed for 60s.  The 
DNA must be stored at -20C unless progressing immediately onto PCR with dCAP 
primers.     
The 20µl PCR reaction included: 2µl DNA, 10µl Taq PCR Master Mix (Qiagen, DNA 
Polymerase enzyme, MgCl2, PCR Buffer and dNTPs), 1µl forward (5’-
TAGCCGTACCTGTTTTCTTTTCCAGGATAT-3’) oligonucleotide primer, 1µl 
reverse (5’-GAGAGACTGCAGGACGAGCAGGA-3’) oligonucleotide primer and 6µl 
RNAse free water.  PCR conditions included an annealing temperature of 61C and 30 
cycles.  To confirm adequate extraction of DNA and of the expected size (156bp), gel 
electrophoresis and imaging (as in section 2.3.7) was performed. 
The 20µl restriction enzyme digest reaction included: 5µl PCR DNA, 0.2µl restriction 
enzyme (EcoRV), 2µl restriction enzyme buffer 3, 0.2µl bovine serum albumin (1mg/ml 
BSA) and 12.6µl RNAse free water.  The restriction enzyme/PCR DNA mix was 
incubated at 37C for a minimum of 4 hrs.  Subsequently, the products were run on a 
2% agarose gel (prepared as in section 2.4.7), sentinel embryos were confirmed as those 
measuring 156bp, in which the restriction enzyme did not cut the DNA. 
2.5.3 Rapamycin treatment 
Rapamycin (Sigma) powder was dissolved in 1% DMSO (dimethyl sulfoxide) and 
diluted in E2 media, to prepare treatment solutions of 0.1µM and 0.05µM.  Embryos 
from 3 pairs of golden zebrafish were collected to form a control group and 3 pairs of 
sentinel zebrafish.  There were four treatment arms based on the different media which 
embryos were bathed in: E2 (standard incubation media), 0.05% DMSO/E2 (drug 
vehicle), 0.05µM Rapamycin/0.05% DMSO (Rapa B) or 0.1µM Rapamycin/0.05% 
DMSO (Rapa A).  40-100 golden and sentinel embryos from 2 different pairs were 
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bathed in each of the above solutions and incubated at 28.5ºC.  Both golden and sentinel 
embryos from the 3
rd
 mating pairs were maintained in E2 media for the first 24hpf, then 
separated into groups to be bathed in the drug vehicle or Rapamycin treatments from 
24-48hpf, to assess the effect of delaying the onset of exposure to treatment.  The 
experiment protocol is shown as a flow chart in Figure 2.3. Each media was removed 
and replaced every 24 hours to maintain continuous exposure.  Mortality assessments 
and determination of phenotypes/side effects were performed as above (see sections 
2.3.5-2.3.6). 
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Figure 2.3 Protocol for Rapamycin treatment trial in zebrafish embryos 
Following birth wild type and sentinel embryos were divided into 4 different treatment 
groups: E2 (standard incubation media), 0.05% DMSO (dimethyl sulfoxide, the drug 
vehicle), 0.05µM Rapamycin/0.05% DMSO (Rapa B), 0.1µM Rapamycin/0.05% 
DMSO (Rapa A).  The treatment solutions were replaced with fresh solution every 
24hrs.  To assess the effect of exposure to treatment at different stages of development, 
additional embryos which had been maintained in E2 media from birth were exposed to 
the Rapamycin therapies from 24 and 48hpf.  Mortality and phenotypes were assessed 
using standard methods.  hrs, hours; Rapa, Rapamycin. 
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2.6 In situ hybridisation 
2.6.1 Overview 
In order to define the expression of ahi1 during zebrafish development, clusters of 
uninjected WT golden embryos were fixed at various time points and a typical in situ 
hybridisation protocol (Thisse and Thisse, 2008) performed.  Additionally, to facilitate 
localisation of KV in WT and following ahi1 MO injection, a charon riboprobe (a kind 
gift from Dr Hibi) was used.  Embryos were mounted in 3% methylcellulose or PBS 
media and images captured using a stereomicroscope (Leica, MZ16F) or axioplan 
microscope (Axiocam HRC, Zeiss). Embryos were stored in PBT (phosphate buffered 
saline/0.1% Tween-20) in the dark at 4C. 
2.6.2 Embryo fixation and preparation for in situ hybridisation 
Only golden embryos were used for in situ hybridisation as these have minimal pigment 
and avoid the need to bleach embryos.  Embryos of greater or equal to 24hpf must be 
dechorionated prior to fixation.  Embryos of 8-10 somites (for KV), can be 
dechorionated following fixation.  After selection of embryos, they were incubated in 
4% PFA at 4C overnight.  Subsequently, in a fumehood, PFA was removed and 
embryos were washed in PBS for 5 mins (twice).  A dehydration series was then 
performed, involving 5min washes in 25%, 50%, 75% methanol in ddH2O, up to 100% 
methanol (for at least 2 hours).  Embryos were stored at -20C or progressed onto the in 
situ hybridisation protocol. 
2.6.3 Preparation of in situ hybridisation probes 
To generate an ahi1 template to make riboprobes, PCR (35 cycles, annealing 
temperature 55C) was performed using genomic zebrafish DNA and ahi1 specific 
oligonucleotide primer pairs: forward (5’-TCATTCGTGTACTGTGCCAAG-3’) and 
reverse (5’-CAACCTGGTCACCTGTCTCA-3’).  This generated a 544bp ahi1 PCR 
fragment which was cloned into a pGEM-T Easy vector (Promega), with T7 and SP6 
promoters on either side, which facilitated production of sense and antisense transcripts 
respectively.  To linearize the vector containing the ahi1 template, a restriction enzyme 
digest using EcoRV was performed at 37C for 2 hours.  A Digoxigenin (DIG)-labelled 
UTP (Roche Diagnostics) is incorporated into the following reaction to label the probe: 
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1µg cDNA template (use the concentration determined using a Nanodrop 
Spectrophotometer to calculate the volume), xµl (13µl total volume when combined 
with cDNA template) RNAse free water, 2µl 10xNTP labelling mix, 2µl transcription 
buffer, 1µl RNAse inhibitor and 2µl RNA polymerase (a SP6 RNA polymerase is used 
for the antisense probe and a T7 RNA polymerase to generate the sense (control) 
probe).  The reaction was incubated at 37C for 2 hours.  The DIG labelling reaction 
was terminated by adding 2µl 0.2M EDTA (pH8).   
For extraction of the probe 80µl DEPC treated (diethylpyrocarbonate, RNAse free) Tris 
EDTA, 10µl 4M lithium chloride (LiCl) and 250µl 100% ice cold ethanol were added 
and incubated at -80C for 2 hours.  Subsequently the probe mixture was centrifuged at 
4C for 30mins, the probe should be visible as a pellet, the supernatant was removed 
and discarded.  The probe pellet was then air dried at room temperature for 5-10 mins.  
Finally, 100µl of DEPC treated Tris EDTA and 2µl RNAse inhibitor were added.  The 
quality of the probe was checked by running it on a 1% agarose gel, where two distinct 
bands representing RNA should be seen.  Unfortunately there were no bands visible on 
the gel in which I had attempted to prepare the ahi1 probe and since Dr John Sayer had 
performed the experiment in parallel, he kindly donated his ahi1 probe.   
The antisense Shh and cardiac myosin light chain 2 (cmcl2) probes were gratefully 
received from Dr Nic Child.  Sense probes and no probe were used as negative controls. 
2.6.4 In situ hybridisation protocol 
Day 1 
All media contained 0.1% DEPC and Tween-20.  Embryos must be in 100% methanol 
to begin and were transferred into flat base eppendorfs, approximately 20 embryos from 
each group per eppendorf.  They were rehydrated by 5min washes at room temperature 
in: 75% methanol in PBT, 50% methanol in PBT, 25% methanol in PBT and four 
washes in PBT.  Embryos were permeabilised by incubating in Proteinase K (10µg/ml, 
Roche, a protease which digests and removes unwanted, contaminated proteins during 
extraction of DNA) in PBT at room temperature.  The duration of incubation depends 
on the age of embryos:  
8-10 somites (KV) - 3mins; 24hpf - 15mins; 48hpf - 30mins; 72hpf - 40mins. 
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The Proteinase K solution was removed and embryos were briefly washed in PBT 
(3mins) and the permeabilisation reaction ceased by refixing in 4% PFA at room 
temperature for 20mins. 
The PFA was removed and embryos were profusely washed (5 times) for 5mins each, at 
room temperature.  Prehybridisation was performed by incubating embryos in the pre-
hyb mix for 2-3 hours at 65C in a water bath.  The pre-hyb mix contains: 50% 
Formamide, 5 x SCC (3M sodium chloride/0.3M sodium citrate, pH6), 0.1% Tween-20 
in DEPC H20, tRNA (500µg/ml Baker’s yeast as a block) and heparin (50µg/ml).  In 
practice it was useful to prepare a stock of prehyb without tRNA and heparin as washes 
on day 2 do not contain these constituents. 
The pre-hyb solution was removed and to perform hybridisation, 5µl of chosen RNA 
probe (antisense or sense) was added to 300µl of fresh ‘prehyb’ including tRNA and 
heparin, and incubated at 65C in a water bath overnight.  As a negative control, no 
probe was added to 300µl of fresh ‘prehyb’ including tRNA and heparin, to eppendorfs 
of appropriately age matched embryos which were also incubated at 65C in a water 
bath overnight.  
Day 2 
A thermomixer set at 65C was required to maintain a constant temperature during 
exchange of washes, otherwise embryos were maintained in the water bath at 65C.  No 
tRNA or heparin was included in the stock prehyb solution which was prepared on day 
1. 
The hybridisation solution was removed and the following 15min washes at 65C 
performed: 75% prehyb/2 x SCC, 50% prehyb/2 x SCC, 25% prehyb/2 x SCC, 2 x 
SCC; then two 30min washes in 0.2 x SCC. 
Further 10min washes at room temperature included: 75% 0.2 x SCC/PBT, 50% 0.2 x 
SCC/PBT, 25% 0.2 x SCC/PBT and PBT.  During the final wash, embryos were 
transferred to glass beakers (2ml solution per beaker), using separate pipettes to avoid 
inadvertent mix up of embryos.   
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Embryos were then incubated in a 1% blocking solution (Roche) in MABT (maleic acid 
buffer/tween, pH7.5) on a rocker at room temperature for 2-5 hours.  Meanwhile, the 
anti-DIG-AP (alkaline phosphatase) antibody (1:5000, Roche) was dissolved in 1% 
blocking solution/MABT at 4C for 1 hour.  The blocking solution was removed from 
the embryos and they were incubated in the prepared anti-DIG antibody/blocking 
solution on a gentle rocker at 4C overnight. 
Day 3 
The antibody/blocking solution was removed and embryos were washed in PBT at room 
temperature for 15mins, 8 times.  Embryos were then stored in PBT at 4C for 2 days 
prior to staining. 
Day 4 
PBT was removed and embryos were washed in NTMT (100mM tri HCl pH9.5, 50mM 
MgCl2, 100mM NaCl, 0.1% Tween-20) at room temperature for 5mins, 3 times.  
Embryos were then incubated in staining solution (18µl BCIP/NBT (Roche)/ml NTMT) 
in the dark and carefully checked at 15min intervals (earlier if the first time a probe was 
used) using a stereomicroscope.  When satisfied with the level of staining, which 
typically varied depending on the age of embryos, the staining solution was removed 
and embryos were washed in PBT for 5min, 3 times.  Thereafter embryos must be 
maintained in the dark and preferably at 4C.   
For optimal imaging of embryos, depending on their age, they were mounted in 3% 
methylcellulose, or small volumes of PBT, in 30mm petri dishes and images were 
captured using a stereomicroscope (Leica, MZ16F) or axioplan microscope (Axiocam 
HRC, Zeiss).  To further concentrate and enhance the signal, embryos were dehydrated 
in graduated washes up to 100% methanol, then rehydrated back to PBT and re-imaged.  
To attempt to tackle the problem of a pigmented yolk sac (a consequence of exposure to 
light), embryos were washed in BABB (benzyl alcohol, benzyl benzoate 1:2), which 
increases the overall transparency of embryos, however in practice, this solution was 
difficult to work with effectively.  The staining protocol could be repeated if imaging 
was suboptimal, by washing embryos back to NTMT, providing they had not already 
been refixed in 4% PFA.  
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2.7 Wholemount Immunohistochemistry 
2.7.1 Overview 
In order to evaluate cilia at various stages of development, embryos (both uninjected 
WT controls and following MO injection) were fixed at various time points.  In 
particular, cilia were studied in the developmental organ of laterality, KV and in the 
pronephros.  A standard immunofluorescence protocol was performed using antibodies 
to detect cilia, centrosomes or the apical epithelium of KV.  Embryos were mounted and 
imaged using confocal microscopy (LSM 510Meta, Zeiss and A1R Confocal, Nikon). 
2.7.2 Selection of embryos and fixation for Immunofluorescence 
Claudin-b:Lyn-GFP transgenic zebrafish embryos were predominantly used in 
experiments for immunofluorescence, as the claudin-b is expressed at epithelial cell 
junctions of KV and the pronephros.  When double antibody staining was performed, 
golden zebrafish embryos were used, to avoid confusion of GFP signal.  Embryos were 
selected at 8-10 somites (for KV) and 72hpf (to study the cloaca of the pronephros) and 
manually dechorionated.  Embryos were fixed in 4% PFA at 4C: for 1-2 hours 
(minimum of 1hr, max 1-5hrs for 8-10 somite stage) or overnight at 4C for 72hpf 
embryos.  Subsequently, PFA was removed and embryos were washed in PBT for 
5mins.  Embryos were either dehydrated in 5min washes up to 100% methanol and 
stored at 4C or -20C (for longer periods) until use, or immediately processed into the 
immunofluorescence protocol. 
2.7.3 Wholemount Immunofluorescence protocol and antibodies 
Approximately 20 embryos from each group were transferred into screw top eppendorfs 
and all washes/incubations were performed on a rocker at room temperature, unless 
otherwise stated.  To permeabilise embryos, they were washed in ddH2O for 5mins, 
then pre-chilled (-20C) acetone at -20C for 7mins.  Embryos were washed in ddH2O 
for 5mins and transferred to a fresh eppendorf before addition of block (5% BSA/PBS 
and 1% DMSO and 0.1% Tween) for 2 hours.  The block was removed and the primary 
antibody (Table 2.3) added to 5% BSA/PBS, to incubate at 4C overnight.  The 
following day, the primary antibody was removed and embryos washed in PBS for 
5mins, 3 times.  Embryos were then transferred into a fresh eppendorf, wrapped in tin 
foil (to maintain in the dark) and the secondary antibody (Table 2.3) in 5% BSA/PBS 
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applied, overnight at 4C.  The following day, the secondary antibody was removed, 
embryos were maintained in the dark and washed in PBS for 5mins, 4 times, prior to 
storing in the dark at 4C until imaging.   
The dilution of primary and secondary antibodies (Table 2.3) was determined following 
a series of experiments testing different dilutions to identify the optimal signal with the 
minimal background.  The initial choice of antibody dilutions tested were as a result of 
previous experience in the laboratory performing immunofluorescence on cells or 
published methods (Kramer-Zucker et al., 2005). 
When double antibody staining was performed, the primary antibodies were put on 
together, however the secondary antibodies were put on sequentially because that is 
custom in our laboratory, although it was acknowledged that there would be little  risk 
of the secondary antibodies cross reacting if put on together. 
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Table 2.3 Antibodies and dilutions used in immunofluorescence  
Species and dilution of primary and secondary antibodies used for immunofluorescence. 
Primary Antibody Dilution Secondary Antibody Dilution 
Mouse Acetylated tubulin, 
Sigma, T6793 
1:500 Donkey Alexa Fluoro (red) 
594, Invitrogen 
1:200 
Rabbit Pericentrin, Abcam, 
AB4448 
1:200 Goat FITC (green) 488, 
Invitrogen 
1:200 
Rabbit Atypical protein 
kinase C, Santa Cruz, SC216 
1:500 Goat FITC (green) 488, 
Invitrogen 
1:200 
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2.7.4 Preparation for imaging 
After trialling several methods of mounting 8-10 somite stage embryos, the following 
technique was chosen as optimal (similar to section 2.3.7).  Embryos were placed on 
Vectashield hardset mounting media with DAPI, on ultra thin (0.175 ± 0.02µm) glass 
culture plates (Iwaki), or occasionally if 72hpf, on inverted concavity microscope slides 
and imaged through coverslips.  Following the immunofluorescence protocol and 
mounting, embryos were stored in the dark at 4ºC, prior to imaging with confocal 
microscopy (LSM 510Meta, Zeiss and A1R Confocal, Nikon).  Images and z-stacks 
were captured using a 20x lens and 3x optical zoom. 
2.7.5 Measuring cilia length on confocal images 
To measure the length of cilia in KV, the following method was recommended by Dr 
Aoife Waters from Professor Phil Beales zebrafish laboratory in London.  Z-stack 
images of KV captured during confocal microscopy were opened in the simple neurite 
tracer programme (Fiji).  After selecting the z-stack image of KV of maximal diameter, 
with most cilia in view, the length of each cilium (in µm, 9-29 cilia per embryo) was 
measured and the average length of cilium per embryo was calculated. 
2.8 Zebrafish Histology 
2.8.1 Overview 
To evaluate the histology of eye, brain and kidney development associated with NPHP 
related ciliopathies, histological examination was performed following MO knockdown 
in zebrafish embryos.  Uninjected WT controls and embryos following MO injection 
were fixed at 72-120hpf.  Embryos were embedded in resin, sectioned on a microtome, 
mounted on slides, stained and imaged. 
2.8.2 Fixation for histological studies 
Groups of both WT controls and morphant embryos between 72-120hpf were selected, 
dechorionated and euthanised in 4mg/ml Tricaine for 1min.  Embryos were washed in 
PBS at room temperature for 5mins and then fixed in 4% PFA at 4C overnight.  The 
following day, embryos were washed in PBS for 5mins twice and dehydrated by 
washing in an ascending ethanol series as follows: 25% ethanol/ddH2O for 5mins, 50% 
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ethanol/ddH2O for 5mins, 75% ethanol/ddH2O for 5mins, 100% ethanol.  Embryos were 
then stored in 100% ethanol at 4C until ready for resin embedding. 
2.8.3 Resin embedding protocol 
The evening prior to resin embedding, silica crystals (Sigma) were dehydrated by 
inserting them in an open glass jar into a 60C oven overnight.  Embryos stored in 
100% ethanol were divided into groups of up to 20 embryos per eppendorf.  A further 
two 30min washes in 100% ethanol were performed at room temperature.  A fresh 
eppendorf containing hardener 1 (benzoyl peroxide) media (Technovit 8100, Heraeus 
Kulzer GmbH) was prepared and approximately 5 embryos transferred (in minimal 
100% ETOH) to the eppendorf.  Embryos were allowed to sink to the bottom of the 
eppendorf, which can take up to 10 mins.  Hardener 1 was removed using a pipette and 
fresh hardener 1 added to the eppendorf, which was incubated at room temperature for 1 
hour, with a further replacement of hardener 1 during this time, to maximally dehydrate.   
An airtight container was prepared containing dehydrated silica crystals (blue in colour) 
and a rack for holding up to 6 moulds.  A solution of hardener 1 and hardener 2 
(N,N,3,5-tetramethylaniline, very viscous) was prepared (30:1, 1.7ml hardener 1, 57µl 
hardener 2 per mould) and poured into a mould.  Up to 5 embryos were transferred in 
minimal hardener 1 to the mould and carefully orientated (the heads were closely 
aligned to an edge), to facilitate sectioning.  A plastic plug was carefully position on top 
of the mould and the airtight container carefully incubated at 4C for 24-72 hours to 
harden into a resin. 
2.8.4 Preparing resin block for sectioning 
The resin blocks were removed from the mould and dried.  The embryos should be 
clearly visible in the resin block and were reviewed with a stereomicroscope to plan 
removal as a wedge from the resin block.  A bench top vice was used to hold the mould 
and a hacksaw, to cut out the block of embryos with a small volume of surrounding 
resin.  The resin edges were filed, to ensure smooth and the base of the zebrafish resin 
block was glued (Super Glue, Loctite) at 90 onto the remaining resin block and 
allowed to set for 24 hours.  The following day, to maintain continuous orientation of 
sections, the top right corner of the resin block was cut off using a scalpel. 
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2.8.5 Microtome sectioning 
The prepared resin block was sectioned at 5µm.  Sections were positioned on a 
microscope slide using 15% ethanol/ddH2O as an adherent and air dried overnight.   
2.8.6 Staining histology sections 
A standard methylene blue-basic fuschin staining protocol was used (Bennett et al., 
1976).  The necessary solutions were prepared and decanted into 50ml falcon tubes in 
which microscope slides could be dipped.  To make 50ml of the methylene blue-basic 
fuschin stain the following were mixed: 10ml methylene blue (0.5g methylene blue in 
400ml ddH2O), 10ml basic fuschin (0.5g basic fuschin in 400ml ddH2O), 17.5ml 
phosphate buffer pH6.8 ((49ml 0.2M sodium phosphate dibasic anhydrous (28.4g 
Na2H2PO4 in 1L ddH2O)); 51ml 0.2M sodium phosphate monobasic monohydrate 
(27.8g NaH2PO4H2O in 1L ddH2O); 100ml ddH2O) and 12.5ml 95% ethanol.   
The protocol which appeared optimal for staining slides was: 20 dips in methylene blue-
basic fuschin stain, 15 dips in ddH2O, 10 dips in 95% ethanol and 15 dips in water.  
Slides were left to dry in a fumehood overnight.  The following day, coverslips were 
applied using DPX (Distrene, Plasticiser, Xylene) mountant (Sigma).  Images were 
obtained using 20-40x objectives on an axioplan microscope (Axiocam HRC, Zeiss).   
2.9 Electron Microscopy 
2.9.1 Overview  
To evaluate changes to cilia within KV, wholemount scanning electron microscopy 
(SEM) was performed in uninjected WT controls and following MO knockdown in 
zebrafish embryos.   
2.9.2 Fixation and processing for Electron microscopy 
Embryos were fixed at the 8-10 somite stage in 2% glutaraldehyde in Sorenson’s 
phosphate buffer for 24 hours at 4C.  Further preparation including dehydration and 
processing of embryos was performed by Dr Kath White and Ms Tracey Davey at the 
Electron Microscopy Research Services (EMRS), Newcastle University.   
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2.9.3 Mounting and imaging 
Embryos were mounted onto SEM aluminium stubs using self adhesive tape.  Images 
were captured with help from the EMRS using a Cambridge Stereoscan 240 SEM.  KV 
could not be identified in any embryos (n=40) and therefore no comments regarding the 
structure of cilia within KV can be made.  Possible reasons for the failure to identify 
KV could be because of: damage during fixation; distortion of the embryo surface 
during mounting; malorientation of embryos during mounting leading to KV effectively 
being hidden from the SEM. 
2.10 Statistical analyses 
A minimum of 3 different spawning pairs of zebrafish were utilised to generate embryos 
for experiments.  Additionally several experiments were repeated to assess 
reproducibility and consistency of results.  Data was recorded in GraphPad Prism 
software, which was used to calculate means and standard error of the means (SEM).  
Where appropriate, contingency tables were generated to compare phenotypes.  When 
comparing two different groups, Fisher’s exact test was used and a Chi-squared test to 
compare greater than two groups.  Graphs were created using the GraphPad Prism 
software.    
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Chapter 3 Characterisation of a novel zebrafish model of the ciliopathy 
Joubert Syndrome using ahi1 knockdown 
3.1 Introduction 
Mutations in Abelson-helper integration site-1 (AHI1) are the most common genetic 
cause of JBTS, accounting for approximately 12% of affected individuals (Parisi et al., 
2006).  A range of different pathogenic mutations (including nonsense, missense, splice 
site, insertion and frameshift) have been identified in patients, with no single founder 
mutation, even in consanguineous families.  In addition to the pathognomonic, 
neurodevelopmental anomaly of ‘molar tooth sign’ (MTS) on cerebral MRI (Maria et 
al., 1999), patients with AHI1 mutations have been found to have: the cystic kidney 
disease, NPHP (Utsch et al., 2006) and retinopathy, such as Leber’s congenital 
amaurosis (Valente et al., 2006a) in up to 20% of cases.   
3.1.1 Human AHI1 Genomic and Proteomic Information 
Human AHI1 has been mapped to chromosome 6q23.2-23.3 (Ferland et al., 2004).  
There are 18 transcripts for this gene, 10 of which are protein coding, for the Ahi1 
protein, Jouberin.  Using the online Vertebrate Genome Annotation database 
(http://vega.sanger.ac.uk), a transcript with 5921bp (AHI1_008 
OTTHUMT00000391948) has the best supporting evidence, consensus coding sequence 
data and encodes an 1196 amino acid protein called Jouberin.  Using SMART (Simple 
Modular Architecture Research Tool, http://smart.embl-heidelberg.de) domain analysis, 
Jouberin is predicted to have an N-terminal coiled-coil domain, 6 WD40 repeats and a 
Src homology domain (SH3) (Figure 3.1).  The functional implications of Jouberin can 
be hypothesised from this structural information.  Coiled-coil domains have been 
described as structural motifs (Mason and Arndt, 2004), this suggests that Jouberin 
could be an important scaffolding protein and plays a role in maintaining tissue 
structure (Hsiao et al., 2009).  Whilst, SH3 domains are recognised as important in 
protein to protein interactions (Mayer, 2001), Jouberin has been shown to interact with 
nephrocystin-1 (Eley et al., 2008), mks-1 (Sang et al., 2011) and inversin (nphp2) (Sang 
et al., 2011).  Ahi1 mRNA is expressed in human fetal kidney tissue (Ferland et al., 
2004).  Jouberin is known to be expressed in human fetal and adult cerebellum and the 
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medulla of the brainstem (Ferland et al., 2004); also in renal epithelial collecting duct 
cells at cell-cell junctions and at the basal body of primary cilia (Eley et al., 2008).   
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Figure 3.1 AHI1 gene transcript and partial protein product (Jouberin) structure 
in humans and zebrafish  
(A) AHI1 transcript in humans (OTTHUMT00000391948) and schematic representation 
of encoded protein product, Jouberin (B).  (C) ahi1 transcript in zebrafish 
(OTTDART00000049821) and schematic representation of encoded protein product, 
Jouberin (D).  aa, amino acids; CC, coiled coil; Ch., chromosome; WD40 repeats; SH3, 
Src homology domain.  
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3.1.2 AHI1 evolutionary conservation 
AHI1 is highly conserved throughout evolution and has been shown to be particularly 
conserved between humans and a hierarchy of mammals including mice, rats, hamsters, 
cats and cows (Jiang et al., 2002).  To date, orthologues of AHI1 have been identified 
(http://ensembl.org) in 54 species, all vertebrates including zebrafish and a range of 
invertebrate model organisms such as Drosophilia melanogaster, Caenorhabditis 
elegans and in the ciliated protozoa Tetrahymena thermophilia (Simms et al., 2012).  
Previously, expression of ahi1 mRNA has been shown in the brain, retina and inner ear 
of zebrafish between 2.5-5.2 days post fertilisation (dpf) (Doering et al., 2008).  Figure 
3.2 shows the evolutionary conservation of Jouberin between humans, mice and 
zebrafish.  
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Figure 3.2 Evolutionary conservation of Ahi1 (Jouberin) in humans, mice and 
zebrafish 
Jouberin peptide sequence alignment in humans (OTTHUMP00000234456), mice 
(ENSMUSP00000101164) and zebrafish OTTDARP00000039088).  Conservation of 
amino acid alignment (red font). 
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3.1.3 Aims of this chapter 
The main aim of this chapter was to utilise zebrafish as a model organism to elucidate 
the role of ahi1 in the development of the kidney, brain and retina.  To evaluate this, 
temporal expression of ahi1 during zebrafish embryonic development was investigated.  
To study the effect of interference with ahi1 expression on the development of JBTS, 
ahi1 knockdown was performed in zebrafish embryos and a cerebello-oculo-renal 
phenotype was hypothesised.  The pathogenesis of this ciliopathy was evaluated by 
studying cilia in Kupffer’s Vesicle (KV), the zebrafish organ of laterality, and the effect 
on: cardiac left-right development; rudimentary renal (pronephric duct) development 
and cystogenesis. 
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3.2 Results 
3.2.1 Expression of ahi1 during zebrafish embryogenesis 
In order to ascertain the spatial and temporal expression of ahi1 in zebrafish during 
development, in situ hybridisation was performed, using an ahi1 antisense riboprobe, in 
whole mount WT embryos at key time points (Figure 3.3).  At the 8 somite (8s) stage, 
ahi1 is expressed in the eye, notochord and KV (Figure 3.3A-B).  At 24hpf, ahi1 is 
expressed in the retina, midbrain and hindbrain (Figure 3.3C-D).  By 48hpf, ahi1 
continues to be expressed in the retina and is also seen in the hypothalamus and inner 
ear (Figure 3.3E-F).  At 72hpf, expression of ahi1 continues in the inner ear, 
specifically the ganglion cell and pigmented epithelial retinal cell layers and is also seen 
in the olfactory bulbs (Figure 3.3G-H).  The pattern of expression of ahi1 was similar 
using two additional riboprobes which targeted different regions of the ahi1 transcript.  
The in situ hybridisation was repeated using these two additional ahi1 probes as the 
expression was fairly ubiquitous, to determine if other riboprobes may generate a more 
specific focused signal, this did not occur.  The riboprobe used in Figure 3.3 was chosen 
because it generated the most intense and specific staining in the most timely manner.  
Expression of ahi1 in the developing pronephros of zebrafish at 48hpf was identified on 
tissue sections by performing resin embedding and tissue sectioning at 5µm following 
whole mount in situ hybridisation (Figure 3.4). 
Overall the expression of ahi1 appears ubiquitous particularly during the first 24hpf 
confirmed by utilising three different riboprobes.  Since the ahi1 riboprobe in situ 
experiments followed several learning attempts in which riboprobes with published 
expression patterns (shh (Wang et al., 2007); cmcl2 (Ott et al., 2008)) were recapitulated 
as shown in Figure 3.6, this likely reflects the nature of the ahi1 riboprobes used herein.  
Of note, the same images were used to demonstrate the expression of ahi1 during 
embryogenesis in these figures as used in the peer reviewed and accepted publication 
(Simms et al., 2012) of this data as shown in Figure 2 of Appendix F. 
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Figure 3.3 Expression of ahi1 during zebrafish embryogenesis  
Lateral (A, C, E, G) and dorsal (B, D, F, H) images of whole-mount in situ 
hybridisation using an ahi1 antisense riboprobe on golden, wild type embryos at 8 
somites (8s) (A, B), 24hpf (C, D), 48hpf (E, F) and 72hpf (G, H).  ahi1 is expressed as 
follows: at 8s in the eye (black arrowhead, A), diffusely in the notochord and in 
Kupffer's vesicle (white arrow, A, B); at 24hpf in the midbrain, hindbrain (arrows, C, D) 
and retina (arrowhead, C); at 48hpf in the retina, hypothalamus (arrow, E, F) and inner 
ear; at 72hpf in the inner ear (arrowhead, G), olfactory bulbs (arrowheads, H), and 
specific retinal layers (GCL and RPE, H).  GCL=ganglion cell layer, hpf=hours post 
fertilisation, RPE=retinal pigmented epithelium.  
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Figure 3.4 Expression of ahi1 in zebrafish pronephros.   
Transverse section at the level of the medial tubules of the pronephros following whole-
mount in situ hybridisation using an ahi1 antisense riboprobe on golden, wild type 
embryos at 48 hpf.  In both images, the arrows demonstrate ahi1 expression in the 
pronephros.  Images were taken with a 20x (A) and 40x (B) objective lens.  Scale bars 
are 20µm. n=notochord, s=somites. 
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3.2.2 Expression of control in situ hybridisation probes during zebrafish 
embryogenesis 
To exclude nonspecific background staining, whole mount in situ hybridisation was 
performed using an ahi1 sense riboprobe and a ‘no probe’ control during temporal 
zebrafish development (Figure 3.5).  There was no specific staining of embryos using 
the ahi1 sense riboprobe and no background staining when no riboprobe was used.  In 
parallel with ahi1 riboprobe experiments, positive controls for the in situ hybridisation 
technique were performed and generated similar results to those published, using shh 
antisense (Concordet et al., 1996; Wang et al., 2007) and cardiac myosin light chain 2 
(cmcl2) antisense (Ott et al., 2008; Wythe et al., 2011) riboprobes in WT zebrafish 
embryos (Figure 3.6).  shh is expressed in the notochord at the 8s stage (Figure 3.6A), 
in the eye and floor plate at 24hpf (Figure 3.6C) and additionally in the telencephalon, 
diencephalon, hypothalamus and pharyngeal arches by 48hpf (Figure 3.6E).  cmcl2 
expression is not present at the 8s stage (Figure 3.6B), however it is seen clearly and 
specifically in the single zebrafish ventricle at both 24 and 48hpf (Figure 3.6, F). 
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Figure 3.5 In situ hybridisation controls for ahi1 antisense riboprobe during 
zebrafish embryogenesis 
Lateral views of whole-mount in situ hybridisation using ahi1 sense riboprobe (A, C, E, 
G) and no probe (B, D, F, H) on golden, wild type embryos at 8 somites (8s) (A, B), 
24hpf (C, D), 48hpf (E, F) and 72hpf (G, H).  hpf, hours post fertilisation. 
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Figure 3.6 In situ hybridisation positive controls for ahi1 antisense riboprobe 
during zebrafish embryogenesis  
Lateral views of whole-mount in situ hybridisation using shh antisense (A, C, E, G) and 
cmcl2 antisense (B, D, F, H) riboprobes on golden, wild type embryos at 8 somites (8s) 
(A, B), 24hpf (C, D), 48hpf (E, F) and 72hpf (G).  shh is expressed in the notochord 
(A) at the 8s stage; in the eye and floorplate at 24hpf (C); additionally in the 
telencephalon, diencephalon, hypothalamus and pharyngeal arches at 48hpf (E) and 
72hpf (G).  cmcl2 expression is not detectable at the 8s stage (B), however at 24hpf (D) 
and 48hpf (F) it is evident specifically in the single ventricle.  cmcl2, cardiac myosin 
light chain 2; hpf, hours post fertilisation; shh, sonic hedgehog. 
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3.2.3 Design and effect of ahi1 morpholino oligonucleotides 
In order to study the effects of gene knockdown in zebrafish models of human disease, 
MOs were created to interfere with ahi1 expression.   
Figure 3.7 shows the target sites for both the ahi1 translation and splice blocking MOs 
on the zebrafish ahi1 exon sequence.  The splice blocking MO leads to an inframe 
deletion in exon 8 and a predicted loss of 3 WD40 repeats from the encoded protein, 
Jouberin. 
The injection of MOs is performed promptly after fertilisation, at the 1-4 cell stage, and 
any increased mortality associated with MO delivery was evaluated at 24hpf.  Figure 
3.8 depicts the mortality at 24hpf as mean percentage and standard error of the mean for 
a range of doses of ahi1 splice and translation blocking MOs.  24hpf mortality data is 
also shown for uninjected WT control embryos from the same parental pairs and for 
embryos injected with a standard negative control MO.  It must be acknowledged that 
24hpf mortality rates for controls, both standard negative control MO injected and 
uninjected WT embryos, were at times as high as 50% (Figure 3.8C).  Most users of our 
zebrafish facility have experienced this problem periodically and there has been no 
consensus as to why this can occur.  As discussed in section 2.2.1, the facilities within 
the zebrafish laboratory are carefully monitored.  A collective decision amongst 
zebrafish researchers in our laboratory has therefore been to keep careful records to 
monitor mortality rates and providing the mortality rates in the MO injected embryos 
were not significantly different from matched control experiments, not to exclude such 
work as on occasions this may restrict the ability to generate data.  An alternative 
method to consider in future when evaluating data would be to subtract the percentage 
mortality in controls from the percentage mortality in MO injected embryos. 
With ahi1 splice blocking MO, there is a dose dependent association between MO dose 
and 24hpf mortality (Figure 3.8A).  There was no significant difference in mortality 
rates at 24hpf between MO injected and uninjected embryos. 
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Figure 3.7 ahi1 morpholino oligonucleotide design 
(A) Schematic representation of zebrafish ahi1showing target sites of translation (ATG) 
and splice (ahi1iex8) blocking morpholino oligonucleotides (MO). (B) Schematic 
representation of the effect of the splice blocking MO designed to target exon 8, leading 
to an inframe deletion and loss of 3 WD40 repeats from the protein product, Jouberin 
(C).  
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Figure 3.8 Mortality at 24hpf following MO injection   
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) and 
standard error of the mean (where appropriate) in zebrafish embryos injected with 
morpholino oligonucleotide (MO) compared to matched uninjected wild type (WT) 
controls.  (A) ahi1 splice (Sp) MO induces a dose dependent effect on mortality.  (B) 
ahi1 translation (ATG) blocking MO has a more variable effect on mortality. (C) 
Injection of a standard control (Std Con) MO induced no significant difference (p=0.92, 
unpaired t-test) in mortality at 24hpf compared to uninjected WT controls 
.
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3.2.4 Phenotypes of zebrafish morphants created by ahi1 MO knockdown 
Zebrafish embryos were phenotyped by light microscopy at 72hpf.  Uninjected WT 
embryos and those injected with a standard negative control (Std Con, defined in 
section 2.3.2) MO were phenotypically normal (Figure 3.9A, B).  However, both ahi1 
splice (ahi1 Sp) and ahi1 translation (ahi1 ATG) targeting MOs caused abnormal 
development including a curved body axis, hydrocephalus, cardiac oedema and altered 
number of otoliths (Figure 3.9).  Additionally ahi1 morphants develop cysts throughout 
the pronephros (Figure 3.10) and cystic dilatation of the distal pronephros at the cloaca 
(Figure 3.11).  
Figure 3.10 shows light and fluorescent microscopy images of uninjected claudin-
b:Lyn-GFP transgenic WT and ahi1 splice MO injected zebrafish embryos, highlighting 
the cysts throughout the pronephros in the ahi1 morphants (Figure 3.10C-F). 
In addition to light microscopy of cloacal dilatation, Figure 3.11 shows: resin histology 
cross sections of dilated pronephric tissue at the level of the posterior tubules (Figure 
3.11D) and cloaca (Figure 3.11F) in ahi1 morphants; fluorescent microscopy of cystic 
dilatation of the cloaca in claudin-b:Lyn-GFP transgenic ahi1 morphants (Figure 
3.11H), compared to uninjected WT controls. 
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Figure 3.9 Phenotype following ahi1 MO knockdown at 72 hpf 
Lateral views show wild type uninjected (A) zebrafish embryos and those following 
injection with a standard negative control MO (Std Con MO, B) were morphologically 
normal.  Injection of ahi1 splice (Sp, C, D) and translation (ATG, E, F) blocking MOs 
leads to curved body axis, hydrocephalus (arrows), cardiac oedema (*), pronephric cysts 
and altered number of otoliths (single in F (arrowhead). hpf, hours post fertilisation; 
MO, morpholino oligonucleotide. 
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Pg2 Fig 3.9 
  
 ________________________ Chapter 3:  A zebrafish model of Joubert Syndrome using ahi1 knockdown  
136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 ahi1 knockdown induces pronephric cysts in zebrafish embryos 
Light and fluorescent microscopy images of pronephric cysts in golden (A, C-E) and 
claudin-b:Lyn-GFP transgenic (B, F) zebrafish embryos at 72hpf.  Lateral views of wild 
type, uninjected embryos were normal (A, B).  1-4ng of ahi1 splice blocking MO 
induces proximal (lateral and dorsal views, arrowed, C, D) and distal (at the cloaca, 
arrowed E, F) pronephric cysts.  MO, morpholino oligonucleotide; hpf, hours post 
fertilisation. 
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Figure 3.11 ahi1 knockdown induces cystic dilatation, cloacal dilatation and 
obstruction in zebrafish embryos 
Light microscopy images of distal pronephric cysts (arrows) leading to cloacal 
obstruction in golden ahi1 morphant (ahi1 Sp MO) embryo at 72hpf (B), compared to 
uninjected wild type (WT) control (A).  Resin histology 5µm sections through the 
pronephros (arrows) in embryos at 72hpf, stained with methylene blue-basic fuchsin 
stain.  Images taken with a 40x objective lens at the level of the posterior pronephric 
tubules (arrows, C-D) and the cloaca (E-F).  In ahi1 morphants, the posterior tubules are 
modestly dilated (D, diameter 5μm), compared to WT controls (C, diameter 3μm).  This 
pronephric dilatation becomes more pronounced in ahi1 morphants at the level of the 
cloaca (F, diameter 10μm), compared to WT controls (E, diameter 2μm).  Scale bar = 
10μm.  Fluorescent images of the cloaca (G,H) using the claudinb:Lyn-GFP transgenic 
line, taken with a 20x objective. ahi1 morphants have cystic dilatation of the cloaca (H, 
arrow), compared to WT controls (G).  Scale bar = 50μm.  
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At 48 and 72hpf, ahi1 morphant embryos may also have abnormal eye development 
including coloboma formation seen on light microscopy; and retinal dystrophy is 
identified on resin histology cross sections of the eyes (Figure 3.12).  There is loss of 
formation of the normal discrete retinal layers (Liu et al., 2011) in ahi1 morphants 
(Figure 3.12F, H) compared to uninjected WT controls (Figure 3.12E, G). 
To further characterise the apparent hydrocephalus and disruption to the development of 
the brain induced by ahi1 knockdown in zebrafish morphants, resin histology cross 
sections through the brain at the level of the otic vesicle reveals both hydrocephalus and 
expansion of the notochord (Figure 3.13), compared to uninjected WT controls. 
Development of the rudimentary ear is altered in ahi1 morphants as shown by lateral 
and dorsal light microscopy images of their heads (Figure 3.14).  ahi1 morphants may 
develop an empty otic vesicle, or an abnormal number of otoliths (one or three), 
compared to uninjected WT controls, which usually develop two otoliths.    
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Figure 3.12 ahi1 knockdown induces coloboma formation and retinal dystrophy in 
zebrafish embryos 
Light microscopy images comparing the eyes of uninjected wild type (WT) embryos (A, 
B) and ahi1 morphants (C, D) at 48hpf and 72hpf.  In ahi1 morphants there is abnormal 
eye development with coloboma formation (arrowed, C, D).  Resin histology of eyes at 
72hpf, sectioned at 5-7µm and stained with methylene blue-basic fuchsin stain.  Images 
taken with a 20x (E, F) and 40x (G, H) objective lens, scale bars = 20μm.  In WT 
control embryos (E, G), there is normal retinal lamination (arrowed, E) including 
formation of the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear 
layer (ONL).  In ahi1 morphants (F, H) there is severe disruption to normal retinal 
development, with failure of discrete retinal layer formation, however, the outer retinal 
pigmented epithelium (RPE, arrowed in F) remains present.  hpf, hours post 
fertilisation. 
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Figure 3.13 ahi1 knockdown induces hydrocephalus and abnormal brain 
development in zebrafish embryos 
Light microscopy images demonstrating hydrocephalus (arrowed, B, C) and abnormal 
hindbrain development in ahi1 morphant zebrafish embryos, compared to normal brain 
development in uninjected wild type (WT) control embryos (A) at 72hpf. Resin 
histology cross sections (5-7μm) through the brain at the level of the otoliths in WT 
controls (D) and ahi1 morphants (E, F) at 72hpf.  In ahi1 morphants there is 
hydrocephalus (asterisk, E, F) and expanded notochord (midline diameter 52μm in ahi1 
morphants, compared to 34μm in WT controls.  Scale bar = 50μm. hpf, hours post 
fertilisation; N, notochord. 
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Figure 3.14 ahi1 knockdown induces abnormal ear development with altered 
number of otoliths in the otic vesicle of zebrafish embryos 
Light microscopy lateral (A, C, E, G) and dorsal (B, D, F, H) images of the head of 
zebrafish embryos focusing on the otic vesicles (developmental ear) at 72hpf.  
Uninjected wild type (WT) control embryos have 2 otoliths in each otic vesicle (A, B), 
whilst ahi1 morphants have either no otoliths and an empty otic vesicle (C, D), a single 
otolith (E, F), or three otoliths (left otic vesicle G, H).  hpf, hours post fertilisation.  
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The mean frequencies of the development of each abnormal phenotype at 72hpf 
following injection of ahi1 splice (ahi1 Sp) or translation (ahi1 ATG) blocking MO are 
shown in Figure 3.15.  The frequency of development of abnormal phenotype is 
predominantly dose dependent, with generally lower doses of splice (Figure 3.15A-C) 
blocking MO required to induce a phenotype (mean percentage (±SEM)).  Injection of 
1-2ng of ahi1 Sp MO induced the following frequency of phenotypes: pronephric cysts 
in 7% (±3.1%) to 10.9% (±2.7%); curved body axis in 36.2% (±7.6%) to 39.9% 
(±7.6%); cardiac oedema in 34.5% (±6.9%) to 35.1% (±6.9%); hydrocephalus in 20.4% 
(±4.6%) to 29.3% (±5.4%); otic defects in 2% (±0.7%) to 3.7% (±1.2%) and colobomas 
in 0.5% (±0.4%) to 0.9% (±0.5%).  With injection of 4-6ng of ahi1 ATG MO, the 
following frequency of phenotypes occurred: pronephric cysts in 3.8% (±3.1) to 7.5% 
(±3.6%); curved body axis in 11.8% (±4.9%) to 27% (±7.8%); cardiac oedema in 13% 
(±6.4%) to 25.5% (±6.5%); hydrocephalus in 3% (±0.7%) to 12.5% (±4.3%); otic 
defects in 0.8% (±0.8%) to 3% (±3%) and colobomas (at 4ng only) in 0.5% (±0.5%).  
This array of abnormal phenotypes identified in the ahi1 morphant zebrafish, including 
curved body axis, cardiac oedema, hydrocephalus, pronephric cysts, otic defect and 
retinal anomalies are characteristic of a zebrafish ciliopathy model (Ferrante et al., 
2009; Obara et al., 2006).     
3.2.5 Specificity of ahi1 MO knockdown in ahi1 zebrafish morphants 
To ensure the described phenotype of ahi1 morphants was not an off-target or non-
specific effect, appropriate control experiments were performed in parallel and embryos 
evaluated at 72hpf.  Zebrafish embryos injected with either a standard negative control 
(Std Con) MO (Figure 3.9B) or p53 MO (Figure 3.16B) alone were phenotypically 
normal.  Following the combined injection of ahi1 splice and p53 MO or ahi1 
translation blocking and p53 MO images show that embryos continue to develop a 
morphant phenotype (Figure 3.16C-D), excluding off-target effects.   
The complete rescue of the ahi1 morphant phenotype to a normal appearance, following 
coinjection of mouse Ahi1 mRNA with ahi1 MO, confirms specificity of the ahi1 MO 
sequence used for knockdown (Figure 3.16F).  All embryos injected with mouse Ahi1 
mRNA alone (100%, n=117), and 99% of uninjected embryos (n=2699) or those 
injected with standard control MO (n=197) were phenotypically normal (Figure 3.17).  
There was a statistically significant fall in the percentage of ahi1 morphants and rescue 
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to a normal phenotype, following co-injection of 100pg mouse Ahi1 mRNA with 2-4ng 
of ahi1 MO, compared to embryos injected with 2-4ng ahi1 MO alone (p < 0.0001, chi-
squared test).  Figure 3.17B shows quantification of the raw numbers of embryos by 
normal WT or abnormal morphant phenotype when classified by treatment with 
injection of 2-4ng ahi1 MO alone (n=517) or co-injection of 100pg mouse Ahi1 mRNA 
with 2-4ng of ahi1 MO (n=88).  The degree of overall rescue from ahi1 morphant to 
WT appearance and reduced frequency of the majority of abnormal phenotypes (curly 
tail, cardiac oedema, hydrocephalus and pronephric cysts) following co-injection of 
ahi1 MO and mouse Ahi1 mRNA were statistically significant (p < 0.0001, chi-squared 
test). 
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Figure 3.15 Quantification of abnormal phenotypes at 72hpf following injection 
with ahi1 splice or translation blocking MO 
Data are displayed as mean ± SEM. The percentage frequency of each abnormal 
phenotype was higher following injection of a lower dose of ahi1 splice (Sp) MO (A-
C), compared to following injection of an equivalent dose of ahi1 translation (ATG) 
MO (D-F). With ahi1 Sp MO knockdown, there was a dose dependent effect on the 
frequency of curly tail, cardiac oedema, hydrocephalus and coloboma (B, C).  
Following ahi1 ATG MO knockdown, there was a dose dependent effect on the 
frequency of pronephric cysts, curly tail, cardiac odema and otic defects (D-F).  The 
total number of zebrafish embryos phenotyped at 72hpf following ahi1 Sp MO were 
1498 and following ahi1 ATG MO were 458.  hpf, hours post fertilisation; MO, 
morpholino oligonucleotide. 
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Figure 3.16 Exclusion of off-target effects and confirmation of specificity of 
phenotype with ahi1 MO knockdown   
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type (WT) 
uninjected (A), embryos injected with p53 MO alone (B) and embryos injected with 
mouse Ahi1 mRNA alone (E), were morphologically normal.  Embryos co-injected with 
p53 MO and ahi1 splice (C) or translation blocking (D) MOs continued to develop a 
morphant phenotype including hydrocephalus (C, (*)), pronephric cysts (D, arrowhead) 
and altered number of otoliths (C, arrow), and excludes the possibility of off-target 
effects.  Co-injecting mouse ahi1 mRNA with ahi1 splice blocking MO rescued 
embryos to a normal phenotype (F), confirming the specificity of targeted ahi1 MO 
knockdown.  MO, morpholino oligonucleotide. 
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Figure 3.17 Rescue of ahi1 morphant phenotype following co-injection with mouse 
Ahi1 mRNA 
(A) Percentage of normal wild type (WT) and abnormal morphant phenotype of 
embryos: uninjected (n=2699); 2ng standard control MO (n=197); 100pg mouse Ahi1 
mRNA (n=117); 2-4ng ahi1 MO (n=517); coinjection of mouse Ahi1 mRNA and 2-4ng 
ahi1 MO (n=88).  Rescue to WT phenotype by coinjection with 100pg mouse Ahi1 
mRNA was statistically significant (*, p < 0.0001, chi-squared test).  (B) Raw 
quantification of overall rescue from ahi1 morphant to WT phenotype after co-injection 
with 100pg mouse Ahi1 mRNA was statistically significant (*, p < 0.0001, chi-squared 
test).  (C)  There was a statistically significant rescue of ahi1 morphants to the WT 
phenotype, and reduced frequency of anomalies (curly tail, cardiac oedema, 
hydrocephalus, pronephric cysts) after co-injection with mouse Ahi1 mRNA (*, p < 
0.0001, chi-squared test).  Data are % mean ± SEM.  MO, morpholino oligonucleotide.   
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3.2.6 Specificity of ahi1 splice MO knockdown and direct sequencing 
RT-PCR of (equal concentrations of isolated RNA from) individual uninjected WT 
zebrafish embryos at 24-72hpf revealed the expected product size of 807bp.  However, 
in ahi1 splice MO injected zebrafish embryos there was abnormal splicing suggested by 
an additional smaller RT-PCR product (faint band at 453bp) at 24 and 72hpf (Figure 
3.18A).  Additionally there is almost complete loss of expression of ahi1 (faint 807bp 
band) at 48hpf with recovery by 72hpf due to the waning effect of MO knockdown 
(Figure 3.18A). 
The smaller PCR fragment was isolated from the gel, purified and sent for sequencing, 
which identified a 453bp product created by an inframe deletion of exon 8 and 
introduction of a premature stop codon (Figure 3.18B).  The chromatogram showing the 
quality of the sequenced smaller ahi1 product is also shown (Figure 3.18C). 
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Figure 3.18 Evidence of ahi1 splice MO knockdown by RT-PCR and direct 
sequencing 
(A) RT-PCR of single embryos at 24, 48 and 72hpf following ahi1 splice MO 
knockdown reveals a smaller RT-PCR product (white arrowhead) compared to 
uninjected wild type (WT) control embryos.  The normal RT-PCR product of 807bp is 
maximally reduced in ahi1 morphants at 48hpf, with recovery at 72hpf.  (B) Direct 
sequencing of the smaller product (453bp) in ahi1 morphants identifies direct skipping 
of exon 8 and introduction of a premature stop codon.  bp, base pairs; hpf, hours post 
fertilisation; MO, morpholino oligonucleotide. 
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Figure 3.18 (C) Evidence of ahi1 splice MO knockdown by direct sequencing   
Chromatogram showing good quality of sequencing of smaller ahi1 product at 72hpf.  
hpf, hours post fertilisation. 
NB this is 2
nd
 page of Figure 3.18 
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3.2.7 Gross morphology of Kupffer’s vesicle in ahi1 MO injected embryos 
KV was evaluated to determine whether this ciliated structure may offer an explanation 
for the ciliopathy phenotype which ahi1 morphants develop (Figure 3.9, Figure 3.10, 
Figure 3.11, Figure 3.12, Figure 3.13, Figure 3.14).  Figure 3.19 contains light 
microscopy images and shows KV, seen as a spherical concave sac at the tailbud, is 
evident in time-matched WT and ahi1 MO injected embryos at 8-10 somites.  There are 
no obvious differences in the gross morphology of KV between uninjected WT control 
and ahi1 MO injected zebrafish embryos.   
In situ hybridisation was also performed using a charon riboprobe, which is specifically 
expressed around KV (Hashimoto et al., 2004), and confirmed no overt change in the 
pattern of expression following ahi1 MO injection (Figure 3.19C, F). 
3.2.8 Loss of cilia from Kupffer’s vesicle following ahi1 MO injection 
Fluid flow generated by cilia within KV is essential for determining patterning of left-
right asymmetry (Essner et al., 2005).  Immunostaining of cilia using an antibody to 
acetylated tubulin showed loss of cilia in ahi1 MO injected embryos (Figure 3.20).  The 
zebrafish embryos utilised for immunostaining express claudin-b at cell to cell junctions 
(tight junctions) of KV epithelial cells and this expression is also abnormal and 
disrupted in ahi1 MO injected embryos compared to WT embryos. 
To further evaluate KV and cilia, immunostaining was performed using two antibodies, 
anti-acetylated tubulin to highlight cilia and pericentrin to identify centrosomes.  This 
was an attempt to determine more about the extent of disruption to ciliogenesis 
following ahi1 MO injection, for example, whether centrosomes were able to form.  
This experiment was additionally performed in embryos injected with the standard 
mismatched control (Std Con) MO to identify whether there were any anomalies noted 
regarding cilia as a consequence of MO injection.  Figure 3.21 shows that in uninjected 
WT, Std Con MO injected and ahi1 MO injected embryos there was no discrete 
centrosomal staining, demonstrating failure of the pericentrin antibody to work.  Further 
evidence of failure of the pericentrin antibody to work was the presence of cilia in the 
uninjected WT, Std Con MO injected and in some ahi1 MO injected embryos, implying 
that centrosomes were present however not identified by the pericentrin antibody.  This 
failure of the pericentrin antibody to work occurred despite attempting to optimise 
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conditions including dilutions of antibody used and duration of incubation.  
Subsequently following further evaluation, it is possible that the pericentrin antibody 
utilised herein does not react with zebrafish and an alternative antibody such as γ-
tubulin could have utilised as a centrosomal marker (Lessman, 2012).  In future work, 
this could be performed as it would be interesting to further clarify the apparent loss of 
cilia identified in some ahi1 morphants.   
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Figure 3.19 The gross morphology of Kupffer's vesicle is preserved in ahi1 MO 
injected embryos 
Images of uninjected wild type (WT) control (A-C) and ahi1 MO injected (D-F) golden 
zebrafish embryos at the 8-10 somite stage to illustrate Kupffer's vesicle (KV, arrowed).   
Both lateral (A, D) and dorsal (B, E) light microscopy images of live embryos at the 8-
10 somite stage confirm the presence of KV in both WT (A, B) and ahi1 MO injected 
(D, E) embryos.  A charon in situ hybridisation probe is expressed in the region around 
KV, confirming its presence in both WT controls (C) and ahi1 MO injected embryos 
(F).    
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Figure 3.20 Loss of cilia from Kupffer's vesicle in ahi1 MO injected embryos 
Confocal microscopy images of cldnb:Lyn-GFP zebrafish embryos following fixation at 
the 8-10 somite stage and fluorescent immunostaining using anti-acetylated tubulin 
(AT, red) to study cilia in Kupffer's vesicle (KV).  Overlay images using 20x objective 
(KV arrowed, A, E, scale bar = 50µm ) and higher magnification (zoom of 3) showing 
individual (B, C, F, G, scale bars = 20µm) and overlay (D, H, scale bars = 20µm) 
images.  Uninjected wild type (WT, A-D) control embryos show cldnb:Lyn-GFP 
expression in an organised pattern at epithelial cell-cell junctions within KV (B) and 
apical cilia (red, C) extending from cells lining KV.  ahi1 MO injected embryos (E-H) 
have disorganised expression of cldnb:Lyn-GFP (F) and loss of cilia (G) from KV.  
MO, morpholino oligonucleotide.    
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Figure 3.21 Cilia remain present in Kupffer's vesicle in Standard Control MO 
injected embryos and some ahi1 MO injected embryos 
Confocal microscopy images of cldnb:Lyn-GFP zebrafish embryos following fixation at 
the 8-10 somite stage and double fluorescent immunostaining using anti-acetylated 
tubulin (AT, red) and pericentrin (PC, green) to study cilia and centrosomes 
respectively in Kupffer's vesicle (KV).  Images are standard control MO injected (Std 
Con, A-C), ahi1 MO injected (D-F) and uninjected wild type (WT, G, H) for 
comparison.  Individual green channel images (A, D) fail to show discrete centrosome 
staining, KV is represented as a dark lumen.  Individual red channel images (B, E, G) 
show staining of cilia at KV in Std Con (B), some ahi1 (E) MO injected embryos and 
WT (G).  Overlay fluorescent images (C, F, H) are shown.  All images were taken using 
a 20x objective and zoom of 3, scale bars = 20µm. GFP, green fluorescent protein; MO, 
morpholino oligonucleotide. 
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Since the experiments performed thus far suggest that the presence of cilia in KV 
following ahi1 MO injection is variable, a further attempt to evaluate this involved 
double antibody staining using atypical protein kinase C (aPKC, to study the apical 
epithelial membrane of KV) (Amack et al., 2007) and anti-acetylated tubulin to stain for 
cilia.  This experiment was performed in golden embryos fixed at 8-10 somites.  Figure 
3.22 shows further evidence of the variable appearance of KV following ahi1 MO 
injection.  The development of KV appears organised and normal in some ahi1 MO 
injected embryos (Figure 3.22A-C), however the apical epithelial membrane (green, 
Figure 3.22A, C) whilst apparent in these images is not clearly distinct from the rest of 
embryo and likely reflects background staining and failure of the aPKC antibody to 
work.  In other ahi1 MO injected embryos with more marked disruption of KV (white 
arrow, Figure 3.22D-F), it is impossible to ascertain anything meaningful regarding the 
appearance of the apical epithelial membrane (Figure 3.22D) and only a reduction in the 
number of cilia (Figure 3.22) can be identified. 
Analysis of the presence or absence of cilia in KV in uninjected WT, ahi1 MO injected 
and Std Con MO injected embryos is shown in Figure 3.23.  The raw number of 
embryos for each treatment group is graphed in Figure 3.23A and shows that only 3 of 
32 embryos injected with ahi1 MO had a ciliated KV, compared to 30 of 35 uninjected 
WT embryos.  This was a statistically significant difference, p < 0.0001, using a chi-
squared test.  A stacked bar chart (Figure 3.23B) shows the same data as percentages 
and highlights that the majority of Std Con MO injected embryos also had a ciliated 
KV.  This excludes the possibility than abnormality in KV is induced by injection of a 
MO alone. 
Although ahi1 MO injected embryos generally had no cilia in KV, when they were 
present, the cilia appeared shorter and stubbier than in uninjected wild type embryos.  A 
simple neurite tracer application from Fiji software package was used to formally 
measure the length of all cilia using z-stack images of KV, at the level of the maximal 
diameter of KV.  Figure 3.23C graphs the mean and standard error of the mean length 
of cilia in KV in ahi1 MO injected embryos (3.5±0.5µm) compared to uninjected WT 
embryos (5.7±0.3µm) and shows that cilia in KV were significantly (p=0.0057, 
unpaired t-test) shorter in ahi1 MO injected embryos.   
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Figure 3.22 Variable spectrum of disruption to the development of Kupffer's 
Vesicle in ahi1 MO injected zebrafish 
Confocal microscopy images of golden zebrafish embryos injected with ahi1 MO 
following fixation at the 8-10 somite stage and double fluorescent immunostaining 
using atypical protein kinase C (aPKC, green, A, D) antibody to label the apical 
membrane of KV cells and anti-acetylated tubulin (AT,red, B, E) antibody to label cilia.  
Whilst the development of KV appears normal in some ahi1 MO-injected embryos (A-
C), in others there is marked disruption of the KV apical membrane (D), with reduction 
in the number of cilia (E).  Images were taken with a 20x objective and zoom of 3.  
Scale bars = 20 µm.  MO, morpholino oligonucleotide. 
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Figure 3.23 Analysis of cilia in Kupffer's vesicle of ahi1 MO injected embryos 
(A) Quantification of KV phenotype, whether ciliated or not, as determined by confocal 
microscopy of embryos fixed at 8-10 somite stage and labelled with anti-acetylated 
tubulin antibody to detect cilia.  ahi1 MO injected embryos (n=32) had a statistically 
significant reduction in the number of embryos with cilia in KV (*, p < 0.0001 chi-
squared test), compared to uninjected wild type (WT) control embryos (n=35) and 
embryos injected with a standard control (Std Con) MO (n=5).  (B) Stacked bar chart 
showing the percentage reduction in KV with cilia in ahi1 morphants, compared to 
uninjected and Std Con MO injected embryos.  (C) Data are shown as mean ± SEM of 
length of cilia in in KV.  Cilia in KV were significantly shorter, when present, in ahi1 
MO injected embryos (n=2, 3.50± 0.50µm), compared to uninjected WT controls (n=6, 
5.68± 0.25µm) (*, p=0.0057, unpaired t-test).  Simple neurite tracer (Fiji software) was 
used to measure the length of cilia from confocal z-stack images of embryos labelled 
with anti-acetylated tubulin antibody.  Approximately 20 cilia in KV were measured per 
embryo.  MO, morpholino oligonucleotide. 
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3.2.9 Left-right asymmetry defects following ahi1 MO injection 
Leftward fluid flow, generated by cilia beating in KV, is essential for left-right body 
patterning and determining the laterality of organogenesis (Amack et al., 2007; Essner 
et al., 2005).  Cardiac left-right asymmetry begins from around 24hpf, when the initially 
straight cardiac tube ‘jogs’ to the left and subsequently from 36hpf the heart tube 
‘loops’ to the right, leading to the final positioning of the single ventricle to the right of 
the single atrium by approximately 48hpf (Ahmad et al., 2004).  This two stage 
development of cardiac asymmetry is considered predictable from the initial position of 
the heart tube (jogging) to the final direction of the heart (looping) and was suggested to 
be coupled by the same genetic signalling mechanism and predicted by the initial heart 
tube position in embryos with a normal notochord (Chen et al., 1997; Chin et al., 2000).  
However in zebrafish embryos with an abnormal notochord, which mediates a ‘midline 
barrier’ to genetic molecular signals, the initial heart tube position and subsequent 
direction of heart looping were found to be uncoupled or randomised (Chin et al., 2000).  
Further midline barriers mediated by Bmp signalling and lefty2 expression regulate left-
right patterning and understanding of these conserved important pathways continues to 
be established (Lenhart et al., 2011). 
The normal pattern of cardiac looping in zebrafish embryos is rightward or D-looping.  
Alterations in cardiac looping and ultimate cardiac laterality can be a consequence of 
abnormal fluid flow in KV and a read out of cilial defects.  Indeed, an absence of 
normal cilia in KV of zebrafish morphants has been shown to be associated with loss of 
fluid movement in KV (Kramer-Zucker et al., 2005).  Although one might expect this to 
lead to randomisation of left-right patterning (Amack and Yost, 2004), loss of cilia in 
KV has been shown to lead to aberrant (predominantly right-sided) expression of left-
right genes such as southpaw (spaw) (Kramer-Zucker et al., 2005).  spaw is a zebrafish 
nodal related gene and has been identified as the earliest marker of left-right asymmetry 
showing strong left-sided expression at the 10-12 somite stage (Long et al., 2003).  MO 
knockdown of spaw leads to loss of downstream asymmetrical molecular markers 
(Essner et al., 2005), thus clearly it plays a fundamental role. 
Cardiac looping can be evaluated by light microscopy, however the use of transgenic 
zebrafish which express GFP under a cardiac myosin light chain (cmcl2) promoter 
highlights the heart (Huang et al., 2003), making scoring more obvious and enabling the 
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acquisition of clearer images.  Figure 3.24 shows paired light and fluorescent 
microscopy ventral images of the three different patterns of cardiac looping used to 
score the embryos.  An uninjected WT control embryo displays the normal rightward 
looping (D-looping), whereas ahi1 morphants showed either no looping, with a straight 
heart tube (this midline heart position is also referred to as randomised) (Chin et al., 
2000), or reversed leftward looping (L-looping) (Figure 3.24).  Quantification of the 
cardiac looping phenotype revealed that all uninjected WT control embryos had normal, 
D-looping (n=145), whereas in ahi1 morphants only 58 of 221 (26%) developed D-
looping.  In the remaining ahi1 morphants: 13 (6%) failed to develop a cardiac loop and 
had a straight heart tube; whilst 150 (68%) had a reversed appearance with a L-loop.  
This difference in normal D-looping between uninjected WT control embryos and ahi1 
morphants was statistically significant (p < 0.0001, chi-squared test) (Figure 3.25A).  
To ascertain whether altered cardiac left-right asymmetry was a consequence of MO 
injection alone, a standard negative control MO was injected.  Only 1 of 39 embryos 
injected with the Std Con MO developed the reversed cardiac L-loop, the rest of the 
embryos developed normal D-looping.  Figure 3.25B is a stacked bar chart displaying 
the percentage cardiac looping phenotype of each experimental group. 
  
 ________________________ Chapter 3:  A zebrafish model of Joubert Syndrome using ahi1 knockdown  
160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24 Defects in heart laterality after ahi1 knockdown in cmcl2-GFP 
zebrafish embryos 
Paired light and fluorescent microscopy ventral images of cardiac myosin light chain 2 
(cmcl2-GFP) zebrafish embryos at 56 hours post fertilisation (hpf) to assess cardiac 
looping.  The normal rightward looping (D-looping) of the zebrafish heart tube leads to 
positioning of the single ventricle (V) to the right of the single atrium (A) as seen in 
uninjected wild type (WT) control embryos (A, B).  In contrast, in ahi1 morphant 
embryos there is either no looping of the heart tube (C, D) or a reversal of the normal 
pattern with leftward looping (L-looping, E , F).     
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Figure 3.25 Analysis of cardiac looping reveals laterality defects in ahi1 MO 
injected embryos 
(A) Quantification of orientation of cardiac looping at 56hpf in cardiac myosin light 
chain 2 (cmcl2-GFP) embryos.  Normal looping is to the right (D-looping), alternatives 
are no looping or looping to the left.  There is a significant reduction in frequency of 
normal cardiac D-looping in ahi1 MO injected embryos (n=221) (*, p < 0.0001, chi 
squared test), compared to uninjected wild type (WT) controls (n=145) and embryos 
injected with a standard control (Std Con) MO (n=39).  (B) Stacked bar chart showing 
the percentage frequency of each cardiac looping orientation in each experimental group 
(D-loop, white; no loop, checked; L-loop, black).  hpf, hours post fertilisation; MO, 
morpholino oligonucleotide. 
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3.2.10 ahi1 morphants develop dilated cloacae and variable loss of pronephric cilia   
Given the previous identification of cystic dilatation of the distal pronephros and cloaca 
of ahi1 morphants using both light and fluorescent microscopy, which was confirmed 
on histology sections (Figure 3.11), it was important to evaluate whether this cyst 
formation and dilatation of the cloaca in ahi1 morphants was associated with differences 
in pronephric cilia.  At 72hpf, claudin-b:Lyn-GFP transgenic WT and ahi1 morphant 
embryos were fixed in 4% PFA and immunostaining performed using anti-acetylated 
tubulin antibody to detect cilia.  Confocal microscopy images of uninjected WT control 
embryos show that the pronephric ducts are lined by cilia and meet in apposition at the 
cloaca (Figure 3.26A, B).  In ahi1 morphants, there is dilatation of the cloaca (Figure 
3.26D, F) and a variable appearance of pronephric cilia.  Compared to 100% (n=48) of 
uninjected WT control embryos which had an undilated cloaca and pronephric ducts 
closely apposed, 75% (n=30) of ahi1 morphants had a dilated cloaca (Figure 3.27A, B).  
This difference in cloacal appearance was statistically significant, p < 0.0001, chi-
squared test.   
In a minority of ahi1 morphants, cilia remain present lining the dilated cloaca (Figure 
3.26C, D).  Whilst the pronephric cilia appeared shorter in length when present in ahi1 
morphants compared to uninjected WT controls, it was not possible to quantify the 
length of individual cilia (Figure 3.26C).  In most other ahi1 morphants, there was 
complete absence of cilia from the pronephros (Figure 3.26E).  All uninjected WT 
control embryos (n=9) had cilia lining the distal pronephric ducts compared to only 1 of 
8 ahi1 morphants (Figure 3.27C), this loss of pronephric cilia from ahi1 morphants was 
statistically significant (p < 0.0003, chi-squared test). 
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Figure 3.26 Variable spectrum of disruption to cilia at the cloaca in ahi1 morphant 
zebrafish embryos 
Confocal microscopy images of claudinb:Lyn-GFP zebrafish embryos fixed at 72hpf 
and immunostained with anti-acetylated tubulin antibody (AT, red, A-C) to identify 
cilia.  Uninjected wild type controls (WT, A, B) have cilia (arrows, A) lining the 
pronephros which meets at the cloaca (B).  In ahi1 morphants, the pronephric ducts are 
dilated at the cloaca (star, D, F), with variable preservation of cilia (enlarged image, 
arrows, C) or complete absence of cilia (E).  Images were taken with a 20x objective 
and zoom of 3.  Scale bars = 50 μm.   
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Figure 3.27 Analysis of cloaca for dilatation and cilia in ahi1 MO injected 
zebrafish embryos 
(A) Quantification of cloaca phenotype in claudinb:Lyn GFP zebrafish embryos at 72 
hours post fertilisation (hpf) reveals that there was a statistically significant difference 
between ahi1 morphants, which mostly have a dilated cloaca (n=30), compared to the 
normal apposed appearance of the cloaca in uninjected wild type (WT) controls (n=48, 
*, p < 0.0001 chi-squared test).  (B) Stacked bar chart showing the percentage 
difference in the cloaca phenotype between ahi1 morphants and WT zebrafish embryos.  
(C) Cilia were mainly absent from the cloaca in ahi1 morphant (n=7) zebrafish embryos 
compared to WT controls (n=9, *, p < 0.0003 chi-squared test). 
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3.3 Discussion 
3.3.1 Creating a zebrafish model to study AHI1 
In order to study the role of AHI1 in development, the presence of a representative ahi1 
gene transcript and conservation of its encoded protein, Jouberin, was first confirmed in 
the zebrafish veterbrate model organism.  The temporal expression of ahi1 during 
development, was identified including in the: fundamental ciliated organising centre, 
KV; eye; brain; inner ear; olfactory bulbs and pronephros.  To ascertain a functional 
role for ahi1 in organogenesis, MOs were used to knockdown ahi1 and a detrimental 
effect on normal development was detected.  Abnormal phenotypes identified in ahi1 
morphants included abnormal body curvature, hydrocephalus, cardiac anomalies, 
pronephric cysts, eye and ear defects.  This range of anomalies is well recognised in 
zebrafish models of ciliopathy disorders (NPHP, JBTS, MKS) and cystic kidney disease 
following silencing of ciliary genes (Ferrante et al., 2009; Kramer-Zucker et al., 2005; 
Obara et al., 2006; Sullivan-Brown et al., 2008). 
Specificity of the ahi1 morphant zebrafish model was confirmed by co-injecting 
embryos with mouse Ahi1 mRNA, which rescued the ciliopathy phenotypes back to a 
normal pattern of development in the majority of embryos.  
3.3.2 Abnormalities of Kupffer’s vesicle in ahi1 morpholino injected zebrafish 
embryos 
Following ahi1 MO knockdown, disruption of the apical membrane of cells lining the 
zebrafish organising centre, KV and a dramatic loss of cilia in the majority of embryos 
were observed.  Interestingly, disruption to apical tissue organisation and cytoskeleton 
networks has previously been identified in murine IMCD3 kidney cell culture model 
systems of Ahi1 knockdown (Hsiao et al., 2009; Sang et al., 2011; Simms et al., 2012).  
siRNA mediated knockdown of Ahi1 in murine renal collecting duct cells was 
associated with a significant reduction in the formation of cilia, from 74% in negative 
control transfected cells to only 24% in Ahi1 siRNA treated cells (see Figure 7a,b of 
Appendix F) (Simms et al., 2012).  The efficacy of the described siRNA knockdown 
experiments was confirmed by western blotting and all siRNA experiments and cell 
culture work was performed by Dr Helen Dawe, University of Exeter. 
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In the few ahi1 MO injected zebrafish embryos with detectable cilia in KV, the length 
of cilia was found to be significantly shorter than the length of cilia in KV of WT 
embryos.  This work provides more detailed evidence of the nature of ‘KV defects’ in 
zebrafish embryos following ahi1 MO knockdown.  Previously, nonspecific 
abnormalities in KV were reported in approximately 45% of zebrafish embryos in 
which ahi1 was knocked down (Sang et al., 2011).   
Further nonspecific abnormalities in KV have been reported following MO knockdown 
of other genes which are known to cause ciliopathy disorders (NPHP, JBTS, MKS) 
including nphp1, nphp4, nphp5 and nphp8 in zebrafish embryos (Sang et al., 2011).  
Similarly, in a zebrafish model of NPHP and MKS created by nphp3 MO knockdown, 
fewer and shorter cilia were detected in KV, suggesting that nphp3 must play a role in 
ciliary function (Zhou et al., 2010b).   
In the ciliopathy, BBS, knockdown of 6 BBS genes (bbs2 and bbs4-bbs8) in zebrafish 
also resulted in a range of abnormalities within KV including: a  reduction in KV 
diameter; complete absence of KV; progressive loss of cilia; shorter cilia and ultimately 
complete absence of cilia (Yen et al., 2006).  The authors (Yen et al., 2006) suggested 
that the progressive loss of cilia from KV inferred that BBS proteins were required for 
the maintenance of cilia. 
In order to try to understand the functional implications on development of 
abnormalities within KV, including short or absent cilia, live imaging to study cilia 
motility within KV has been performed.  Knockdown of cordon-bleu, a gene involved 
in neural tube formation, therefore important in body patterning and morphogenesis, 
resulted in shorter cilia within KV (Ravanelli and Klingensmith, 2011).  Live imaging 
of cordon-bleu zebrafish morphants revealed disturbed fluid flow within KV (Ravanelli 
and Klingensmith, 2011).  Sufficient, effective fluid flow within KV is essential to 
enable the establishment of asymmetrical left-right body patterning and has been 
reported as a requirement for normal organogenesis of the kidney and brain (Kramer-
Zucker et al., 2005).  Unfortunately live imaging to assess KV in the zebrafish embryos 
herein was not feasible and therefore cilia motility or fluid flow in the ahi1 MO injected 
embryos cannot be commented on. 
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3.3.3 Abnormalities of cilia in Kupffer’s vesicle mediates aberrant left-right body 
patterning in ahi1 morpholino injected zebrafish embryos 
Leftward fluid flow induced by cilia beating in KV, is responsible for determining left-
right body asymmetry (Kramer-Zucker et al., 2005).  This fact is widely accepted 
however is established via a complex series of genetic signalling interactions.  At least 
five pathways are proposed to play a role in the development of KV and establishment 
of left-right asymmetry: dorsal forerunner cells must develop and form KV; nodal 
signalling pathways control expression of a ciliary motor protein (left-right dynein) 
which directs fluid flow; cilia must develop in cells lining the lumen of KV and become 
motile (Essner et al., 2005).  It has been suggested by examining left-right mutants and 
morphants that subtle interference in any of the steps in KV development and the 
establishment of left-right asymmetry pathway leads to a uniform endpoint of aberrant 
left-right asymmetry, however this may be mediated by altered expression of various 
downstream left-right genes (Essner et al., 2005).  Whilst changes within KV and cilia 
are most likely to account for the altered left-right patterning, two further caveats are 
notable: cilia are also found in other midline structures such as the notochord which is 
considered to play a role in left-right development (Danos and Yost, 1996); additionally 
the proteins of many of the studied genes are expressed in other non-ciliary locations 
which may have an influence (Essner et al., 2005) 
Herein it was interesting to identify that heart laterality as assessed by cardiac looping, 
was defective, with development of a L-loop in the majority of ahi1 morphant embryos.  
This predominantly reversed cardiac looping in ahi1 morphants was slightly surprising, 
since loss of cilia from KV was the prevalent finding, one might have expected an equal 
split or randomisation (Oteiza et al., 2010; Schneider et al., 2010) between L-looping 
and no looping of the cardiac tube.  Our results would suggest that ahi1 is essential for 
the development of cilia in KV and that ahi1 interferes with expression of left-right 
nodal genes such as spaw.  In future work, this could be further established by 
performing in situ experiments utilising a spaw probe.  An alternative hypothesis for the 
reversed cardiac looping identified herein in ahi1 morphants may be that left-right 
developmental signalling is arrested following the initial jogging of the heart to the left 
and there is a failure of subsequent looping to right.  This latter hypothesis could be 
addressed by assessing both cardiac jogging and looping phenotypes and ascertaining 
whether these were coupled or not.   
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Cilia length (Lopes et al., 2010) is recognised to play an important influence on the 
speed and direction of fluid flow within KV and mediate asymmetrical expression of 
molecular markers.  Unfortunately assessment of cilia motility and fluid flow in the 
ahi1 MO injected embryos was not feasible as real time imaging of cilia within KV was 
not feasible, all of the embryos in the experiments herein were fixed, furthermore cilia 
were undetected in the majority.  
Assumedly, fluid flow within KV of ahi1 morphants with short or absent cilia, would 
not be coordinated and either too slow, not leftward, or randomised, therefore limit the 
correct expression of asymmetric genes essential for establishing normal left-right 
asymmetry and organogenesis (Essner et al., 2005). 
Loss of cilia (Schneider et al., 2010) and shorter cilia (Lopes et al., 2010) in KV leading 
to defective left-right asymmetry has been reported in other zebrafish models of NPHP 
(Slanchev et al., 2011; Zhou et al., 2010b) and in studies of ciliary genes (Duldulao et 
al., 2009; Ferrante et al., 2009; Oteiza et al., 2010).  In the ciliopathy, BBS, knockdown 
of bbs4-bbs8 resulted in altered cardiac looping in 5-30% of zebrafish embryos and as 
noted above was associated with a range of abnormalities within KV (Yen et al., 2006).  
Shorter cilia were detected in KV following MO knockdown of PCP genes wnt11 and 
prickle1a (Oteiza et al., 2010).  This was associated with ‘randomised’ heart laterality, 
which following closer review was predominantly leftward cardiac looping (Oteiza et 
al., 2010).  Interestingly, other groups investigating ciliopathy genes such as nphp4 have 
reported ‘randomised’ heart looping in zebrafish morphants, however after examining 
their work, leftward looping also appears to be more prevalent than middle or no loop 
(Slanchev et al., 2011).  These findings of predominantly leftward cardiac looping 
rather than truly randomised organ laterality were evident in our ahi1 morphants and 
hypotheses for why this may be are suggested above. 
3.3.4 Alterations in cilia in ahi1 morphant zebrafish embryos are associated with 
pronephric cysts and dilatation of the cloaca  
The development of cysts within the pronephros of ahi1 morphants were identified by 
light and fluorescent (using claudinb:Lyn-GFP transgenic embryos) microscopy, which 
was confirmed on resin histology sections.  Of particular interest, dilatation of the distal 
pronephros at the cloaca and a variable pattern of cilia expression including complete 
absence of cilia from some ahi1 morphants were observed.   
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Previously, cystic dilation and obstruction of the cloaca has been reported in zebrafish 
models of a related ciliopathy gene, nphp4 (Burckle et al., 2011; Slanchev et al., 2011).  
These groups report no reduction in the number of cilia on cells in the pronephric duct, 
however cilia are described as shorter (Burckle et al., 2011), curly, disorientated 
(Slanchev et al., 2011) and less motile (Burckle et al., 2011).  Inspite of this, they 
concluded that cloacal abnormalities were likely independent of ciliogenesis but rather 
structural, related to defective migration of distal pronephric duct cells which they 
observed during live imaging (Slanchev et al., 2011). 
It would have been interesting to assess the motility of cilia, when present, in the distal 
pronephros/cloaca in the ahi1 morphant embryos herein, to determine whether the cystic 
dilation is mediated by dysfunctional cilia motility.  Unfortunately embryos were fixed 
prior to performing antibody staining to detect cilia.  Additionally it would have been 
interesting to assess whether the ahi1 morphants with a dilated cloaca were in fact 
obstructed, by injecting the pericardium with a rhodamine labelled dextran and 
evaluating clearance from the pericardium and/or via the cloaca (Hentschel et al., 2005).  
Despite attempts and practice, the performance of pericardial injections in ahi1 
morphants with a dilated cloaca was not reproducible, perhaps because embryos 
frequently had a curved body axis, which caused difficulties with manipulating them 
into an appropriate position.  
3.3.5 ahi1 knockdown in zebrafish is associated with defective ciliogenesis  
Mechanisms for how ahi1 knockdown may influence the length of cilia could be 
because Jouberin contains coiled coil domains important for maintaining the structure of 
cellular scaffolding (Hsiao et al., 2009), or because Jouberin interacts with Rab8a (a 
protein involved in membrane trafficking) thus the proteins together regulate cilium 
formation (Hsiao et al., 2009).  Furthermore, the presence of SH3 domains within 
Jouberin emphasises its role as an interacting protein.  This is supported by the 
proposition that Jouberin behaves as a bridging protein to link three protein modules 
which function to mediate apical organisation, Hh signalling and maintaining cilia 
integrity.  Together these protein modules make up the recently identified NPHP-
Joubert-Meckel-Gruber protein network (Sang et al., 2011).  Ideally it would have been 
interesting to assess the motility of cilia (when present) by performing live imaging of 
ahi1 MO injected embryos.  Also, particularly when cilia were not detected, it would 
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have been interesting to further evaluate the extent of this structural aberration using 
other basal body/centrosomal antibodies.  The use of three dimensional cell culture 
models would have complimented further evaluation of the role of ahi1 in ciliogenesis 
and tissue PCP.   
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Chapter 4 Zebrafish models demonstrating the phenotypic spectrum of 
Joubert Syndrome related ciliopathies caused by cc2d2a, nphp6 
and mks3 knockdown  
4.1 Introduction 
The ciliopathy JBTS is an autosomal recessive genetically heterogeneous disorder, with 
up to 19 causal genes presently identified, which together account for 50% of patients 
(refer to Table 1.2).  The phenotype of affected individuals is very variable, even within 
the same family and genetic pleiotropy is evident (Coppieters et al., 2010).  For 
example, NPHP6 mutations can cause isolated blindness or NPHP, as well as JBTS and 
BBS, with additional features of obesity and hypogonadism (Forsythe and Beales, 2012; 
Leitch et al., 2008), however there is a poor genotype-phenotype correlation (Coppieters 
et al., 2010).  Interestingly, at least 3 genes, CC2D2A, NPHP6 and MKS3/TMEM67, can 
cause both JBTS and the more severe, often lethal, related ciliopathy, MKS (Bachmann-
Gagescu et al., 2012).  Both CC2D2A and NPHP6 each account for approximately 20% 
of patients diagnosed with MKS.  MKS3 is the third most frequently identified cause of 
MKS and accounts for approximately 10% of patients (CA. Johnson, personal 
communication).   
Understanding of the clinical heterogeneity remains primitive, however, oligogenicity, 
whereby a third mutation in a different gene, in combination with a pathogenic 
compound heterozygous or homozygous mutation, has been hypothesised as a 
mechanism for modifying the severity of a clinical phenotype (Hoefele et al., 2007).  
Oligogenicity has been identified in patients with ciliopathy syndromes including NPHP 
(Hoefele et al., 2007), JBTS (Tory et al., 2007) and BBS (Katsanis et al., 2001).   
4.1.1 Zebrafish models of JBTS related ciliopathies 
In 2008, a zebrafish mutant, sentinel, with a spontaneous nonsense mutation in cc2d2a, 
was reported to develop a sine wave shaped tail and pronephric cysts (Gorden et al., 
2008), however further details characterising the phenotype were sparse and not 
published.  The sentinel zebrafish did however appear to be a useful model for 
evaluating oligogenicity, as when nphp6 (which colocalises with cc2d2a at the basal 
body of cilia) was knocked down in sentinel embryos, there was a synergistic increase 
in the development of pronephric cysts (Gorden et al., 2008).  However, no 
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oligogenicity was identified in a cohort of patients with JBTS including consanguineous 
families (Gorden et al., 2008).  Interestingly however in patients with the more severe 
MKS ciliopathy, missense changes in both NPHP6 and CC2D2A have been identified 
(Hopp et al., 2011).  
In 2006, MO knockdown of nphp6 was used to create a zebrafish model of JBTS, with 
pronephric cysts and developmental defects in the retina, cerebellum and otic cavity 
(Sayer et al., 2006).  No difference in the length or motility of cilia were detected in the 
pronephros of zebrafish cystic nphp6 morphants (Sayer et al., 2006), however cilia in 
KV were not assessed/reported.  
There are no zebrafish models of MKS caused by mks3 knockdown and although there 
was a mouse model with cystic kidney disease (Cook et al., 2009), it lacked the 
associated features of MKS including cerebellar anomalies/occipital encephalocele, 
liver cysts.  Furthermore in the mouse model challenges of infertility and mortality 
within 3 weeks, limited their ability to study the pathogenesis of MKS (Cook et al., 
2009).    
4.1.2 Aims of this chapter 
In order to study a spectrum of JBTS related ciliopathies (NPHP, MKS), the aim was to 
create zebrafish models of these human disorders, in particular to characterise the 
phenotypes associated with each of the following ciliary genes: CC2D2A, NPHP6 and 
MKS3. 
To study CC2D2A, further definition of the sentinel zebrafish mutant phenotype during 
development was sought, including evaluating the retina and cilia within KV.  
Furthermore, since homozygous sentinel embryos have been reported to develop 
pronephric cysts in up to 33% (Gorden et al., 2008), the response to Rapamycin (an 
antiproliferative therapy proven to be effective in mouse (Shillingford et al., 2006) and 
zebrafish (Tobin and Beales, 2008) models of cystic kidney diseases, and being 
evaluated in human patients with ADPKD (Serra et al., 2007)) was assessed.  
Additionally, an aim was to create and characterise an alternative zebrafish model of 
CC2D2A related ciliopathies, by MO knockdown of cc2d2a.  The cc2d2a morphants 
would enable a study of the effect of gene dose, which would be informative for later 
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work, Chapter 5, evaluating oligogenicity.  Secondly, the cc2d2a morphants were 
generated to increase the data regarding cc2d2a in development and ciliopathy diseases. 
Using nphp6 MO knockdown, an aim herein was to recapitulate the published 
ciliopathy phenotype (Sayer et al., 2006) to demonstrate the genetic pleiotropy and by 
studying cilia within KV, to evaluate any subsequent effect on cardiac left-right 
asymmetry. 
Finally, to study the severe end of the ciliopathy spectrum, an aim was to create a 
zebrafish model of MKS by mks3 knockdown, to characterise the phenotype and study 
the effect of interference with mks3 on development. 
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4.2 Results 
4.2.1 CC2D2A genomic and proteomic information in humans and zebrafish 
Human CC2D2A was mapped to chromosome 4p15.33 (Noor et al., 2008) and 
confirmed as a pathogenic ciliopathy gene by homozygosity mapping of 
consanguineous families with JBTS (Gorden et al., 2008) and MKS (Tallila et al., 
2008).  Interestingly, a correlation between CC2D2A genotype and ciliopathy 
phenotype was suggested following identification of missense mutations leading to 
JBTS and null mutations causing MKS (Mougou-Zerelli et al., 2009).  CC2D2A in both 
humans (Tallila et al., 2008) and zebrafish (Gorden et al., 2008) contains 38 exons.  
Using the online Vertebrate Genome Annotation database (http://vega.sanger.ac.uk), 17 
human CC2D2A transcripts, 7 of which were protein coding were identified.  The best 
evidence supports a transcript (CC2D2A_002 OTTHUMT00000359906) with 5175bp 
and encodes the associated 1620 amino acid protein, CC2D2A 
(OTTHUMP00000217873) (Figure 4.1A,B).  CC2D2A contains 3 coiled-coil domains 
and a C2 domain.  As previously noted, coiled-coil domains are structurally important 
(Mason and Arndt, 2004), whilst C2 domains involve calcium-dependent binding and 
mediate signal transduction (Tallila et al., 2008).  CC2D2A is strongly expressed in 
fetal: brain and kidney tissue; adult: retina, kidney, heart and lung tissue (Gorden et al., 
2008).  
No zebrafish orthologues for CC2D2A were apparent using the ‘vega.sanger’ database, 
however using the ensembl browser (www.ensembl.org/Danio_rerio) a single, 
representative transcript (ENDSDART00000126768) on chromosome 23.2 was 
identified, which consisted of 5001bp and encoded a cc2d2a protein product 
(ENDSDARP00000107405) of 1666 amino acids.  The zebrafish cc2d2a protein 
consisted of 5 coiled-coil domains (Burkhard et al., 2001) and a C2 domain (involved in 
signal transduction and vesicular trafficking (Sutton and Sprang, 1998)) (Figure 
4.1C,D).  Figure 4.1E shows the effect of the nonsense mutation in sentinel zebrafish, 
which leads to a stop codon, instead of a tryptophan, in exon 14 of cc2d2a (Owens et 
al., 2008).  The sentinel mutation is associated with loss of 68% of the cc2d2a protein 
and therefore is considered likely to be physiologically relevant (Owens et al., 2008).  
The sentinel zebrafish was initially identified as a protective mutant from 
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aminoglycoside induced hair cell death (Owens et al., 2008), which led to early 
hypotheses that cc2d2a may play a role in regulating cilia.  
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Figure 4.1 CC2D2A gene transcript and partial protein product structure in 
humans and zebrafish 
(A) CC2D2A gene transcript in humans (OTTHUMT00000359906) and schematic 
representation of encoded protein product, coiled coil domain containing protein 2A 
(CC2D2A), with 3 coiled-coil domains and 1 C2 domain, consisting of 1620 amino 
acids (OTTHUMP00000217873) (B).  (C) cc2d2a transcript in zebrafish 
(ENDSDART00000126768) and schematic representation of encoded protein product, 
cc2d2a (ENDSDARP00000107405) (D).  (E) Schematic representation of zebrafish 
cc2d2a showing the nonsense mutation, a stop codon present in exon 14.   aa, amino 
acids; CC, coiled coil; Ch., chromosome; C2 domain  
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4.2.2 CC2D2A evolutionary conservation 
CC2D2A is highly conserved with orthologues in a diverse range of species from 
humans to sea anemones, mice, chicken, cattle and monkeys (Gorden et al., 2008).  
Using multalin, the evolutionary conservation between humans, mice and zebrafish is 
shown (Figure 4.2).  Zebrafish cc2d2a is 56% identical and 73% similar to human 
CC2D2A (Owens et al., 2008). 
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Figure 4.2 Evolutionary conservation of Cc2d2a in humans, mice and zebrafish 
Cc2d2a peptide sequence alignment in humans (homo sapiens, 
OTTHUMP000000217873), mice (mus musculus, ENSMUSP00000048320), zebrafish  
(danio rerio, ENSDASP00000107405) and consensus sequence is shown (Multalin).  
Conservation of amino acid alignment (red font).   
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4.2.3 Establishment of sentinel and transgenic sentinel:claudin-b:Lyn-GFP 
zebrafish  
A sentinel zebrafish line was established in our laboratory following the kind gift of a 
batch of embryos from Dan Doherty’s laboratory in Washington.  Once mature, in order 
to facilitate utilising the sentinel zebrafish line particularly to study the pronephros, 
adult sentinel zebrafish heterozygotes were crossed with transgenic claudin-b:Lyn-GFP 
line, which are recognised for their prominent GFP expression within the pronephros 
(Haas and Gilmour, 2006).  The F2 offspring were phenotyped at 72hpf and the parents 
of embryos with both a sinusoidal shaped tail and an appropriate GFP signal were 
maintained as a heterozygote sentinel:claudin-b:Lyn-GFP strain. 
Figure 4.3 shows light and fluorescent microscopy images of the temporal development 
of sentinel:claudin-b:Lyn-GFP zebrafish embryos at 24-72hpf.  By 72hpf, both 
hydrocephalus and the characteristic sine wave shaped tail were evident in sentinel 
homozygous embryos.  Claudin-b was also prominently expressed in the telencephalon, 
otic placode and the posterior lateral line (Lopez-Schier et al., 2004). 
4.2.4 Confirmation of sentinel genotyping and sequencing 
To confirm the association between phenotype and genotype, a single embryo with a 
sine wave shaped tail (presumed sentinel) and a linear (presumed WT) tail were fixed 
and DNA was isolated.  PCR using dCAP primers which introduce a restriction enzyme 
site into the WT embryos was performed and an agarose gel run to confirm adequate 
DNA from each sample, both measured the expected 156bp (Figure 4.4C).  
Subsequently a restriction enzyme digest was performed which resulted in a smaller 
product in WT embryos (128bp, as the enzyme cuts the DNA) compared to sentinel 
homozygotes (156bp, Figure 4.4D).  The sentinel and WT products visualised in the 
agarose gel were cut out, purified and sent for direct sequencing to identify the 
molecular difference.  The chromatograms are shown in Figure 4.5.  The cDNA 
sequences show the relevant difference in the WT, which encodes a tryptophan amino 
acid, whilst in the sentinel mutants, a nonsense mutation (G>A) in exon 14 resulted in a 
stop codon and truncation of the protein at 491 amino acids (Figure 4.5B).  This work 
confirms the published mechanism of the sentinel mutation, which was considered 
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significant and to cause loss of the cc2d2a gene and protein function (Owens et al., 
2008).  
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Figure 4.3 Development of sentinel and transgenic sentinel:claudin-b:Lyn-GFP 
zebrafish embryos 
Lateral views of sentinel (snl) (A,C,E) and snl:cldn-b:Lyn-GFP (B,D,F) zebrafish 
embryos at 24, 48 and 72 hours post fertilisation (hpf).  The characteristic sine wave 
shaped tail (*, E-F) of snl homozygous zebrafish embryos is evident at 72hpf.   
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Figure 4.4 Genotyping of sentinel zebrafish embryos 
Lateral views of presumed homozygote sentinel (snl/snl) with sine wave shaped tail (A) 
and golden uninjected wild type control (+/+ WT) (B) zebrafish embryos at 72hpf.  
DNA was isolated from each single embryo and PCR performed with dCAP primers, 
which introduce a restriciton enzyme recognition site into WT embryos.  The agarose 
gel (C) confirms sufficient DNA for each sample (156 bp).  Following a restriction 
enzyme digest, the gel (D) shows the snl homozygotes have a product of 156bp, 
whereas WT embryos are cut and have a smaller product of 128bp.  This confirms the 
phenotype.  bp, base pairs; hpf, hours post fertilisation. 
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Figure 4.5 Sequencing of sentinel (snl) and uninjected wild type (WT) zebrafish 
embryos at 72hpf 
(A) Chromatogram of PCR product across predicted point mutation in snl mutant 
obtained by RT-PCR of RNA at 72 hpf. Zoomed view of WT and snl mutant cDNA 
sequencing (B) shows there was a nonsense mutation (G>A), (circled in red in each 
sequence), in the snl homozygous embryos resulting in a trytophan changing to a 
premature stop codon and truncation at 498 amino acids, compared to the WT controls.   
hpf, hours post fertilisation; Lys, lysine; Ser, serine; STOP, stop codon; Trp, tryptophan. 
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4.2.5 Phenotypes of sentinel mutants includes hydrocephalus, cardiac anomalies, 
pronephric cysts and ocular defects  
Embryos born from sentinel heterozygous matings were phenotyped by light and 
fluorescent microscopy at 72hpf.  A sine wave shaped tail, defining a sentinel 
homozygote was identified in only 12% (n=153) of embryos, rather than in 25% as 
would be expected from Mendelian genetics.  The frequency of aberrant ciliopathy type 
phenotypes detected in the sentinel mutants is shown in Figure 4.6A.  The mean 
mortality rate in sentinel embryos was 12% and 3% at 24 and 72hpf respectively 
(Figure 4.6B). 
A variable severity of cardiac oedema (Figure 4.7B-D) occurs in up to 3% (n=36), 
hydrocephalus (Figure 4.7D) in 1% (n=12), proximal pronephric cysts (Figure 4.8C-H) 
in 0.5% (n=6) and ocular anomlies (Figure 4.9) in 0.2% (n=2) of homozygous sentinel 
mutants.  Ocular anomalies include either unilateral microphthalmia or a coloboma.  To 
further assess the eyes of sentinel mutants, embryos were fixed at 5 days post 
fertilisation (dpf), embedded in resin and sectioned to obtain 5µm cross sections of the 
eyes.  Although the outer retinal pigmented epithelial layer is grossly preserved in 
sentinel mutants, there is indistinct definition of the other retinal layers, compared to 
uninjected WT embryos (Figure 4.10).  No abnormalties of development of the otic 
placode or vesicles were detected in sentinel mutants. 
Unfortunately a much lower frequency of aberrant phenotypes were detected in the 
offspring of sentinel heterozygous matings herein than in the previously published work 
using sentinel mutant zebrafish, even allowing for a degree of incomplete penetrance of 
phenotypes (Gorden et al., 2008).  It is difficult to determine how this significant caveat 
could be modified for future work utilising sentinel mutants, since breeding of 
homozygous zebrafish mutants who may develop a severe phenotype is not encouraged 
and is usually associated with failure to survive. 
  
 ________________ Chapter 4:  Zebrafish models of ciliopathies using cc2d2a, nphp6 or mk3 knockdown  
185 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Phenotypes & Mortality rates of sentinel zebrafish embryos   
(A) Quantification of the percentage (%) frequency of abnormal phenotypes at 72hpf in 
embryos born from two sentinel (snl) heterozygous (het) parents (n=1254).  A sine 
wave tail phenotypically defines a snl embryo, however only 12% (n=153) of clutches 
of embryos were identified with this appearance.  The low percentage of snl 
homozygotes may account for the overall low percentage of abnormal phenotypes.  2% 
(n=24) had a non-sine wave curly tail, 3% (n=32) had cardiac oedema, 1% (n=12) had 
hydrocephalus, 0.5% (n=6) had pronephric cysts and 0.2% had an abnormal eye (either 
coloboma or unilateral micropthalmia, n=2).  A cyclops appearance was not identified 
in any embryos.  (B) The percentage mortality rates at 24 (n=178) and 48 (n=35) hpf are 
shown as mean and standard error of the mean in embryos born from snl het parents.  
hpf, hours post fertilisation. 
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Figure 4.7 Phenotypes (Tail, Cardiac, Brain) in sentinel zebrafish embryos at 
72hpf 
The characteristic sine wave shaped tail of sentinel (snl) mutant zebrafish is shown in 
(B), compared to the normal appearance of uninjected wild type (WT) controls (A).  
The variable spectrum of severity of cardiac anomalies and oedema are highlighted (*) 
in B-D.  Hydrocephalus is arrowed in D.    
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Figure 4.8 Pronephric cysts in sentinel and sentinel:claudin-b:Lyn-GFP zebrafish 
embryos at 72hpf 
Light and fluorescent microscopy images of the normal appearance of uninjected wild 
type (WT) claudin-b:Lyn-GFP (cldn-b:GFP) controls (A, B), compared to sentinel (snl) 
and sentinel:claudin-b:Lyn-GFP (snl:cldn-b:GFP) zebrafish mutant embryos.  Some snl 
mutants display proximal pronephric cysts (arrowed, lateral view (C, D), dorsal view 
(E); large cysts at the level of the proximal convuluted/straight tubule (red dotted line, 
F); distal pronephros (arrowed, G, H).  The variable severity of developmental 
deformities in the snl mutants is evident.   
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Figure 4.9 Abnormal eye development in sentinel zebrafish embryos at 72hpf 
Light microscopy, lateral and dorsal, images focusing on the eyes of an uninjected wild 
type (WT, A-C) and a sentinel (snl, D-G) mutant zebrafish embryo.  In the snl mutant 
embryo, there is abnormal eye development with both unilateral microphthalmia (black 
arrows, D-G) and a coloboma (red arrow, E).   
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Figure 4.10 Abnormal retinal histology in sentinel zebrafish embryos   
Resin histology 5µm sections of the eyes of uninjected wild type (WT, A, B) and 
sentinel (snl, C, D) mutant zebrafish embryos, stained with methylene blue-basic 
fuchsin stain.  A shows overview of the normal retina, with formation of discrete retinal 
layers from 72 hours post fertilisation.  B-D show that at 5 days post fertilisation, whilst 
the retinal pigmented epithelial layer is preserved in snl mutants (C, D), there is 
disorganisation of retinal development, with loss of definition of retinal layers. Images 
are taken with 20x objective (A-C) and 40x objective (D).  Scale bars = 20µm 
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4.2.6 Gross reduction in number of cilia in Kupffer’s vesicle of sentinel mutants 
Since cc2d2a is known to be expressed at the basal body of cilia and sentinel mutants 
develop a ciliopathy phenotype, KV was grossly assessed.  Immunostaining of cilia 
using an antibody to acetylated tubulin showed a reduction in the number of cilia in an 
8-10 somite stage embryo born from heterozygous sentinel:claudin-b:Lyn-GFP 
zebrafish pairs (Figure 4.11).  In addition to an overall reduction in the number of cilia, 
there was no apparent expression of claudin-b at epithelial cell junctions of KV.  
Therefore, although KV in sentinel embryos appears to continue to develop as a cavity 
with some cilia, the organisation and polarity of its epithelium could not be further 
evaluated and may be abnormal.  Several sentinel embryos were damaged during 
processing for KV imaging and the numbers actually assessed were very small.  
Samples were fixed, therefore cilia motility and fluid flow within KV could not be 
assessed, however would be interesting to perform in future work. 
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Figure 4.11 Reduction in number of cilia in Kupffer's vesicle in embryo from 
heterozygous snl zebrafish parents 
Confocal microscopy images of cldnb:Lyn-GFP wild type (WT, A-C) and those born to 
heterozygous sentinel:cldnb:Lyn-GFP (snl, D-F) parents, following fixation at the 8-10 
somite stage and fluorescent immunostaining using anti-acetylated tubulin (red) to study 
cilia in Kupffer's vesicle (KV). Overlay images of KV (arrowed, scale bar = 50µm, 20x 
objective) in WT (A) and snl (D) embryos.  Higher magnification images B, C, E, F 
(zoom of 3, scale bar = 20µm).  Red laser shows a normally ciliated (arrowed) KV in 
WT (B), whilst a sparse number of cilia are apparent in snl (E) embryos.  In WT (C) 
expression of cldnb:Lyn-GFP at epithelial cell-cell junctions within KV is organised 
(C).  In this snl (F) there is no distinct delineation of KV epithelium (cldnb:Lyn-GFP), 
cilia are sparse (arrow). 
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4.2.7 No reduction in aberrant phenotypes in sentinel mutants following 
Rapamycin therapy 
Rapamycin was dissolved in 0.05% DMSO (drug solvent vehicle) and added to E2 
zebrafish water to make concentrations of 0.1µM (Rapa A) and 0.05µM (Rapa B).  
These concentrations of Rapamycin therapy were chosen because previous zebrafish 
models of ciliopathies have shown efficacy in reducing pronephric cysts with 
Rapamycin concentrations between 0.002-0.1µM (Tobin and Beales, 2008).  To ensure 
any effects were genuine and not secondary to the drug vehicle, DMSO or E2 media 
alone, these solutions were evaluated in parallel, therefore there were four arms being 
assessed in total.  Where relevant, each solution of Rapamycin was replaced every 24 
hours, to ensure continued exposure, as has been performed in previous zebrafish 
studies using Rapamycin (Makky et al., 2007).   
The toxicity of Rapamycin therapy was investigated by evaluating mortality in 
uninjected WT and sentinel mutants at 24 and 72 hours following exposure to the drug.  
There was no significant difference in 24 hour mortality rates (24-44%) between any of 
the four solutions in either WT or sentinel embryos (Figure 4.12A).  Longer term 
toxicity was low, less than 4% in any treated group, and was evaluated by calculating 
mortality between 24-72 hours following exposure to each media (Figure 4.12B).  
Delaying the onset of exposure to either concentration of Rapamycin therapy did not 
alter mortality rates at 72 hours, which remained less than 4% (Figure 4.12C). 
The side effect profile following exposure to Rapamycin therapy from 0hpf was 
investigated by evaluating the phenotype of WT embryos at 72hpf.  There was no 
significant difference in the frequency of abnormal phenotypes in WT embryos exposed 
to each media (Figure 4.12D).   
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Figure 4.12 Safety and Efficacy of Rapamycin therapy for use in zebrafish 
embryos 
Wild type (WT) and sentinel (snl, born to heterozygous snl parents) embryos were 
selected from the same parental pairs and exposed to four different media: E2, 0.05% 
DMSO (a solvent vehicle for Rapamycin), Rapa A (0.1µM), Rapa B (0.05µM).  There 
was no significant difference (chi-squared test) in the mortality rates of WT and snl 
embryos at 24 (A) and 72 (B) hpf/following 24 or 72 hours exposure to the four 
different media. (continued next page) 
NB 2 pages 
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Pg2 of Fig The delayed introduction of Rapamycin therapy to later stages of 24 and 
48hpf (C) did not alter mortality rates.  The side effect profile of eachmedia was 
evaluated at 72hpf in WT embryos exposed from 0hpf (D).  All embryos exposed to 
standard E2 media were phenotypically normal.  There was no significant difference in 
the frequency of abnormal phenotypes in WT embryos exposed to different media, 
however some developmental anomalies occurred in embryos exposed to 0.05% DMSO 
and increasing concentrations of Rapamycin therapy (dose-dependent).  All WT 
embryos exposed to Rapa A or B from 24hpf and 48hpf were phenotypically normal, 
suggesting any toxicity is associated with early exposure (prior to 24hpf).   No WT 
embryos developed an abnormal eye phenotype or pronephric cysts.  The efficacy of 
two doses of Rapamycin therapy was evaluated in snl embryos exposed from 
fertilisation (0hpf, E).  The timing of initiation of Rapamycin was also evaluated, in snl 
embryos exposed from 24hpf and 48hpf (F).  There was no significant difference in the 
percentage frequency of abnormal phenotypes of snl embryos treated with different 
doses of Rapamycin therapy and no difference introduced by varying the timing of 
initiation of therapy.  DMSO, dimethyl sulfoxide; E2, standard zebrafish embryo media; 
hpf, hours post fertilisation; Rapa, Rapamycin.  
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However, it is likely that the DMSO drug vehicle and increasing concentrations of 
Rapamycin exert a toxic effect, since: 100% of WT embryos exposed to the standard E2 
zebrafish media were normal; 6% of WT embryos exposed to DMSO were abnormal 
and up to 9% of WT embryos were abnormal following exposure to Rapamycin in a 
dose-dependent manner (Table 4.1, Figure 4.13).  No WT embryos developed 
pronephric cysts or an abnormal eye phenotype following exposure to Rapamycin.  Of 
note, all WT embryos with delayed exposure to Rapa A (0.1µM) or B (0.05µM) from 
24hpf and 48hpf were phenotypically normal (Figure 4.13D), suggesting any toxicity is 
associated with early exposure (prior to 24hpf) to Rapamycin. 
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 Phenotype  
Media Normal 
% 
Other Curly tail 
% 
Cardiac oedema 
% 
Hydrocephalus 
% 
Otic defect 
% 
Total n 
E2 100 0 0 0 0 96 
0.05% DMSO 94 6 6 0 0 54 
Rapa B (0.05µM) 95 3 5 0 0 68 
Rapa A (0.1µM) 91 9 6 1 1 64 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Effect of Rapamycin therapy and drug vehicle media on wild type zebrafish embryos 
Percentage (%) frequency of phenotypes at 72hpf of wild type zebrafish embryos exposed to various media from 0hpf.  ‘Other curly tail’ describes a 
non-sine wave curly tail, to distinguish from sentinel embryos (sine wave shaped curly tail).  100% of embryos kept in standard E2 media were normal.  
6% (n=3) of embryos exposed to the drug vehicle 0.05% DMSO had an abnormal curly tail and cardiac oedema.  In embryos exposed to Rapamycin 
therapy, the frequency of anomalies increased in a dose dependent manner.  This suggests there is some toxicity associated with 0.05% DMSO and 
increasing concentrations of Rapamycin therapy.  Of note, all embryos exposed to Rapa A or B from 24hpf and 48hpf were phenotypically normal, 
suggesting any toxicity is associated with early exposure (prior to 24hpf).  No embryos developed an abnormal eye phenotype or pronephric cysts.  
Data are reported as percentages, except the column entitled ‘Total n’, which is the total raw data numbers.  DMSO, dimethyl sulfoxide; Rapa A, 
0.1µM Rapamycin; Rapa B, 0 05µM Rapamycin. 
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Figure 4.13 Phenotypes of wild type zebrafish embryos exposed to Rapamycin: 
toxicity associated with dose and timing of onset of exposure 
Light microscopy images of wild type (WT) zebrafish embryos at 72hpf.  (A) shows a 
normal WT embryo maintained in the standard embryo media (E2) from 0hpf.  (B, C) 
show WT embryos maintained in two different doses of Rapamycin (Rapa B= 0.05µM, 
Rapa A=0.1µM) from 0hpf, the media was replaced every 24hpf.  B has developed 
gross cardiac odema (*), whilst exposure to a higher dose of Rapamycin (0.1µM) from 
0hpf can lead to more severe developmental anomalies (C) including growth arrest 
(short tail) and a single otolith (arrow, C).  D is a WT embryo maintained in E2 for the 
first 24hpf prior to exposure to high dose Rapamycin (Rapa A, 0.1µM) from 24hpf.  D 
has a normal appearance (n=85), suggesting any toxicity associated with Rapamycin 
occurs during early exposure, in the inital 24hrs of development. 
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The efficacy of the two doses of Rapamycin therapy (0.1µm and 0.05µm) following 
exposure from fertilisation (0hpf) was evaluated in sentinel embryos by phenotyping at 
72hpf (Figure 4.12E).  There were fewer normal embryos (66%) after being maintained 
in the standard E2 media, compared to 75% and 80% of embryos appearing normal after 
being maintained in 0.1µM and 0.05µM Rapamycin respectively, however this 
difference was not statistically significant.  There were similar numbers of homozygous 
sentinel embryos exposed to each of the media/Rapamycin treatments (n=5-8).  Figure 
4.14 shows light microscopy images of the aberrant phenotypes of sentinel embryos 
maintained in each of the different media/Rapamycin therapy.  A sentinel embryo 
maintained in the drug vehicle 0.05% DMSO developed a dorsal curly tail, pronephric 
cyst, single otolith and unilateral microphthalmia (Figure 4.14D).   There was no 
significant difference in the frequency of abnormal phenotypes in sentinel embryos, 
particularly no reduction in hydrocephalus or pronephric cysts following treatment with 
Rapamycin 0.05-0.1µM therapy (Figure 4.12E).  Whilst delaying the initiation of 
exposure to Rapamycin therapy from 0hpf (n=225) to 24hpf (n=152) resulted in a dose 
dependent reduction in the frequency of cardiac oedema from 9-23% to 3%, this 
difference was not statistically significant (Figure 4.12F).  Overall, there was no 
significant difference in the percentage frequency of abnormal phenotypes in sentinel 
embryos as a consequence of varying the timing of initiation of Rapamycin therapy 
(Figure 4.12F).  Up to 48 hours of a dose range of 0.05-0.1 µM of Rapamycin therapy is 
not efficacious in preventing aberrant development in sentinel mutants.  
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Figure 4.14 Phenotypes of sentinel zebrafish embryos exposed to Rapamycin from 
0hpf 
Light microscopy images of sentinel zebrafish embryos at 72hpf.  (A, B) shows a 
sentinel (Snl) embryo maintained in the standard embryo media (E2).  The characteristic 
sine wave tail is evident and a pronephric cyst is arrowed (A, B).  C, D show snl 
embryos maintained in 0.05% DMSO (the solvent vehicle for Rapamycin).  D shows a 
snl which has developed cardiac oedema (*), a pronephric cyst (black arrow), a single 
otolith (black arrowhead) and unilateral microphthalmia (white arrow).  E,F show snl 
embryos which have been maintained in two different doses of Rapamycin (E, Rapa B= 
0.05µM) and (F, Rapa A=0.1µM) from 0hpf, the media was replaced every 24hpf.  In 
addition to the characteristic sine wave shaped tail, F has developed cardiac odema (*).  
DMSO, dimethyl sulfoxide; Rapa, Rapamycin.  
 ________________ Chapter 4:  Zebrafish models of ciliopathies using cc2d2a, nphp6 or mk3 knockdown  
200 
 
4.2.8 Design of cc2d2a morpholino oligonucleotide to mimic sentinel mutants 
Since the number of sentinel homozygous offspring from sentinel heterozygous 
crossings was lower than anticipated and because studying oligogenicity would be 
important to try to understand the variable clinical phenotype even within families, we 
sought to create an alternative zebrafish model of cc2d2a related ciliopathies.  In order 
to study the effects of cc2d2a gene knockdown, a MO was designed.  Figure 4.15 shows 
the exon map of cc2d2a in zebrafish, the spontaneous mutation in exon 14 responsible 
for sentinel mutants (Figure 4.15A) and how the cc2d2a MO (Figure 4.15B) was 
designed to target exon 14 and therefore mimic the sentinel mutation.   
4.2.9 Evidence of cc2d2a morpholino oligonucleotide knockdown  
RT-PCR of equal concentrations of isolated RNA from individual uninjected WT and 
cc2d2a splice blocking MO injected zebrafish embryos was performed at 24-72hpf.  In 
the WT embryos, the expected cc2d2a product size of approximately 692bp was 
evident.  In both WT and cc2d2a splice blocking MO injected embryos there was an 
additional larger band of approximately 800bp, likely the result of mispriming and does 
not appear to be functionally relevant.  However sequencing of this additional 800bp 
band would be required to determine its exact identity.  Importantly, in cc2d2a splice 
blocking MO injected embryos there was a maximal reduction in the normal RT-PCR 
product at 24hpf and an additional smaller product measuring approximately 500bp 
(Figure 4.15C).  Although this smaller RT-PCR product at 24hpf was not cut out and 
sent for direct sequencing because of time constraints, we postulate that it represents 
splicing of exon 14 (which would result in loss of 157bp) and therefore an expected 
product of 535bp in cc2d2a morphants.  Formal direct sequencing of the smaller 
approximately 500bp product would have to be performed in order to confirm or refute 
this hypothesis.  Of note, although a maximal knockdown or reduction of the normal 
cc2d2a product is evident at 24hpf, a modestly sized normal product band persists, this 
acknowledges a limitation of MO experiments, the fact that MO knockdown is 
incomplete (Bill et al., 2009).  The increased intensity of the normal cc2d2a product of 
approximately 692bp at 48 and 72hpf in cc2d2a MO injected embryos would be in 
keeping with the reported temporary effect of some MO (Eisen and Smith, 2008). 
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Figure 4.15 cc2d2a morpholino design 
(A) Schematic representation of zebrafish cc2d2a showing the spontaneous nonsense 
mutation, a stop codon, present in exon 14 of sentinel mutants. (B) Schematic 
representation of the splice blocking (cc2d2a ie14) morpholino oligonucleotide (MO) 
designed to mimic the spontaneous mutation in sentinels, by targeting the same exon 
(14).  All MO sequences are in the Methods/Appendix.  (C) RT-PCR of single embryos 
at 24-72hpf following cc2d2a splice MO knockdown reveals maximal reduction of the 
normal 692bp product at 24hpf and an additional smaller product in cc2d2a morphants 
measuring approximately 500bp (white arrow). The larger band at 800bp in all 24-48hpf 
embryos does not appear relevant. hpf, hours post fertilisation; MO, morpholino 
oligonucleotide; WT, wild type. 
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4.2.10 Phenotypes of zebrafish morphants created by cc2d2a MO knockdown 
Zebrafish embryos were phenotyped by light microscopy at 72hpf.  Uninjected WT 
embryos were phenotypically normal (Figure 4.16A).  Embryos were injected with a 
dose range of 4-8ng of cc2d2a splice blocking MO (cc2d2a MO) which led to abnormal 
development including a dorsally curved body axis, hydrocephalus, cardiac oedema, 
pronephric cysts, a wavy notochord, altered number of otoliths (Figure 4.16) and 
abnormal eye development (Figure 4.17).  A 6ng dose of cc2d2a MO resulted in the 
most prevalent frequency of abnormal phenotypes (Figure 4.18B) without resulting in 
an excess mortality rate at 24 hours (Figure 4.18A).  Although the overall 24 hpf 
mortality rate in embryos injected with 6ng cc2d2a MO was 15% compared to 24% in 
embryos injected with 4ng cc2d2a MO, the relative 24 hpf mortality rate (to 
appropriately matched uninjected embryos) was higher (5:1) with the increased (6ng) 
dose of cc2d2a MO, confirming the expected dose dependent effect of MO.   
If cc2d2a morphants injected with 6ng MO developed a curly tail (14%, n=21), it was 
always a dorsal curly tail (Figure 4.16B, C), possibly mimicking the sine wave pattern 
of sentinel mutants.  Proximal pronephric cysts were detected in 7% (n=10, Figure 
4.16B, D) of 6ng cc2d2a morphants.  In only 1% of 6ng injected cc2d2a morphants, an 
abnormal number of otoliths (Figure 4.16C) or a wavy notochord (Figure 4.16D, Figure 
4.18B) were detected.  Abnormalities of rudimentary ear and notochord development 
were not apparent in homozygous sentinel mutants. 
Abnormal eye development occurred in 2% (n=3) of 6ng injected cc2d2a morphants 
and included microphthalmia and coloboma formation (Figure 4.17). This low 
frequency of aberrant ocular phenotypes was similar in homozygous sentinel embryos. 
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Figure 4.16 Phenotype with cc2d2a MO knockdown 
Lateral views of zebrafish embryos 72 hours post fertilisation.  A is an uninjected wild 
type control (WT) and is phenotypically normal.  Embryos injected with 6ng of cc2d2a 
splice MO develop a range of anomalies including: cardiac oedema (*); hydrocephalus 
(white arrows, B, C); pronephric cysts (B, D), altered number of otoliths (single in C, 
white arrowhead) and a wavy notochord (red arrow, D).  MO, morpholino 
oligonucleotide.     
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Figure 4.17 Abnormal eye development in zebrafish embryos injected with cc2d2a 
MO 
Lateral views of the head of zebrafish embryos 72 hours post fertilisation.  A is an 
uninjected wild type control (WT) and is phenotypically normal.  Embryos injected with 
cc2d2a splice MO (arrows, B-D) have abnormal eye development including 
microphthalmia or coloboma formation.  MO, morpholino oligonucleotide.    
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Figure 4.18 Mortality at 24hpf and phenotypes at 72hpf of zebrafish embryos 
following cc2d2a MO injection 
Mortality at 24hpf (A) is not significantly higher in embryos injected with cc2d2a MO 
(n=234), compared to uninjected wild type controls (n=85, p=0.31, chi-squared test).  
The percentage mortality rises in both cc2d2a MO injected embryos from 15% (6ng, 
n=151) to 24% (4ng, n=83) and from 3% to 10% in matched WT embryos, however the 
mortality ratio of cc2d2a MO injected embryos relative to WT embryos falls from 5:1 
(6ng) to 2.4:1 (4ng), confirming the dose dependent effect of increasing MO dose on 
mortality.  Graph B shows the percentage frequency of abnormal phenotypes at 72hpf in 
embryos injected with 6ng (n=150) of cc2d2a MO.  7% of embryos developed 
pronephric cysts following 6ng of cc2d2a MO.  hpf, hours post fertilisation; MO, 
morpholino oligonucleotide.     
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4.2.11 NPHP6 Genomic and Proteomic Information in humans and zebrafish 
Human NPHP6 was identified by positional cloning on chromosome 12q21.32 in 2006 
(Sayer et al., 2006).  Using the online Vertebrate Genome Annotation database 
(http://vega.sanger.ac.uk), NPHP6 is shown to consist of 54 exons (Figure 4.19A) and 
has 7 transcripts, 4 of which are protein coding.  The transcript 
(OTTHUMT00000406344) has 7948bp, the best supporting evidence and encodes the 
protein, nephrocystin-6 (OTTHUMP00000242341) which consists of 2479 amino acids 
and 13 coiled-coil domains (Figure 4.19B).  Nephrocystin-6 expression is evident to 
varying degrees in an extensive array of human tissues.  Real-time PCR analysis of 
human tissues identified highest expression in the neural retina, nasal epithelium, spinal 
cord, thyroid gland, testis, heart, lung, bone marrow, cerebellum and uterus.  Weaker 
expression was also identified in the fetal brain, kidney and to a lesser extent in the 
trachea, thymus, muscle, salivary gland, liver, and placenta (Papon et al., 2010). 
In zebrafish a nphp6 orthologue has been identified on chromosome 25, consists of 53 
exons (Figure 4.19C) and has a single transcript (OTTDART00000051136) of 7706bp.  
This nphp6 transcript encodes a protein (OTTDARP00000040195) of 2439 amino 
acids, consisting of 19 coiled-coil domains (Figure 4.19D).   
4.2.12 NPHP6 is conserved throughout evolution 
NPHP6 is highly conserved throughout evolution, with 49 orthologues currently 
identified (http://ensembl.org) in mammals (Chang et al., 2006), birds, amphibians, 
zebrafish (http://www.ncbi.nlm.nih.gov/gene) and a range of invertebrate model 
organisms including the honeybee Apis mellifera, the sea squirt Ciona intestinalis 
(Sayer et al., 2006) and in the ciliated protozoa Tetrahymena thermophilia.  Figure 4.20 
shows the evolutionary conservation of Nphp6 (nephrocystin-6) or centrosomal protein 
290 (cep290) between humans, mice and zebrafish.  The conserved amino acid regions 
are shown in red.  
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Figure 4.19 NPHP6 gene transcript and partial protein product structure in 
humans and zebrafish 
(A) NPHP6 gene transcript in humans (OTTHUMT00000406344) and schematic 
representation of encoded protein product, centrosomal protein of 290kDa (CEP290) 
which includes 13 coiled-coil domains (CC) and has 2479 amino acids 
(OTTHUMP00000242341) (B).  (C) nphp6 gene transcript in zebrafish 
(OTTDART00000051136) and schematic representation of encoded protein product, 
cep290 (OTTDARP00000040195), which includes 19 CC domains and has 2439 amino 
acids (D).  aa, amino acids; Ch., chromosome. 
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Figure 4.20 Evolutionary conservation of Nphp6 (CEP290) in humans, mice and 
zebrafish 
Nphp6 (CEP290) peptide sequence alignment in humans (OTTHUMP00000242341), 
mouse (ENSMUSP00000130899) and zebrafish (OTTDARP00000040195).  
Conservation of amino acid alignment (red font).  
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4.2.13 Design and effect of nphp6 morpholino oligonucleotides 
Both translation (ATG) and splice (ie42) blocking MO were created to interfere with 
nphp6.  Figure 4.21A shows the 53 exons in zebrafish nphp6 and the target sites for 
both nphp6 MO on the predicted zebrafish nphp6 exon sequence.  The splice blocking 
MO targets exon 42 and leads to abnormal splicing with inclusion of a 1227bp intron 
after exon 43 (Figure 4.21B).  At the protein level, the intron is included after 2029 
amino acids and results in loss of 2 coiled coil domains from the nephrocystin-6 protein 
(Figure 4.21C). 
Following the injection of nphp6 MO at the 1-4 cell stage and again at 24hpf, mortality 
rates were assessed.  Figure 4.22 depicts the mortality at 24hpf as mean percentage and 
standard error of the mean for a range of doses of nphp6 splice and translation blocking 
MO.  Comparative 24hpf mortality data is also shown for uninjected WT control 
embryos from the same parental pairs.  Both nphp6 splice (Figure 4.22A) and nphp6 
translation (Figure 4.22B) blocking MO induced a dose dependent effect on 24hpf 
mortality rates.  However there was no significant difference in mortality rates at 24hpf 
between MO injected and uninjected embryos, as shown in Figure 4.22. 
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Figure 4.21 Design of nphp6 MO and the effect of the splice blocking MO at the 
protein level 
(A) Schematic representation of zebrafish nphp6 showing target sites of translation 
(ATG) and splice (nphp6iex42) blocking morpholino oligonucleotides (MO). (B) The 
splice blocking MO, nphp6iex42, designed to target exon 42, leads to abnormal splicing 
with inclusion of a 1227bp intron (red) after exon 43.  At the protein level, the intron is 
included after 2029 amino acids and results in loss of 2 coiled coil domains (C).  
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Figure 4.22 Mortality at 24hpf following nphp6 MO injection 
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) and 
standard error of the mean (where appropriate) in zebrafish embryos injected with a 
range of morpholino oligonucleotide (MO) doses.  Matched uninjected wild type (WT) 
controls are shown.  Both nphp6 splice (A) and nphp6 translation blocking (B) MO 
induce a dose dependent effect on mortality.  For the splice blocking MO (A), total 
numbers of embryos at 24hpf were 547 from 7 pairs (6ng), 342 from 3 pairs (4ng) and 
73 from 1 pair (2ng).  For the translation blocking MO (B), total numbers of embryos at 
24hpf were 430 from 4 pairs (2ng) and 303 from 2 pairs (1ng).   
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4.2.14 Phenotypes of zebrafish morphants created by nphp6 MO knockdown 
Zebrafish embryos were phenotyped by light microscopy at 72hpf.  Uninjected WT 
embryos were phenotypically normal (Figure 4.23A).  Embryos injected with either 
nphp6 splice (nphp6 Sp) or nphp6 translation (nphp6 ATG) targeting MO had abnormal 
development including: convergent extension defects leading to shortened or curved 
body axis; hydrocephalus, cardiac oedema and altered number of otoliths (Figure 
4.23B-E).  Additionally nphp6 morphants develop cysts of varying sizes throughout the 
pronephros (Figure 4.24) and cystic dilatation of the distal pronephros at the cloaca in 
some embryos (Figure 4.24E). 
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Figure 4.23 Phenotype with nphp6 MO knockdown 
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type (WT) 
uninjected control embryos are phenotypically normal (A).   Embryos injected with 
nphp6 translation (B, C) and splice (D, E) blocking MO develop hydrocephalus (black 
arrows), cardiac oedema (*), curved body axis (C-E) and altered number of otoliths 
(none, black arrowhead, E).  MO, morpholino oligonucleotide.    
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Figure 4.24 nphp6 MO knockdown induces pronephric cysts in zebrafish embryos 
Lateral views of pronephric cysts (black arrowheads) in nphp6 morphants at 72 hours 
post fertilisation (B-E).  (A) is a phenotypically normal uninjected wild type (WT) 
control embryo.  nphp6 morphants develop proximal (B-C), distal (D) and cloacal (E) 
pronephric cysts.  The cloaca in E is very dilated and distorted, this embryo also has 
hydrocephalus and a single otolith.     
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The abnormal eye and ear development found in nphp6 morphants was further 
characterised by light microscopy images of their heads at 72hpf.  Abnormal 
rudimentary ear development was identified as an empty otic vesicle or a single otolith 
(Figure 4.25B-D).  Anomalies of eye development included unilateral microphthalmia 
and coloboma formation (Figure 4.25E-H). 
The mean frequency of the development of each abnormal phenotype at 72hpf 
following injection of a dose range of nphp6 translation (nphp6 ATG) or splice (nphp6 
Sp) blocking MO is shown in Figure 4.26.  The frequency of development of abnormal 
phenotypes was dose dependent, with higher doses of splice (Figure 4.26B) blocking 
MO required to induce a phenotype (mean percentage (±SEM)) compared to translation 
blocking MO (Figure 4.26A).  Injection of 1-2ng of nphp6 ATG MO induced the 
following frequency of phenotypes: curved body axis in 11.3% (±7.5%) to 13.5% 
(±6.9%); cardiac oedema in 13.3% (±8.4%) to 15.7% (±7.8%); pronephric cysts in 5.7% 
(±3.8) to 6% (±3.5%); hydrocephalus in 3.7% (±0.3%); otic defects in 0.7% (±0.7%) to 
1.3% (±0.3%) and colobomas in 0.7% (±0.7%) to 1.3% (±0.3%).  Injection of 4-8ng of 
nphp6 Sp MO induced the following frequency of phenotypes: curved body axis in 16% 
(±14%) to 56.7% (±17%); cardiac oedema in 13% (±10%) to 56.7% (±17%); 
hydrocephalus in 2.5% (±0.5%) to 42.7% (±22.6%); pronephric cysts in 1.5% (±1.5) to 
19.3% (±8.3%); otic defects in 2% (±1%) to 16.3% (±13%) and colobomas in 1.5% 
(±1.5%) to 6.3% (±6.3%).  These abnormal developmental phenotypes identified in the 
nphp6 zebrafish morphants are characteristic of a zebrafish ciliopathy. 
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Figure 4.25 Abnormal eye and ear development following nphp6 MO knockdown 
Views of the head of zebrafish embryos at 72 hours post fertilisation, focusing on the 
otic vesicles (A-D) and eyes (A, E-H).  Wild type (WT) uninjected control embryos 
have normal eyes of equal size and two otoliths in each otic vesicle (green arrows, A).  
Lateral views of embryos injected with nphp6 MO show abnormal ear development 
with either an empty otic vesicle (black arrow, B-C) or a single otolith (red arrow, D).  
Abnormal eye development includes unilateral microphthalmia (black arrowheads, 
lateral (E) and dorsal (F) views) and coloboma formation (red arrowheads, lateral (G) 
and ventral (H) views) in nphp6 morphants.  MO, morpholino oligonucleotide. 
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Figure 4.26 Quantification of abnormal phenotypes at 72hpf following injection 
with nphp6 splice or translation blocking MO 
Data are displayed as mean ± SEM. The percentage frequency of each abnormal 
phenotype was higher following nphp6 splice (Sp) MO (B) knockdown, compared to 
following nphp6 translation (ATG) MO (A) knockdown.  There was a dose dependent 
effect on the frequency of each abnormal phenotype.  The total number of zebrafish 
embryos phenotyped at 72hpf following each dose of nphp6 ATG MO was 236 (2ng) 
and 158 (1ng) (A).  The total number of zebrafish embryos phenotyped at 72hpf 
following each dose of nphp6 Sp MO were 84 (8ng), 216 (6ng) and 261 (4ng).  MO, 
morpholino oligonucleotide.      
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4.2.15 Specificity of nphp6 splice MO knockdown and direct sequencing 
RT-PCR of (equal concentrations of isolated RNA from) individual uninjected WT 
zebrafish embryos at 24hpf revealed the expected product size of 309bp.  RT-PCR of 
single nphp6 splice MO injected zebrafish embryos at 24hpf suggested abnormal 
splicing by the presence of an additional larger RT-PCR product (band greater than 
1000bp, Figure 4.27A).  The larger RT-PCR fragment identified in nphp6 MO injected 
embryos was isolated from the gel, purified and sent for sequencing, which identified a 
1536bp product created by inclusion of the intron (1227bp) situated after exon 43 
(Figure 4.27B). 
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Figure 4.27 Evidence of nphp6 splice MO knockdown by RT-PCR and direct 
sequencing 
(A) RT-PCR of single embryos at 24hpf following nphp6 splice MO knockdown 
reveals an additional larger RT-PCR product (circled in white), compared to uninjected 
wild type (WT) control embryos, which only have the normal RT-PCR product of 
309bp.  (B) Direct sequencing (data not shown) confirmed the identity of the larger 
product in nphp6 morphants which included  intronic sequence after exon 43, 
confirming abnormal splicing. hpf, hours post fertilisation. 
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4.2.16 Shorter cilia in Kupffer’s vesicle of nphp6 MO injected embryos 
KV was evaluated to determine whether there were any overt differences in cilia which 
may facilitate explanation of the ciliopathy phenotype in nphp6 morphants (Figure 4.23, 
Figure 4.24, Figure 4.25).  Immunostaining of cilia using an antibody to acetylated 
tubulin showed fewer and shorter cilia in nphp6 MO injected embryos (n=8) compared 
to uninjected WT (Figure 4.28).  The zebrafish embryos utilised for immunostaining 
express claudin-b at cell to cell junctions (tight junctions) of KV epithelial cells and this 
expression is also abnormal and less distinct in nphp6 MO injected embryos. 
  
 ________________ Chapter 4:  Zebrafish models of ciliopathies using cc2d2a, nphp6 or mk3 knockdown  
221 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.28 Shorter cilia in Kupffer's Vesicle of nphp6 MO injected zebrafish 
embryos 
Confocal microscopy images of cldb:Lyn-GFP wild type (WT, A-C) and nphp6 MO 
injected (D-F) zebrafish embryos following fixation at the 8-10 somite stage and 
fluorescent immunostaining using anti-acetylated tubulin (AT, red, B, E) antibody to 
label cilia.  Cilia appear shorter and of a reduced number in KV of nphp6 MO injected 
embryos (E-F), compared to uninjected WT (B-C).  Images were taken with a 20x 
objective, zoom of 3.  Scale bars = 20 µm.  KV, Kupffer's vesicle; MO, morpholino 
oligonucleotide.  
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4.2.17 Dose dependent left-right cardiac asymmetry defects following nphp6 MO 
injection 
To evaluate whether the shortened cilia within KV of nphp6 MO injected embryos 
would impede generation of sufficient fluid flow to establish normal left-right body 
patterning, cardiac looping was evaluated at 56hpf (Essner et al., 2005).  Cardiac 
looping was evaluated by light microscopy, as the cardiac myosin light chain (cmcl2-
GFP) transgenic zebrafish were not available for injection.  Images were not acquired as 
the heart does not project as overtly using light microscopy, however scoring was as 
described in section 3.2.9.  Figure 4.29A shows quantification of the raw numbers of 
cardiac looping phenotype in uninjected WT control embryos (n=80) and nphp6 
morphants (n=74) at 56hpf.  There was a significant reduction in the normal, D-looping 
(n=11) asymmetry in nphp6 morphants compared to uninjected WT control embryos 
(n=79, p < 0.0001, chi-squared test).  Figure 4.29B shows the percentage frequency of 
cardiac looping following 6-8ng of nphp6 MO, 15% develop normal D-looping whilst 
80% develop L-looping.   
The effect on cardiac looping appears to be dose dependent.  In morphants injected with 
6ng nphp6 MO, 7 (24%) develop D-looping, 21 (72%) develop L-looping and only 1 
(4%) develop no loop.  Expressed as a ratio of left:right cardiac looping, 6ng nphp6 MO 
leads to 3:1 developing L-looping relative to normal D-looping.  Following a higher 
dose of nphp6 MO (8ng), 4 (9.3%) develop D-looping, 36 (83.7%) develop L-looping 
and 3 (7%) develop no loop.  The 8ng dose of nphp6 MO leads to 9:1 developing L-
looping relative to normal D-looping. 
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Figure 4.29 Analysis of cardiac looping reveals laterality defects in nphp6 
morphants at 56hpf 
Quantification of orientation of cardiac looping at 56hpf in zebrafish embryos (A) 
reveals there is a significant reduction in the normal rightward cardiac looping (D-
looping) in nphp6 morphants (n=11, *, p < 0.0001, chi squared test), compared to 
uninjected wild type (WT) controls (n=79).  (B) Stacked bar chart showing the 
percentage frequency of cardiac looping orientation in each experimental group.  In the 
WT embryos, 99% (n=79) have D-looping and 1% (n=1) L-looping, compared to nphp6 
morphants in which 15% (n=11) have D-looping, 5% (n=4) have No looping and 80% 
(n=59) have L-looping.  hpf, hours post fertilisation. 
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4.2.18 Cilia are present in the distal pronephros however appear reduced in 
number and shorter in the cloaca of nphp6 morphants  
At 72hpf, claudin-b:Lyn-GFP transgenic nphp6 morphant embryos were fixed in 4% 
PFA and immunostaining performed using anti-acetylated tubulin antibody to detect 
cilia.  Using confocal microscopy the distal pronephric ducts and cloaca were studied 
(Figure 4.30) and the presence of cilia confirmed in the pronephros more proximal to 
the cloaca (Figure 4.30E,F) in all nphp6 morphants (n=6).  However in some nphp6 
morphants, the number of cilia appeared to reduce and even be absent (Figure 4.30E, F) 
or very short at the cloaca (Figure 4.30H, I).  Unfortunately it was not possible to 
formally quantify the length of individual cilia to detect any differences from cilia in 
uninjected WT control embryos.   
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Figure 4.30 Cilia in the distal pronephros and cloaca of nphp6 morphant zebrafish 
embryos 
Confocal microscopy images of claudinb:Lyn-GFP zebrafish embryos following 
fixation at 72hpf and immunostaining with anti-acetylated tubulin antibody (AT, red) to 
identify cilia.  Uninjected wild type control (WT, A-C) embryos have cilia (white 
arrows, B) lining the pronephros which meet in apposition at the cloaca (A, C).  In 
nphp6 morphants, cilia are present in the distal pronephros, however reduce in 
number/disappear as the cloaca is approached (white circle, E, F).  G-I show a cross 
sectional view of a dilated cloaca in an nphp6 morphant with what appears to be short 
cilia.  Images were taken with a 20x objective and zoom of 3.  Scale bars = 20 µm.   
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4.2.19 MKS3 Genomic and Proteomic Information in humans and zebrafish 
Human MKS3 was identified on chromosome 8q22.1 in 2006 (Smith et al., 2006).  
Using the online Vertebrate Genome Annotation database (http://vega.sanger.ac.uk), 
human MKS3 is shown to consist of 28 exons (Figure 4.31A) and has 22 transcripts, 8 
of which are protein coding.  The transcript with the best evidence is 
OTTHUMT00000329641, has 4651bp and encodes the protein, meckelin 
(OTTHUMP00000203157) which consists of 995 amino acids and has 4 
transmembrane domains (Figure 4.31B).  Of note, Smith et al. reported that meckelin 
consists of 3-7 transmembrane domains (Smith et al., 2006).  Meckelin is expressed in 
the human embryonic kidney (proximal renal tubule epithelial cells), liver, retina and 
hindbrain (Dawe et al., 2007) and localises at the ciliary transition zone of the primary 
cilium (Williams et al., 2011).   
Using the http://vega.sanger.ac.uk database, 1 zebrafish orthologue of MKS3 was 
identified on chromosome 16, consisting of 28 exons.  There were 2 mks3 transcripts, 1 
of which was protein coding (OTTDART00000042166) with 3193bp (Figure 4.31C).  
This mks3 transcript encodes a protein, meckelin (OTTDARP00000033569) of 982 
amino acids, consisting of 5 transmembrane domains (Figure 4.31D).   
4.2.20 MKS3 is conserved throughout evolution 
MKS3 is highly conserved throughout evolution, with orthologues in 52 vertebrate 
species (http://ensembl.org), including zebrafish and a range of invertebrate model 
organisms: Drosophilia melanogaster, Caenorhabditis elegans; Chlamydomonas 
reinhardtii plant (Hodges et al., 2010) and the unicellular organism Trypanosoma cruzi 
(Smith et al., 2006).  Figure 4.32 shows the evolutionary conservation of meckelin 
between humans, mice and zebrafish.  The conserved amino acid regions are shown in 
red.  
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Figure 4.31 MKS3 gene transcript and partial protein product structure in humans 
and zebrafish 
(A) MKS3 gene transcript in humans (OTTHUMT00000329641) has 28 exons and 
schematic representation of encoded protein product, Meckelin which includes 4 
transmembrane domains (TM) and has 995 amino acids (OTTHUMP00000203157) (B).  
(C) mks3 gene transcript in zebrafish (OTTDART00000042166) has 28 exons and 
schematic representation of encoded protein product, meckelin 
(OTTDARP00000033569), which has 5 TM domains and 982 amino acids (D).  aa, 
amino acids; Ch., chromosome. 
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Figure 4.32 Evolutionary conservation of Mks3 protein, Meckelin, in humans, mice 
and zebrafish 
Meckelin peptide sequence alignment in humans (homo sapiens, ENSP00000389998), 
mice (mus musculus, ENSMUSP00000103928) and zebrafish (danio rerio, 
ENSDARP00000116688).  Conservation of amino acid alignment (red font).  
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4.2.21 Design and effect of mks3 morpholino oligonucleotide 
A splice (mks3ei4) blocking MO was designed to interfere with mks3 expression.  
Figure 4.33A shows the MO target site on the predicted zebrafish mks3 exon sequence.  
The mks3 ei4 MO induces abnormal splicing and a predicted inclusion of a 165bp intron 
after exon 3 (Figure 4.33B, Figure 4.34) resulting in a premature stop codon after 144 
amino acids and loss of 4 transmembrane domains from meckelin (Figure 4.33C). 
There was a dose dependent increased mortality rate at 24hpf in embryos injected with 
mks3 MO compared to uninjected WT controls (Figure 4.35).  The 24hpf mortality rate 
associated with mks3 MO was 52.4% (±6.8%) for 2ng and 67.2% (±5.7%) for 4ng. 
4.2.22 Specificity of mks3 splice MO knockdown and direct sequencing 
RT-PCR of (equal concentrations of isolated RNA from) individual uninjected WT 
zebrafish embryos at 24hpf revealed the expected product size of 390bp.  However, in 
mks3 splice MO injected zebrafish embryos there was abnormal splicing suggested by 
an additional larger RT-PCR product over 500bp (circled in white, Figure 4.34A).  This 
larger PCR fragment was isolated from the gel, purified and sent for sequencing (Figure 
4.34B), which identified a 555bp product created by inclusion of the intron (165bp) 
situated after exon 3.  This splicing defect led to an alternative reading frame after 
amino acid 125, a premature stop codon after amino acid 144, predicting a truncated 
protein. 
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Figure 4.33 Design of mks3 splice blocking MO and the effect at the protein level 
(A) Schematic representation of zebrafish mks3 showing the target site of the splice 
blocking MO is exon 4 (mks3ei4).  Knockdown with mks3 MO leads to abnormal 
splicing with inclusion of a 165bp intron (red) after exon 3 (B).  At the protein level, 
this leads to an alternative reading frame after 125 amino acids and a premature stop 
codon after 144 amino acids, resulting in a truncated protein with loss of 4 
transmembrane domains (C).  MO, morpholino oligonucleotide. 
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Figure 4.34 Evidence of mks3 splice MO knockdown by RT-PCR and direct 
sequencing 
(A) RT-PCR of single zebrafish embryos at 24hpf following mks3splice MO 
knockdown reveals an additional larger RT-PCR product (circled in white), compared 
to uninjected wild type (WT) control embryos, which only have the normal RT-PCR 
product of 390bp.  (B) Direct sequencing of the larger product (555bp) in mks3 
morphants identifies that it includes the intron (165bp) situated after exon 3, as a result 
of abnormal splicing. bp, base pairs; hpf, hours post fertilisation; mks3cDNA, reference 
mks3 cDNA sequence.  
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Figure 4.35 Mortality at 24hpf following mks3 MO injection 
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) and 
standard error of the mean in zebrafish embryos injected with two different doses of 
morpholino oligonucleotide (MO).  Matched uninjected wild type (WT) controls are 
shown.  There is a dose dependent effect on mortality associated with mks3 MO 
injection.  The total numbers of embryos at 24hpf were 837 from 12 pairs (4ng) and 968 
from 16 pairs (2ng).   
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4.2.23 Phenotypes of zebrafish morphants created by mks3 knockdown 
Zebrafish embryos were phenotyped by light microscopy at 72hpf.  mks3 morphants 
develop abnormally with: a curved body axis; tail and notochord anomalies; 
hydrocephalus; pronephric cysts; cardiac oedema; altered number of otoliths and 
unilateral microphthalmia.  Pronephric cysts are evident both proximally (Figure 4.36B-
D) and distally at the cloaca (Figure 4.36E-F), which in some embryos led to an 
obstructive picture with cystic dilatation extending proximally and the development of 
gross generalised oedema (Figure 4.36F).  The pronephros was examined histologically 
by sectioning resin embedded embryos at 5dpf.  Figure 4.36G-H shows the pronephros 
of mks3 morphants was dilated to a diameter of 29.2-29.7µm compared to a pronephros 
diameter of 9.7-13.6µm in uninjected WT controls. 
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Figure 4.36 mks3 knockdown induces pronephric and cloacal cysts, leading to 
obstruction of the cloaca 
Lateral views of zebrafish embryos at 72 hours post fertilisation (A-F).  Wild type (WT) 
uninjected control embryos are normal (A).  Embryos injected with mks3 MO develop 
pronephric cysts both proximally (arrow, B-D) and distally at the cloaca (arrow E, 
arrowhead F).  The cloacal cyst (E) appears to cause outflow obstruction as there is 
marked associated cardiac oedema (*).  The large cloacal cyst (arrowhead F) leads to 
proximal cystic dilatation of the pronephros (arrows).  Resin histology 5µm sections 
through the pronephros (arrows) at 5 days (G-H) reveals dilatation in mks3 morphants 
(diameter 29.2-29.7µm, H), compared to WT controls (diameter 9.7-13.6µm, G).  Scale 
bars = 20µm.  Stained with methylene blue-basic fuchsin stain. 
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In addition to abnormalities of the pronephros, mks3 morphants develop variable 
severities of hydrocephalus by 72hpf.  Anomalies of brain development including 
encephalocele formation are evident on resin histology sections by 5dpf (Figure 4.37).  
mks3 morphants develop convergent extension defects, which are common to many 
ciliopathy genes, however interestingly they also develop abnormal notochords and 
tails.  Compared to uninjected WT control embryos, mks3 morphants frequently develop 
wavy notochords (Figure 4.38B-E), which in severe cases can extend dorsally through 
the floorplate, neural tube, myotomes and dorsal fin layers to the surface (Figure 
4.38C).  In mks3 morphants without convergent extension defects, abnormalities which 
appeared like vacuoles were observed within the dorsal fin of the tail (Figure 4.38F-I).  
Figure 4.39 shows images of the heads of mks3 morphants at 72hpf, focusing on eye 
and ear abnormalities.  Eye development is disturbed with unilateral microphthalmia 
(Figure 4.39G-H) and rudimentary ear development is altered in mks3 morphants with 
either an empty otic vesicle, a single otolith or 3 otoliths (Figure 4.39C-H).  
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Figure 4.37 mks3 knockdown induces hydrocephalus and abnormal brain 
development in zebrafish embryos 
Lateral views of zebrafish embryos at 72hpf (A-F).  Wild type (WT) uninjected control 
embryos are normal (A).  Embryos injected with mks3 MO develop hydrocephalus 
(arrows, B-F).  Resin histology 5µm sections through the brain at 5dpf (G-H) reveals an 
encephalocele in mks3 morphants (arrow, H) compared to WT controls (G).  Scale bars 
= 20µm.  Stained with methylene blue-basic fuchsin stain.  dpf, days post fertilisation; 
hpf, hours post fertilisation; MO, morpholino oligonucleotide.  
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Figure 4.38 mks3 knockdown induces notochord defects and abnormal tail 
development in zebrafish embryos 
Lateral views of zebrafish embryos 72hpf (A-F).  Wild type (WT) uninjected control 
embryos are normal (A).   Embryos injected with mks3 MO (B-I) develop abnormal, 
wavy notochords (B-E), in severe cases the notochord projects dorsally to the skin 
surface (B).  mks3 morphants also have abnormal tail development (F-I), with 
disruption of myotome and fin layers (arrows), representative of human meningoceles.  
hpf, hours post fertilisation; MO, morpholino oligonucleotide. 
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Figure 4.39 Abnormal ear and eye development following mks3 MO knockdown 
Views of the head of zebrafish embryos at 72 hours post fertilisation, focusing on the 
otic vesicles (A-F) and eyes (A, B, G, H).  Wild type (WT) uninjected control embryos 
have normal eyes of equal size and two otoliths in each otic vesicle (black arrows, A, 
B).  mks3 morphants show abnormal ear development with either a single otolith (black 
arrow, lateral and dorsal views, C-D), unilateral empty otic vesicle (black arrow, E, H) 
or 3 otoliths in an otic vesicle (black arrows, F).  Abnormal eye development with 
unilateral microphthalmia (red arrows, G-H) is also seen in mks3 morphants.  MO, 
morpholino oligonucleotide.  
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The mean percentage (±SEM) frequency of the development of each abnormal 
phenotype at 72hpf following injection of 2-4ng of mks3 splice blocking MO increased 
in a dose dependent manner.  Figure 4.40 shows a graph of the frequency of each 
phenotype following injection of 2-4ng of mks3 MO: convergent extension defect with 
curly tail in 22.1% (±4.3%) to 25.5% (±4.6%); cardiac oedema in 20.7% (±4.9%) to 
28.3% (±3.7%); hydrocephalus in 13.3% (±3.5%) to 13.8% (±2.7%); pronephric cysts 
in 9.3% (±2.4%) to 11.2% (±1.5%); otic defects in 3.9% (±1.8%) to 7.2% (±2.4%); 
meningocele/vacuolated dorsal fin 2.3% (±1.2%) to 4.3% (±3.8%); wavy notochord in 
1.7% (±0.9%) to 4.7% (±1.3%) and abnormal eye development in 1% (±1%) to 2.6% 
(±1.6%). 
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Figure 4.40 Quantification of abnormal phenotypes at 72hpf following injection 
with mks3 splice blocking MO 
Data are displayed as mean ± SEM.  Following injection with 2-4ng of mks3 splice 
blocking MO, there was a dose dependent effect on the percentage frequency of each 
abnormal phentoype (A).  The total number of zebrafish embryos phenotyped at 72hpf 
following mks3 MO injection of: 2ng was 325 and 4ng was 233.  hpf, hours post 
fertilisation; MO, morpholino oligonucleotide.   
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4.2.24 Specificity of mks3 MO knockdown in mks3 zebrafish morphants 
To evaluate the specificity of morphant phenotypes induced by mks3 MO knockdown, 
embryos were coinjected with human MKS3 mRNA to see if this rescued the morphant 
phenotype.  Embryos were injected with 50-100pg of human MKS3 mRNA alone and 
phenotyped by light microscopy at 72hpf confirmed normal morphology in 96% of 
embryos (n=197, Figure 4.41B).  Subsequently, coinjection of 50-100pg of MKS3 
mRNA and 2-4ng of mks3 MO resulted in partial (n=69, Figure 4.41C) and complete 
(n=249, Figure 4.41D) rescue from the mks3 morphant phenotype in 22% and 78% 
respectively (n=318).  Quantification of the raw numbers of embryos with a normal WT 
appearance or morphant phenotype are classified by treatment group following 2-4ng of 
mks3 MO alone (n=691) or co-injection with 50-100pg of human MKS3 mRNA (n=318, 
Figure 4.42A).  The raw overall rescue from a morphant phenotype to a normal WT 
appearance in embryos co-injected with 50-100pg of human MKS3 mRNA and 2-4ng 
of mks3 MO was just significant (*, p=0.052, chi-squared test).  When comparing the 
frequency of individual morphant phenotypes (curly tail, cardiac oedema, 
hydrocephalus, meningocele, pronephric cyst, wavy notochord, abnormal eye, otic 
defect) of embryos injected with mks3 MO alone and those rescued with human MKS3 
mRNA, there was a significant decrease in the raw numbers (p < 0.0001, chi-squared 
test) and percentage frequency (p=0.0058, chi-squared test) of abnormal phenotypes in 
embryos co-injected with human MKS3 mRNA (Figure 4.42B).  A normal 
morphological appearance was recovered in a mean of 83.8% (±4.7%, ±SEM) of 
embryos coinjected with mks3 MO and human MKS3 mRNA.  The human mRNA is not 
predicted to be affected by the zebrafish MO as it does not share any target sequence.  
  
 ________________ Chapter 4:  Zebrafish models of ciliopathies using cc2d2a, nphp6 or mk3 knockdown  
242 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.41 Rescue of mks3 morphant phenotype by co-injection of mks3 MO with 
human MKS3 mRNA 
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type uninjected (A) 
and embryos injected with 50-100pg of human MKS3 mRNA alone (B) were 
morphologically normal.  Partial (C) and complete (D) rescue of embryos co-injected 
with mks3 MO and 50-100pg of human MKS3 mRNA.  A small notochord defect is 
arrowed in C.  MO, morpholino oligonucleotide.  
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Figure 4.42 Quantification of Rescue of mks3 morphant phenotype  
Raw quantification of overall rescue from a morphant phenotype to a normal, wild type 
appearance in embryos co-injected with 50-100pg of human MKS3 mRNA and 2-4ng of 
mks3 MO (n=318).  The degree of rescue to the normal wild type phenotype was just 
significant (*, p=0.052, chi-squared test).  The total number of embryos injected with 2-
4ng of mks3 MO alone was 691.  (B) Percentage of each phenotype shown as mean ± 
SEM, in embryos injected with 2-4ng of mks3 MO alone, compared to those co-injected 
with 50-100pg human MKS3 mRNA.  There was a significant degree of rescue to the 
wild type phenotype and reduction of each abnormal phenotype following co-injection 
with MKS3 mRNA (*, p=0.0058, chi-squared test).  MO, morpholino oligonucleotide. 
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4.3 Discussion  
In order to study a spectrum of severity of cystic kidney disease related ciliopathies and 
to enable later evaluation of the potential role of oligogenicity which may influence the 
clinical heterogeneity, it was important to develop robust models of individual gene 
morphants.  Zebrafish models were created and the phenotypes were evaluated in detail 
to determine the role of CC2D2A, NPHP6 and MKS3 during development.  
4.3.1 Zebrafish models to study CC2D2A - the sentinel mutant zebrafish 
Embryos born from sentinel heterozygous zebrafish were phenotyped at 72hpf.  In 
homozygotes with a pathognomonic sine wave shaped tail, the nonsense mutation in 
cc2d2a was confirmed by genotyping and sequencing, consistent with previously 
published work (Gorden et al., 2008).  In all of the experiments, it was disappointing to 
find that only 12% of embryos were sentinel homozygotes rather than nearer 25% 
which is what would have been expected from Mendelian genetics.  Increased mortality 
in sentinel homozygotes may be a reason for this reduction in numbers as mortality at 
24hpf was 12% in sentinel embryos. However confirmation of this potential explanation 
was not possible as genotyping deceased (necrotic) embryos is not feasible.   
The low numbers of sentinel homozygotes corresponded to an overall low frequency of 
aberrant ciliopathy phenotypes.  In particular pronephric cysts were only detected in 
0.5% of all sentinel offspring, equivalent to 4.2% of sentinel homozygotes.  The 
pronephric cyst phenotype has been described as incompletely penetrant yet reported to 
occur in 33-50% of sentinel homozygotes (Bachmann-Gagescu et al., 2011; Gorden et 
al., 2008) at 6dpf.  However disappointingly, in the experiments herein, the pronephric 
cyst phenotype was considerably less penetrant.  Working within our Home Office 
animal licence only enabled work with zebrafish embryos to be performed up to 5dpf 
when they become capable of independent feeding and must be euthanised.  It is 
therefore possible that by studying the pronephros within this limited time, the 
development of pronephric cysts which may become apparent beyond 5dpf were 
missed.     
Interestingly, although low in frequency, the phenotypes of cardiac oedema, 
hydrocephalus and pronephric cysts detected in the sentinel homozygous mutants herein 
were of varying severity, consistent with the genetic pleiotropy apparent in patients with 
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CC2D2A mutations.  A genotype-phenotype correlation has been suggested in patients 
following the identification of missense CC2D2A mutations being associated with 
JBTS, whilst truncating CC2D2A mutations have resulted in the more severe MKS 
disorder (Mougou-Zerelli et al., 2009; Tallila et al., 2008).  
Developmental anomalies of the rudimentary ear, the otic placode, were not detected in 
any sentinel homozygous mutants in this work, although can be a recognised feature of 
other ciliopathy models (Lee et al., 2012a; Simms et al., 2012).  This protection of 
normal development of the ear in sentinel mutants may relate to how the sentinel 
zebrafish were first discovered, as a protective mutant from aminoglycoside-antibiotic-
induced mechanosensory hair cell death (Owens et al., 2008).  
Ocular anomalies including oculomotor apraxia, colobomas and retinal defects are 
reported in patients with CC2D2A mutations and JBTS or MKS (Mougou-Zerelli et al., 
2009).  Detection of these ocular anomalies including colobomas and unilateral 
microphthalmia were confirmed herein in a low proportion of sentinel homozygous 
zebrafish embryos.  On retinal histology sections of 5dpf sentinel homozygotes, the 
outer retinal pigmented epithelial layer was preserved, however there was indistinct 
definition of the other retinal layers.  These findings are in contrast to those 
subsequently reported by Bachmann-Gagescu et al., who identified an overall normal 
eye size and retinal lamination, however a thinner photoreceptor cell layer in sentinel 
homozygous mutants at 5dpf (Bachmann-Gagescu et al., 2011).  Reasons for these 
differing results may be the phenotypic heterogeneity associated with CC2D2A 
mutations and other ciliopathy genes.  
Since cc2d2a is known to be expressed at the basal body of cilia (Bachmann-Gagescu et 
al., 2011; Gorden et al., 2008) and sentinel mutants develop a ciliopathy phenotype, it is 
possible that CC2D2A plays a role in the regulation of cilia (Owens et al., 2008).  In this 
work, cilia were evaluated in the developmental zebrafish organising centre, KV and a 
reduction in the number of cilia in embryos born from heterozygous sentinel:claudin-
b:Lyn-GFP zebrafish pairs was detected.  To my knowledge, this is the first report 
following evaluation of KV in sentinel embryos.  Unfortunately further assessment of 
cilia within KV in terms of motility and fluid flow was not possible.  However, of 
notable interest was the apparent disruption or lack of clearly organised epithelial cell to 
cell junctions of KV.  This combination of abnormal features within KV in sentinel 
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embryos may lead to defective left-right body patterning and ciliopathy phenotypes, 
ideally future work would address this by evaluating subsequent left-right body 
asymmetry.  
Cilia within the pronephros of sentinel homozygous mutants have previously been 
grossly studied at 48hpf and no obvious differences in the number or structure of cilia 
were noted (Gorden et al., 2008).  
The transgenic sentinel:claudin-b:Lyn-GFP zebrafish line were developed to facilitate 
studying the pronephros for cysts with the particular intention of testing the influence of 
drug therapies on cyst development.  This work was performed in December 2009 when 
there was considerable interest in the mTOR (mammalian target of rapamycin) 
inhibitors as a potential treatment for the related cystic kidney disease, ADPKD.  There 
was evidence of a reduction in cyst volume with preserved kidney function in a rat 
model of ADPKD (Tao et al., 2005) and two mouse models of polycystic kidney 
disease (Shillingford et al., 2006) after treatment with Rapamycin.  Furthermore, 
zebrafish models of the ciliopathies NPHP and BBS, specifically nphp2, nphp6, bbs6 
and bbs8 morphants treated with 0.002-0.1µM of Rapamycin effectively had a reduction 
in the development of pronephric cysts (Tobin and Beales, 2008). 
A significant difference in the efficacy of Rapamycin therapy in reducing any of the 
aberrant sentinel phenotypes particularly no reduction in hydrocephalus or pronephric 
cysts was detected herein.  Embryos were treated with 0.05-0.1µM of Rapamycin and it 
could be that a higher dose may have been more effective, as whilst a dose range of 
0.002-0.1µM Rapamycin was reported to be effective, the images in the published work 
related to a treatment dose of 10µM (Tobin and Beales, 2008).  However, perhaps more 
importantly, the overall low numbers of sentinel homozygotes and therefore low 
frequency of aberrant phenotypes made it difficult to detect a significant difference 
between treatment groups.    
In the Rapamycin therapy experiments, embryos were not dechorionated and 
permeability of the chorion to Rapamycin was assumed because previous groups using 
Rapamycin have not dechorionated embryos and generated successful results (Makky et 
al., 2007; Tobin and Beales, 2008).  Although there is no data available regarding the 
pharmacokinetics or in particular the half life of Rapamycin therapy in zebrafish, in the 
Rapamycin trial performed herein, the treatment solutions were replaced every 24 hours 
 ________________ Chapter 4:  Zebrafish models of ciliopathies using cc2d2a, nphp6 or mk3 knockdown  
247 
 
to try to control for the potential of any therapeutic effect waning after 24 hours.  It 
would however have been useful to be able to determine the half life of Rapamycin in 
zebrafish to ensure that the dose was appropriate. 
Although there was an increased frequency of cardiac oedema in WT embryos exposed 
to Rapamycin therapy, this was not statistically significant and was only associated with 
early exposure, from zero hours post fertilisation.  There was no significant difference 
in mortality rates in any of the treatment groups. 
Treatment trials with Rapamycin therapy were prematurely ceased because of the 
publication of negative results regarding the efficacy of mTOR inhibitors in patients 
with ADPKD, no reduction in cystic kidney volume (Serra et al., 2010) or change in 
kidney function (Serra et al., 2010; Walz et al., 2010).   
4.3.2 Creating zebrafish models to study CC2D2A  - MO knockdown 
MO knockdown of cc2d2a confirmed the abnormal phenotypes detected in sentinel 
homozygotes, implicating that cc2d2a has a role to play in normal organogenesis of the 
brain, kidney and eye.  To my knowledge, this is the first work to use MO knockdown 
to study cc2d2a in combination with studies in cc2d2a mutant zebrafish.   
Interestingly if a cc2d2a morphant developed a curly tail, this was always a dorsal body 
curvature, akin to the sine wave shape of sentinel homozygotes.  There are few other 
ciliopathy morphants which consistently develop a dorsal body curvature, however pkd2 
morphants mimicking ADPKD are one such example (Sun et al., 2004).  The 
significance of whether dorsal or ventral body curvature develops in zebrafish mutants 
and morphants is not known, however the mechanisms of abnormal convergent 
extension and disrupted PCP signalling are of considerable interest (Torban et al., 2004) 
and being evaluated in other ciliopathy disorders (Ferrante et al., 2009).  
An abnormal ocular phenotype was again observed in cc2d2a morphants including 
colobomas and microphthalmia, consistent with the developmental anomalies apparent 
in sentinel homozygotes.  An abnormal developmental ear phenotype with a reduced 
number of otoliths was evident in a small percentage of cc2d2a morphants, this 
phenotype does occur in other ciliopathy morphants (Ferrante et al., 2009; May-Simera 
et al., 2010; Simms et al., 2012), however did not occur in sentinel homozygotes 
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suggesting that the potential protective effect of cc2d2a (Owens et al., 2008) on the 
normal development of the rudimentary ear was interfered with by our cc2d2a targeting 
MO. 
The identification of an abnormal, wavy notochord in some cc2d2a morphants was of 
particular interest as this phenotype had not previously been observed in any MO 
experiments herein.  Normally, the notochord functions transiently as an essential rod-
like structure which acts like a skeletal tissue for developing embryos enabling them to 
generate movement (Anderson et al., 2007).  Additionally the notochord produces 
growth factors which facilitate differentiation of the surrounding tissues which is 
important in the development of the central nervous system (CNS) and left-right body 
asymmetry (Stemple, 2005).  Therefore defects in the appearance of the notochord in 
cc2d2a morphants may be associated with impaired motility of embryos and abnormal 
CNS development, which can be pathognomonic of JBTS and MKS in patients.      
4.3.3 Zebrafish models to study NPHP6  
Since mutations in NPHP6 are a recognised cause of NPHP, JBTS and MKS, the role of 
nphp6 in the normal development of the kidney, brain and eye has been investigated.  
The temporal expression of nphp6 in the retina and cerebellum of zebrafish embryos at 
24-48hpf has been confirmed by in situ hybridisation (Sayer et al., 2006).  A functional 
role for nphp6 in normal organogenesis was suggested when targeted splice and 
translation blocking MO led to aberrant kidney, brain, eye and ear development in 
zebrafish morphants (Sayer et al., 2006).  In this work, similar splice and translation 
blocking nphp6 MO were utilised to recapitulate the developmental ciliopathy 
phenotypes in zebrafish embryos, however there were some interesting differences 
identified in our results. 
Similar to Sayer et al. (2006), a difference in the penetrance of ciliopathy phenotypes 
was apparent depending on whether the splice or translation blocking nphp6 MO was 
used.  There was an increased frequency of developmental defects following nphp6 
splice blocking MO injections, this was in contrast to Sayer et al. (2006).  
In the experiments reported herein, the occurrence of pronephric cysts diffusely 
throughout the pronephros and cloaca reproduced the published (Sayer et al., 2006) 
nphp6 morphant models of JBTS.  Obstructive cloacal cysts and defective cloaca 
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formation have also been described in nphp4 (Slanchev et al., 2011) and ahi1 (Simms et 
al., 2012) zebrafish models of NPHP related ciliopathies.  Confocal microscopy and 
immunofluorescence were used to confirm that whilst cilia remain present in the 
pronephros of nphp6 morphants at 72hpf, in some morphants they appeared reduced in 
number and even to disappear towards the cloaca.  Unfortunately further 
characterisation of these cilia in terms of motility or length was not possible.  There 
have however been reports of no difference in the length (Sayer et al., 2006; Tse, 2012) 
or motility (Sayer et al., 2006) of cilia in the pronephros of nphp6 zebrafish morphants.   
The abnormal eye and ear phenotypes associated with nphp6 morphants herein included 
retinal coloboma formation, unilateral microphthalmia and defective ear development 
with reduction or complete absence of otoliths.  The eye and ear phenotypes reported in 
the nphp6 morphant zebrafish embryos created in this work are entirely consistent with 
published developmental defects (Sayer et al., 2006).  Ideally, further assessment of the 
eye phenotypes by performing retinal histology would have been informative.  
Nephrocystin-6 is known to be expressed in connecting cilium of mouse photoreceptor 
cells (Sayer et al., 2006) and interesting sensory cilia in the photoreceptors of nphp6 
morphants have recently been described as shortened (Tse, 2012).  
Since NPHP6 related disorders are developmental ciliopathies, evaluation of cilia 
within the zebrafish organising centre, KV was performed.  Using confocal 
micropscopy and immunostaining of cilia in fixed nphp6 MO injected embryos, fewer 
and shorter cilia in KV compared to uninjected WT embryos were identified.  These 
results have been confirmed in a recent publication evaluating cilia in nphp6 zebrafish 
morphants (Tse, 2012).  
The shortened cilia within KV of nphp6 MO injected embryos appear to be functionally 
unable to generate sufficient fluid flow to establish normal left-right body patterning.  
Cardiac looping at 56hpf was evaluated by light microscopy and a significant reduction 
in the normal, D-looping cardiac asymmetry was detected in nphp6 morphants 
compared to uninjected WT control embryos.  To my knowledge, this is the first report 
of aberrant left-right cardiac development in nhph6 morphants.  Situs inversus can occur 
in patients with NPHP6 mutations, however is a rare finding (Baala et al., 2007a).  
Hypotheses and potential mechanisms for the reversal of cardiac looping detected in 
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nphp6 morphants herein are considered during discussion of the reversed cardiac 
looping apparent in ahi1 morphants in section 3.3.3.  
4.3.4 Creating a zebrafish model to study MKS3 
Mutations in MKS3 cause disorders at the severe end of the ciliopathy spectrum, JBTS 
and the lethal condition MKS characterised by a triad of cystic kidneys, liver fibrosis 
and neurodevelopmental defects including occipital encephalocele (Dawe et al., 2007).  
Expression of meckelin, the protein product of MKS3 has been confirmed in human 
embryonic kidney, liver, retina and hindbrain (Dawe et al., 2007), however animal 
models to further evaluate the function of meckelin are limited.  In 2009, a mouse 
model of MKS3 (Cook et al., 2009) was identified caused by a spontaneous deletion in 
MKS3 resulting in bilateral polycystic kidneys; hydrocephalus and retinal degeneration 
in some embryos.  However these Mks3 mutant mice do not develop some of the other 
typical MKS phenotypes described in patients including hepatic duct dysplasia/cysts, 
occipital encephalocele and polydactyly.  They are further limited as an MKS model by 
infertility and death within 3 weeks of birth (Cook et al., 2009).  In order to overcome 
some of these limitations and further evaluate the role of MKS3 in organogenesis, MOs 
were used to knockdown mks3 in zebrafish embryos and an abnormal effect on 
development was identified.   
Aberrant phenotypes detected in mks3 morphants were typical of other zebrafish 
ciliopathy models (Ferrante et al., 2009; Sayer et al., 2006; Slanchev et al., 2011; Zhou 
et al., 2010b) and beginning with the highest frequency included abnormal body 
curvature, cardiac oedema, hydrocephalus, pronephric cysts, ear defects, 
‘meningoceles’, wavy notochords and eye defects.  In order to attempt to increase the 
frequency of abnormal features, particularly of pronephric cysts, the MO dose was 
uptitrated, however unfortunately, as predicted this led to an increased 24 hour mortality 
rate and experiments were not practically feasible (in terms of yield) beyond 4ng mks3 
MO.   
To confirm specificity of our mks3 morphant zebrafish model, embryos were co-
injected with human MKS3 mRNA, which rescued the ciliopathy phenotypes back to a 
normal WT pattern of development in 78% of embryos.  
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Interestingly, in the mks3 morphants, pronephric cysts of variable size developed 
diffusely throughout the pronephros and cloaca, similar to the kidney phenotypes 
described with other ciliopathy genes: nphp4 (Slanchev et al., 2011), nphp6 (Sayer et 
al., 2006) and ahi1 (Simms et al., 2012).  Although evaluation of cilia in KV or the 
pronephros of the mks3 zebrafish model would have been interesting, this was not 
performed because the mks3 MO work was undertaken as a consequence of a 
collaboration with Professor Colin Johnson.  The focus of this mks3 related 
collaboration was to create zebrafish models to evaluate whether mks3 may interact with 
filamin A (an actin-binding protein).  The theory was that mks3-filamin A: interact, 
mediate ciliogenesis and adversely influence Wnt signalling which may be important in 
the pathogenesis of MKS.  The personally performed zebrafish work was united with 
data from Professor Colin Johnson’s laboratory and published (Appendix G (Adams et 
al., 2012)).  The filamin A zebrafish work was not presented in this thesis as although an 
interesting interacting partner and relevant methodically to the combination MO 
experiments performed in Chapter 5, filamin A did not originally relate clearly to the 
cystic kidney disease ciliopathy story.  The specific mks3 and filamin A zebrafish data 
are shown in Figure 5 and Supplementary Figures 5-6 of Appendix G).  
To date, in the other ciliary genes (AHI1, CC2D2A and NPHP6) in which cilia were 
evaluated in KV/the pronephros herein, the general finding has been of defective 
ciliogenesis with a shortening of cilia and/or reduction in number of cilia.  Consistent 
with this pattern of defective ciliogenesis, in human and mouse kidney cell lines 
following MKS3 siRNA there is loss of cilia (Adams et al., 2012).  However in contrast, 
in the Mks3 mouse model, cilia were reported as longer in mutants (Cook et al., 2009).  
Therefore it would be interesting in future experiments to explore cilia in the zebrafish 
mks3 morphant.   
As previously observed in some cc2d2a morphants, a ‘wavy’ notochord was identified 
in up to 5% of mks3 morphant zebrafish embryos.  A similar pattern of abnormal 
‘wavy’ notochord development has been reported in sneezy mutants (Stemple, 2005), 
which have a mutation in the α subunit of the coatomer vesiclular complex (Coutinho et 
al., 2004).  Sneezy mutants, like other coatomer mutants, with this ‘wavy’ notochord 
appearance, fail to develop the normal perinotochordal basement membrane and the 
essential secretion of signalling proteins is blocked (Coutinho et al., 2004).  
Corresponding the implications surrounding this destruction to the normal development 
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of the notochord in sneezy mutants to mks3 morphants and recognising the critical role 
of the notochord during development, provides compelling evidence to suggest that 
mks3 is required for normal organogenesis and tissue differentiation (Stemple, 2005).   
The identification of dorsal extension of the notochord to breach the dorsal fin layers, 
reaching the surface in some mks3 morphants, suggests more severe developmental 
defects than those seen in cc2d2a morphants, however the overall numbers were low.  
In patients with CC2D2A mutations a genotype-phenotype association has been 
indicated since those with misense mutations tend to develop JBTS, whilst those with 
null CC2D2A mutations develop the more severe MKS (Mougou-Zerelli et al., 2009). 
The abnormal eye and ear development observed in the mks3 morphants was not 
evaluated beyond light microscopy since it is not a prominent clinical feature in affected 
patients.  As previously discussed aberrant eye and ear development can be a typical 
feature of ciliary genes in zebrafish models of ciliopathy related disorders.  
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Chapter 5 Using zebrafish models to explore the genetics of 
nephronophthisis related ciliopathies focusing on nphp6, cc2d2a 
and ahi1  
5.1 Introduction 
NPHP and the associated ciliopathies: JBTS and MKS, are autosomal recessive 
conditions with considerable genetic heterogeneity.  Over forty causal genes have been 
identified in patients with ciliopathies (Waters and Beales, 2011) (Table 1.2).  Table 5.1 
lists the currently identified mutated genes in patients with NPHP, JBTS and MKS.  The 
capability of mutations in several genes particularly NPHP6 (Coppieters et al., 2010), 
CC2D2A (Mougou-Zerelli et al., 2009), AHI1 (Dixon-Salazar et al., 2004; Louie et al., 
2010), MKS3 (Baala et al., 2007b; Doherty et al., 2010; Smith et al., 2006), RPGRIP1L 
(Arts et al., 2007; Delous et al., 2007; Doherty et al., 2010), and NPHP3 (Olbrich et al., 
2003; Omran et al., 2002) to cause a variable range and spectrum of clinical phenotypes 
is highlighted in Table 5.1 and emphasises the genetic pleiotropy.  Although mutations 
in certain genes, may be more likely to be associated with a specific phenotype, such as 
homozygous NPHP5 mutations leading to retinal degeneration (Otto et al., 2005), for 
most genes there has been difficulty in determining a genotype-phenotype association 
(Coppieters et al., 2010).  This is clinically important as when a mutation is known, it 
would enable the appropriate screening of selected potentially affected organs, facilitate 
the delivery of prognostic information to patients and guide genetic counselling.  
However in practice, even when the mutation is known, there can be considerable 
variation in the severity of phenotypes within families (Caridi et al., 2006; Hoefele et 
al., 2007).   
In the related ciliopathy, BBS, mutations in more than one gene have been identified 
(Katsanis et al., 2001), suggesting oligogenicity, where an abnormality in a third allele 
may modify the severity or nature of presentation and prognosis.  In 2007, this theory 
was applied to patients with NPHP and led to the screening of four genes (NPHP1-
NPHP4), which were known to interact at the protein level, for mutations (Hoefele et 
al., 2007).  This resulted in several novel findings underlying the genetic basis of 
NPHP.  Triallelism (two homozygous mutations in one gene and an additional 
heterozygous mutation in another gene); digenic disease (heterozygous mutations in two 
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different genes) and a single heterozygous mutation, with no second mutation were 
identified in patients known to have NPHP (Hoefele et al., 2007). 
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Nephronophthisis Joubert Syndrome Meckel Gruber Syndrome 
Gene locus Gene symbol Chromosome Gene 
locus 
Gene symbol Chromosome Gene locus Gene symbol Chromosome 
NPHP1 NPHP1* 2q13 JBTS1 INPP5E 9q34.3 MKS1 MKS1 17q22 
NPHP2 INVS 9q31 JBTS2 TMEM216 11q13.1 MKS2 MKS2 11q13 
NPHP3 NPHP3* 3q22.1 JBTS3 AHI1* 6q23.3 MKS3 TMEM67* 8q22.1 
NPHP4 NPHP4 1p36.22 JBTS4 NPHP1* 2q13 MKS4 CEP290* 12q21.32 
NPHP5 IQCB1 3q21.1 JBTS5 CEP290* 12q21.32 MKS5 RPGRIP1L* 16q12.2 
NPHP6 CEP290* 12q21.32 JBTS6 TMEM67* 8q21.1-q22.1 MKS6 CC2D2A* 4p15.33 
NPHP7 GLIS2 16p13.3 JBTS7 RPGRIP1L* 16q12.2 MKS7 NPHP3* 3q22.1 
NPHP8 RPGRIP1L* 16q12.2 JBTS8 ARL13B 3q11.2 MKS8 TCTN2* 12q24.31 
NPHP9 NEK8 17q11.1 JBTS9 CC2D2A* 4p15.33 MKS9 B9D1 17p11.2 
NPHP10 SDCCAG8 1q44 JBTS10 OFD1 Xp22.2    
NPHP11 TMEM67* 8q22.1 JBTS11 TTC21B 2q24.3    
NPHP12 TTC21B 2q24.3 JBTS12 KIF7 15q26.1    
NPHP13 WDR19 4p14 JBTS13 TCTN1 12q24.11    
 AHI1* 6q23.3 JBTS14 TMEM237     
 ATXN10 22q13.31 JBTS15 CEP41 7q32    
NPHP14 ZNF423 16q12 JBTS16 TMEM138 11q12.2    
 CEP164 11q23.3 JBTS17 C5ORF42 5p13.2    
    TCTN2* 12q24.31    
    TMEM231 16q23.1    
 
 
Table 5.1 Molecular genetics of Nephronophthisis, Joubert Syndrome and Meckel Gruber Syndrome 
*Highlights genetic pleiotropy, ability of gene to induce variable spectrum of phenotypes.   
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Triallelism has been reported in patients with NPHP, JBTS and MKS caused by: 
homozygous NPHP1 and heterozygous NPHP3 (Hoefele et al., 2007) or NPHP4 
(Hoefele et al., 2007) or NPHP6 (Tory et al., 2007) or AHI1 (Tory et al., 2007) 
mutations (Hoefele et al., 2007; Tory et al., 2007); homozygous NPHP6 and 
heterozygous NPHP4 (Hoefele et al., 2005) or AHI1 (Tory et al., 2007) or MKS3 
(Leitch et al., 2008) mutations (Table 1.6).  Digenic inheritance of MKS has been 
described as a consequence of heterozygous mutations in NPHP6 and CC2D2A (Table 
1.6) (Hopp et al., 2011).   
Failure to identify a second mutation in autosomal recessive disorders emphasises that 
several NPHP related causal genes are as yet undiscovered.  This concept has recently 
been confirmed following analysis of 18 NPHP associated ciliopathy genes by DNA 
pooling and next generation sequencing failed to identify a causal gene in 90 of 120 
affected patients (Otto et al., 2011).  Furthermore, only a single heterozygous mutation 
was identified in 21 patients with NPHP, JBTS or MKS.  Interestingly, this study did 
not identify any evidence of oligogenicity, however investigators admitted that the 
methods used may have been insufficiently sensitive (Otto et al., 2011).   
In 2011, in order to further evaluate potential relationships between genotype and 
phenotype, clinical data were reviewed in a worldwide cohort of patients with NPHP 
related ciliopathies and known mutations (Chaki et al., 2011).  It was hypothesised that 
genotype-phenotype associations were influenced by gene locus heterogeneity, allelism 
and the effect of additional modifier genes.  Investigators concluded that gene locus 
heterogeneity was the most important influence on subsequent phenotype, however as 
mutation screening was not performed in all NPHP genes in the study, the impact of 
oligogenicity could not be evaluated (Chaki et al., 2011).   
5.1.1 Aims of this chapter 
The possibility of known or unidentified genes epistatically modifying the clinical 
phenotype in the NPHP related ciliopathies is an interesting mechanism to further study.  
Several of the NPHP, JBTS and MKS protein products interact and have been shown to 
function in pathways (Sang et al., 2011), suggesting that many of these genes may 
closely interact.   
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Zebrafish models have previously been utilised when evaluating NPHP related 
phenotypes and to determine the physiological relevance of potential genetic 
interactions.  Combined MO knockdown of nphp5 and nphp6 demonstrated synergy of 
morphant phenotypes including pronephric cysts and hydrocephalus, underlining a 
genetic interaction between NPHP5 and NPHP6 (Schafer et al., 2008).  Following 
recognition of interaction between CC2D2A and NPHP6 at the protein level, MO 
knockdown of nphp6 in sentinel (cc2d2a mutant) zebrafish resulted in a synergistic 
increase in pronephric cysts, again proving a physiologically relevant genetic interaction 
between these two NPHP related ciliopathy genes (Gorden et al., 2008).  The concept 
‘genetic interaction’ when discussed herein is considered to relate to an inferred 
functional relationship between genes or signalling pathways or even the encoded 
proteins, suggested by a synergistic increase in the frequency or severity of phenotype 
induced following mutation or knockdown of two genes (Mani et al., 2008).  An 
acceptable alternative term may be ‘molecular interaction’. 
The aim of this chapter was to evaluate oligogenicity in NPHP related ciliopathies.  
Since oligogenicity has previously been described in patients with NPHP/JBTS/MKS 
caused by mutations in NPHP6 and AHI1 (Tory et al., 2007) or CC2D2A and NPHP6 
(Hopp et al., 2011), the aim was to focus on these genes.  In addition to using MO 
knockdown of combinations of ahi1, nphp6 and cc2d2a in zebrafish to evaluate the 
effect on organogenesis and create models of NPHP related ciliopathies, the effect of 
MO knockdown of nphp6 or ahi1 in sentinel (cc2d2a mutant) embryos, which have 
been proposed as a useful model for evaluating oligogenicity (Gorden et al., 2008), were 
studied.   
Initially, using nphp6 MO knockdown in sentinel embryos, the aim was to recapitulate 
the published ciliopathy phenotype (Gorden et al., 2008).  Subsequently, evaluation of 
the potential interaction between AHI1 and CC2D2A by two different methods: 
performing ahi1 MO knockdown in sentinel embryos and combined ahi1 and cc2d2a 
MO knockdown was performed.  Finally, ahi1 and nphp6 MO knockdown in zebrafish 
embryos was completed to further evaluate the digenic inheritance of NPHP related 
ciliopathies, which has been described in patients (Tory et al., 2007) (Table 1.6).
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5.2 Results 
5.2.1 Phenotypes following nphp6 MO knockdown in sentinel (cc2d2a mutant) 
embryos 
Embryos were phenotyped by light microscopy at 72hpf.  A reminder of the typical 
phenotypes associated with sentinel embryos and nphp6 morphants in isolation are 
shown (Figure 5.1).  Uninjected sentinel homozygous embryos alone develop a 
characteristic dorsal sine wave shaped tail (Figure 5.1A).  WT embryos injected with 
nphp6 splice blocking MO develop a ventral curly tail, hydrocephalus, cardiac oedema 
and empty otic vesicle (Figure 5.1B). 
Embryos born from sentinel heterozygous matings were injected with 4-6ng of splice 
blocking nphp6 MO and develop a range of abnormal phenotypes including 
ventral/dorsal curly tail, cardiac oedema, hydrocephalus, wavy notochord (Figure 5.1C-
D), pronephric cysts, aberrant rudimentary eye and ear development including absent 
otoliths in the otic vesicle (Figure 5.2D-I).  In order to exclude non-specific off-target 
effects, nphp6 MO was co-injected with p53 MO into sentinel embryos.  Figure 5.1E 
shows that sentinel embryos injected with nphp6 and p53 MOs continue to develop an 
aberrant phenotype with disrupted organogenesis including dorsal curly tail, cardiac 
oedema, hydrocephalus and unilateral microphthalmia. 
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Figure 5.1 Phenotypes following combination of nphp6 MO knockdown in sentinel 
(snl) zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Uninjected sentinel 
(snl, A) zebrafish embryos have a characteristic sine wave shaped tail.  B is a wild type 
(not snl) embryo injected with nphp6 MO which has a ventrally curved tail, 
hydrocephalus, cardiac oedema and empty otic vesicle (black arrowhead).  Combination 
of nphp6 MO knockdown in snl embryos (C, D) induces a range of abnormal 
phenotypes including wavy notochord (C), cardiac oedema, hydrocephalus, dorsal curly 
tail (D) and delayed development of otoliths in the otic vesicle (black arrowhead, D).  
Snl embryos additionally co-injected with nphp6 and p53 MOs (E) continue to develop 
an aberrant phenotype with dorsal curly tail, cardiac oedema, hydrocephalus and 
unilateral microphthalmia (red arrow), excluding the possibility of the combination 
resulting from an off-target effect.  MO, morpholino oligonucleotide.    
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Focusing on the development of pronephric cysts, cropped images of an uninjected 
sentinel zebrafish embryo with no cyst (Figure 5.2A) can be compared with the variable 
size of proximal pronephric cysts which developed in sentinel embryos injected with 
nphp6 MO by 72hpf (Figure 5.2D, G).   
No abnormal eye or ear development was apparent by light microscopy in this cohort of 
sentinel embryos alone (Figure 5.2B-C), however following injection of sentinels with 
4-6ng of nphp6 MO colobomas (Figure 5.2E, H) and fewer or absent otoliths were 
identified in the otic vesicles (Figure 5.2 E-F, I).  
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Figure 5.2 Pronephric cysts and abnormal eye and ear development following 
combination of nphp6 MO knockdown in sentinel (snl) zebrafish embryos 
Cropped views of snl zebrafish embryos at 72 hours post fertilisation, focusing on the 
proximal pronephros (A, D, G), eyes (B, E, H) and  otic vesicles (C, F, I).  Compared to 
uninjected snl embryos (A-C), snl embryos injected with nphp6 MO develop pronephric 
cysts (red arrows, D, G), colobomas (black arrows, E, H) and fewer otoliths in the otic 
vesicle (single, black arrowhead, F, I(dorsal view)).  MO, morpholino oligonucleotide.  
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5.2.2 Mortality and frequency of abnormal phenotypes following nphp6 MO 
knockdown in sentinel (cc2d2a mutant) embryos 
Mortality at 24hpf was evaluated to ascertain whether nphp6 and cc2d2a gene 
combinations where functionally associated with lethality.  The mean percentage (%) 
and standard error of the mean (±SEM) mortality at 24hpf was calculated for: sentinel 
embryos alone (n=208); WT embryos injected with 4ng (n=342) and 6ng (n=547) of 
nphp6 MO; sentinel embryos injected with 4ng nphp6 MO (n=273) and sentinel 
embryos injected with 6ng nphp6 MO (n=145).  Figure 5.3 shows the mean 24hpf 
mortality was similar in sentinel zebrafish embryos alone (24%), WT embryos injected 
with 4ng nphp6 MO alone (22%) and sentinel embryos injected with 4ng nphp6 MO 
(23%).  Injection of 6ng of nphp6 MO alone was associated with an increased 24hpf 
mortality of 49% and when this dose of nphp6 MO was injected into sentinel embryos, 
mortality rose dramatically up to 70%. 
The total numbers of embryos surviving to 72hpf to be assessed for phenotypes in each 
group were: 321 sentinel embryos; 261 WT embryos injected with 4ng nphp6 MO; 216 
WT embryos injected with 6ng nphp6 MO; 144 sentinel embryos injected with 4ng 
nphp6 MO and 43 sentinel embryos injected with 6ng nphp6 MO.  
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Figure 5.3 Mortality at 24hpf following combination of nphp6 MO knockdown in 
sentinel (snl) zebrafish embryos 
Mortality at 24hpf is shown as mean percentage (%) and standard error of the mean in 
snl zebrafish embryos alone, wild type zebrafish embryos injected with 4-6ng nphp6 
MO alone and snl embryos injected with 4-6ng nphp6 MO (A).  The mean 24hpf 
mortality is similar in snl zebrafish embryos alone (24%), wild type embryos injected 
with 4ng nphp6 MO alone (22%) and snl embryos injected with 4ng nphp6 MO (23%).  
Injection of 6ng of nphp6 MO alone is associated with a much higher 24hpf mortality of 
49% and in snl embryos this rises to 70%.  hpf, hours post fertilisation.  MO, 
morpholino oligonucleotide.   
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The mean and standard error of the mean (where applicable) frequency of the 
development of each abnormal phenotype by 72hpf including curly tail, cardiac 
oedema, hydrocephalus and pronephric cysts were graphed in Figure 5.4.  Both graphs 
show the same data, however Figure 5.4A emphasises the frequency of each phenotype 
across the range of interference in cc2d2a and nphp6.   
Focusing on the frequency of pronephric cyst development, only 1.5% (±1.5%) of 
uninjected sentinel embryos and WT embryos injected with 4ng nphp6 MO developed 
pronephric cysts detected by light microscopy at 72hpf.  The dose dependent effect of 
nphp6 MO was clearly demonstrated, as a 6ng dose of nphp6 MO alone (injected into 
WT embryos) was associated with pronephric cysts in up to 17% (±9.9%) of morphants 
at 72hpf.  A dose dependent functional interaction between cc2d2a and nphp6 was 
implied by the propagation in the development of pronephric cysts in 9% of sentinel 
embryos injected with 4ng nphp6 MO and 33.5% (±16.5%) of sentinel embryos injected 
with 6ng of nphp6 MO (Figure 5.4A).  The frequency of pronephric cysts in sentinels 
injected with each dose of nphp6 MO was more than the sum of combining the 
individual frequencies of pronephric cysts.  This synergistic increase in the development 
of pronephric cysts implied a functionally relevant genetic interaction between cc2d2a 
and nphp6. 
Similarly, there was a dose dependent synergistic increase in the frequency of 
development of curly tail and cardiac oedema from 10.5% (±9.5%) and 2.5% (±0.5%) 
respectively in uninjected sentinels, to 74.5% (±25.5%) and 81.5% (±18.5%) 
respectively in sentinels injected with 6ng nphp6 MO. 
The frequency of development of hydrocephalus in sentinels alone was only 0.5% 
(±0.5%) and was confirmed as dose dependent with nphp6 MO.  Injection of 4-6ng of 
nphp6 MO in WT embryos induced hydrocephalus increasing from 9.5% (±7.5%) to 
30.8% (±10.6%) of morphants.  The injection of 4ng nphp6 MO into sentinel embryos 
led to a synergistic increase in the frequency of hydrocephalus to 36%, however this 
synergy was not sustained when the higher dose of 6ng nphp6 MO was injected into 
sentinels, as this resulted in hydrocephalus in only 22% (±22%).  It may be that the 
marked increase in mortality that occurred when 6ng nphp6 MO was injected into 
sentinels accounted for the reduction in frequency of hydrocephalus, as embryos were 
dying rather than surviving to develop hydrocephalus.  
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Figure 5.4 Percentage frequency of abnormal phenotypes at 72hpf following 
combination of nphp6 MO knockdown in sentinel (snl) zebrafish embryos 
Data are displayed as mean ± SEM.  A emphasises the range of phenotypes in each 
group of zebrafish embryos.  B highlights the effect of the individual genes (cc2d2a in 
snl; nphp6 MO) and gene combinations on the frequency of abnormal phenotypes.  The 
percentage frequency of each abnormal phenotype increases in a dose dependent 
manner following 4-6ng of nphp6 MO knockdown alone (2-42%) and is generally low 
(1-11%) in snl embryos alone (A).  The frequency of abnormal phenotypes following 
6ng of nphp6 MO alone is similar to the cumulative effect of 4ng of nphp6 MO in snl 
embryos (B).  The cumulative effect of 4 or 6ng of nphp6 MO in snl zebrafish embryos 
has a synergistic effect on each abnormal phenotype except for hydrocephalus in snl 
embryos injected with 6ng of nphp6 MO (B).  The total numbers of embryos were 321 
(snl zf), 261 (4ng nphp6 MO), 216 (6ng nphp6 MO), 144 (snl zf+4ng nphp6 MO) 43 
(snl zf+6ng nphp6 MO).  hpf, hours post fertilisation; SEM, standard error of the mean; 
zf, zebrafish.  MO, morpholino oligonucleotide. 
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The abnormal development of the eye and ear associated with sentinels and nphp6 MO 
were not plotted on the graphs in Figure 5.4, this was because by light microscopy no 
abnormal phenotypes were identified in this cohort of sentinel embryos alone and more 
importantly, there was not a synergistic increase in frequency of abnormal eye 
development.  Ocular anomlies were detected in 0.2% (n=2) of homozygous sentinel 
mutants in the earlier cohort of embryos used in experiments in 4.2.5 (Figure 4.9, Figure 
4.10).  Abnormal eye development was detected in 1.5% (±1.5%) and 3% (±3%) 
following 4 and 6ng nphp6 MO alone.  When the same doses of 4 and 6ng nphp6 MO 
were injected into sentinel embryos, this low frequency of abnormal eye development 
was maintained at only 1% and 3.5%, most likely reflecting the effect of nphp6 MO 
alone. 
Although no abnormal rudimentary ear development was observed in sentinel mutants 
alone, when embryos were injected with 4ng nphp6 MO the occurrence of abnormal ear 
development rose to a frequency of 9%, compared to only 2% (±1%) in WT embryos 
injected with 4ng nphp6 MO alone.  This apparent synergistic increase in the frequency 
of abnormal ear development was dose dependent and occurred in 7.3% (±5.7%) of WT 
embryos injected with 6ng nphp6 MO alone which dramatically increased to 36% 
(±14%) when sentinel embryos were injected with 6ng nphp6 MO.  This suggests that 
cc2d2a may be modifying the aberrant effect of nphp6 on ear development.        
Although reporting results of the same data, the layout of the graph in Figure 5.4B 
focuses on comparing the effects of the individual (cc2d2a in sentinel; nphp6 MO) 
genes with the gene combinations, on the frequency of development of abnormal 
phenotypes.  It was clearly evident that in sentinel embryos alone and WT embryos 
injected with 4ng nphp6 MO, the frequency of each abnormal phenotype was much 
lower than in any of the combinations (4-6ng nphp6 MO in sentinels).  However, the 
frequency of developmental anomalies were similar between embryos injected with 6ng 
of nphp6 MO alone and the combined effect of sentinel embryos injected with 4ng 
nphp6 MO (Figure 5.4B).  As described above, the cumulative effect of 4 or 6ng of 
nphp6 MO in sentinel zebrafish embryos had a synergistic effect on each abnormal 
phenotype except for hydrocephalus in sentinel embryos injected with 6ng of nphp6 
MO.   
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5.2.3 Phenotypes following ahi1 MO knockdown in sentinel (cc2d2a mutant) 
embryos 
The abnormal phenotypes previously identified in WT embryos injected with ahi1 
splice blocking MO include: curved body axis, cardiac oedema, hydrocephalus, 
pronephric cysts, otic defects and retinal anomalies and were extensively imaged in 
Figure 3.9, Figure 3.10, Figure 3.11, Figure 3.12, Figure 3.13 and Figure 3.14.   
Embryos born from sentinel heterozygous matings were injected with 0.5-2ng of splice 
blocking ahi1 MO and phenotyped by light microscopy at 72hpf.  Figure 5.1A shows an 
uninjected sentinel homozygous embryo with cardiac oedema and the characteristic 
dorsal sine wave shaped tail.  Sentinel embryos injected with 0.5-2ng ahi1 MO 
developed a typical range of ciliopathy phenotypes including curly tail, cardiac oedema, 
hydrocephalus, pronephric cysts, abnormal ear and eye development.  Predominantly 
proximal pronephric cysts of varying size were clearly evidence in sentinel embryos 
injected with ahi1 MO (Figure 5.5B, D-I).  Hydrocephalus of varying severity was 
present in many sentinel ahi1 morphants (sentinel embryos injected with ahi1 MO, 
Figure 5.5C-E, G, Figure 5.6E) and a curly tail, with a pronounced sine wave 
appearance was also evident in some morphants (Figure 5.5B-D). 
In these experiments, uninjected sentinel embryos rarely (0.3%, n=2 of 933) developed 
abnormal eyes as determined by light microscopy, such as colobomas (Figure 5.6B-D) 
or unilateral microphthalmia (Figure 5.6E-F).  Low dose (0.5ng) ahi1 MO alone in WT 
embryos failed to induce any abnormal eye development (n=58) as detected by light 
microscopy.  However when combined, 0.5ng ahi1 MO injected into sentinel embryos 
there was a modest increased frequency of abnormal eye development (0.4%, n=1 of 
243, Figure 5.8).  This synergy was more convincing following injection of higher 
doses (1-2ng) of ahi1 MO into sentinel embryos, leading to abnormal eye development 
in 6.5% ± 2.9% (n=18 of 291) and 15.3% ± 2.3% (n=16 of 105) embryos respectively.   
In uninjected sentinel embryos and WT embryos injected with 0.5ng ahi1 MO the 
rudimentary ear development appeared grossly normal by light microscopy, with all 
embryos developing 2 otoliths in each otic vesicle (Figure 5.6A).  However when 
combined (0.5ng ahi1 MO injected into sentinel embryos) up to 2% ± 2% of morphants 
developed an abnormal number of otoliths (none or single) in the otic vesicle (Figure 
5.6B-C).  A synergistic relationship was again apparent with increasing doses of ahi1 
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MO injected into sentinel embryos, increasing the frequency of abnormal ear 
development from 2% (1ng ahi1 MO alone) to 9.3% in 1ng ahi1 sentinel morphants and 
3.7% (2ng ahi1 MO alone) to 8.7% in 2ng ahi1 sentinel morphants. 
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Figure 5.5 Hydrocephalus and pronephric cysts following combination of ahi1 MO 
knockdown in sentinel (snl) zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Uninjected sentinel 
(snl, A) zebrafish embryo with cardiac oedema (*) and characteristic sine wave shaped 
tail.  B-I are snl embryos injected with ahi1 MO and display a range of abnormal 
phenotypes including hydrocephalus (black arrowhead C-E, G) and pronephric cysts 
(red arrow B, D-I).  A pronounced dorsal sine wave shaped tail is seen in D.  MO, 
morpholino oligonucleotide.       
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Figure 5.6 Abnormal eye and ear development following combination of ahi1 MO 
knockdown in sentinel (snl) zebrafish embryos 
Cropped views of snl zebrafish embryos at 72 hours post fertilisation, focusing on the 
eyes and otic vesicles.  Compared to uninjected snl embryos which predominantly have 
normal eyes and 2 otoliths in each otic vesicle (A), snl embryos injected with ahi1 MO 
have abnormal development of the eyes (black arrowheads) and rudimentary ear (red 
arrow) (B-F).  (B) A coloboma and empty otic vesicle, (C) coloboma and single otolith, 
(D) coloboma.  E and F are lateral and dorsal views of an embryo with unilateral 
microphthalmia of the right eye (black arrowhead, F).  MO, morpholino 
oligonucleotide. 
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5.2.4 Mortality following ahi1 MO knockdown in sentinel (cc2d2a mutant) 
embryos 
Previously, a dose dependent association between ahi1 splice blocking MO dose and 
24hpf mortality was demonstrated (Figure 3.8).  Mortality at 24hpf was evaluated to 
ascertain whether ahi1 and cc2d2a gene combinations were functionally associated with 
lethality.  The mean percentage (%) and standard error of the mean mortality at 24hpf 
was calculated for: sentinel embryos alone (n=999); sentinel embryos injected with 
0.5ng ahi1 MO (n=340); sentinel embryos injected with 1ng ahi1 MO (n=438) and 
sentinel embryos injected with 2ng ahi1 MO (n=303).  Figure 5.7 shows that the mean 
24hpf mortality rose in a predominantly dose dependent manner when sentinel zebrafish 
were injected with ahi1 MO.  Mean and standard error of the mean 24hpf  mortality 
rates were only 4.8% ± 1.4% in uninjected sentinel embryos, however when injected 
with 0.5-1ng of ahi1 MO this rose to between 27% ± 4.9% and 26.3% ± 7.4%.  The 
increased lethality associated with injecting 2ng of ahi1 MO in sentinel embryos was 
49.3% ± 4.8% (Figure 5.7). 
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Figure 5.7 Mortality at 24hpf following combination of ahi1 MO knockdown in 
sentinel (snl) zebrafish embryos 
Mortality at 24hpf is shown as mean percentage (%) and standard error of the mean 
(SEM) in snl zebrafish embryos alone and snl embryos injected with 0.5-2ng of ahi1 
MO (A).  The mean 24hpf mortality is only 4.8% ± 1.4% in snl zebrafish embryos alone 
and rises in a predominantly dose dependent manner when snl embryos are injected 
with: 0.5ng ahi1 MO (27% ± 4.9%), 1ng ahi1 MO (26.3% ± 7.4%) and 2ng ahi1 MO 
(49.3% ± 4.8%).  MO, morpholino oligonucleotide. 
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5.2.5 Frequency of abnormal phenotypes following ahi1 MO knockdown in sentinel 
(cc2d2a mutant) embryos 
The total numbers of sentinel and ahi1 MO injected embryos surviving to 72hpf to be 
assessed for phenotypes in each group were: 933 uninjected sentinel embryos; 58 WT 
embryos injected with 0.5ng ahi1 MO injected; 793 WT embryos injected with 1ng 
ahi1 MO; 517 WT embryos injected with 2ng ahi1 MO; 246 sentinel embryos injected 
with 0.5ng ahi1 MO; 291 sentinel embryos injected with 1ng ahi1 MO and 105 sentinel 
embryos injected with 2ng ahi1 MO.  
The mean and standard error of the mean (where applicable) frequency of the 
development of each abnormal phenotype following ahi1 MO knockdown in sentinel 
embryos by 72hpf was graphed in Figure 5.8.  The phenotypes which developed, from 
most to least frequent, included: curly tail, cardiac oedema, hydrocephalus, pronephric 
cysts.  Abnormal rudimentary ear development was more frequent than abnormal eye 
development until a 2ng dose of ahi1 MO was injected into sentinel embryos.   
In the cohort of uninjected sentinel embryos (born from the same pairs of sentinels as 
those injected with doses of ahi1 MO), the frequency of abnormal phenotypes, apart 
from curly tail (13.9% ± 3.7%) was low (0-3%).  Similarly with 0.5ng ahi1 MO 
knockdown alone (in WT) the frequency of aberrant phenotypes was also low (0-5%).  
However, when 0.5ng of ahi1 MO was injected into sentinel embryos there was a more 
than additive increase in the frequency of abnormal phenotypes detected by light 
microscopy (Figure 5.8).  This synergistic effect on phenotype can be clearly seen in 
Table 5.2 by summing the columns.  Most importantly the frequency of pronephric 
cysts rose to 15% ± 9.7% and rates of hydrocephalus increased to 18.7% ± 3.7% with 
0.5ng ahi1 MO knockdown in sentinel embryos.   
The synergistic increase in the frequency of each abnormal phenotype occurred for each 
dose combination of ahi1 with sentinel embryos, suggesting a genetic interaction.  
Again focusing on the NPHP related ciliopathy phenotypes of pronephric cysts and 
hydrocephalus, increased doses of ahi1 MO knockdown in sentinel embryos led to 
pronephric cysts in 41.8% (± 9.6%) to 45.7% (± 7.3%) of embryos (Figure 5.8).  
Similarly increased doses of ahi1 MO in sentinel embryos leads to a frequency of 
hydrocephalus between 47.3% (± 13.8%) and 55% (± 1.5%) (Table 5.2).  
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Figure 5.8 Percentage frequency of abnormal phenotypes following combination of 
ahi1 MO knockdown in sentinel (snl) zebrafish embryos 
The mean and SEM frequency of abnormal phenotypes for snl zebrafish embryos alone 
(white bars, n=933), wild type (WT) embryos injected with 0.5ng ahi1 MO alone (green 
striped bars, n=58), 1ng ahi1 MO alone (black striped bars, n=793), 2ng ahi1 MO alone 
(red striped  bars, n=517) and the combination of snl embryos injected with 0.5ng ahi1 
MO (green bars, n=246), 1ng ahi1 MO (black bars, n=291) and 2ng ahi1 MO (red bars, 
n=105) are shown.  The mean frequency of abnormal phenotypes is low (0-14%) in snl 
embryos alone (white bars) and WT embryos injected with 0.5ng ahi1 MO alone (green 
striped bars).  There is a synergistic and dose dependent increase in abnormal 
phenotypes when 0.5-2ng of ahi1 MO is injected into snl embryos.  MO, morpholino 
oligonucleotide.    
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 Curly tail (%) Cardiac oedema (%) Hydrocephalus (%) Pronephric cysts (%) Abnormal eye (%) Otic defect (%) 
snl zebrafish alone 13.9 ± 3.7 3.0 ± 0.7 1.0 ± 0.8 1.0 ± 0.8 0.3 ± 0.3 0.0 ± 0.0 
0.5ng ahi1 MO alone 3.0 ± 0.0 5.0 ± 0.0 2.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
snl + 0.5ng ahi1 MO 35.3 ± 5.0 30.7 ± 8.1 18.7 ± 3.1 15.0 ± 9.7 0.4 ± 0.4 2.0 ± 2.0 
1ng ahi1 MO alone 36.2 ± 7.6 34.5 ± 6.9 20.4 ± 4.6 7.0 ± 3.1 0.5 ± 0.4 2.0 ± 0.7 
snl + 1ng ahi1 MO 69.8 ± 10.9 78.3 ± 9.5 47.0 ± 13.8 41.8 ± 9.6 6.5 ± 2.9 9.3 ± 2.8 
2ng ahi1 MO alone 39.9 ± 7.6 35.1 ± 6.9 29.3 ± 5.4 10.9 ± 2.7 0.9 ± 0.5 3.7 ± 1.2 
snl + 2ng ahi1 MO 84.0 ± 7.0 89.3 ± 4.5 55.0 ± 1.5 45.7 ± 7.3 15.3 ± 2.3 8.7 ± 2.2 
 
 
 
 
 
 
Table 5.2 Frequency of abnormal phenotypes in sentinel and 0.5-2ng ahi1 MO injected embryos 
Percentage (%) frequency of abnormal phenotypes at 72hpf in sentinel (snl) zebrafish embryos alone, wild type embryos injected with 0.5ng or 1ng or 
2ng ahi1 MO alone and the combination of snl embryos injected with 0.5ng or 1ng or 2ng of ahi1 MO.  MO, morpholino oligonucleotide. 
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5.2.6 Alternative assessment of ahi1 and cc2d2a genetic interaction: Phenotypes 
and mortality following combined ahi1 MO and cc2d2a MO knockdown in 
wild type zebrafish embryos 
Although a genetic interaction between AHI1 and CC2D2A was suggested above by the 
synergistic increase in several ciliopathy phenotypes including pronephric cysts and 
hydrocephalus, there were limitations of relying on the sentinel (cc2d2a mutant) 
zebrafish to study the effect of interference with CC2D2A.  In order to overcome this, a 
cc2d2a zebrafish morphant was created and characterised in section 4.2.10, Figure 4.16, 
Figure 4.17 and Figure 4.18.  Below, the phenotypes generated by combining ahi1 and 
cc2d2a splice blocking MO, which alone caused minimal developmental anomalies, are 
described. 
WT embryos generated from matched zebrafish were injected with: 0.5ng ahi1 MO 
alone; 4ng cc2d2a MO alone; or a combined solution of 0.5ng ahi1 MO and 4ng cc2d2a 
MO.  Phenotyping by light microscopy was performed at 72hpf.  The frequency of 
abnormal phenotypes generated by 0.5ng ahi1 MO alone (n=58) were low and included 
curly tail (3%, n=2), cardiac oedema (5%, n=3) and hydrocephalus (2%, n=1) (Figure 
5.9A).  The frequency of abnormal phenotypes (mean ± standard error of the mean) 
generated by 4ng cc2d2a MO alone (n=96, Figure 5.9B) were low and included curly 
tail (0.7% ± 0.7%, n=1), cardiac oedema (1.7% ± 1.7%, n=3) and pronephric cysts 
(2.7% ± 2.7%, n=1).  When these doses of MO were combined (0.5ng ahi1 and 4ng 
cc2d2a, n=10), there was a marked increase in the frequency of all phenotypes with 
hydrocephalus in 50% and pronephric cysts in 10%.  Additionally combined ahi1 and 
cc2d2a MO knockdown at these doses led to abnormal eye (30%) and ear (40%) 
development (Figure 5.10A).  However the number of embryos surviving to be 
phenotyped at 72hpf following combined ahi1 and cc2d2a MO injection were low 
(n=10) because of increased mortality rates at 24hpf (Figure 5.10B).  Compared to 
paired uninjected WT embryos whose 24hpf mortality rate was 26%, the mortality rate 
in embryos injected with combined 0.5ng ahi1 and 4ng cc2d2a MOs was 88%, a 
relative 24hpf mortality rate 3.4 times that of WT. 
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Figure 5.9 Phenotypes following combination of low dose ahi1 and cc2d2a MO 
knockdown in zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Wild type (WT) 
zebrafish embryos injected with a low dose of ahi1 MO (0.5ng, A) and cc2d2a MO 
(4ng, B) alone showed minimal cardiac oedema (*, A) or were phenotypically normal.  
WT zebrafish embryos co-injected with low dose ahi1 (0.5ng) and cc2d2a (2ng) MOs 
develop abnormal phenotypes, which persist when also co-injected with p53 MO (to 
exclude off-target effects, C-F).  The range of abnormal phenotypes following co-
injection of low dose ahi1 and cc2d2a MOs includes: cardiac oedema (*, D, E); 
hydrocephalus (black arrowhead, C-F); curved body axis (D, E); pronephric cysts (red 
arrow E); coloboma (black arrow, G); single otolith (green arrow, F, G).  MO, 
morpholino oligonucleotide.   
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Figure 5.10 Percentage frequency of abnormal phenotypes following combined 
MO knockdown using 0.5ng ahi1 and 4ng cc2d2a in zebrafish embryos and 
associated mortality at 24hpf 
Low dose (0.5ng) ahi1 MO alone (black bars, n=58) and 4ng cc2d2a MO alone (green 
bars, n=96) induce a low frequency (≤5%) of abnormal phenotypes (B).  The combined 
MO knockdown of 0.5ng ahi1 and 4ng cc2d2a (red bars, n=10) leads to a synergistic 
increase in the frequency of development of each abnormal phenotype (B).  Mortality at 
24hpf (A) is shown as mean percentage (%) and standard error of the mean (where 
possible) in zebrafish embryos following: 0.5ng of ahi1 MO alone, 4ng cc2d2a MO 
alone and co-injection of 0.5ng ahi1 MO + 4ng cc2d2a MO.  hpf, hours post 
fertilisation; MO, morpholino oligonucleotide. 
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To attempt to circumvent the high toxicity associated with combined 0.5ng ahi1 and 
4ng cc2d2a MO injection, a lower dose of cc2d2a MO (2ng) was used in future 
combination injections.  Additionally, in case the combination of MOs were inducing 
death via programmed cell death or p53 mediated off-target effects (Robu et al., 2007), 
p53 MO was co-injected with future combination injections to knockdown p53 and 
ameliorate this effect. 
5.2.7 Assessing ahi1 and cc2d2a genetic interaction:  Mortality rates and 
phenotypes following combined ahi1 MO, low dose cc2d2a MO and p53 MO 
knockdown in wild type zebrafish embryos 
WT embryos were injected with a combination of 0.5ng ahi1 MO, 2ng cc2d2a MO and 
2ng p53 MO.  The lower dose combination of ahi1 and cc2d2a MO and addition of p53 
MO resulted in a reduced mean (± standard error of the mean) 24hr mortality rate of 
49% (± 4%).  These results were plotted with the mean 24hr mortality rates of embryos 
following injection of 0.5ng ahi1 MO alone, 4ng cc2d2a MO alone and uninjected WT 
matched embryos for each group (Figure 5.11A).  As would be expected, the 24hpf 
mortality rates were higher following a MO injection, however even with combined MO 
injection, the relative 24hpf mortality rates were now between 1.2 and 1.4 times that of 
matched uninjected WT embryos (Figure 5.11A). 
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Figure 5.11 Mortality at 24hpf and percentage frequency of abnormal phenotypes 
following combined ahi1, cc2d2a and p53 MO knockdown in zebrafish embryos 
(A) Mortality at 24hpf is shown as mean percentage (%) and standard error of the mean 
(where possible) in zebrafish embryos following: 0.5ng of ahi1 MO alone, 4ng cc2d2a 
MO alone and co-injection of 0.5ng ahi1 MO, 2ng cc2d2a MO and 2ng p53 MO.  
Mortality in uninjected WT matched for each MO experiment are shown (white bars).  
Low dose (0.5ng) ahi1 MO alone (black bars, n=58) and 4ng cc2d2a MO alone (green 
bars, n=96) induce a low frequency (<5%) of abnormal phenotypes (B).  The combined 
MO knockdown of 0.5ng ahi1, 2ng cc2d2a and 2ng p53 MO leads to a synergistic 
increase in the frequency of each abnormal phenotype (B, red bars, n=53). hpf, hours 
post fertilisation; MO, morpholino oligonucleotide; WT, wild type. 
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Phenotyping by light microscopy was performed at 72hpf.  The number of embryos 
injected with 0.5ng ahi1 MO, 2ng cc2d2a MO and 2ng p53 MO which survived to be 
phenotyped at 72hpf were 53.  The range of abnormal phenotypes which developed 
included a curly tail (Figure 5.9D-E); cardiac oedema and abnormal cardiac 
development (Figure 5.9D-G); hydrocephalus (Figure 5.9C-G); pronephric cysts (Figure 
5.9E) and single otolith in otic vesicles (Figure 5.9C, F-G).  No abnormal eye 
development was detected by light microscopy following 0.5ng ahi1 MO alone; 4ng 
cc2d2a MO alone; or combined 0.5ng ahi1 MO, 2ng cc2d2a MO and 2ng p53 MO.  
Figure 5.11B shows the frequency of abnormal phenotypes generated by 0.5ng ahi1 
MO alone, 4ng cc2d2a MO alone and lower dose combination MO (0.5ng ahi1, 2ng 
cc2d2a and 2ng p53).  Despite using a lower dose of cc2d2a MO (2ng) in the 
combination injection (with 0.5ng ahi1 and 2ng p53 MO), there was a synergistic 
increase in the frequency of all phenotypes and abnormal ear development with altered 
otolith numbers were identified (Figure 5.11B, Table 5.3). 
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 Curly tail (%) Cardiac oedema (%) Hydrocephalus (%) Pronephric cysts (%) Otic defect (%) 
0.5ng ahi1 MO alone 3.0 ± 0.0 5.0 ± 0.0 2.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
4ng cc2d2a MO alone 0.7 ± 0.7 1.7 ± 1.7 0.0 ± 0.0 2.7 ± 2.7 0.0 ± 0.0 
0.5ng ahi1 + 2ng cc2d2a + 2ng p53 MO 38.0 ± 27.0 53.0 ± 9.0 17.0 ± 6.0 9.5 ± 5.5 2.0 ± 2.0 
 
 
 
 
 
 
 
 
Table 5.3 Frequency of abnormal phenotypes in ahi1 and cc2d2a MO injected embryos  
Percentage (%) frequency of abnormal phenotypes at 72hpf in WT embryos injected with 0.5ng ahi1 MO alone, 4ng cc2d2a MO alone or combination 
of: 0.5ng ahi1 MO, 2ng cc2d2a MO and 2ng p53 MO.  Data are shown as mean ± standard error of the mean where possible.  No abnormal eye 
development was apparent by light microscopy.  MO, morpholino oligonucleotide. 
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The similarities in the synergistic increase in frequency of aberrant phenotypes 
following injection of 0.5ng ahi1 MO into sentinel embryos can be compared with the 
effect of combination MO knockdown of 0.5ng ahi1 and 2ng cc2d2a MO (and 2ng p53 
MO) by studying Table 5.2 and Table 5.3 ahi1 MO knockdown in sentinel embryos 
compared to combined MO knockdown in WT embryos led to: a curly tail in 35.3% and 
38% respectively; hydrocephalus in 18.7% and 17% respectively and pronephric cysts 
in 15% and 9.5% respectively.  Both experiments support a genetic interaction between 
ahi1 and cc2d2a and suggest that the combination MO injections closely mimic the 
perhaps more physiological MO knockdown in the spontaneous zebrafish mutant, 
sentinel.    
5.2.8 Evaluating the role of gene dosage in ahi1 and cc2d2a genetic interactions  
Although when higher doses of MOs were used in combination injections they could be 
associated with increased early mortality, the above experiments enabled some 
hypotheses to be made regarding the effect of gene dosage on certain phenotypes.  
Figure 5.12 shows the percentage frequency of abnormal phenotypes following 0.5ng 
ahi1 MO alone; 4ng cc2d2a MO alone; combined 0.5ng ahi1 MO, 2ng cc2d2a MO and 
2ng p53 MO; combined 0.5ng ahi1 MO and 4ng cc2d2a MO.  Unfortunately the 2ng 
cc2d2a MO dose alone or the combination of 0.5ng ahi1 MO and 2ng cc2d2a MO 
without p53 MO were not injected and for completeness should have been performed. 
The more than double increase in frequency of curly tail (38% to 80%) and 
hydrocephalus (17% to 50%, Figure 5.12) phenotypes when an additional 2ng of 
cc2d2a MO was combined with 0.5ng ahi1 MO/2ng cc2d2a MO was of curious interest 
and cannot be logically explained, particularly when 4ng cc2d2a MO alone only 
induced these phenotypes in very low frequency.  This observation may reflect the 
complex interplay and unpredictable synergy on phenotype between interacting genes.    
Low dose (0.5ng) ahi1 MO alone did not induce any pronephric cysts in these 
experiments, however appeared to play an influential role when it was combined with 
4ng cc2d2a as there was a synergistic increase in phenotype which led to pronephric 
cysts in 10% of embryos.  However, the fact that the frequency of pronephric cysts was 
similar (9.5%) when 0.5ng ahi1 MO was combined with only 2ng cc2d2a MO may 
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suggest that there will be a maximal effect of a gene interaction and it will not all be 
explained by ‘gene dosage’. 
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Figure 5.12 Effect of gene dosage on the frequency of abnormal phenotypes 
following combined ahi1 and cc2d2a MO knockdown in wild type zebrafish 
embryos 
Low dose (0.5ng) ahi1 MO alone (black bars, n=58) and 4ng cc2d2a MO alone (green 
bars, n=96) induce a low frequency (≤5%) of abnormal phenotypes.  Combination of 
0.5ng ahi1, with a lower dose (2ng) cc2d2a and 2ng p53 MO leads to a synergistic 
increase in the frequency of abnormal phenotypes (red checked bars, n=53).  
Combination injection with an additional 2ng cc2d2a MO and without p53 MO further 
increases the frequency of aberrant phenotypes (red bars, n=10). MO, morpholino 
oligonucleotide. 
 _____________________ Chapter 5:  Exploring the genetics of cystic kidney disease related ciliopathies 
286 
 
The abnormal eye phenotype which was not apparent with low dose individual 
knockdown of ahi1 or cc2d2a, however was detected in up to 30% of embryos 
following combination knockdown suggested a powerful interplay between these two 
genes regarding eye development or subsequent degeneration.  In Figure 3.3 expression 
of ahi1 was shown in the retina of zebrafish from the 8 somite stage to at least 72hpf.  
Elsewhere it has been reported that cc2d2a localises to the connecting cilium in 
photoreceptors of zebrafish (Bachmann-Gagescu et al., 2011).    
5.2.9 Phenotypes and mortality rates following combined ahi1 MO and nphp6 MO 
knockdown in wild type zebrafish embryos 
To attempt to further understand the oligogenicity and digenic inheritance identified in 
patients with NPHP/JBTS/MKS caused by mutations in NPHP6 and AHI1 (Tory et al., 
2007), WT embryos were injected with a combination of nphp6 and ahi1 splice 
blocking MO.  Above, injection of 0.5ng ahi1 MO alone (n=58) was shown to be 
associated with a low frequency of abnormal phenotypes (≤5%, Table 5.2, Figure 5.9A, 
Figure 5.10A), this dose was therefore chosen for combination injections with nphp6 
MO. 
In section 4.2.14, following injection of 4-6ng of nphp6 splice blocking MO, the 
development of aberrant phenotypes including: curly tail, cardiac oedema, 
hydrocephalus, pronephric cysts (proximal, distal and cloacal), abnormal eye and ear 
development (Figure 4.23, Figure 4.24, Figure 4.25 and Figure 4.26B) was confirmed.  
Even with an nphp6 splice blocking MO dose of 4ng the frequency of abnormal 
phenotypes such as curly tail, was up to 16% (Figure 4.26B).  However injection of 2ng 
nphp6 splice blocking MO alone was not associated with any abnormal phenotypes 
(Figure 5.13B, n=64), therefore a 2ng dose of nphp6 MO was selected for combination 
injections with ahi1 MO. 
WT embryos were injected with a combination of 0.5ng ahi1 MO and 2ng nphp6 MO 
and phenotyped by light microscopy at 72hpf (n=19).  The range of abnormal 
phenotypes seen following co-injection of ahi1 and nphp6 MOs included: curved body 
axis, more often dorsal (Figure 5.13C, F); cardiac oedema (Figure 5.13C, D, F, G); 
hydrocephalus (Figure 5.13C, F, G); pronephric cysts (Figure 5.13D, G); coloboma 
(Figure 5.13C); unilateral microphthalmia (Figure 5.13G); empty otic vesicle (Figure 
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5.13F, G) and single otolith in the otic vesicle (Figure 5.13D).  The frequency of these 
phenotypes were shown in Figure 5.14A, with a curly tail in 53%, hydrocephalus in 
47%, pronephric cysts in 11% and developmental eye and ear anomalies in 26-31%.  
The mean 24hpf mortality rate following combined MO injection was 72.5% (± 5.5%), 
this was 1.7 times higher than matched uninjected WT embryos (41.5% ± 15.5%). 
To assess and again control for the effect of toxicity potentially mediated by off-target 
effects (Robu et al., 2007), when combined MO injections were performed, the 0.5ng 
ahi1 and 2ng nphp6 MO combination were also injected with 2ng p53 MO (n=26).  
This confirmed that the development of abnormal phenotypes continued when also co-
injected with p53 MO (Figure 5.13E).  A synergistic increase in the frequency of 
abnormal phenotypes following co-injection of ahi1, nphp6 and p53 MOs were again 
apparent (Figure 5.14B).  No pronephric cysts were detected by light microscopy and 
the frequency of abnormal eye and ear development was only 4%, this may be because 
the overall number of embryos phenotyped was low, or as previously discussed, 
because embryos were phenotyped at 72hpf. 
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Figure 5.13 Phenotypes following combination of low dose ahi1 and nphp6 MO 
knockdown in zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Golden zebrafish 
embryos injected with a low dose of ahi1 MO (0.5ng, A) and nphp6 MO (2ng, B) alone 
were phenotypically normal.  Golden zebrafish embryos co-injected with low dose ahi1 
and nphp6 MOs (C, D, F, G) develop abnormal phenotypes, which persist when also co-
injected with p53 MO (to exclude off-target effects, E).  The range of abnormal 
phenotypes seen following co-injection of ahi1 and nphp6 MOs includes: 
hydrocephalus (black arrowhead C, E, F, G); curved body axis (C, E, F); cardiac 
oedema (C-G); pronephric cysts (red arrowhead D, G); coloboma (black arrow C); 
unilateral microphthalmia (green arrow G); empty otic vesicle (red arrow F, G) and 
single otolith (red arrow D).  MO, morpholino oligonucleotide. 
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Figure 5.14 Percentage frequency of abnormal phenotypes following individual 
and combined ahi1 and nphp6 (±p53) MO knockdown in zebrafish embryos 
0.5ng ahi1 MO alone induces a low frequency of abnormal phenotypes and no 
pronephric cysts, developmental eye or ear abnormalties (black bars, A-B, n=58).  2ng 
of nphp6 MO alone does not induce any developmental anomalies (green bars, A-B, 
n=64).  Combined MO knockdown using 0.5ng ahi1 and 2ng nphp6 leads to a 
synergistic increase in the frequency of each abnormal phenotype (red bars, A, n=19).  
B shows the synergistic increase in the frequency of abnormal phenotypes when 2ng 
p53 MO is combined with 0.5ng ahi1 and 2ng nphp6 MOs (red/white checked bars, 
n=26). MO, morpholino oligonucleotide. 
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Figure 5.15 shows the comparison in the mortality rates at 24hpf in matched uninjected 
WT embryos to mortality following ahi1, nphp6 MO combination with or without p53 
MO knockdown.  As would be expected, 24hpf mortality rates were higher following a 
MO injection.  The addition of p53 MO to a combination injection reduced relative 
mortality rates from 1.7 times to 1.1 times that of matched uninjected WT embryos 
(Figure 5.15). 
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Figure 5.15 Mortality rates at 24hpf following combined ahi1 and nphp6 ± p53 MO 
knockdown compared to matched uninjected zebrafish embryos 
Data are shown as mean percentage (%) and standard error of the mean.  Mortality rates 
are increased following combined MO injections.  Mortality at 24hpf following 
injection of 0.5ng ahi1 and 2ng nphp6 MO (black bar) is 72.5% (1.7 times) compared to 
41.5% in matched uninjected WT embryos (white bar).  Mortality at 24hpf following 
injection of 2ng p53 MO in combination with 0.5ng ahi1 and 2ng nphp6 MO 
(black/white checked bar) is 68% (1.1 times) compared to 59.5% in matched uninjected 
WT embryos (white spotted bar).  comb, 0.5ng ahi1+2ng nphp6; MO, morpholino 
oligonucleotide; WT, wild type. 
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To increase the number of embryos studied in the ahi1 and nphp6 MO combination 
experiments, because the ciliopathy phenotypes continued to develop with the addition 
of p53 MO, this data was pooled for subsequent phenotypical analysis.  Although 
injection of 2ng nphp6 MO alone (n=64) was not associated with the development of 
any abnormal phenotypes and injection of 0.5ng ahi1 MO alone (n=58) led to a curly 
tail, cardiac oedema or hydrocephalus in less than five percent of embryos, when 
embryos were injected with a combination of 0.5ng ahi1 MO and 2ng nphp6 MO, with 
or without 2ng p53 MO (n=45), there was a dramatic increase in the frequency of 
ciliopathy phenotypes.  Figure 5.16A shows the synergistic increase in the frequency of 
curly tail (51.5% ± 1.5%), cardiac oedema (70% ± 7%), hydrocephalus (41% ± 6%), 
pronephric cysts (5.5% ± 5.5%), abnormal eye (15% ± 11%) and aberrant ear (17.5% ± 
13.5%) development.  This data strongly suggested a genetic interaction between ahi1 
and nphp6.  Although the graphs in Figure 5.14A,B and Figure 5.16A appear very 
similar, the subtle difference is that Figure 5.16 is a pool of the results shown in Figure 
5.14A,B to increase the data numbers. 
The mean mortality rates at 24hpf were compared between individual ahi1 or nphp6 
MO injections and combination ahi1 and nphp6 MO injections relative to matched 
uninjected embryos (Figure 5.16B).  The increase in 24hpf mortality rates relative to 
uninjected embryos following 0.5ng ahi1 MO was 1.2 times, following 2ng nphp6 MO 
was 1.1 times and following combination of ahi1 and nphp6 was 1.4 times.   
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Figure 5.16 Percentage frequency of abnormal phenotypes and mortality at 24hpf 
following combined ahi1 and nphp6 MO knockdown in zebrafish embryos 
Injection of 0.5ng ahi1 MO alone induces a low frequency of abnormal phenotypes and 
no pronephric cysts, developmental eye or ear abnormalties (black bars, A, n=58).  2ng 
of nphp6 MO alone does not induce any developmental anomalies (green bars, A, 
n=64).  Combined MO knockdown using 0.5ng ahi1 and 2ng nphp6 ±2ng p53 MO (red 
bars, A, n=45) leads to a synergistic increase in the frequency of each abnormal 
phenotype.  Mortality at 24hpf is shown (B) as mean percentage (%) and standard error 
of the mean in zebrafish embryos following: 0.5ng of ahi1 MO alone, 2ng nphp6 MO 
alone and co-injection of 0.5ng ahi1 MO + 2ng nphp6 MO ± 2ng p53 MO (B).  
Mortality rates in uninjected WT embryos matched for each group (white bars).  MO 
injections are associated with a relative increase in 24hpf mortality rates.  hpf, hours 
post fertilisation; MO, morpholino oligonucleotide; WT, wild type. 
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5.3 Discussion  
The NPHP related ciliopathies are well recognised for their genetic heterogeneity, 
however the mechanisms which lead to the associated clinical heterogeneity remain 
incompletely understood.  In this chapter by utilising zebrafish models, the role of 
oligogenicity was explored and the effect on subsequent phenotype was evaluated.   
Previously, oligogenicity has been evaluated when studying normal kidney 
development, disease pathophysiology and the effect on the severity of phenotype, in 
zebrafish models.  In podocyte development, combination knockdown of wt1 and 
foxc1a resulted in complete failure of podocytes to form (O'Brien et al., 2011).  The 
genetic interaction between WT1 and FOXC1A was confirmed by co-
immunoprecipitation and protein studies which demonstrated a physical interaction 
(O'Brien et al., 2011).  
The pathophysiology of ADPKD has been further evaluated in zebrafish by combined 
MO knockdown of pkd2 and sec10 (part of the ‘exocyst’, a protein membrane 
trafficking complex), which led to a synergistic increase in the frequency of cilia 
phenotypes including pronephric cysts (Fogelgren et al., 2011).  This genetic interaction 
was supported by co-localisation data and biochemical interaction of proteins 
(Fogelgren et al., 2011).   
In NPHP, the functional role of NPHP2 and NPHP9 on pronephros development and 
left-right patterning was studied in zebrafish (Fukui et al., 2012).  Combined nphp2 and 
nphp9 MO knockdown led to a synergistic increase in pronephric cysts and abnormal 
left-right cardiac development.  Since nphp9 mRNA rescued nphp2 morphants, 
however the converse was not true, it was postulated that nphp9 must function 
downstream of nphp2 (Fukui et al., 2012).  
Although the extra-renal manifestations of NPHP are variable, NPHP5 and NPHP6 
mutations are usually associated with retinal degeneration (Schafer et al., 2008).  To 
evaluate a functionally relevant, potential genetic interaction, combined MO 
knockdown of nphp5 and nphp6 in zebrafish was performed and led to a synergistic 
increase in the frequency of morphant phenotypes including pronephric cysts and 
hydrocephalus.  This genetic interaction was confirmed by identifying the protein 
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binding sites where the physical interaction occurs between nephrocystins 5 and 6 
(Schafer et al., 2008).   
In BBS, a NPHP related oligogenic ciliopathy, combined MO knockdown of mgc1203 
(which encodes a pericentriolar protein and co-localises with BBS proteins, however 
cannot cause BBS alone) with bbs4 or bbs6 or bbs1 led to an increased frequency and 
severity of BBS phenotypes (Badano et al., 2006a).  It was concluded that combined 
MO knockdown in zebrafish was a useful method for evaluating the effect of epistatic 
mutations (for example in mgc1203) and trying to improve understanding of the 
subsequently variable clinical phenotype. 
In order to study potential genetic interactions, it was important to initially define the 
range and frequency of aberrant developmental phenotypes induced by interfering with 
the expression of a single gene.  In Chapter 3, Figure 3.9, the effect of ahi1 on 
development following a range of doses of MO knockdown was characterised.  In 
Chapter 4 the effect of cc2d2a using the sentinel mutant and a range of doses of MOs to 
knockdown cc2d2a and nphp6 were individually characterised.  This prior work 
enabled the study of the effects of combinations of gene interference: cc2d2a and 
nphp6; cc2d2a and ahi1; ahi1 and nphp6 to be reported herein.       
5.3.1 Recapitulation of genetic interaction between CC2D2A and NPHP6 using 
sentinel (cc2d2a mutant) embryos 
Patients with MKS caused by mutations in CC2D2A and NPHP6 have been identified 
(Hopp et al., 2011), suggesting this gene combination may lead to austere 
developmental anomalies and account for ciliopathies at the severe end of the spectrum.  
Embryos born from sentinel heterozygous matings injected with 4 or 6ng of splice 
blocking nphp6 MO developed pronephric cysts in 9% and 36% respectively.  This was 
a synergistic increase in the frequency of pronephric cysts identified compared to those 
identified in sentinel embryos alone (1.5%), embryos injected with 4ng nphp6 (1.5%) or 
6ng nphp6 (17%) MO alone.  A limitation of this work when studying embryos born to 
sentinel heterozygous parents, was a failure to genotype every embryo, this may account 
for the low frequency of phenotypes/pronephric cysts identified in this group, as some 
may have been heterozygous.  Ideally in future to avoid this potential ambiguity, 
gentopying would be performed in all embryos.   
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It is important to note the marked increase in frequency in pronephric cysts associated 
with a 6ng dose of nphp6 MO alone, this dose appeared to clearly be associated with a 
cystic phenotype and was similar to the published percentage of cysts detected in WT 
embryos injected with 5ng nphp6 (20%) splice blocking MO (Gorden et al., 2008).  
Although a synergistic increase in the frequency of pronephric cysts (36%) with 
injection of 6ng nphp6 MO into embryos born from sentinel heterozygous parents was 
detected, this was much lower than the 89% of pronephric cysts reported in the original 
nphp6 and sentinel paper (Gorden et al., 2008).  Whilst methods for detecting 
pronephric cysts were not described in the publication, the only supporting evidence 
they showed for pronephric cysts were light microscopy images (Gorden et al., 2008) 
and there was no description of experiments involving histology.  Gorden et al. (2008) 
did however report a much higher percentage of pronephric cysts (33%) in sentinel 
embryos alone and they phenotyped for up to 6dpf.  This extended period of study was 
not feasible with our animal license and therefore the possibility of later development of 
perhaps more overt pronephric cysts, beyond 72hpf when they were phenotyped cannot 
be excluded.   
In addition to inducing a synergistic increase in the development of pronephric cysts, 
markedly more curly tails in up to 74.5% were identified when embryos born to sentinel 
heterozygous parents were injected with 6ng nphp6 MO.  This may suggest that 
interaction between cc2d2a and nphp6 subsequently mediates changes in PCP 
pathways.  To date reports of CC2D2A and NPHP6 interacting have focused on the 
basal body (Gorden et al., 2008), however it would be interesting to explore further 
downstream signalling pathways.  Future experiments to assess for potential changes in 
PCP pathways could involve performing in situ hybridisation of PCP genes before and 
after MO knockdown of cc2d2a or nphp6.   
Previously, the use of proteomic studies to assess the NPHP related ciliopathies resulted 
in a model which groups the various genes into pathways and relevant associated 
proteins into functional networks (Sang et al., 2011).  Cc2d2a has been suggested to 
function in Hh signalling and Nphp6 in maintaining cilia architecture (Sang et al., 
2011).  In future work it would therefore be interesting to evaluate for any changes in 
Hh signalling following cc2d2a MO knockdown.  This could be evaluated by 
performing in situ hybridisation using a shh riboprobe following MO knockdown of 
cc2d2a in zebrafish embryos.    
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The original sentinel nphp6 paper (Gorden et al., 2008) did not identify any additional 
developmental defects such as brain malformation or cardiac laterality defects, however 
a synergistic increase in the frequency of developmental anomalies in several other 
organs was observed herein.  There was a synergistic increase in the frequency of 
cardiac oedema from 2.5% in embryos born to sentinel heterozygous parents, 39% 
when WT were injected with 6ng nphp6 MO and 81.5% when sentinel were injected 
with 6ng nphp6 MO.  The gross readout of cardiac oedema may reflect primary 
developmental anomalies of the heart linked to disordered left-right patterning 
(previously shown in nphp6 morphants in section 4.2.17) or secondary to structural or 
functional anomalies of the pronephros.   
Hydrocephalus was a frequent phenotype seen in WT embryos injected with 4-6ng 
nphp6 MO alone (9.5-30.8%) and of low frequency in embryos born to sentinel 
heterozygous parents (0.5%).  When 4ng nphp6 MO was injected into sentinel embryos 
there was a synergistic increase in hydrocephalus in up to 36% of embryos, however 
this was not sustained when 6ng nphp6 MO was injected (22%), possibly because more 
of the embryos which would mature to develop hydrocephalus were dying within the 
first 24hpf.  Certainly increased rates of mortality at 24hpf were evident following 
injection of 6ng nphp6 MO into WT (49%) or sentinel (70%) embryos.  If projecting 
this data from zebrafish models to humans, this combination of nphp6 and sentinel 
(cc2d2a) may represent the MKS end of the ciliopathy spectrum, associated with high 
perinatal mortality (Alexiev et al., 2006). 
By light microscopy, the frequency of abnormal eye development was not altered by 
combining nphp6 MO knockdown in embryos born from sentinel heterozygotes and 
remained low, between 1-3.5%, similar to rates following nphp6 MO knockdown alone.  
In matched experiments no abnormal eye development was detected in embryos born to 
sentinel heterozygous parents, this would be in keeping with the absence of detection of 
phenotypes other than pronephric cysts previously reported (Gorden et al., 2008).  
However these latter results are in contrast with the very low frequency, although 
definitely abnormal eye development reported albeit in a different clutch of sentinel 
embryos in Chapter 4, Figure 4.9.  Interestingly, the abnormal retinal phenotype and 
altered visual function of sentinels (Bachmann-Gagescu et al., 2011) has subsequently 
been reported in detail and confirmed by Gorden et al. (2008) who initially evaluated 
nphp6 in sentinels (Gorden et al., 2008).  Unfortunately they did not explore the impact 
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of additional nphp6 knockdown, which would have been interesting, particularly since it 
is known that NPHP6 mutations are the leading cause of isolated congenital retinal 
degeneration (den Hollander et al., 2006). 
Although to date, there are no publications relating to abnormal ear development or 
hearing impairment in the NPHP related ciliopathies, a synergistic increase in the 
frequency of abnormal development of the rudimentary ear in zebrafish models of 
CC2D2A and NPHP6 mutations were observed in this work.  This was perhaps 
surprising, as CC2D2A may have been hypothesised to play a protective role in ear 
development, since the sentinel zebrafish were initially discovered as a protective 
mutant during a screen for genes influencing aminoglycoside induced hair cell death 
(Owens et al., 2008).   
Previously, in situ hybridisation in developing zebrafish embryos of nphp6 alone has 
identified expression predominantly in the tail, cerebellum and retina (Sayer et al., 
2006), whilst cc2d2a alone was expressed ubiquitously at 64 hpf (Owens et al., 2008).  
In future experiments it would be informative to further define the expression of cc2d2a 
during development.  Subsequently, another method of further evaluating the apparent 
genetic interaction between CC2D2A and NPHP6 would be to perform double in situ 
hybridisation using cc2d2a and nphp6 riboprobes to assess for co-expression.   
5.3.2 Genetic interaction between CC2D2A and AHI1 using ahi1 knockdown in 
sentinel (cc2d2a mutant) embryos   
Whilst oligogenic inheritance has been described in patients with JBTS caused by a 
heterozygous mutation in AHI1 and a homozygous mutation in NPHP6 or NPHP1 
(Tory et al., 2007), digenic inheritance has not yet been described for AHI1 and 
CC2D2A.  However, it may be that mutations are present in affected individuals, 
however not yet identified, as screening or mutation analysis of the various NPHP 
associated ciliopathy genes does not occur routinely because of the limitation of 
resources.  Furthermore, previously patients with JBTS have been reported even when 
only a single heterozygous change in AHI1 (Otto et al., 2011; Parisi et al., 2006) was 
identified, meaning the second disease causing mutation remains unidentified.   
Both CC2D2A (Gorden et al., 2008) and Jouberin (Eley et al., 2008; Hsiao et al., 2009) 
colocalise at the basal body of primary cilia, however information regarding protein 
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interaction is currently sparse.  Such an interaction may be postulated if we recognise 
that Jouberin is suggested to behave as a bridging protein to link the ‘Hh signalling’ 
module, including CC2D2A, to other functioning networks in the NPHP, JBTS, MKS 
ciliopathy disorders (Sang et al., 2011).   
Embryos born from sentinel heterozygous matings injected with 0.5-2ng of ahi1 splice 
blocking MO developed pronephric cysts in 15% to 45.7% in a dose dependent manner.  
This was a synergistic increase from the frequency of pronephric cysts of 1-10.9% 
detected by interruption of CC2D2A or AHI1 alone.  These genes are frequently 
associated with causing JBTS and MKS, therefore it was perhaps not suprising that 
there was also a synergistic increase in the frequency of hydrocephalus.  Most 
strikingly, the frequency of hydrocephalus increased from 1-2% in embryos born to 
sentinel heterozygotes or WT injected with 0.5ng ahi1 MO alone, to 18.7% when 
combined. 
Similar to the synergistic increase in frequency of curly tail, cardiac oedema and 
abnormal ear development detected in embryos born to sentinel heterozygotes injected 
with nphp6 MO, this occurred when sentinels were injected with ahi1 MO.  The strong 
synergistic influence on altering body curvature associated with AHI1 and CC2D2A 
interacting, ranging between 35.3-84%, may in part relate to the fact that sentinel 
mutants have a characteristic dorsal body curvature and again may implicate a role for 
disordered PCP. 
In 3.2.9 altered cardiac looping and left-right body patterning was detected in ahi1 
morphants.  This propensity to aberrant cardiac development may facilitate explanation 
of the synergistic increase in cardiac oedema detected when embryos born to sentinel 
heterozygotes were injected with ahi1 MO.  Compared to a frequency of cardiac 
oedema of 3-35.1% following interference with CC2D2A or AHI1 alone, this increased 
to 30.7-89.3% with combination experiments.  Again, the cardiac oedema may reflect 
defective pronephric function, failing to sufficiently filter body fluid.    
Although mutations in AHI1 or CC2D2A are not known to cause isolated blindness in 
humans, up to 20% of patients with associated cerebral-renal disorders are blind 
(Gorden et al., 2008; Parisi et al., 2006; Valente et al., 2006a).  It was therefore 
interesting to identify a synergistic increase in the frequency of abnormal eye 
development on light microscopy when ahi1 MO was injected into embryos born to 
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sentinel heterozygotes.  Isolated interference with cc2d2a or ahi1 led to aberrant eye 
development in a maximum of 0.9% of embryos, compared to up to 15.3% when 2ng 
ahi1 was injected into embryos born to sentinel heterozygotes.  A mechanism of this 
interaction may be the fact that in photoreceptors both AHI1 (Hsiao et al., 2009) and 
CC2D2A (Bachmann-Gagescu et al., 2011) have been shown to independently regulate 
vesicular trafficking via their relationships with Rab8 (Rab8a).  Following knockdown 
of AHI1 or CC2D2A in cell models, Rab8 was mislocalised which led to aberrant 
trafficking in photoreceptors (Bachmann-Gagescu et al., 2011; Hsiao et al., 2009). 
The synergy in all ciliopathy phenotypes detected when embryos born to sentinel 
heterozygotes were injected with ahi1 MO provides compelling evidence for a genetic 
interaction between CC2D2A and AHI1.  However a regretable limitation of this work 
was the uncertainty of the genotype of embryos born to sentinel heterozygotes, to try to 
overcome this, the alternative zebrafish MO mediated model of cc2d2a related 
ciliopathies (created in section 4.2.10) was used and combination MO injections were 
performed to knockdown cc2d2a and ahi1. 
5.3.3 Recapitulation of the genetic interaction between CC2D2A and AHI1 using 
MO knockdown in wild type embryos   
Whilst sentinel zebrafish have been postulated to be a useful zebrafish line to study 
oligogenicity (Gorden et al., 2008), there were limitations associated with their use as a 
tractable model to study the effect of interference with cc2d2a; possibly because of 
incomplete penetrance of important phenotypes such as pronephric cysts (Gorden et al., 
2008) and potentially increased early mortality in sentinel homozygotes. 
Although the frequency of aberrant ciliopathy developmental phenotypes was less than 
5% when performing 0.5ng ahi1 or 4ng cc2d2a MO injections individually, with 24hpf 
mortality rates 1.2 to 1.4 times relative to matched WT embryos, when injected in 
combination although a synergistic increase in abnormal phenotypes was induced, this 
dose combination was associated with excess lethality.  Injection of 0.5ng ahi1 and 4ng 
cc2d2a MO led to the 24hpf mortality rate rising to 88%, 3.4 times the matched WT 
24hpf mortality rate.  In order to enable more embryos to survive to be phenotyped at 
72hpf following combined ahi1 and cc2d2a MO injection, the dose of cc2d2a MO was 
reduced to 2ng for future experiments.  Unfortunately the 2ng dose of cc2d2a MO was 
not injected into WT embryos alone, however since MO injections tend to have a dose 
 _____________________ Chapter 5:  Exploring the genetics of cystic kidney disease related ciliopathies 
301 
 
dependent effect on the development of abnormal phenotypes, it would be expected that 
any aberrancies associated with a 2ng dose of cc2d2a MO would be less than the 2.7% 
frequency which was induced by a 4ng dose of cc2d2a MO.   
There was a synergistic increase in the frequency of pronephric cysts, hydrocephalus, 
curly tail and cardiac oedema when WT embryos were injected with a combination of 
0.5ng ahi1 and 2ng cc2d2a MOs.  This dose combination enabled increased survival of 
embryos to be phenotyped at 72hpf.  With combination knockdown of cc2d2a and ahi1, 
the frequency of pronephric cysts increased to 9.5% and hydrocephalus to 17%.  
Although there was a synergistic increase in the frequency of pronephric cysts, this was 
still only up to 9.5% and if embryos had been phenotyped at a later date, such as 5dpf, 
this frequency may have further increased.  If these experiments were to be repeated, it 
would definitely be wise to consider reviewing embryos at 72hpf and 5dpf as this may 
allow for maximal capture of data, ideally without any excess death of embryos between 
72hpf and 5dpf. 
The synergistic increase in the frequency of cardiac oedema to 53% may again relate to 
a combination of: aberrant cardiac looping/development.  It was evident herein (3.2.9) 
that ahi1 knockdown alone adversely interfered with cardiac development; with oedema 
presumed secondary to impaired pronephric clearance of fluid.  Cardiac looping was not 
formally assessed in the combination morphants, however would have been interesting 
to evaluate.  Again, although not formally assessed or documented, a reduced frequency 
of heart beat was noted when phenotyping morphants at 72hpf, compared to that of WT 
embryos.  This may have preceded subsequent mortality and from observations whilst 
performing experiments, it would be surprising if all morphants which were phenotyped 
at 72hpf would survive to be phenotyped at 5dpf.   
Although of low frequency, the combination of 0.5ng ahi1 and 2ng cc2d2a MOs led to 
abnormal ear development with altered numbers of otoliths, whilst knockdown of either 
MO alone at this dose did not.  When the cc2d2a MO dose was reduced from 4ng to 
2ng in combination injections, abnormal eye development no longer occurred.  This 
may suggest a gene dosage effect was required to induce abnormal eye development, or 
in the context of eye development that cc2d2a plays more of an influence than ahi1.   
The synergistic increase in the frequency of aberrant phenotypes continued when p53 
MO was added to the ahi1 and cc2d2a MO combination, excluding the induction of off-
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target effects (Robu et al., 2007) and confirmed a genetic interaction between AHI1 and 
CC2D2A as originally identified with the injection of ahi1 MO into sentinel (cc2d2a 
mutant) embryos.  The use of combination MO knockdown generated similar results to 
the perhaps more physiological evaluation of a genetic interaction between AHI1 and 
CC2D2A using ahi1 knockdown in sentinel mutants, however proved to be a robust and 
efficacious model for evaluating genetic interactions.  It would be useful for this 
apparent genetic interaction between AHI1 and CC2D2A to be assessed at the protein 
level and an interesting expansion of the work evaluating interacting protein networks 
(Sang et al., 2011) in the NPHP, JBTS and MKS ciliopathy disorders.  The current 
absence of the identification of patients with NPHP related ciliopathies caused by 
digenic mutations in AHI1 and CC2D2A may relate to the fact that the cost implications 
restrict the widespread assessment of several other genes and screening is therefore 
currently not routinely available.  It is however noteworthy that in a recent attempt to 
further characterise and understand the phenotypic variation in NPHP associated 
ciliopathies, mutation analysis of eighteen ciliopathy genes including AHI1 and 
CC2D2A was undertaken and failed to identify any oligogenicity (Otto et al., 2011).  
Furthermore a causal mutation was not identified in any of the eighteen ciliopathy genes 
in 75% (n=90) of patients in the cohort with NPHP related ciliopathies, suggesting that 
several causal genes remain currently unidentified. 
In future experiments, to further evaluate the potential impact of an interaction between 
CC2D2A and AHI1 it would be interesting to evaluate differences in ahi1 expression by 
in situ hybridisation following MO knockdown of cc2d2a.      
5.3.4 Genetic interaction between AHI1 and NPHP6 using combined ahi1 and 
nphp6 knockdown in wild type embryos   
Patients with JBTS caused by heterozygous mutations in both AHI1 and NPHP6 have 
been identified (Hopp et al., 2011), however since the numbers were low, it was not 
clear whether this influenced the subsequent phenotype.  Both Jouberin (Eley et al., 
2008; Hsiao et al., 2009) and nephrocystin-6 (Valente et al., 2006b) colocalise at the 
basal body of primary cilia, however to date there is no information regarding if a direct 
interaction exists between the proteins.  A functional interaction is plausible from the 
proposed model of NPHP-JBTS-MKS protein network, which suggests that Jouberin 
 _____________________ Chapter 5:  Exploring the genetics of cystic kidney disease related ciliopathies 
303 
 
acts as a bridging protein to the ‘cilia integrity’ complex which consists of NPHP6, 
NPHP5 and Ataxin10 (Sang et al., 2011). 
WT embryos injected with a combination of low doses of ahi1(0.5ng) and nphp6(2ng) 
MO which when injected in isolation did not, or only minimally (less than 5%) induced 
abnormal cardiac, brain and renal development, led to a synergistic increase in the 
frequency of abnormal organogenesis.  The frequency of pronephric cysts detected at 
72hpf increased from occurring in no embryos injected with low dose of either ahi1 or 
nphp6 MO alone, to 11% in combination morphants.  The frequency of pronephric cysts 
with this combination of gene interference could more than likely have been further 
increased by uptitrating the MO doses, however initially it seemed important to evaluate 
if there was an effect by combining subeffective individual doses.  Hydrocephalus 
occurred in 47% of embryos following combination of ahi1 and nphp6 compared to 
only 2% of embryos with knockdown of either gene alone, using the same MO doses.  
Since both AHI1 and NPHP6 are important causes of JBTS which is characterised by 
abnormal brain development and in particular cerebellar vermis hypoplasia(Parisi et al., 
2007), it is not surprising that this was a prevalent phenotype. 
A synergistic increase in the frequency of abnormal eye and ear development were also 
evident.  Eye anomalies were only studied by light microscopy and occurred in up to 
26% of combination morphants, compared to none of the embryos injected with either 
low dose of ahi1 or nphp6 MO alone.  We may assume this phenotype is caused by the 
effect of NPHP6 predominantly as we know it is the leading cause of isolated 
congenital retinal degeneration (den Hollander et al., 2006) and when low dose ahi1 
(0.5ng) was combined with a low/subeffective dose of nphp6 (2ng) no abnormal eye 
development occurred.    
Curiously, abnormal ear development, with altered numbers of otoliths occurred with a 
frequency of up to 31% in ahi1 and nphp6 combination morphants.  This phenotype is 
not described in patients, however may represent a general marker of abnormal 
ciliopathy phenotypes in the zebrafish model organism (Colantonio et al., 2009). 
The combination of ahi1 and nphp6 MOs led to a 24hpf mortality rate 1.7 times that of 
matched WT embryos, therefore to try to minimise any increased mortality associated 
with programmed cell death or off-target effects, p53 MO was added to the combination 
of individual MO doses.  This successfully reduced the relative 24hpf mortality rate to a 
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comparable 1.1 times that of matched WT embryos.  The lethality associated with a 
combination of AHI1 and NPHP6 interference may have been predicted and disease 
severity has recently been recognised in patients with NPHP related ciliopathies, where 
the disease phenotypes were most severe when two null allelles occurred in NPHP6 and 
AHI1 (Chaki et al., 2011).   
Understandably the identification of high 24hr mortality rates following individual or 
combined MO experiments may lead to concerns regarding the risk of off-target effects 
leading to confounding, however the experiments performed above were controlled for 
this by repeating with co-injection of a p53 MO.  Additionally, as discussed in section 
3.2.3 the consensus amongst fellow zebrafish workers was that it was acceptable to 
include these experiments in data analysis providing there was consistent and careful 
comparison with matched control embryos.  Furthermore there is patient data to support 
recognition of the severest phenotypes associated with mutations in NPHP6 and AHI1 
(Chaki et al., 2011). 
A synergistic increase in abnormal phenotypes, particularly hydrocephalus still 
occurred, when ahi1, nphp6 and p53 MOs were combined, however there was no 
synergistic increase in the frequency of pronephric cysts.  There is no logical 
explanation for this, however may be explained by the overall low number of embryos 
included in the experiment.  Ideally, to exclude any ambiguity, this experiment would 
be repeated aiming to generate larger numbers of morphants at least surviving to be 
phenotyped at 72hpf to 5dpf, to potentially enable the later detection of pronephric 
cysts.  Overall, the combined knockdown of ahi1 and nphp6 was associated with a 
synergistic increase in the spectrum of ciliopathy phenotypes suggesting a genetic 
interaction.  In future work, this apparent genetic interaction could be further explored 
by injecting different combinations of MO dose, to attempt to determine if there was an 
influence on subsequent phenotypes, trying to advance understanding of epistasis and 
genotype-phenotype correlations.  In the recent evaluation of genotype and phenotype in 
440 patients with NPHP related ciliopathies, they concluded that the gene locus was the 
key determinant of subsequent clinical characteristics (Chaki et al., 2011).  Although 
they carefully studied the phenotypes associated with the known/identified causal gene, 
they did not perform screening for additional mutations, thus the influence of 
oligogenicity, which is likely to occur in at least some of these patients, cannot be 
considered.   
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To further evaluate the effect of an interaction between AHI1 and NPHP6, in future 
work nphp6 MO knockdown could be performed followed by comparing the effect on 
ahi1 expression using in situ hybridisation.  Alternatively further evaluation of protein 
to protein interactions between Jouberin and nephrocystin-6 could be performed to 
identify potential physical and functional interactions, as modelled in the recent 
ciliopathy protein network and NPHP related gene pathway paper (Sang et al., 2011).   
The experiments reported herein support the hypotheses that there are genetic 
interactions between many of the ciliopathy genes.  This work confirms a genetic 
interaction between NPHP6 and CC2D2A and reports novel data proving an interaction 
between both: AHI1 and CC2D2A; AHI1 and NPHP6.   
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Chapter 6 Concluding Discussion 
6.1 Summary of findings 
This work focused on studying the developmental phenotypes induced by knockdown 
of certain genes known to cause cystic kidney disease and related ciliopathies.  At times 
this involved assessing if the phenotypes were associated with a change in cilia, since 
increasingly these organelles are considered to play an important role in the 
pathogenesis of cystic kidney disease.  A principal aspiration of this work was to try to 
further understanding of the clinical heterogeneity of cystic kidney disease related 
ciliopathies by studying oligogenicity and to ascertain if any reliable genotype-
phenotype predictions could be determined.  Zebrafish embryos were a tractable and 
useful model organism for this work.  The key findings are outlined below and will 
subsequently be further discussed.  
1) ahi1 is normally expressed in developing zebrafish embryos in KV (the organ of 
laterality), the retina, brain and pronephros.  ahi1 knockdown in zebrafish embryos 
caused abnormal development with a curved body axis, hydrocephalus, pericardial 
oedema, pronephric cysts and retinal anomalies, creating a novel zebrafish model of the 
cystic kidney disease related ciliopathy, JBTS. 
2) ahi1 knockdown in zebrafish was associated with disruption to cilia in both KV and 
the distal pronephros, at the cloaca.  Following ahi1 knockdown, cilia were mostly 
absent from KV, or if present, they appeared shorter.  Similarly, in the cloaca which was 
dilated, cilia were predominantly absent or shorter in ahi1 morphants.  As a 
consequence of loss of cilia from KV and presumed associated impaired nodal flow, 
establishment of left-right patterning was altered, which led to reversed cardiac 
asymmetry.  
3) In sentinel zebrafish mutants (spontaneous mutation in cc2d2a) a low frequency of 
ciliopathy phenotypes were identified, however novel findings included: hydrocephalus; 
coloboma; unilateral microphthalmia and aberrant retinal development.  Rapamycin had 
no effect on reversing or reducing the low frequency of phenotypes in sentinel mutants. 
4) An alternative model of CC2D2A related ciliopathies was created by performing 
cc2d2a knockdown in zebrafish and generated an increased frequency of phenotypes 
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(compared to sentinel mutants) which included: dorsal curved axis, pericardial oedema, 
hydrocephalus, pronephric cysts, wavy notochord, coloboma and unilateral 
microphthalmia. 
5) A zebrafish nphp6 morphant was created and in addition to developing the typical 
ciliopathy phenotypes of: curved body axis; cardiac oedema, hydrocephalus, eye and ear 
anomalies; cysts were identified throughout the pronephros with cystic dilatation at the 
cloaca.  Evaluation of cilia at KV revealed fewer and shorter cilia following nphp6 
knockdown which was associated with aberrant left-right body patterning and reversed 
cardiac asymmetry.    
6) The severe end of the cystic kidney disease related ciliopathy spectrum was modelled 
by performing mks3 knockdown in zebrafish embryos.  In addition to typical ciliopathy 
phenotypes, cysts were apparent throughout the pronephros leading to dilatation at the 
cloaca and associated with gross generalised oedema.  Interestingly, development of the 
notochord and tail were markedly abnormal in some mks3 morphants: with a wavy 
notochord extending dorsally through the floorplate and myotomes to the surface; or the 
appearance of vacuoles within the dorsal fin.  These developmental anomalies likely 
represent the severe end of the spectrum of ciliopathies. 
7) A genetic interaction between NPHP6 and CC2D2A was demonstrated in zebrafish 
by creating a synergistic increase in the frequency of ciliopathy phenotypes following 
nphp6 knockdown in sentinel mutants.  A similar genetic interaction was suggested 
between AHI1 and CC2D2A when ahi1 knockdown in sentinel mutants led to a 
synergistic increase in ciliopathy phenotypes.   
8) A genetic interaction between AHI1 and CC2D2A was further evaluated by creating 
an alternative model using combined MO knockdown of ahi1 and cc2d2a in zebrafish 
embryos.  A synergistic increase in ciliopathy phenotypes confirmed a likely genetic 
interaction and even a potential for oligogenic inheritance. 
9) The genetic association between AHI1 and NPHP6 was modelled in zebrafish 
embryos by performing combined MO knockdown of ahi1 and nphp6 and yielded a 
synergistic increase in ciliopathy phenotypes.    
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6.2 ahi1 knockdown in zebrafish is associated with loss of cilia and models Joubert 
Syndrome 
Although the frequency of developmental anomalies following ahi1 knockdown in 
zebrafish was dose dependent, interestingly, on subjective observation there was a 
variable spectrum of severity, very much reflecting the clinical heterogeneity which is 
apparent in patients.  The mechanisms of this variability in the context of monogenic 
JBTS related disease, following only ahi1 knockdown, unfortunately remains a puzzle. 
The higher prevalence of brain anomalies and hydrocephalus, than pronephric cysts or 
retinal disease in the ahi1 zebrafish morphants reported herein is also in keeping with 
the pattern of ahi1 related JBTS in humans.  The most frequent clinical findings 
associated with AHI1 mutations in patients are molar tooth sign (on cerebral MRI) with 
retinal disease or additional cystic kidney disease (Valente et al., 2008). 
Following examination of KV in many embryos, it was apparent that injection of ahi1 
MO resulted in complete loss of cilia or development of shorter cilia.  Several different 
antibodies were utilised to further attempt to identify cilia, associated centrosomes or 
the apical epithelium of KV where cilia should sprout from, however these confirmed 
absence of cilia or occasionally the presence of shorter cilia.  These findings may be 
explained physiologically by recall that Jouberin, the protein product of AHI1 is 
expressed at the basal body and is now recognised to function as part of the ciliary 
transition zone which regulates ciliogenesis (Davis and Katsanis, 2012).  This work 
mimics the identification of shortening and loss of cilia in KV of nphp3 zebrafish 
models of the related ciliopathies NPHP and MKS, which led authors to hypothesise 
that the encoded protein was involved in the development of cilia (Zhou et al., 2010b).   
In ahi1 morphants, as a consequence of loss or shortening of cilia, reversal of left-right 
cardiac asymmetry was evident.  This association between aberrations in left-right body 
patterning as a consequence of changes in cilia in KV has been reported in other 
zebrafish ciliopathy models (Slanchev et al., 2011; Zhou et al., 2010b) and is 
understandable because fluid flow generated by cilia in KV is responsible for 
determining body asymmetry (Kramer-Zucker et al., 2005).  Although mutations in 
AHI1 have not yet been linked with situs inversus in humans, other developmental 
cardiac defects, such as an atrial septal defect have been identified (Dixon-Salazar et al., 
2004).   
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Cystic dilatation of the cloaca and the absence or existence of shorter cilia was an 
interesting finding in ahi1 morphants.  This pattern of abnormal cloacal development 
and ciliary changes has been reported in other zebrafish models of cystic kidney disease 
including nphp6 (Sayer et al., 2006) and nphp4 (Slanchev et al., 2011).  The protein 
products of AHI1, NPHP6 and NPHP4 are all expressed in the basal body of cilia (Eley 
et al., 2008; Sayer et al., 2006; Slanchev et al., 2011) and it has been suggested that the 
basal body regulates the Wnt PCP signalling pathway (Burckle et al., 2011), which 
coordinates orientated cell growth (Borovina et al., 2010).  Recently, knockdown of 
wtip, a gene whose protein product is expressed in the basal body, led to pronephric 
cysts with malformation of the cloaca and was associated with: fewer ciliated cells and 
reduced motility of cilia (Bubenshchikova E., 2012).  The resulting ciliopathy 
phenotypes observed in wtip morphants were similar to vangl2 morphants, suggesting 
an association between the development of cloacal abnormalities and PCP (Borovina et 
al., 2010; Bubenshchikova E., 2012; Burckle et al., 2011).  The reported aberrant cloaca 
and ciliary findings are similar to those detected in this work in ahi1 morphants.    
6.3 Future work involving AHI1  
This work on the role of AHI1 in cystic kidney disease and related ciliopathies has led 
to several further questions which could be investigated.  Live imaging could be used to 
assess whether when present, cilia in ahi1 morphants are motile or not.  Injection of 
fluorescent dextran into the pericardium followed by assessment of the intensity of 
fluorescence remaining 24 hours later could be performed to assess kidney function and 
whether dilatation of the cloaca was associated with obstruction.   
To further understand the generalised oedema which many ahi1 morphants developed, 
immunofluorescence using an antibody to alpha6F Na
+
/K
+
 ATPase could be performed 
to assess cell polarity and determine whether the membrane transporter is not located at 
its expected site of the basolateral membrane.  Several zebrafish mutants with 
pronephric cysts have been found to mislocalise Na
+
/K
+
 ATPase (Drummond et al., 
1998) within cells leading to aberrant osmoregulation.   
Since several mechanisms are likely to be involved in the pathogenesis of AHI1 related 
ciliopathies and given the cloacal phenotype, it would be interesting to knockdown ahi1 
in zebrafish trilobite embryos, which have a mutation in the central PCP gene, vangl2.  
Previously, this type of experiment has identified a synergistic increase in pronephric 
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cysts following nphp4 knockdown in trilobites (Burckle et al., 2011).  Similarly, it 
would be interesting to evaluate whether there were changes in the expression of Shh 
following ahi1 knockdown by performing in situ hybridisation to evaluate the 
expression of Shh on ahi1 morphants.   
6.4 Models of CC2D2A related ciliopathies and further work 
Characterisation of sentinel embryos, with a spontaneous mutation in CC2D2A led to 
the novel identification of additional ciliopathy phenotypes including hydrocephalus, 
cardiac oedema and ocular anomalies, which were confirmed on histology.  
Interestingly, the ocular phenotype of sentinel embryos has subsequently been further 
characterised and although different anomalies were reported (Bachmann-Gagescu et 
al., 2011), this may be explained by genetic heterogeneity.  However, a limitation of this 
work using sentinel embryos was that genotyping was not always performed and 
therefore embryos which were not genotyped were presumed to be sentinels until 72hpf 
when a sine wave tail became apparent as a distinguishing feature.  If future work were 
performed using sentinel embryos, genotyping should be routine.  The idea of working 
with sentinel embryos was to facilitate studying oligogenicity and therefore clear 
characterisation of respective mutants and morphants was required prior to evaluating 
double gene knockdown.     
A reduction in the number of cilia in KV in sentinel mutants detected herein may be 
explained physiologically by the recent identification of CC2D2A as a transition zone 
complex protein involved in regulating ciliogenesis (Davis and Katsanis, 2012).  It 
would have been interesting to assess if this impacted on left-right asymmetry by 
analysing cardiac looping in sentinel embryos, this could be performed in future work. 
Generation of cc2d2a morphants using a MO designed to knockdown the same exon 
which is mutated in sentinel embryos resulted in an increased frequency of phenotypes 
including pronephric cysts, hydrocephalus and ocular anomalies.  Interesting if a 
convergent extension defect developed in cc2d2a morphants, it was always a dorsal 
body curvature, like the sine wave shaped tail of sentinel mutants, the significance of 
this is unclear, however the cc2d2a morphants were certainly representative.  The 
cc2d2a morphants were a useful model to characterise because the frequency of 
anomalies in sentinel embryos was lower than expected.     
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Following publication of a proposed model of CC2D2A functioning in a network with 
MKS1 and TCTN2 to regulate Hh signalling (Sang et al., 2011), in future work it would 
be interesting to assess the expression of Shh in sentinel mutants and cc2d2a morphants 
using in situ hybridisation.  This may be particularly informative in cc2d2a morphants 
with a wavy notochord, since Hh signalling is required for normal development of the 
notochord (Choi and Harfe, 2011).  
It was disappointing that treatment with Rapamycin had no significant impact on 
reducing the ciliopathy phenotypes in sentinel mutants.  This may be because the 
overall frequency of aberrant phenotypes was low in sentinel mutants and it may have 
been worthwhile repeating the Rapamycin therapy experiment in cc2d2a morphants.  Or 
perhaps as a positive control, nphp6 morphants should also have been treated, since 
Rapamycin has been reported to effectively reduce the development of pronephric cysts 
in nphp6 morphants (Tobin and Beales, 2008).  However at the time of these 
experiments, results of clinical trials in human patients with cystic kidney disease failed 
to show any beneficial reduction in the volume of cysts (mTOR inhibitors) (Serra et al., 
2010; Walz et al., 2010), thus it seemed appropriate to terminate this avenue of enquiry.  
6.5 Characterisation of nphp6 and mks3 morphants models the severe end of the 
nephronophthisis related ciliopathy spectrum 
To enable future combined gene knockdown studies, nphp6 knockdown was performed 
to characterise a representative model (Sayer et al., 2006).  The development of cysts 
throughout the pronephros and in particular at the cloaca, which was dilated, was 
interesting.  Evaluating any changes in the expression of Shh in nphp6 morphants and 
performing nphp6 knockdown in trilobites would again be informative to evaluate 
signalling pathways.  The observation of a gross reduction in the number of cilia at the 
cloaca in nphp6 morphants with a dilated cloaca reported herein was in contrast to a 
report of no difference in the length nor motility of cilia in the pronephros (Tse, 2012), 
the contrasting findings may relate to genetic pleiotropy.   
Fewer and shorter cilia at KV were identified following nphp6 knockdown herein and 
these results have recently been confirmed (Tse, 2012).  The apparent shortening of cilia 
in KV was functionally relevant as this work shows it was associated with aberrant left-
right body patterning and in particular reversal of cardiac asymmetry.  These findings 
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confirm the rare although real occurrence of cardiac defects particularly situs inversus 
which is seen in some patients with NPHP6 mutations (Baala et al., 2007a).     
The identification of cysts throughout the pronephros and dilatation of the cloaca in 
mks3 morphants was again an interesting observation.  In this work, knockdown of 
ahi1, nphp6 and mks3 have independently been shown to lead to dilatation of the cloaca 
in some embryos.  Although cilia were not studied in the mks3 morphants, in both ahi1 
and nphp6 morphants cilia were shorter or absent.  In future work, studying potential 
aberrant mechanisms of PCP/cloacal development as performed in the nphp4 model 
(Slanchev et al., 2011) may facilitate understanding of the pathogenesis.    
In mks3 morphants in addition to dilatation of the cloaca, gross generalised oedema 
developed in some embryos and in future work utilising this model, it may be prudent to 
assess whether the cloaca was obstructed.  The abnormal development of the notochord 
and tail in mks3 morphants may again reflect changes in Shh activity and could 
similarly be assessed in future experiments. 
6.6 Assessing the interplay between: NPHP6 and CC2D2A; AHI1 and CC2D2A; 
NPHP6 and AHI1. 
A growing body of evidence supports the physical and functional interaction between 
numerous ciliary proteins (Davis and Katsanis, 2012; Sang et al., 2011), which when 
disturbed lead to a variety of cystic kidney disease related ciliopathies.  Whilst 
mutations in NPHP6 (Baala et al., 2007a; Leitch et al., 2008; Sayer et al., 2006) and 
AHI1 (Utsch et al., 2006) are independently capable of causing disease, they are also 
acknowledged as genetic modifiers (Louie et al., 2010; Tory et al., 2007).  The extent to 
which assessing the mutation load in patients with ciliopathies is evaluated is variable 
and may be limited by both the cost and success of screening for mutations.  Recently, 
an attempt to tackle this by ascertaining causal mutations in a large cohort of patients 
with NPHP related ciliopathies using DNA pooling and next generation sequencing 
failed to identify any mutations (in 18 known genes) in 75% of patients (Otto et al., 
2011).  This suggests that many unidentified genes are yet to be discovered or the 
screening technique was not sufficiently sensitive to detect mutations.   
A key interest for many scientists and clinicians is to try to explain the variable clinical 
phenotype to help counsel patients and direct investigations appropriately.  In this work, 
two methods of assessing a potential association between genes were performed.  The 
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first involved recapitulating the knockdown of nphp6 in sentinel mutants which led to a 
synergistic increase in the frequency of all phenotypes, suggesting an interaction 
between the genes NPHP6 and CC2D2A.  The protein products of these genes are 
expressed in the basal body and it has been proposed that they play a role in maintaining 
the cilium and downstream Hh signalling respectively (Sang et al., 2011).  More 
recently, oligogenicity has been described in patients with MKS as a consequence of 
heterozygous missense changes in CC2D2A and NPHP6 (Hopp et al., 2011).     
Although to date, no triallelism or oligogenic inheritance has been described for AHI1 
and CC2D2A in patients, both Jouberin (Eley et al., 2008) and CC2D2A (Gorden et al., 
2008) are expressed in the basal body, therefore it seemed a reasonable hypothesis that 
they may interact.  Additionally, Jouberin has been described as a bridging protein, 
linking CC2D2A with other proteins in the ‘NPHP-JBTS-MKS’ protein network (Sang 
et al., 2011).  Following ahi1 knockdown in sentinel mutants a synergistic increase in 
several phenotypes was observed including pronephric cysts, hydrocephalus and 
abnormal eye development.  The abnormal eye development was interesting since to 
date, mutations in neither AHI1 nor CC2D2A have been identified as causes of 
blindness, however mutations in either gene seem to upregulate retinal degeneration 
(Louie et al., 2010), perhaps because of an interaction with Rab8a (Bachmann-Gagescu 
et al., 2011; Hsiao et al., 2009).  The apparent genetic interaction between AHI1 and 
CC2D2A reported herein was also demonstrated using combined MO knockdown in 
WT zebrafish and following co-injection of p53 to exclude non-specific, ‘off-target’ 
effects.  The fact that AHI1 and CC2D2A mutations have not yet been reported in 
patients more likely reflects a failure to identify the mutations rather than their lack of 
co-existence, this argument is supported by recall of occasions when only a single 
heterozygous mutation has been identified in a patient with NPHP, JBTS or MKS 
recessive ciliopathies (Otto et al., 2011). 
Compound heterozygous NPHP6 and heterozygous AHI1 mutations have on rare 
occasions been reported in patients with JBTS (Tory et al., 2007).  Furthermore both 
NPHP6 and Jouberin have been found to have similar, however independent expression 
patterns in the human kidney, brain and retina (Cheng et al., 2012).  Since NPHP6 and 
AHI1 are frequent causes of particularly developmental brain and retinal anomalies in 
patients, oligogenicity was evaluated by performing combined MO knockdown in 
zebrafish embryos.  This work demonstrated a synergistic increase in the frequency of 
 ________________________________________________________ Chapter 6:  Concluding Discussion 
314 
 
ciliopathy phenotypes including pronephric cysts, hydrocephalus and abnormal eye 
development, confirming a genetic interaction. 
Unfortunately despite the synergy identified, the combined gene interference data 
presented herein does not identify a clear association between the increase in a specific 
phenotype and a particular combination of genotypes.  Understanding this clinical 
heterogeneity remains a challenge, however advances in the knowledge of the function 
and interactions of proteins in the ciliary network is likely to help resolve this clinically 
important issue.  With regards to AHI1 and NPHP6, future work to study interactions 
could include evaluating alterations in expression of ahi1 by in situ hybridisation 
following knockdown of nphp6.  Additionally to evaluate downstream signalling 
pathways such as Hh signalling and PCP, in situ hybridisation using Shh and vangl2 
probes could be used to assess expression in morphants following combined knockdown 
of ahi1 and nphp6.    
6.7 Cystic kidney disease related ciliopathies beyond 2012 
Although the nature of genetic mutations often suggest a clue to the clinical phenotypes 
which patients with NPHP, JBTS and MKS related ciliopathies may develop, this 
involves a huge leap within the hierarchy of systems.  The widespread availability of 
detailed genetic knowledge will inevitably be limited by cost and methods to perform 
reliable targeted genomic sequencing.  Further understanding the various steps involved 
from molecular communication within signalling pathways, which appears to be 
instigated around cellular organelles such as the cilium, to the interplay between 
proteins which leads to the development of renal, cerebral and retinal disease of varying 
severity in patients, will require ongoing collaboration between researchers from 
different disciplines across the field.  Whilst the cilium on the apical cell surface is 
currently and for understandable reasons, receiving much attention, it is worth 
considering it analogous to an iceberg, with a significant proportion of its functionbelow 
the surface.  Perhaps maintaining a degree of focus on the intracellular activity and 
basolateral cell surface is prudent, as these are almost certainly significantly involved. 
In this work, the field of cystic kidney disease related ciliopathies has been thoughtfully 
and carefully studied.  In line with the advancing developments of science generated 
throughout the genomic era, there has been the discovery of several causal genes 
including detailed characterisation by whole exome sequencing (Hong and Oh, 2010).  
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Whilst one acknowledges that information can be very powerful, an essential 
component or tool of this weaponry is to understand the meaning and relevance of this 
information.  Working through this large volume of information is a current challenge 
for the scientific community and to facilitate this computerised tools are being 
developed (Hong and Oh, 2010).  Indeed, it would be anticipated that with the 
increasing availability of genetic information and the evolving field of personalised 
medicine, that explanations and appropriate interventions will continue to be sought 
(Hong and Oh, 2010).  There is little doubt that improved understanding of the variable 
pathophysiology and identification of treatments, likely combination therapies, will 
involve further understanding of proteomics.   
In terms of the future study of cystic kidney disease related ciliopathies, it would seem 
prudent to build on the acquired genetic knowledge, however accept it is a variant 
which will in part influence the multifaceted pathophysiology of these clinically 
heterogeneous conditions.  It will be exciting to continue to be involved in the evolution 
of this field and hopefully through teamwork contribute to improvements in patient 
centred health care.  
6.8 If researching the topic of Zebrafish models of cystic kidney disease related 
ciliopathies now…  
If this research were to be conducted now, the aim would be to focus more on the cystic 
kidney phenotype and understanding the pathogenesis.  During the discussion of each 
chapter throughout this thesis further relevant experiments that ideally would be 
performed have been suggested in relation to the results presented.   
In terms of methods, the zebrafish would continue to be utilised as a model, however 
three additional experiments would be performed when assessing each gene.  The first 
would involve live microscopy imaging of KV following MO injection to assess cilia 
motility when present and the effect on fluid flow.  Secondly, an assessment of kidney 
function would be performed on embryos at three days following MO knockdown by 
injecting a rhodamine labelled dextran into the pericardium and assessing for changes in 
the intensity of fluorescence, as a marker of renal clearance.  Finally, further in situ 
hybridisation experiments would be performed to evaluate: alterations in the expression 
of a gene following MO knockdown of another gene for example in situ using an ahi1 
riboprobe following nphp6 MO knockdown; double in situ using an ahi1 and a nphp6 
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riboprobe to look for coexpression which may provide further evidence of a genetic 
interaction.  For all of these experiments, essential controls would include uninjected 
embryos and embryos injected with a standard negative control MO. 
In addition to zebrafish experiments, it would be interesting to perform cell culture 
work to further assess genetic interactions and evaluate changes to cilia.  This would 
include co-immunoprecipitation experiments to assess for an interaction between: 
cc2d2a and nephrocystin-6; cc2d2a and jouberin; jouberin and nephrocystin-6.  Finally 
siRNA knockdown of individual genes and gene combinations could be performed 
followed by immunofluorescence to study the effects on cell structure (tight junctions, 
adherens junctions) and ciliogenesis.  
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Appendices 
Appendix A: E2 Media modified from (C Nusslein-Volhard, 2002). 
To make a 1L solution: 5ml of E2A media, 1ml E2B media, 1ml E2C media added to 
double distilled water (ddH20).  Ensure pH is approximately 7.25 (7.0-7.5).  Store at 
room temperature. 
 
E2A media – To make a 1L solution, dissolve the following reagants in ddH20. 
87.5g NaCl, 3.75g KCl, 12g MgSO4, 2.06g KH2PO4, 0.69g Na2HPO4   
Autoclave, then store at 4C. 
 
E2B media – Dissolve 5.5g CaCl2 in 100ml ddH20. 
Autoclave, then aliquot into 1ml screw top eppendorfs, store at -20C. 
 
E2C media – Dissolve 3g NaHCO3 in 100ml ddH20.    
Autoclave, then aliquot into 1ml screw top eppendorfs, store at -20C. 
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Appendix B: Zebrafish experiment mortality data sheet 
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Appendix C: Zebrafish experiment phenotype data sheet  
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Appendix D: Zebrafish cardiac looping data sheet 
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Appendix E: Preparing 1xTAE buffer for agarose gel electrophoresis 
To make a 1L solution of 1xTAE buffer add 20ml of 50xTAE stock to 980ml of ddH20. 
 
Make 50x TAE: 
To make a 1L solution, dissolve 242g Trizma Base (T1503, Sigma) in 57.1ml glacial 
acetic acid (A/0360/PB117, Fisher Scientific), add 100ml 0.5M EDTA (pH 8.0, 
BPE118-500, Fisher Scientific).  Add ddH2O to make a total volume of 1 litre. 
 
Make a 0.5M EDTA solution: 
Dissolve 186.1g EDTA in 800ml ddH2O, adjust pH to 8.0 with NaOH.  Add ddH2O to 
make a total volume of 1 litre.  
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Appendix F: Simms RJ., A.M. Hynes, L Eley, D Inglis, B Chaudhry, H.R. Dawe, J.A. 
Sayer. 2012. Modelling a ciliopathy: Ahi1 knockdown in model systems reveals an 
essential role in brain, retinal and renal development. Cell Mol Life Sci., 69, 993-
1009. 
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Appendix G: Adams M, R.J, Simms, Z Abdelhamed, H.R. Dawe, K Szymanska, 
C.V Logan, G Wheway, E Pitt, K Gull, M.A. Knowles, E Blair, S.H. Cross, J.A 
Sayer, C.A. Johnson. 22012.  A meckelin-filamin A interaction mediates 
ciliogenesis.  Hum Mol Genet., 21, 1272-86. 
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Supporting Information: figure legends 
Figure S1: Meckelin protein sequence and nucleotide sequence of the FLNA 
encoding the meckelin-interacting region 
A. Meckelin amino acid sequence predicted from transcript NM_153704.5 showing 
the indicated domains, two epitopes for rabbit polyclonal antibodies (‘Nt Ab’ and 
‘Ct Ab’, see Figure 1A), and the location of the MKS pathogenic mutation 
p.919delF (red). The C-terminal intracellular domain, including the coiled-coil 
domain (underlined) is shown in grey shading. 
B. Filamin A (FLNA) amino acid sequence for the meckelin interacting domain (6531-
7017 nt) from transcript NM_001456.3, encoding amino acids 2171-2339 between 
the hinge and dimerisation domain of filamin A encompassing FLNA repeats 20 to 
22 (see Figure 1D). 
Figure S2: Characterization of anti-meckelin antibodies, HA-vectors and non-
ciliary effects of meckelin knockdown 
A. Characterization of anti-meckelin antibodies against either the N-terminus (α-
meckelin Nt, left panel) or the C-terminus (α-meckelin Ct, right panel) using 
immunoblotting (IB) of endogenous protein isoforms. The full-length of meckelin 
is 110 kDa, with the sizes of shorter protein species indicated. 
B. Transfection and expression of full-length wild-type HA-meckelin (size 110 kDa) 
followed by immunoblotting (IB) with antibodies against either HA (left panel) or 
meckelin Ct (right panel). 
C. Immunostaining and confocal microscopy of ciliated IMCD3 cells for meckelin 
(green; Ct Ab) and filamin A (red). A 2m baso-lateral projection is shown in the 
upper panels demonstrating a vesicular-like meckelin distribution (arrowhead) 
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colocalisation with baso-lateral filamin A. Lower panels show immunostaining for 
meckelin (green) and actin (red). A 2m basal projection shows meckelin ‘cables’ 
(arrows) with an enlarged section (orange border) showing colocalisation with the 
basal actin cytoskeleton. Scale bar = 5 mm. 
D. Western immunoblots (IB) with either an anti-meckelin Ct antibody or anti-β-actin 
(a loading control) to show loss of full-length meckelin A expression following 
transfection of mouse IMCD3 cells with Mks3 siRNA duplexes but not scrambled 
(scr.) siRNA control. 
E. Co-immunocytostaining and confocal microscopy of IMCD3 confluent epithelial 
monolayers transfected with scrambled (scr.) or Mks3 siRNAs and stained for actin 
(green) and DAPI (blue), showing gaps in the confluent cell monolayer indicating 
disruption of cell-cell contacts (*),and loss of baso-lateral actin (arrow). A 3m 
baso-lateral projection is shown. Scale bar = 5 mm 
F. Co-immunocytostaining and confocal microscopy of IMCD3 confluent epithelial 
monolayers transfected with scrambled (scr.) or Mks3 siRNAs and stained for actin 
(green) and acetylated (Ac) α-tubulin, showing disruption of cell-cell contacts (*), 
loss of basal actin and disruption of baso-lateral actin, concurrent with cilia loss. A 
single confocal x-y planar projection (plan. projn.) and x-z side projection are 
shown for cells treated with scrambled siRNA. Scale bar = 5 mm 
Figure S3: Actin cytoskeleton and filamin localization in FLNA-mutated 
fibroblasts, loss of filamin A expression following siRNA knockdown and 
distribution of filamin B in IMCD3 cells 
A. Co-immunostaining and confocal microscopy of serum-starved immortalized 
dermal fibroblasts (fibs) from a female patient with periventricular heterotopia 
(PVH) carrying the FLNA frameshift mutation c.1587delG p.K529fs. Stainings are 
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for filamin A (green), filamin B (red) and actin (blue), showing apparent mosaic 
loss of expression of filamin A due to random X-inactivation and no apparent 
disruption of the actin cytoskeleton. Scale bar = 10 mm. 
B. Western immunoblots (IB) with either an anti-filamin A monoclonal antibody or 
anti-histone H3 (a loading control) to show loss of filamin A expression following 
transfection of mouse IMCD3 cells with two separate filamin A (Flna) siRNA 
duplexes (dup.) but not scrambled (scr.) siRNA control. 
C. Immunostaining and confocal microscopy of ciliated IMCD3 cells for MKS1 (basal 
body marker; green) and filamin B (red). A 2m x-y apical projection is shown in 
the upper panels demonstrating localisation of filamin at the basal body (arrow; 
enlarged inset). Lower panels show the mid cell distribution of filamin B at the 
baso-lateral and basal surfaces. A x-z side projection also demonstrates filamin B 
localization tto the basal body (arrow). Scale bar = 5 mm. 
Figure S4: Control experiments for Wnt signalling assays in MKS3-mutated 
fibroblasts 
The TOP Flash reporter assay was used to measure levels of activated β-catenin and 
hence canonical Wnt signalling in normal immortalized control dermal fibroblasts 
(control fibs, blue bars) and MKS3-mutated dermal fibroblasts (MKS3 fibs, red bars; see 
Figure 4E). Activity is expressed as ratios of transfected TOP Flash or negative control 
FOP Flash luciferase reporter constructs expression, normalized for loading by 
measurement of a Renilla construct expression. The responses are shown to 0.5 x L cell 
control conditioned media (control), and either 0.5 x or 1.0 x conditioned media 
containing expressed Wnt3A or Wnt5A. Values shown are means of two independent 
replicates. 
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Figure S5: Meckelin is required for development of notochord, eye, ear and kidney 
in zebrafish embryos following morpholino oligonucleotide knockdown of mks3. 
A. Schematic representation of Danio rerio meckelin protein with predicted 
transmembrane domains (TM) marked and length 982 amino acids (aa). The mks3 
splice-site morpholino oligonucleotide (MO) was directed towards the exon-intron 
site of exon 4 of the Danio rerio mks3 gene. Following RT-PCR of mks3 in MO-
injected embryos, direct sequencing confirmed insertion of an 165bp intronic 
sequence after exon 4 (data not shown). This leads to an alternative reading frame 
after amino acid 125, a premature stop codon reached after amino acid 144, and a 
predicted truncated protein. 
B. RT-PCR of mRNA from wild-type and mks3 MO-injected embryos at 48 hpf 
demonstrates a splicing defect, with inclusion of intronic sequence into the mRNA 
(arrow), confirmed by direct sequencing (data not shown). 
C. Examples of minor disruption of myotome and fin layers, representative of human 
meningoceles (panels a to c, indicated by arrows), following mks3 MO injection 
and seen in embryos at 72 hpf. 
D. Examples of severe notochord defects (panels a to c) following mks3 MO injection 
and seen in embryos at 72 hpf. 
E. Abnormal eye formation with unilateral micropthalmia (arrow) 
F. Single otic placode (arrow) 
G. Detail of severe notochord defects (arrow) 
H. Renal cyst formation (arrow) 
I. Axial section through Zebrafish controls (a & c) and following mks3 MO injection 
(b & d). Brain sections are shown in panels a & b with the arrow highlighting 
encephalocele. Glomerulus and pronephrotic duct shown in panels c & d with 
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arrowheads showing moderately dilated pronephrotic ducts in mks3 MO. The black 
pigmented tissue is neural crest cells forming part of the ventral stripe. 
J.  Percentage incidence and range of morphant phenotypes at 72hpf following mks3 
MO injection with 3.0 and 1.5 ng doses. Numbers of embryos were 254 for 3ng and 
438 for 1.5ng. 
K. Coinjection of 100 pg of human MKS3 mRNA (n=132) almost completely rescues 
the morphant phenotype of the mks3 MO (3 ng dose; n=254). Injection of MKS3 
mRNA alone (n=168) has minimal effect on embryo phenotype. The y-axis 
represents the percentage of embryos displaying severe (black), moderate (dark 
grey), mild (light grey) and normal (white) phenotypes. 
L. Dose-dependant effect on mortality at 24 hpf seen with increasing dose (0.04 to 4 
ng) of mks3 MO. 
Figure S6: Developmental defects in zebrafish embryos following morpholino 
oligonucleotide knockdown of flna. 
A. Example of otic placode defects (arrowhead) seen with flna MO injection in 
embryos at 72hpf. 
B. otic placode defect as in A) 
C. Example of severe eye defects (arrowhead) seen with flna MO injection in embryos 
at 72hpf. 
D. severe eye defect as in C) 
Frequency and range of phenotypes at 72 hpf following mks3, flna MO and combination 
injection. Numbers of embryos were 438 for mks3, 129 for flna and 50 for the co-
injection. Combining low dose mks3 MO (1.5ng) and low dose flna MO (0.04ng) 
increased the frequency of tail defects, notochord abnormalities, hydrocephalus, renal 
cysts and otic placode/eye defects. Meningoceole-like abnormalities of the notochord 
were specific to mks3 MO treatment.  
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A 
Meckelin amino acid sequence from transcript NM_153704.5 
this represents the longest transcript and encodes the meckelin isoform 1 protein 
NP_714915.3 
MATRGGAGVAMAVWSLLSARAVTAFLLLFLPRFLQAQTFSFPFQQPEKCDNNQYFDI
SALSCVPCGANQRQDARGTSCVCLPGFQMISNNGGPAIICKKCPENMKGVTEDGWN
CISCPSDLTAEGKCHCPIGHILVERDINGTLLSQATCELCDGNENSFMVVNALGDRCV
RCEPTFVNTSRSCACSEPNILTGGLCFSSTGNFPLRRISAARYGEVGMSLTSEWFAKY
LQSSAAACWVYANLTSCQALGNMCVMNMNSYDFATFDACGLFQFIFENTAGLSTVH
SISFWRQNLPWLFYGDQLGLAPQVLSSTSLPTNFSFKGENQNTKLKFVAASYDIRGNF
LKWQTLEGGVLQLCPDTETRLNAAYSFGTTYQQNCEIPISKILIDFPTPIFYDVYLEYTD
ENQHQYILAVPVLNLNLQHNKIFVNQDSNSGKWLLTRRIFLVDAVSGRENDLGTQPRV
IRVATQISLSVHLVPNTINGNIYPPLITIAYSDIDIKDANSQSVKVSFSVTYEMDHGEAHV
QTDIALGVLGGLAVLASLLKTAGWKRRIGSPMIDLQTVVKFLVYYAGDLANVFFIITVGT
GLYWLIFFKAQKSVSVLLPMPIQEERFVTYVGCAFALKALQFLHKLISQITIDVFFIDWE
RPKGKVLKAVEGEGGVRSATVPVSIWRTYFVANEWNEIQTVRKINSLFQVLTVLFFLE
VVGFKNLALMDSSSSLSRNPPSYIAPYSCILRYAVSAALWLAIGIIQVVFFAVFYERFIED
KIRQFVDLCSMSNISVFLLSHKCFGYYIHGRSVHGHADTNMEEMNMNLKREAENLCS
QRGLVPNTDGQTFEIAISNQMRQHYDRIHETLIRKNGPARLLSSSASTFEQSIKAYHM 
MNKFLGSFIDHVHKEMDYFIKDKLLLERILGMEFMEPMEKSIFYNDEGYSFSSVLYYGN
EATLLIFDLLFFCVVDLACQNFILASFLTYLQQEIFRYIRNTVGQKNLASKTLVDQRFLI 
 
Meckelin motifs: 
 
signal peptide (predicted by SignalP--HMM) 
 
transmembrane domains (predicted by TMHMM v2) 
 
transmembrane domains (predicted by HMMTOP v2.0) 
 
coiled coil domain A798 to R820 (predicted by COILS) 
 
meckelin intracellular C--terminal domain D761 to Y925, used as the bait for the 
yeast two hybrid assay 
 
peptide for antibody Nt Ab 
 
peptide for antibody Ct Ab 
 
F MKS3 mutation (p.919delF) 
 
B 
Filamin A (FLNA) amino acid sequence for the meckelin interacting domain 
(6531--7017 nt) from transcript NM_001456.3 
this represents the predominant transcript and encodes the filamin A isoform 1 protein 
NP_001447 
 
TSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGE
GGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGS
CGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLK 
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Figure 3.1 AHI1 gene transcript and partial protein product (Jouberin) 
structure in humans and zebrafish  
(A) AHI1 transcript in humans (OTTHUMT00000391948) and schematic 
representation of encoded protein product, Jouberin (B).  (C) ahi1 transcript in 
zebrafish (OTTDART00000049821) and schematic representation of encoded 
protein product, Jouberin (D).  aa, amino acids; CC, coiled coil; Ch., 
chromosome; WD40 repeats; SH3, Src homology domain.  
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Figure 3.2 Evolutionary conservation of Ahi1 (Jouberin) in humans, mice 
and zebrafish   
Jouberin peptide sequence alignment in humans (homo sapiens, 
OTTHUMP00000234456), mice (mus musculus, ENSMUSP00000101164) and 
zebrafish (danio rerio, OTTDARP00000039088).  Conservation of amino acid 
alignment (red font).  
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Figure 3.3 Expression of ahi1 during zebrafish embryogenesis    
Lateral (A, C, E, G) and dorsal (B, D, F, H) images of whole-mount in situ hybridisation using an ahi1 antisense riboprobe on golden, wild type 
embryos at 8 somites (8s) (A, B), 24hpf (C, D), 48hpf (E, F) and 72hpf (G, H).  ahi1 is expressed at: 8s in the eye (black arrowhead, A), the 
notochord and in Kupffer's vesicle (white arrow, A, B); 24hpf in the midbrain, hindbrain (arrows, C, D) and retina (arrowhead, C); 48hpf in the 
retina, hypothalamus (arrow, E, F) and inner ear; 72hpf in the inner ear (arrowhead, G), olfactory bulbs (arrowheads, H), and specific retinal 
layers (GCL and RPE, H).  GCL, ganglion cell layer; hpf, hours post fertilisation; RPE, retinal pigmented epithelium. 
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Figure 3.4 Expression of ahi1 in zebrafish pronephros   
Transverse section at the level of the medial tubules of the pronephros 
following whole-mount in situ hybridisation using an ahi1 antisense riboprobe 
on golden, wild type embryos at 48 hpf.  In both images, the arrows 
demonstrate ahi1 expression in the pronephros.  Images were taken with a 20x 
(A) and 40x (B) objective lens.  Scale bars are 20µm. n, notochord; s, somites.  
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Figure 3.5 In situ hybridisation controls for ahi1 antisense riboprobe during zebrafish embryogenesis 
Lateral views of whole-mount in situ hybridisation using ahi1 sense riboprobe (A, C, E, G) and no probe (B, D, F, H) on golden, 
wild type embryos at 8 somites (8s) (A, B), 24hpf (C, D), 48hpf (E, F) and 72hpf (G, H).  hpf, hours post fertilisation. 
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Figure 3.6 In situ hybridisation positive controls for ahi1 antisense riboprobe during zebrafish embryogenesis   
Lateral views of whole-mount in situ hybridisation using shh antisense (A, C, E, G) and cmcl2 antisense (B, D, F, H) riboprobes 
on golden, wild type embryos at 8 somites (8s) (A, B), 24hpf (C, D), 48hpf (E, F) and 72hpf (G).  shh is expressed in the 
notochord (A) at the 8s stage; in the eye and floorplate at 24hpf (C); additionally in the telencephalon, diencephalon, hypothalamus 
and pharyngeal arches at 48hpf (E) and 72hpf (G).  cmcl2 expression is not detectable at the 8s stage (B), however at 24hpf (D) and 
48hpf (F) it is evident specifically in the single ventricle.  cmcl2, cardiac myosin light chain 2; hpf, hours post fertilisation; shh, 
sonic hedgehog. 
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Figure 3.7 ahi1 morpholino oligonucleotide design 
(A) Schematic representation of zebrafish ahi1showing target sites of 
translation (ATG) and splice (ahi1iex8) blocking morpholino oligonucleotides 
(MO). (B) Schematic representation of the effect of the splice blocking MO 
designed to target exon 8, leading to an inframe deletion and loss of 3 WD40 
repeats from the protein product, Jouberin (C).  
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Figure 3.8 Mortality at 24hpf following MO injection 
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) 
and standard error of the mean (where appropriate) in zebrafish embryos injected 
with morpholino oligonucleotide (MO) compared to matched uninjected wild 
type (WT) controls.  (A) ahi1 splice (Sp) MO induces a dose dependent effect on 
mortality.  (B) ahi1 translation (ATG) blocking MO has a more variable effect 
on mortality. (C) Injection of a standard control (Std Con) MO induced no 
significant difference (p=0.92, unpaired t-test) in mortality at 24hpf compared to 
uninjected WT controls. 
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Figure 3.9 Phenotype following ahi1 MO knockdown at 72 hpf 
Lateral views show wild type uninjected (A) zebrafish embryos and those following injection with a standard negative control MO (Std Con 
MO, B) were morphologically normal.  Injection of ahi1 splice (Sp, C, D) and translation (ATG, E, F) blocking MOs leads to curved body 
axis, hydrocephalus (arrows), cardiac oedema (*), pronephric cysts and altered number of otoliths (single in F (arrowhead). hpf, hours post 
fertilisation; MO, morpholino oligonucleotide. 
Figure 3.10 ahi1 knockdown induces pronephric cysts in zebrafish embryos 
Light and fluorescent microscopy images of pronephric cysts in golden (A, C-E) and claudin-b:lyn-gfp transgenic (B, F) zebrafish embryos at 
72hpf.  Lateral views of wild type, uninjected embryos were morphologically normal (A, B).  1-4ng of ahi1 splice blocking MO induces 
proximal (lateral and dorsal views, arrowed, C, D) and distal (at the cloaca, arrowed E, F) pronephric cysts.  MO=morpholino oligonucleotide  
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Figure 3.11 ahi1 knockdown induces cystic dilatation, cloacal dilatation and obstruction in zebrafish embryos 
Light microscopy images of distal pronephric cysts (arrows) leading to cloacal obstruction in golden ahi1 morphant (ahi1 Sp MO) embryo at 
72hpf (B), compared to uninjected wild type (WT) control (A).  Resin histology 5µm sections through the pronephros (arrows) in embryos at 
72hpf, stained with methylene blue-basic fuchsin stain.  Images taken with a 40x objective lens at the level of the posterior pronephric tubules 
(arrows, C-D) and the cloaca (E-F).  In ahi1 morphants, the posterior tubules are modestly dilated (D, diameter 5μm), compared to WT controls 
(C, diameter 3μm).  This pronephric dilatation becomes more pronounced in ahi1 morphants at the level of the cloaca (F, diameter 10μm), 
compared to WT controls (E, diameter 2μm).  Scale bar = 10μm.  Fluorescent images of the cloaca (G,H) using the claudinb:Lyn-GFP 
transgenic line, taken with a 20x objective. ahi1 morphants have cystic dilatation of the cloaca (H, arrow), compared to WT controls (G).  Scale 
bar = 50μm.  
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Figure 3.12 ahi1 knockdown induces coloboma formation and retinal dystrophy in zebrafish embryos 
Light microscopy images comparing the eyes of uninjected wild type (WT) embryos (A, B) and ahi1 morphants (C, D) at 48hpf and 72hpf.  
In ahi1 morphants there is abnormal eye development with coloboma formation (arrowed, C, D).  Resin histology of eyes at 72hpf, sectioned 
at 5-7µm and stained with methylene blue-basic fuchsin stain.  Images taken with a 20x (E, F) and 40x (G, H) objective lens, scale bars = 
20μm.  In WT control embryos (E, G), there is normal retinal lamination (arrowed, E) including formation of the ganglion cell layer (GCL), 
inner nuclear layer (INL) and outer nuclear layer (ONL).  In ahi1 morphants (F, H) there is severe disruption to normal retinal development, 
with failure of discrete retinal layer formation, however, the outer retinal pigmented epithelium (RPE, arrowed in F) remains present.  hpf, 
hours post fertilisation. 
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Figure 3.13 ahi1 knockdown induces hydrocephalus and abnormal brain development in zebrafish embryos 
Light microscopy images demonstrating hydrocephalus (arrowed, B, C) and abnormal hindbrain development in ahi1 morphant zebrafish 
embryos, compared to normal brain development in uninjected wild type (WT) control embryos (A) at 72hpf. Resin histology cross sections 
(5-7μm) through the brain at the level of the otoliths in WT controls (D) and ahi1 morphants (E, F) at 72hpf.  In ahi1 morphants there is 
hydrocephalus (asterisk, E, F) and expanded notochord (midline diameter 52μm in ahi1 morphants, compared to 34μm in WT controls.  
Scale bar = 50μm. hpf, hours post fertilisation; N, notochord. 
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Figure 3.14 ahi1 knockdown induces abnormal ear development with altered number of otoliths in the otic vesicle of 
zebrafish embryos 
Light microscopy lateral (A, C, E, G) and dorsal (B, D, F, H) images of the head of zebrafish embryos focusing on the otic vesicles 
(developmental ear) at 72hpf.  Uninjected wild type (WT) control embryos have 2 otoliths in each otic vesicle (A, B), whilst ahi1 
morphants have either no otoliths and an empty otic vesicle (C, D), a single otolith (E, F), or three otoliths (left otic vesicle G, H).  
hpf, hours post fertilisation.  
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Figure 3.15 Quantification of abnormal phenotypes at 72hpf following injection with ahi1 splice or translation blocking MO 
Data are displayed as mean ± SEM. The percentage frequency of each abnormal phenotype was higher following injection of a lower dose of 
ahi1 splice (Sp) MO (A-C), compared to following injection of an equivalent dose of ahi1 translation (ATG) MO (D-F).  With ahi1 Sp MO 
knockdown, there was a dose dependent effect on the frequency of curly tail, cardiac oedema, hydrocephalus and coloboma (B, C).  Following 
ahi1 ATG MO knockdown, there was a dose dependent effect on the frequency of pronephric cysts, curly tail, cardiac odema and otic defects 
(D-F).  The total number of zebrafish embryos phenotyped at 72hpf following ahi1 Sp MO were 1498 and following ahi1 ATG MO were 458.  
hpf, hours post fertilisation; MO, morpholino oligonucleotide. 
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Figure 3.16 Exclusion of off-target effects and confirmation of specificity of phenotype with ahi1 MO knockdown   
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type (WT) uninjected (A), embryos injected with p53 MO alone (B) and 
embryos injected with mouse Ahi1 mRNA alone (E), were morphologically normal.  Embryos co-injected with p53 MO and ahi1 splice (C) or 
translation blocking (D) MOs continued to develop a morphant phenotype including hydrocephalus (C, (*)), pronephric cysts (D, arrowhead) 
and altered number of otoliths (C, arrow), and excludes the possibility of off-target effects.  Co-injecting mouse ahi1 mRNA with ahi1 splice 
blocking MO rescued embryos to a normal phenotype (F), confirming the specificity of targeted ahi1 MO knockdown.  MO, morpholino 
oligonucleotide. 
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Figure 3.17 Rescue of ahi1 morphant phenotype following co-injection 
with murine Ahi1 mRNA 
(A) Percentage of normal wild type (WT) and abnormal morphant phenotype of 
embryos: uninjected (n=2699); 2ng standard control MO (n=197); 100pg 
murine Ahi1 mRNA (n=117); 2-4ng ahi1 MO (n=517); coinjection of murine 
Ahi1 mRNA and 2-4ng ahi1 MO (n=88).  Rescue to WT phenotype by 
coinjection with 100pg murine Ahi1 mRNA was statistically significant (*, p < 
0.0001, chi-squared test).  (B) Raw quantification of overall rescue from ahi1 
morphant to WT phenotype after co-injection with 100pg murine Ahi1 mRNA 
was statistically significant (*, p < 0.0001, chi-squared test).  (C)  There was a 
statistically significant rescue of ahi1 morphants to the WT phenotype, and 
reduced frequency of anomalies (curly tail, cardiac oedema, hydrocephalus, 
pronephric cysts) after co-injection with murine Ahi1 mRNA (*, p < 0.0001, 
chi-squared test).  Data are % mean ± SEM.  MO, morpholino oligonucleotide.  
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Figure 3.18 Evidence of ahi1 splice MO knockdown by RT-PCR and direct sequencing 
(A) RT-PCR of single embryos at 24, 48 and 72hpf following ahi1 splice MO knockdown reveals a smaller RT-PCR product (white 
arrowhead) compared to uninjected wild type (WT) control embryos.  The normal RT-PCR product of 807bp is maximally reduced in ahi1 
morphants at 48hpf, with recovery at 72hpf.  (B) Direct sequencing of the smaller product (453bp) in ahi1 morphants identifies direct skipping 
of exon 8 and introduction of a premature stop codon.  bp, base pairs; hpf, hours post fertilisation. 
A 
B 
          24hpf                       48hpf                       72hpf 
500bp 
800bp 807bp 
453bp 
 100bp         WT         ahi1           WT         ahi1         WT           ahi1 
C 
Figure 3.18 continued (C) Evidence of ahi1 splice MO knockdown by direct sequencing   
Chromatogram showing good quality of sequencing of smaller ahi1 product at 72hpf.  hpf, hours post fertilisation; MO, morpholino 
oligonucleotide.  
Figure 3.19  The gross morphology of Kupffer's vesicle is preserved in ahi1 MO injected embryos 
Images of uninjected wild type (WT) control (A-C) and ahi1 MO injected (D-F) golden zebrafish embryos at the 8-10 somite stage to illustrate 
Kupffer's vesicle (KV, arrowed).  Both lateral (A, D) and dorsal (B, E) light microscopy images of live embryos at the 8-10 somite stage 
confirm the presence of KV in both WT (A, B) and ahi1 MO injected (D, E) embryos.  A charon in situ hybridisation probe is expressed in the 
region around KV, confirming its presence in both WT controls (C) and ahi1 MO injected embryos (F). MO, morpholino oligonucleotides.   
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Figure 3.20 Loss of cilia from Kupffer's vesicle in ahi1 MO injected embryos 
Confocal microscopy images of cldnb:Lyn-GFP zebrafish embryos following fixation at the 8-10 somite stage and fluorescent 
immunostaining using anti-acetylated tubulin (AT, red) to study cilia in Kupffer's vesicle (KV).  Overlay images using 20x objective (KV 
arrowed, A, E, scale bar = 50µm ) and higher magnification (zoom of 3) showing individual (B, C, F, G, scale bars = 20µm) and overlay (D, 
H, scale bars = 20µm) images.  Uninjected wild type (WT, A-D) control embryos show cldnb:Lyn-GFP expression in an organised pattern at 
epithelial cell-cell junctions within KV (B) and apical cilia (red, C) extending from cells lining KV.  ahi1 MO injected embryos (E-H) have 
disorganised expression of cldnb:Lyn-GFP (F) and loss of cilia (G) from KV.  MO, morpholino oligonucleotide.  
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Figure 3.21 Cilia remain present in Kupffer's vesicle in Standard Control MO injected embryos and some ahi1 MO injected embryos 
Confocal microscopy images of cldnb:Lyn-GFP zebrafish embryos following fixation at the 8-10 somite stage and double fluorescent 
immunostaining using anti-acetylated tubulin (AT, red) and pericentrin (PC, green) to study cilia and centrosomes respectively in Kupffer's 
vesicle (KV).  Images are standard control MO injected (Std Con, A-C), ahi1 MO injected (D-F) and uninjected wild type (WT, G, H) for 
comparison.  Individual green channel images (A, D) fail to show discrete centrosome staining, KV is represented as a dark lumen.  Individual 
red channel images (B, E, G) show staining of cilia at KV in Std Con (B), some ahi1 (E) MO injected embryos and WT (G).  Overlay 
fluorescent images (C, F, H) are shown.  All images were taken using a 20x objective and zoom of 3, scale bars = 20µm. GFP, green 
fluorescent protein; MO, morpholino oligonucleotide. 
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Figure 3.22  Variable spectrum of disruption to the development of Kupffer's Vesicle in ahi1 MO injected zebrafish 
Confocal microscopy images of golden zebrafish embryos injected with ahi1 MO following fixation at the 8-10 somite stage and 
double fluorescent immunostaining using atypical protein kinase C (aPKC, green, A, D) antibody to label the apical membrane of KV 
cells and anti-acetylated tubulin (AT,red, B, E) antibody to label cilia.  Whilst the development of KV appears normal in some ahi1 
MO-injected embryos (A-C), in others there is marked disruption of the KV (white arrow, D), with reduction in the number of cilia 
(white arrow, E).  Images were taken with a 20x objective and zoom of 3.  Scale bars = 20 µm.  MO, morpholino oligonucleotide.    
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Figure 3.23 Analysis of cilia in Kupffer's vesicle of ahi1 MO injected 
embryos 
(A) Quantification of KV phenotype, whether ciliated or not, as determined by 
confocal microscopy of embryos fixed at 8-10 somite stage and labelled with 
anti-acetylated tubulin antibody to detect cilia.  ahi1 MO injected embryos 
(n=32) had a statistically significant reduction in the number of embryos with 
cilia in KV (*, p < 0.0001 chi-squared test), compared to uninjected wild type 
(WT) control embryos (n=35) and embryos injected with a standard control 
(Std Con) MO (n=5).  (B)  Stacked bar chart showing the percentage reduction 
in KV with cilia in ahi1 morphants, compared to uninjected and Std Con MO 
injected embryos.  (C) Data are shown as mean ± SEM of length of cilia in in 
KV.  Cilia in KV were significantly shorter, when present, in ahi1 MO injected 
embryos (n=2, 3.50± 0.50µm), compared to uninjected WT controls (n=6, 
5.68± 0.25µm) (*, p=0.0057, unpaired t-test).  Simple neurite tracer (Fiji 
software) was used to measure the length of cilia from confocal z-stack images 
of embryos labelled with anti-acetylated tubulin antibody.   Approximately 20 
cilia in KV were measured per embryo.  MO, morpholino oligonucleotide.  
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Figure 3.24  Defects in heart laterality after ahi1 knockdown in cmcl2-GFP 
zebrafish embryos 
Paired light and fluorescent microscopy ventral images of cardiac myosin light 
chain 2 (cmcl2-GFP) zebrafish embryos at 56 hours post fertilisation (hpf) to 
assess cardiac looping.  The normal rightward looping (D-looping) of the 
zebrafish heart tube leads to positioning of the single ventricle (V) to the right of 
the single atrium (A) as seen in uninjected wild type (WT) control embryos (A, 
B).  In contrast, in ahi1 morphant embryos there is either no looping of the heart 
tube (C, D) or a reversal of the normal pattern with leftward looping (L-looping, 
E , F).     
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Figure 3.25 Analysis of cardiac looping reveals laterality defects in ahi1 MO 
injected embryos 
(A) Quantification of orientation of cardiac looping at 56hpf in cardiac myosin 
light chain 2 (cmcl2-GFP) embryos.  Normal looping is to the right (D-looping), 
alternatives are no looping or looping to the left.  There is a significant reduction 
in frequency of normal cardiac D-looping in ahi1 MO injected embryos (n=221) 
(*, p < 0.0001, chi squared test), compared to uninjected wild type (WT) 
controls (n=145) and embryos injected with a  standard control (Std Con) MO 
(n=39).  (B) Stacked bar chart showing the percentage frequency of each cardiac 
looping orientation in each experimental group (D-loop, white; no loop, 
checked; L-loop, black).  hpf, hours post fertilisation; MO, morpholino 
oligonucleotide.  
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Figure 3.26 Variable spectrum of disruption to cilia at the cloaca in ahi1 morphant zebrafish embryos 
Confocal microscopy images of claudinb:Lyn GFP zebrafish embryos fixed at 72hpf and immunostained with anti-acetylated tubulin antibody 
(AT, red, A-C) to identify cilia.  Uninjected wild type controls (WT, A, B) have cilia (arrows, A) lining the pronephros which meets at the 
cloaca (B).  In ahi1 morphants, the pronephric ducts are dilated at the cloaca (star, D, F), with variable preservation of cilia  (enlarged image, 
arrows, C) or complete absence of cilia (E).  Images were taken with a 20x objective and zoom of 3.  Scale bars = 50 μm.   
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Figure 3.27 Analysis of cloaca for dilatation and cilia in ahi1 MO injected 
zebrafish embryos 
(A) Quantification of cloaca phenotype in claudinb:Lyn GFP zebrafish embryos 
at 72 hours post fertilisation (hpf) reveals that there was a statistically significant 
difference between ahi1 morphants, which mostly have a dilated cloaca (n=30), 
compared to the normal apposed appearance of the cloaca in uninjected wild 
type (WT) controls (n=48, *, p < 0.0001 chi-squared test).  (B) Stacked bar chart 
showing the percentage difference in the cloaca phenotype between ahi1 
morphants and WT zebrafish embryos.  (C) Cilia were mainly absent from the 
cloaca in ahi1 morphant (n=7) zebrafish embryos compared to WT controls 
(n=9, *, p < 0.0003 chi-squared test). 
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Figure 4.1 CC2D2A gene transcript and partial protein product structure 
in humans and zebrafish 
 (A) CC2D2A gene transcript in humans (OTTHUMT00000359906) and 
schematic representation of encoded protein product, coiled coil domain 
containing protein 2A (CC2D2A), with 3 coiled-coil domains and 1 C2 
domain, consisting of 1620 amino acids (OTTHUMP00000217873) (B).  (C) 
cc2d2a transcript in zebrafish (ENDSDART00000126768) and schematic 
representation of encoded protein product, cc2d2a 
(ENDSDARP00000107405) (D).  (E) Schematic representation of zebrafish 
cc2d2a showing the nonsense mutation, a stop codon present in exon 14.   aa, 
amino acids; CC, coiled coil; Ch., chromosome; C2 domain.  
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Figure 4.2 Evolutionary conservation of Cc2d2a in humans, mice and 
zebrafish 
Cc2d2a peptide sequence alignment in humans (homo sapiens, 
OTTHUMP000000217873), mice (mus musculus, ENSMUSP00000048320), 
zebrafish  (danio rerio, ENSDASP00000107405) and consensus sequence is 
shown (Multalin).  Conservation of amino acid alignment (red font).   
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Figure 4.3 Development of sentinel and transgenic sentinel:claudin-b:Lyn-GFP zebrafish embryos 
Lateral views of sentinel (snl) (A,C,E) and snl:cldn-b:GFP (B,D,F) zebrafish embryos at 24, 48 and 72 hours post fertilisation (hpf).  The 
characteristic sine wave shaped tail (*, E-F) of snl homozygous zebrafish embryos is evident at 72hpf.   
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Figure 4.4 Genotyping of sentinel zebrafish embryos 
Lateral views of presumed homozygote sentinel (snl/snl) with sine wave shaped 
tail (A) and golden uninjected wild type control (+/+ WT) (B) zebrafish 
embryos at 72hpf.  DNA was isolated from each single embryo and PCR 
performed with dCAP primers, which introduce a restriciton enzyme recognition 
site into WT embryos.  The agarose gel (C) confirms sufficient DNA for each 
sample (156 bp).  Following a restriction enzyme digest, the gel (D) shows the 
snl homozygotes have a product of 156bp, whereas WT embryos are cut and 
have a smaller product of 128bp.  This confirms the phenotype.  bp, base pairs; 
hpf, hours post fertilisation. 
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Figure 4.5 Sequencing of sentinel (snl) and uninjected wild type (WT) zebrafish embryos at 72hpf 
(A) Chromatogram of PCR product across predicted point mutation in snl mutant obtained by RT-PCR of RNA at 72 hpf. Zoomed view of 
WT and snl mutant cDNA sequencing (B) shows there was a nonsense mutation (G>A), (circled in red in each sequence), in the snl 
homozygous embryos resulting in a trytophan changing to a premature stop codon and truncation at 498 amino acids, compared to the WT 
controls.   hpf, hours post fertilisation; Lys, lysine; Ser, serine; STOP, stop codon; Trp, tryptophan. 
WT 
Trp Lys Ser 
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Figure 4.6 Phenotypes & Mortality rates of sentinel zebrafish embryos   
(A) Quantification of the percentage (%) frequency of abnormal phenotypes at 72hpf in 
embryos born from two sentinel (snl) heterozygous (het) parents (n=1254).  A sine wave 
tail phenotypically defines a snl embryo, however only 12% (n=153) of clutches of 
embryos were identified with this appearance.  The low percentage of snl homozygotes 
may account for the overall low percentage of abnormal phenotypes.  2% (n=24) had a 
non-sine wave curly tail, 3% (n=32) had cardiac oedema, 1% (n=12) had hydrocephalus, 
0.5% (n=6) had pronephric cysts and 0.2% had an abnormal eye (either coloboma or 
unilateral micropthalmia, n=2).  A cyclops appearance was not identified in any embryos.  
(B) The percentage mortality rates at 24 (n=178) and 72 (n=35) hpf are shown as mean 
and standard error of the mean in embryos born from snl het parents.  hpf, hours post 
fertilisation. 
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Figure 4.7 Phenotypes (Tail, Cardiac, Brain) in sentinel zebrafish embryos at 72hpf 
The characteristic sine wave shaped tail of sentinel (snl) mutant zebrafish is shown in (B), 
compared to the normal appearance of uninjected wild type (WT) controls (A).  The 
variable spectrum of severity of cardiac anomalies and oedema are highlighted (*) in B-D.  
Hydrocephalus is arrowed in D.    
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A WT 
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* 
snl 
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Figure 4.8 Pronephric cysts in sentinel and sentinel:claudin-b:Lyn-GFP zebrafish embryos at 72hpf 
Light and fluorescent microscopy images of the normal appearance of uninjected wild type (WT) claudin-b:Lyn-GFP (cldn-b:GFP) controls 
(A, B), compared to sentinel (snl) and sentinel:claudin-b:Lyn-GFP (snl:cldn-b:GFP) zebrafish mutant embryos.  Some snl mutants display 
proximal pronephric cysts (arrowed, lateral view (C, D), dorsal view (E); large cysts at the level of the proximal convuluted/straight tubule 
(red dotted line, F); distal pronephros (arrowed, G, H).  The variable severity of developmental deformities in the snl mutants is evident.   
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Figure 4.9 Abnormal eye development in sentinel zebrafish embryos at 72hpf 
Light microscopy, lateral and dorsal, images focusing on the eyes of an uninjected wild type (WT, A-C) and a sentinel (snl, D-G) mutant 
zebrafish embryo.  In the snl mutant embryo, there is abnormal eye development with both unilateral microphthalmia (black arrows, D-G) and a 
coloboma (red arrow, E).   
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Figure 4.10 Abnormal retinal histology in sentinel zebrafish embryos  Resin 
histology 5µm sections of the eyes of uninjected wild type (WT, A, B) and 
sentinel (snl, C, D) mutant zebrafish embryos, stained with methylene blue-
basic fuchsin stain.  A shows overview of the normal retina, with formation of 
discrete retinal layers from 72 hours post fertilisation.  B-D show that at 5 days 
post fertilisation, whilst the retinal pigmented epithelial layer is preserved in snl 
mutants (C, D), there is disorganisation of retinal development, with loss of 
definition of retinal layers. Images are taken with 20x objective (A-C) and 40x 
objective (D).  Scale bars = 20µm.     
WT A WT B 
C snl snl D 
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Figure 4.11  Reduction in number of cilia in Kupffer's vesicle in embryo from heterozygous snl zebrafish parents 
Confocal microscopy images of cldnb:Lyn-GFP wild type (WT, A-C) and those born to heterozygous sentinel:cldnb:Lyn-GFP (snl, D-F) 
parents, following fixation at the 8-10 somite stage and fluorescent immunostaining using anti-acetylated tubulin (red) to study cilia in 
Kupffer's vesicle (KV). Overlay images of KV (arrowed, scale bar = 50µm, 20x objective) in WT (A) and snl (D) embryos.  Higher 
magnification images B, C, E, F (zoom of 3, scale bar = 20µm).  Red laser shows a normally ciliated (arrowed) KV in WT (B), whilst a sparse 
number of cilia are apparent in snl (E) embryos.  In WT (C) expression of cldnb:Lyn-GFP at epithelial cell-cell junctions within KV is 
organised (C).  In this snl (F) there is no distinct delineation of KV epithelium (cldnb:Lyn-GFP), cilia are sparse (arrow). 
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Figure 4.12 Safety and Efficacy of Rapamycin therapy for use in zebrafish embryos 
Wild type (WT) and sentinel (snl, born to heterozygous snl parents) embryos were selected from the same parental pairs and exposed to four 
different media: E2, 0.05% DMSO (a solvent vehicle for Rapamycin), Rapa A (0.1µM), Rapa B (0.05µM).  There was no significant 
difference (chi-squared test) in the mortality rates of WT and snl embryos at 24 (A) and 72 (B) hpf following 24 or 72 hours exposure to the 
four different media. (continued next page) 
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Figure 4.12 (cont.) Safety and Efficacy of Rapamycin therapy for use in zebrafish embryos 
The delayed introduction of Rapamycin therapy to 24 and 48hpf (C) did not alter mortality rates.  The side effect profile of each media was 
evaluated at 72hpf in WT embryos exposed from 0hpf (D).  All embryos exposed to standard E2 media were phenotypically normal.  There was 
no significant difference in the frequency of abnormal phenotypes in WT embryos exposed to different media, however some developmental 
anomalies occurred in embryos exposed to 0.05% DMSO and increasing concentrations of Rapamycin therapy (dose-dependent).  All WT 
embryos exposed to Rapa A or B from 24hpf and 48hpf were phenotypically normal, suggesting any toxicity is associated with early exposure 
(prior to 24hpf).   No WT embryos developed an abnormal eye phenotype or pronephric cysts.  The efficacy of two doses of Rapamycin therapy 
was evaluated in snl embryos exposed from fertilisation (0hpf, E).  The timing of initiation of Rapamycin was also evaluated, in snl embryos 
exposed from 24hpf and 48hpf (F).  There was no significant difference in the percentage frequency of abnormal phenotypes of snl embryos 
treated with different doses of Rapamycin therapy and no difference introduced by varying the timing of initiation of therapy.  DMSO, dimethyl 
sulfoxide; E2, standard zebrafish embryo media; hpf, hours post fertilisation; Rapa, Rapamycin.  
Figure 4.13 Phenotypes of wild type zebrafish embryos exposed to 
Rapamycin: toxicity associated with dose and timing of onset of exposure 
Light microscopy images of wild type (WT) zebrafish embryos at 72hpf.  (A) 
shows a normal WT embryo maintained in the standard embryo media (E2) 
from 0hpf.  (B, C) show WT embryos maintained in two different doses of 
Rapamycin (Rapa B= 0.05µM, Rapa A=0.1µM) from 0hpf, the media was 
replaced every 24hpf.  B has developed gross cardiac odema (*), whilst 
exposure to a higher dose of Rapamycin (0.1µM) from 0hpf can lead to more 
severe developmental anomalies (C) including growth arrest (short tail) and a 
single otolith (arrow, C).  D is a WT embryo maintained in E2 for the first 24hpf 
prior to exposure to high dose Rapamycin (Rapa A, 0.1µM) from 24hpf.  D has 
a normal appearance (n=85), suggesting any toxicity associated with Rapamycin 
occurs during early exposure, in the inital 24hrs of development.   
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Figure 4.14 Phenotypes of sentinel zebrafish embryos exposed to 
Rapamycin from 0hpf 
Light microscopy images of sentinel zebrafish embryos at 72hpf.  (A, B) shows 
a sentinel (snl) embryo maintained in the standard embryo media (E2).  The 
characteristic sine wave tail is evident and a pronephric cyst is arrowed (A, B).  
C, D show snl embryos maintained in 0.05% DMSO (the solvent vehicle for 
Rapamycin).  D shows a snl which has developed cardiac oedema (*), a 
pronephric cyst (black arrow), a single otolith (black arrowhead) and unilateral 
microphthalmia (white arrow).  E,F show snl embryos which have been 
maintained in two different doses of Rapamycin (E, Rapa B= 0.05µM) and (F, 
Rapa A=0.1µM) from 0hpf, the media was replaced every 24hpf.  In addition to 
the characteristic sine wave shaped tail, F has developed cardiac odema (*).  
DMSO, dimethyl sulfoxide; Rapa, Rapamycin.  
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Figure 4.15 cc2d2a morpholino design 
(A) Schematic representation of zebrafish cc2d2a showing the spontaneous 
nonsense mutation, a stop codon, present in exon 14 of sentinel mutants. (B) 
Schematic representation of the splice blocking (cc2d2a ie14) morpholino 
oligonucleotide (MO) designed to mimic the spontaneous mutation in sentinels, 
by targeting the same exon (14).  (C) RT-PCR of single embryos at 24-72hpf 
following cc2d2a splice MO knockdown reveals maximal reduction of the 
normal 692bp product at 24hpf and an additional smaller product in cc2d2a 
morphants measuring approximately 500bp (white arrow). The larger band at 
800bp in all 24-48hpf embryos does not appear relevant. hpf, hours post 
fertilisation; MO, morpholino oligonucleotide; WT, wild type. 
sentinel 
nonsense 
mutation 
A 
STOP codon 
Ex1 Ex14 Ex38 
TAA 
cc2d2a 
MO 
B 
Ex1 Ex14 Ex38 
TAA cc2d2a ie14 
MO 
Symbols 
 
       Exon          Exon containing mutation          Morpholino oligonucleotide             
C 
800bp 
500bp 
24hpf 48hpf 72hpf 
100bp WT WT WT cc2d2a 
  MO 
cc2d2a 
  MO 
cc2d2a 
  MO 
~692bp 
 201
B cc2d2a MO 
* 
Figure 4.16 Phenotype with cc2d2a MO knockdown 
Lateral views of zebrafish embryos 72 hours post fertilisation.  A is an 
uninjected wild type control (WT) and is phenotypically normal.  Embryos 
injected with 6ng of cc2d2a splice MO develop a range of anomalies including: 
cardiac oedema (*); hydrocephalus (white arrows, B, C); pronephric cysts (B, 
D), altered number of otoliths (single in C, white arrowhead) and a wavy 
notochord (red arrow, D).  MO, morpholino oligonucleotide.     
A WT 
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cc2d2a MO C 
cc2d2a MO D 
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Figure 4.17 Abnormal eye development in zebrafish embryos injected with 
cc2d2a MO 
Lateral views of the head of zebrafish embryos 72 hours post fertilisation.  A is 
an uninjected wild type control (WT) and is phenotypically normal.  Embryos 
injected with cc2d2a splice MO (arrows, B-D) have abnormal eye development 
including microphthalmia or coloboma formation.  MO, morpholino 
oligonucleotide.     
A WT 
C cc2d2a MO 
B cc2d2a MO 
cc2d2a MO D 
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Figure 4.18 Mortality at 24hpf and phenotypes at 72hpf of zebrafish 
embryos following cc2d2a MO injection 
Mortality at 24hpf (A) is not significantly higher in embryos injected with 
cc2d2a MO (n=234), compared to uninjected wild type controls (n=85, p=0.31, 
chi-squared test).  The percentage mortality rises in both cc2d2a MO injected 
embryos from 15% (6ng, n=151) to 24% (4ng, n=83) and from 3% to 10% in 
matched WT embryos, however the mortality ratio of cc2d2a MO injected 
embryos relative to WT embryos falls from 5:1 (6ng) to 2.4:1 (4ng), confirming 
the dose dependent effect of increasing MO dose on mortality.  Graph B shows 
the percentage frequency of abnormal phenotypes at 72hpf in embryos injected 
with 6ng (n=150) of cc2d2a MO.  7% of embryos developed pronephric cysts 
following 6ng of cc2d2a MO.  hpf, hours post fertilisation; MO, morpholino 
oligonucleotide.     
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Figure 4.19 NPHP6 gene transcript and partial protein product structure in humans and zebrafish 
(A) NPHP6 gene transcript in humans (OTTHUMT00000406344) and schematic representation of encoded protein product, centrosomal 
protein of 290kDa (CEP290) which includes 13 coiled-coil domains (CC) and has 2479 amino acids (OTTHUMP00000242341) (B).  (C) nphp6 
gene transcript in zebrafish (OTTDART00000051136) and schematic representation of encoded protein product, cep290 
(OTTDARP00000040195), which includes 19 CC domains and has 2439 amino acids (D).  aa, amino acids; Ch., chromosome. 
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Figure 4.20 Evolutionary conservation of Nphp6 (CEP290) in humans, mice 
and zebrafish 
Nphp6 (CEP290) peptide sequence alignment in humans (homo sapiens, 
OTTHUMP00000242341), mouse (mus musculus, ENSMUSP00000130899) and 
zebrafish (danio rerio, OTTDARP00000040195).  Conservation of amino acid 
alignment (red font).  
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Figure 4.21 Design of nphp6 MO and the effect of the splice blocking MO 
at the protein level 
(A) Schematic representation of zebrafish nphp6 showing target sites of 
translation (ATG) and splice (nphp6iex42) blocking morpholino 
oligonucleotides (MO). (B) The splice blocking MO, nphp6iex42, designed to 
target exon 42, leads to abnormal splicing with inclusion of a 1227bp intron 
(red) after exon 43.  At the protein level, the intron is included after 2029 
amino acids and results in loss of 2 coiled coil domains (C).   
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Figure 4.22 Mortality at 24hpf following nphp6 MO injection 
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) 
and standard error of the mean (where appropriate) in zebrafish embryos 
injected with a range of morpholino oligonucleotide (MO) doses.  Matched 
uninjected wild type (WT) controls are shown.  Both nphp6 splice (A) and 
nphp6 translation blocking (B) MO induce a dose dependent effect on 
mortality.  For the splice blocking MO (A), total numbers of embryos at 24hpf 
were 547 from 7 pairs (6ng), 342 from 3 pairs (4ng) and 73 from 1 pair (2ng).  
For the translation blocking MO (B), total numbers of embryos at 24hpf were 
430 from 4 pairs (2ng) and 303 from 2 pairs (1ng).   
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Figure 4.23 Phenotype with nphp6 MO knockdown 
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type (WT) uninjected control embryos are phenotypically normal (A).   
Embryos injected with nphp6 translation (B, C) and splice (D, E) blocking MO develop hydrocephalus (black arrows), cardiac oedema (*), 
curved body axis (C-E) and altered number of otoliths (none, black arrowhead, E).  MO, morpholino oligonucleotide.     
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Figure 4.24 nphp6 MO knockdown induces pronephric cysts in zebrafish 
embryos 
Lateral views of pronephric cysts (black arrowheads) in nphp6 morphants at 72 
hours post fertilisation (B-E).  (A) is a phenotypically normal uninjected wild 
type (WT) control embryo.  nphp6 morphants develop proximal (B-C), distal 
(D) and cloacal (E) pronephric cysts.  The cloaca in E is very dilated and 
distorted, this embryo also has hydrocephalus and a single otolith.     
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nphp6 D 
nphp6 E 
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Figure 4.25 Abnormal eye and ear development following nphp6 MO knockdown 
Views of the head of zebrafish embryos at 72 hours post fertilisation, focusing on the otic vesicles (A-D) and eyes (A, E-H).  Wild type (WT) 
uninjected control embryos have normal eyes of equal size and two otoliths in each otic vesicle (green arrows, A).   Lateral views of embryos 
injected with nphp6 MO show abnormal ear development with either an empty otic vesicle (black arrow, B-C) or a single otolith (red arrow, 
D).  Abnormal eye development includes unilateral microphthalmia (black arrowheads, lateral (E) and dorsal (F) views) and coloboma 
formation (red arrowheads, lateral (G) and ventral (H) views) in nphp6 morphants.  MO, morpholino oligonucleotide.  
A WT B nphp6  C nphp6  D nphp6  
nphp6  E F nphp6  G nphp6  nphp6  H 
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Figure 4.26 Quantification of abnormal phenotypes at 72hpf following 
injection with nphp6 splice or translation blocking MO 
Data are displayed as mean ± SEM. The percentage frequency of each abnormal 
phenotype was higher following nphp6 splice (Sp) MO (B) knockdown, 
compared to following nphp6 translation (ATG) MO (A) knockdown.  There 
was a dose dependent effect on the frequency of each abnormal phenotype.  The 
total number of zebrafish embryos phenotyped at 72hpf following each dose of 
nphp6 ATG MO was 236 (2ng) and 158 (1ng) (A).  The total number of 
zebrafish embryos phenotyped at 72hpf following each dose of nphp6 Sp MO 
were 84 (8ng), 216 (6ng) and 261 (4ng).  MO, morpholino oligonucleotide.             
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Figure 4.27 Evidence of nphp6 splice MO knockdown by RT-PCR and 
direct sequencing 
(A) RT-PCR of single embryos at 24hpf following nphp6 splice MO knockdown 
reveals an additional larger RT-PCR product (circled in white), compared to 
uninjected wild type (WT) control embryos, which only have the normal RT-
PCR product of 309bp.  (B) Direct sequencing (data not shown) confirmed the 
identity of the larger product in nphp6 morphants which included  intronic 
sequence after exon 43, confirming abnormal splicing. hpf, hours post 
fertilisation. 
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Figure 4.28  Shorter cilia in Kupffer's Vesicle of nphp6 MO injected zebrafish embryos 
Confocal microscopy images of cldb:Lyn-GFP wild type (WT, A-C) and nphp6 MO injected (D-F) zebrafish embryos following 
fixation at the 8-10 somite stage and fluorescent immunostaining using anti-acetylated tubulin (AT, red, B, E) antibody to label cilia.  
Cilia appear shorter and of a reduced number in KV of nphp6 MO injected embryos (E-F), compared to uninjected WT (B-C).  
Images were taken with a 20x objective, zoom of 3.  Scale bars = 20 µm.  KV, Kupffer's vesicle; MO, morpholino oligonucleotide.  
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Figure 4.29 Analysis of cardiac looping reveals laterality defects in nphp6 
morphants at 56hpf 
Quantification of orientation of cardiac looping at 56hpf in zebrafish embryos 
(A) reveals there is a significant reduction in the normal rightward cardiac 
looping (D-looping) in nphp6 morphants (n=11, *, p < 0.0001, chi squared test), 
compared to uninjected wild type (WT) controls (n=79).  (B) Stacked bar chart 
showing the percentage frequency of cardiac looping orientation in each 
experimental group.  In the WT embryos, 99% (n=79) have D-looping and 1% 
(n=1) L-looping, compared to nphp6 morphants in which 15% (n=11) have D-
looping, 5% (n=4) have No looping and 80% (n=59) have L-looping.  hpf, hours 
post fertilisation. 
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Figure 4.30  Cilia in the distal pronephros and cloaca of nphp6 morphant 
zebrafish embryos 
Confocal microscopy images of claudinb:Lyn GFP zebrafish embryos 
following fixation at 72hpf and immunostaining with anti-acetylated tubulin 
antibody (AT, red) to identify cilia.  Uninjected wild type control (WT, A-C) 
embryos have cilia (white arrows, B) lining the pronephros which meet in 
apposition at the cloaca (A, C).  In nphp6 morphants, cilia are present in the 
distal pronephros, however reduce in number/disappear as the cloaca is 
approached (white circle, E, F).  G-I show a cross sectional view of a dilated 
cloaca in an nphp6 morphant with what appears to be short cilia.  Images were 
taken with a 20x objective and zoom of 3.  Scale bars = 20 µm.   
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Figure 4.31 MKS3 gene transcript and partial protein product structure in humans and zebrafish 
(A) MKS3 gene transcript in humans (OTTHUMT00000329641) has 28 exons and schematic representation of encoded protein product, 
Meckelin which includes 4 transmembrane domains (TM) and has 995 amino acids (OTTHUMP00000203157) (B).  (C) mks3 gene transcript 
in zebrafish (OTTDART00000042166) has 28 exons and schematic representation of encoded protein product, meckelin 
(OTTDARP00000033569), which has 5 TM domains and 982 amino acids (D).  aa, amino acids; Ch., chromosome. 
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Figure 4.32 Evolutionary conservation of Mks3 protein, Meckelin, in 
humans, mice and zebrafish 
Meckelin peptide sequence alignment in humans (homo sapiens, 
ENSP00000389998), mice (mus musculus, ENSMUSP00000103928) and 
zebrafish (danio rerio, ENSDARP00000116688).  Conservation of amino acid 
alignment (red font).  
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Figure 4.33 Design of mks3 splice blocking MO and the effect at the protein 
level 
(A) Schematic representation of zebrafish mks3 showing the target site of the 
splice blocking MO is exon 4 (mks3ei4).  Knockdown with mks3 MO leads to 
abnormal splicing with inclusion of a 165bp intron (red) after exon 3 (B).  At the 
protein level, this leads to an alternative reading frame after 125 amino acids 
and a premature stop codon after 144 amino acids, resulting in a truncated 
protein with loss of 4 transmembrane domains (C).  MO, morpholino 
oligonucleotide. 
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Figure 4.34 Evidence of mks3 splice MO knockdown by RT-PCR and direct sequencing 
(A) RT-PCR of single zebrafish embryos at 24hpf following mks3splice MO knockdown reveals an additional larger RT-PCR product (circled in 
white), compared to uninjected wild type (WT) control embryos, which only have the normal RT-PCR product of 390bp.  (B) Direct sequencing 
of the larger product (555bp) in mks3 morphants identifies that it includes the intron (165bp) situated after exon 3, as a result of abnormal 
splicing. bp, base pairs; hpf, hours post fertilisation; mks3cDNA, reference mks3 cDNA sequence; MO, morpholino oligonucleotide.    
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Figure 4.35 Mortality at 24hpf following mks3 MO injection 
Mortality at 24 hours post fertilisation (hpf) is shown as mean percentage (%) 
and standard error of the mean in zebrafish embryos injected with two different 
doses of morpholino oligonucleotide (MO).  Matched uninjected wild type 
(WT) controls are shown.  There is a dose dependent effect on mortality 
associated with mks3 MO injection.  The total numbers of embryos at 24hpf 
were 837 from 12 pairs (4ng) and 968 from 16 pairs (2ng).   
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Figure 4.36 mks3 knockdown induces pronephric and cloacal cysts leading to obstruction of the cloaca 
Lateral views of zebrafish embryos 72 hours post fertilisation (A-F).  Wild type (WT) uninjected control embryos are normal (A).   Embryos 
injected with mks3 MO develop pronephric cysts both proximally (arrow, B-D) and distally at the cloaca (arrow E, arrowhead F).  The cloacal 
cyst (E) appears to cause outflow obstruction as there is marked associated cardiac oedema (*).  The large cloacal cyst (arrowhead F) leads to 
proximal cystic dilatation of the pronephros (arrows).  Resin histology 5µm sections through the pronephros (arrows) at 5 days (G-H) reveals 
dilatation in mks3 morphants (diameter 29.2-29.7µm, H), compared to WT controls (diameter 9.7-13.6µm, G).  Scale bars = 20µm.  Stained 
with methylene blue-basic fuchsin stain.  MO, morpholino oligonucleotide. 
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Figure 4.37 mks3 knockdown induces hydrocephalus and abnormal brain development in zebrafish embryos 
Lateral views of zebrafish embryos at 72hpf (A-F).  Wild type (WT) uninjected control embryos are normal (A).   Embryos injected with mks3 
MO develop hydrocephalus (arrows, B-F).  Resin histology 5µm sections through the brain at 5dpf (G-H) reveals an encephalocele in mks3 
morphants (arrow, H) compared to WT controls (G).  Scale bars = 20µm.  Stained with methylene blue-basic fuchsin stain.  dpf, days post 
fertilisation; hpf, hours post fertilisation; MO, morpholino oligonucleotide.  
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Figure 4.38 mks3 knockdown induces notochord defects and abnormal tail 
development in zebrafish embryos 
Lateral views of zebrafish embryos 72hpf (A-F).  Wild type (WT) uninjected 
control embryos are normal (A).   Embryos injected with mks3 MO (B-I) 
develop abnormal, wavy notochords (B-E), in severe cases the notochord 
projects dorsally to the skin surface (B).  mks3 morphants also have abnormal 
tail development (F-I), with disruption of myotome and fin layers (arrows), 
possibly representative of human meningoceles.  hpf, hours post fertilisation; 
MO, morpholino oligonucleotide. 
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Figure 4.39 Abnormal ear and eye development following mks3 MO knockdown 
Views of the head of zebrafish embryos at 72 hours post fertilisation, focusing on the otic vesicles (A-F) and eyes (A, B, G, H).  Wild type 
(WT) uninjected control embryos have normal eyes of equal size and two otoliths in each otic vesicle (black arrows, A, B).  mks3 morphants 
show abnormal ear development with either a single otolith (black arrow, lateral and dorsal views, C-D), unilateral empty otic vesicle (black 
arrow, E, H) or 3 otoliths in an otic vesicle (black arrows, F).  Abnormal eye development with unilateral microphthalmia (red arrows, G-H) is 
also seen in mks3 morphants.  MO, morpholino oligonucleotide. 
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Figure 4.40  Quantification of abnormal phenotypes at 72hpf following 
injection with mks3 splice blocking MO 
Data are displayed as mean ± SEM.  Following injection with 2-4ng of mks3 
splice blocking MO, there was a dose dependent effect on the percentage 
frequency of each abnormal phentoype (A).  The total number of zebrafish 
embryos phenotyped at 72hpf following mks3 MO injection of: 2ng was 325 
and 4ng was 233.  hpf, hours post fertilisation; MO, morpholino 
oligonucleotide.   
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Figure 4.41 Rescue of mks3 morphant phenotype by co-injection of mks3 
MO with human MKS3 mRNA 
Lateral views of zebrafish embryos 72 hours post fertilisation.  Wild type 
uninjected (A) and embryos injected with 50-100pg of human MKS3 mRNA 
alone (B) were morphologically normal.  Partial (C) and complete (D) rescue of 
embryos co-injected with mks3 MO and 50-100pg of human MKS3 mRNA.  A 
small notochord defect is arrowed in C.  MO, morpholino oligonucleotide.    
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Figure 4.42 Quantification of Rescue of mks3 morphant phenotype 
(A) Raw quantification of overall rescue from a morphant phenotype to a 
normal, wild type appearance in embryos co-injected with 50-100pg of human 
MKS3 mRNA and 2-4ng of mks3 MO (n=318).  The degree of rescue to the 
normal wild type phenotype was just significant (*, p=0.052, chi-squared test).  
The total number of embryos injected with 2-4ng of mks3 MO alone was 691.  
(B) Percentage of each phenotype shown as mean ± SEM, in embryos injected 
with 2-4ng of mks3 MO alone, compared to those co-injected with 50-100pg 
human MKS3 mRNA.  There was a significant degree of rescue to the wild type 
phenotype and reduction of each abnormal phenotype following co-injection 
with MKS3 mRNA (*, p=0.0058, chi-squared test).  MO, morpholino 
oligonucleotide. 
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Figure 5.1 Phenotypes following combination of nphp6 MO knockdown in 
sentinel (snl) zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Uninjected 
sentinel (snl, A) zebrafish embryos have a characteristic sine wave shaped tail.  
B is a wild type (not snl) embryo injected with nphp6 MO which has a ventrally 
curved tail, hydrocephalus, cardiac oedema and empty otic vesicle (black 
arrowhead).  Combination of nphp6 MO knockdown in snl embryos (C, D) 
induces a range of abnormal phenotypes including wavy notochord (C), cardiac 
oedema, hydrocephalus, dorsal curly tail (D) and delayed development of 
otoliths in the otic vesicle (black arrowhead, D).  snl embryos additionally co-
injected with nphp6 and p53 MOs (E) continue to develop an aberrant 
phenotype with dorsal curly tail, cardiac oedema, hydrocephalus and unilateral 
microphthalmia (red arrow), excluding the possibility of the combination 
resulting from an off-target effect.  MO, morpholino oligonucleotide.      
A snl 
B nphp6 MO nphp6 MO+snl C 
nphp6 MO+snl D E nphp6+p53 MOs+snl 
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Figure 5.2 Pronephric cysts and abnormal eye and ear development 
following combination of nphp6 MO knockdown in sentinel (snl) zebrafish 
embryos 
Cropped views of snl zebrafish embryos at 72 hours post fertilisation, focusing 
on the proximal pronephros (A, D, G), eyes (B, E, H) and  otic vesicles (C, F, 
I).  Compared to uninjected snl embryos (A-C), snl embryos injected with 
nphp6 MO develop pronephric cysts (red arrows, D, G), colobomas (black 
arrows, E, H) and fewer otoliths in the otic vesicle (single, black arrowhead, F, 
I(dorsal view)).  MO, morpholino oligonucleotide.    
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Figure 5.3 Mortality at 24hpf following combination of nphp6 MO 
knockdown in sentinel (snl) zebrafish embryos 
Mortality at 24hpf is shown as mean percentage (%) and standard error of the 
mean in snl zebrafish embryos alone, wild type zebrafish embryos injected with 
4-6ng nphp6 MO alone and snl embryos injected with 4-6ng nphp6 MO (A).  
The mean 24hpf mortality is similar in snl zebrafish embryos alone (24%), wild 
type embryos injected with 4ng nphp6 MO alone (22%) and snl embryos 
injected with 4ng nphp6 MO (23%).  Injection of 6ng of nphp6 MO alone is 
associated with a much higher 24hpf mortality of 49% and in snl embryos this 
rises to 70%.  hpf, hours post fertilisation.  MO, morpholino oligonucleotide.   
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Figure 5.4 Percentage frequency of abnormal phenotypes at 72hpf 
following combination of nphp6 MO knockdown in sentinel (snl) zebrafish 
embryos 
Data are displayed as mean ± SEM.  A emphasises the range of phenotypes in 
each group of zebrafish embryos.  B highlights the effect of the individual 
genes (cc2d2a in snl; nphp6 MO) and gene combinations on the frequency of 
abnormal phenotypes.  The percentage frequency of each abnormal phenotype 
increases in a dose dependent manner following 4-6ng of nphp6 MO 
knockdown alone (2-42%) and is generally low (1-11%) in snl embryos alone 
(A).  The frequency of abnormal phenotypes following 6ng of nphp6 MO alone 
is similar to the cumulative effect of 4ng of nphp6 MO in snl embryos (B).  The 
cumulative effect of 4 or 6ng of nphp6 MO in snl zebrafish embryos has a 
synergistic effect on each abnormal phenotype except for hydrocephalus in snl 
embryos injected with 6ng of nphp6 MO (B).  The total numbers of embryos 
were 321 (snl zf), 261 (4ng nphp6 MO), 216 (6ng nphp6 MO), 144 (snl zf+4ng 
nphp6 MO) 43 (snl zf+6ng nphp6 MO).  hpf, hours post fertilisation; SEM, 
standard error of the mean; zf, zebrafish.  MO, morpholino oligonucleotide.  
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Figure 5.5 Hydrocephalus and pronephric cysts following combination of ahi1 MO knockdown in sentinel (snl) zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Uninjected sentinel (snl, A) zebrafish embryo with cardiac oedema (*) and 
characteristic sine wave shaped tail.  B-I are snl embryos injected with ahi1 MO and display a range of abnormal phenotypes including 
hydrocephalus (black arrowhead C-E, G) and pronephric cysts (red arrow B, D-I).  A pronounced dorsal sine wave shaped tail is seen in D.  
MO, morpholino oligonucleotide.         
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Figure 5.6 Abnormal eye and ear development following combination of 
ahi1 MO knockdown in sentinel (snl) zebrafish embryos 
Cropped views of snl zebrafish embryos at 72 hours post fertilisation, focusing 
on the eyes and otic vesicles.  Compared to uninjected snl embryos which 
predominantly have normal eyes and 2 otoliths in each otic vesicle (A), snl 
embryos injected with ahi1 MO have abnormal development of the eyes (black 
arrowheads) and rudimentary ear (red arrow) (B-F).  (B) A coloboma and 
empty otic vesicle, (C) coloboma and single otolith, (D) coloboma.  E and F are 
lateral and dorsal views of an embryo with unilateral microphthalmia of the 
right eye (black arrowhead, F).  MO, morpholino oligonucleotide.    
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Figure 5.7 Mortality at 24hpf following combination of ahi1 MO 
knockdown in sentinel (snl) zebrafish embryos 
Mortality at 24hpf is shown as mean percentage (%) and standard error of the 
mean (SEM) in snl zebrafish embryos alone and snl embryos injected with 0.5-
2ng of ahi1 MO (A).  The mean 24hpf mortality is only 4.8% ± 1.4% in snl 
zebrafish embryos alone and rises in a predominantly dose dependent manner 
when snl embryos are injected with: 0.5ng ahi1 MO (27% ± 4.9%), 1ng ahi1 
MO (26.3% ± 7.4%) and 2ng ahi1 MO (49.3% ± 4.8%).  MO, morpholino 
oligonucleotide.    
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Figure 5.8 Percentage frequency of abnormal phenotypes following combination of ahi1 MO knockdown in sentinel (snl) zebrafish 
embryos 
The mean and SEM frequency of abnormal phenotypes for snl zebrafish embryos alone (white bars, n=933), wild type (WT) embryos injected 
with 0.5ng ahi1 MO alone (green striped bars, n=58), 1ng ahi1 MO alone (black striped bars, n=793), 2ng ahi1 MO alone (red striped  bars, 
n=517) and the combination of snl embryos injected with 0.5ng ahi1 MO (green bars, n=246), 1ng ahi1 MO (black bars, n=291) and 2ng ahi1 
MO (red bars, n=105) are shown.  The mean frequency of abnormal phenotypes is low (0-14%) in snl embryos alone (white bars) and WT 
embryos injected with 0.5ng ahi1 MO alone (green striped bars).  There is a synergistic and dose dependent increase in abnormal phenotypes 
when 0.5-2ng of ahi1 MO is injected into snl embryos.  MO, morpholino oligonucleotide.     
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F ahi1+cc2d2a+p53 MO 
Figure 5.9 Phenotypes following combination of low dose ahi1 and cc2d2a MO knockdown in zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Wild type (WT) zebrafish embryos injected with a low dose of ahi1 MO (0.5ng, A) and 
cc2d2a MO (4ng, B) alone showed minimal cardiac oedema (*, A) or were phenotypically normal.  WT zebrafish embryos co-injected with low dose 
ahi1 (0.5ng) and cc2d2a (2ng) MOs develop abnormal phenotypes, which persist when also co-injected with p53 MO (to exclude off-target effects, C-F).  
The range of abnormal phenotypes following co-injection of low dose ahi1 and cc2d2a MOs includes: cardiac oedema (*, D, E); hydrocephalus (black 
arrowhead, C-F); curved body axis (D, E); pronephric cysts (red arrow E); coloboma (black arrow, G); single otolith (green arrow, F, G).  MO, 
morpholino oligonucleotide.   
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Figure 5.10  Percentage frequency of abnormal phenotypes following 
combined MO knockdown using 0.5ng ahi1 and 4ng cc2d2a in zebrafish 
embryos and associated mortality at 24hpf 
Low dose (0.5ng) ahi1 MO alone (black bars, n=58) and 4ng cc2d2a MO alone 
(green bars, n=96) induce a low frequency (≤5%) of abnormal phenotypes (B).  
The combined MO knockdown of 0.5ng ahi1 and 4ng cc2d2a (red bars, n=10) 
leads to a synergistic increase in the frequency of development of each abnormal 
phenotype (B).  Mortality at 24hpf (A) is shown as mean percentage (%) and 
standard error of the mean (where possible) in zebrafish embryos following: 
0.5ng of ahi1 MO alone, 4ng cc2d2a MO alone and co-injection of 0.5ng ahi1 
MO + 4ng cc2d2a MO.  hpf, hours post fertilisation; MO, morpholino 
oligonucleotide. 
cu
rly
 ta
il
ca
rd
ia
c 
oe
de
m
a 
hy
dr
oc
ep
ha
lu
s
pr
on
ep
hr
ic 
cy
st
s
ab
n.
 e
ye
ot
ic 
de
fe
ct
0
25
50
75
100 0.5ng ahi1 MO
4ng cc2d2a MO
0.5 ahi1+4ng cc2d2a
Phenotypes
%
 278
A 
B 
Figure 5.11  Mortality at 24hpf and percentage frequency of abnormal 
phenotypes following combined ahi1, cc2d2a and p53 MO knockdown in 
zebrafish embryos 
(A) Mortality at 24hpf is shown as mean percentage (%) and standard error of 
the mean (where possible) in zebrafish embryos following: 0.5ng of ahi1 MO 
alone, 4ng cc2d2a MO alone and co-injection of 0.5ng ahi1 MO, 2ng cc2d2a 
MO and 2ng p53 MO.  Mortality in uninjected WT matched for each MO 
experiment are shown (white bars).  Low dose (0.5ng) ahi1 MO alone (black 
bars, n=58) and 4ng cc2d2a MO alone (green bars, n=96) induce a low 
frequency (<5%) of abnormal phenotypes (B).  The combined MO knockdown 
of 0.5ng ahi1, 2ng cc2d2a and 2ng p53 MO leads to a synergistic increase in the 
frequency of each abnormal phenotype (B, red bars, n=53). hpf, hours post 
fertilisation; MO, morpholino oligonucleotide; WT, wild type. 
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Figure 5.12  Effect of gene dosage on the frequency of abnormal phenotypes following combined ahi1 and cc2d2a MO knockdown in 
wild type zebrafish embryos 
Low dose (0.5ng) ahi1 MO alone (black bars, n=58) and 4ng cc2d2a MO alone (green bars, n=96) induce a low frequency (≤5%) of abnormal 
phenotypes.  Combination of 0.5ng ahi1, with a lower dose (2ng) cc2d2a and 2ng p53 MO leads to a synergistic increase in the frequency of 
abnormal phenotypes (red checked bars, n=53).  Combination injection with an additional 2ng cc2d2a MO and without p53 MO further 
increases the frequency of aberrant phenotypes (red bars, n=10). MO, morpholino oligonucleotide. 
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Figure 5.13 Phenotypes following combination of low dose ahi1 and nphp6 MO knockdown in zebrafish embryos 
Lateral views of zebrafish embryos at 72 hours post fertilisation.  Golden zebrafish embryos injected with a low dose of ahi1 MO (0.5ng, A) and nphp6 
MO (2ng, B) alone were phenotypically normal.  Golden zebrafish embryos co-injected with low dose ahi1 and nphp6 MOs (C, D, F, G) develop 
abnormal phenotypes, which persist when also co-injected with p53 MO (to exclude off-target effects, E).  The range of abnormal phenotypes seen 
following co-injection of ahi1 and nphp6 MOs includes: hydrocephalus (black arrowhead C, E, F, G); curved body axis (C, E, F); cardiac oedema (C-
G); pronephric cysts (red arrowhead D, G); coloboma (black arrow C); unilateral microphthalmia (green arrow G); empty otic vesicle (red arrow F, G) 
and single otolith (red arrow D).  MO, morpholino oligonucleotide. 
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A ahi1 MO  
B nphp6 MO 
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Figure 5.14  Percentage frequency of abnormal phenotypes following 
individual and combined ahi1 and nphp6 (±p53) MO knockdown in 
zebrafish embryos 
0.5ng ahi1 MO alone induces a low frequency of abnormal phenotypes and no 
pronephric cysts, developmental eye or ear abnormalties (black bars, A-B, 
n=58).  2ng of nphp6 MO alone does not induce any developmental anomalies 
(green bars, A-B, n=64).  Combined MO knockdown using 0.5ng ahi1 and 2ng 
nphp6 leads to a synergistic increase in the frequency of each abnormal 
phenotype (red bars, A, n=19).  B shows the synergistic increase in the 
frequency of abnormal phenotypes when 2ng p53 MO is combined with 0.5ng 
ahi1 and 2ng nphp6 MOs (red/white checked bars, n=26). MO, morpholino 
oligonucleotide. 
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Figure 5.15  Mortality rates at 24hpf following combined ahi1 and nphp6 ± 
p53 MO knockdown compared to matched uninjected zebrafish embryos 
Data are shown as mean percentage (%) and standard error of the mean.  
Mortality rates are increased following combined MO injections.  Mortality at 
24hpf following injection of 0.5ng ahi1 and 2ng nphp6 MO (black bar) is 72.5% 
(1.7 times) compared to 41.5% in matched uninjected WT embryos (white bar).  
Mortality at 24hpf following injection of 2ng p53 MO in combination with 0.5ng 
ahi1 and 2ng nphp6 MO (black/white checked bar) is 68% (1.1 times) compared 
to 59.5% in matched uninjected WT embryos (white spotted bar).  comb, 0.5ng 
ahi1+2ng nphp6; MO, morpholino oligonucleotide; WT, wild type. 
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Figure 5.16  Percentage frequency of abnormal phenotypes and mortality 
at 24hpf following combined ahi1 and nphp6 MO knockdown in zebrafish 
embryos 
Injection of 0.5ng ahi1 MO alone induces a low frequency of abnormal 
phenotypes and no pronephric cysts, developmental eye or ear abnormalties 
(black bars, A, n=58).  2ng of nphp6 MO alone does not induce any 
developmental anomalies (green bars, A, n=64).  Combined MO knockdown 
using 0.5ng ahi1 and 2ng nphp6 ±2ng p53 MO (red bars, A, n=45) leads to a 
synergistic increase in the frequency of each abnormal phenotype.  Mortality at 
24hpf is shown (B) as mean percentage (%) and standard error of the mean in 
zebrafish embryos following: 0.5ng of ahi1 MO alone, 2ng nphp6 MO alone 
and co-injection of 0.5ng ahi1 MO + 2ng nphp6 MO ± 2ng p53 MO (B).  
Mortality rates in uninjected WT embryos matched for each group (white bars).  
MO injections are associated with a relative increase in 24hpf mortality rates.  
hpf, hours post fertilisation; MO, morpholino oligonucleotide; WT, wild type. 
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